data_5owi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5owi _Structure_validation_residue.Date_analyzed 2017-11-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 24' ' ' ILE . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.493 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' B' ' 317' ' ' GLN . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.402 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' HD11 ' A' ' 53' ' ' ILE . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.609 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.4 mm100 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.424 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.437 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.551 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.45 HG12 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.544 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.537 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.428 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.74 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.508 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.495 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.407 HD13 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 28' ' ' VAL . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 24' ' ' ILE . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.405 ' HD2' HD11 ' B' ' 53' ' ' ILE . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.405 HD11 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.436 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.436 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.429 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . 0.429 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.463 HG11 HG12 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.491 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.431 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.439 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.455 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.423 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.497 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.446 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.463 HG12 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.41 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.41 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.482 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.483 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . 0.448 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.556 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.548 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . 0.423 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.425 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.554 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.471 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . 0.471 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.731 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . 0.493 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.439 ' O ' HG21 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.439 HG21 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.656 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' HD13 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.499 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' HG12 ' A' ' 79' ' ' ILE . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 76' ' ' ILE . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.432 HG12 HD21 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.722 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.45 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.432 HD21 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.432 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.432 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 261' ' ' GLY . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.402 ' H ' ' CG ' ' A' ' 260' ' ' ASP . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.461 HD23 HD11 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.441 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' A' ' 343' ' ' ARG . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.485 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.456 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.48 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.412 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.491 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.491 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.456 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.485 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.424 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.432 ' HD2' HD13 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.722 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.486 ' O ' HG22 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.418 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.441 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . 0.421 HG12 HD21 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.763 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . 0.421 HD21 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.497 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.497 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.439 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.432 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . 0.413 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.464 HD23 HD11 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.455 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.514 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.563 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.451 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.41 ' O ' HG22 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.451 HG21 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . 0.476 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.547 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.441 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.444 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' HA ' HH12 ' A' ' 45' ' ' ARG . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.409 HG21 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' CG ' ' HZ1' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.562 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.562 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.414 HG12 HD21 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB1' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.428 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.644 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.428 ' O ' ' HE2' ' A' ' 189' ' ' MET . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.542 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.423 ' HB3' ' HZ2' ' A' ' 238' ' ' LYS . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 . . . . . 0 C--O 1.239 0.507 0 N-CA-C 111.339 0.126 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.437 ' O ' HG21 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.41 ' CG1' HG13 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.509 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.463 HE21 HD13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.407 HE21 HG12 ' B' ' 62' ' ' VAL . 24.9 tm0? -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.482 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.426 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 355' ' ' ILE . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.523 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.598 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.545 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' H ' ' B' ' 20' ' ' ALA . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.408 ' H ' ' HB ' ' B' ' 19' ' ' ILE . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.513 ' O ' HG21 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.504 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.463 HD13 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.449 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.644 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.467 ' O ' HG21 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.467 HG21 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.437 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . 0.453 ' CG ' ' HZ1' ' B' ' 146' ' ' LYS . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . 0.453 ' HZ1' ' CG ' ' B' ' 142' ' ' ASP . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' ' 143' ' ' THR . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . 0.426 HG12 HD21 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.448 ' HB1' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.677 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 208' ' ' GLY . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 206' ' ' LYS . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.547 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.547 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' B' ' 238' ' ' LYS . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' B' ' 238' ' ' LYS . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.436 ' O ' HG21 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.436 HG21 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.416 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.474 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.509 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . 0.461 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.465 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.405 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.459 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.459 HG22 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.402 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.561 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.68 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.429 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' HG11 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.575 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.5 ' HE1' ' O ' ' A' ' 199' ' ' GLU . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.5 ' O ' ' HE1' ' A' ' 189' ' ' MET . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.501 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.406 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.0 p-10 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.485 ' O ' HG21 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.406 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.406 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.511 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.414 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.501 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.511 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.426 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.426 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.497 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 401' ' ' VAL . 20.9 t-20 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.575 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.403 ' C ' ' H ' ' A' ' 430' ' ' GLN . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 428' ' ' MET . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.441 ' O ' HG22 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.414 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.515 ' O ' HG22 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.515 HG22 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.443 HG12 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.61 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.552 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.552 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' MET . . . . . 0.482 ' HE1' ' O ' ' B' ' 199' ' ' GLU . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.426 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . 0.482 ' O ' ' HE1' ' B' ' 189' ' ' MET . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.42 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 6.0 p-10 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.469 ' HB3' ' HZ1' ' B' ' 238' ' ' LYS . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.515 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.502 ' O ' HG21 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.633 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.502 HG21 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . 0.439 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . 0.439 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.651 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.651 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.455 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . 0.416 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.408 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.445 ' HG3' HD12 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.455 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' HG22 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.564 HG22 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.575 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.464 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.479 ' O ' HG21 ' B' ' 401' ' ' VAL . 20.5 t-20 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.454 ' O ' HG21 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.454 HG21 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.528 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.597 HG23 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' H ' HG23 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB2' ' ND2' ' B' ' 397' ' ' ASN . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.48 ' O ' HG21 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG22 ' NH2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.564 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' NH1' ' HB3' ' B' ' 191' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.55 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 142' ' ' ASP . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.648 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.443 ' CG ' ' HZ1' ' A' ' 238' ' ' LYS . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.553 ' HB2' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.633 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.513 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.569 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.5 p-10 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.569 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.633 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HZ1' ' CG ' ' A' ' 167' ' ' ASP . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.806 0.336 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.422 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.49 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.41 ' HG2' HG23 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.529 ' HZ3' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.49 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.46 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.411 ' O ' HG21 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.588 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.527 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' B' ' 38' ' ' LYS . 18.7 t-20 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.535 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.593 HG23 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.593 ' H ' HG23 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HB2' HD21 ' A' ' 397' ' ' ASN . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.482 ' O ' HG21 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.44 HG22 ' NH2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.533 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.489 HG22 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.412 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.412 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.4 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.61 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.428 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.528 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . 0.552 ' HB2' ' NH1' ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . 0.583 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.486 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.608 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.438 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.552 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' SER . . . . . 0.511 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.511 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.427 ' O ' HG22 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . 0.413 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.446 HG12 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . 0.473 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.442 HD21 HD11 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.44 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.459 ' NH1' HD12 ' B' ' 330' ' ' LEU . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.493 ' HZ3' ' HB2' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.459 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.433 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . 0.404 ' O ' HG22 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.415 ' O ' HG21 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.437 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.533 HG22 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . 0.412 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . 0.535 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.565 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 38' ' ' LYS . 19.8 t-20 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.428 ' O ' HG21 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . 0.428 HG21 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 35' ' ' VAL . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 31' ' ' GLU . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.446 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.405 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.537 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HZ1' ' HB3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.412 ' O ' HD21 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.523 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.606 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.6 mm100 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.462 HD13 ' HH ' ' A' ' 221' ' ' TYR . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.427 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 205' ' ' HIS . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.443 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.434 ' HD1' ' HA ' ' A' ' 202' ' ' ILE . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.526 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.467 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.462 ' HH ' HD13 ' A' ' 195' ' ' ILE . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.4 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.454 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.454 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 259' ' ' GLU . 3.3 mp0 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 120.517 0.199 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' A' ' 285' ' ' ARG . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.442 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.421 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.521 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HG3' HD11 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.433 HH21 ' HD2' ' A' ' 366' ' ' ARG . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.431 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.61 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' B' ' 38' ' ' LYS . 26.8 t-20 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.442 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.523 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.449 HD21 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.559 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.439 ' HA ' HD22 ' A' ' 397' ' ' ASN . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.421 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.433 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.457 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.427 ' CG ' ' HZ3' ' B' ' 81' ' ' LYS . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HZ3' ' CG ' ' B' ' 77' ' ' ASP . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.454 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . 0.449 ' O ' HD21 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.448 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.544 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.5 mm100 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . 0.405 HG21 HG22 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . 0.443 ' HB1' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.475 HD13 ' HH ' ' B' ' 221' ' ' TYR . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.423 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.467 ' HA ' ' HD1' ' B' ' 205' ' ' HIS . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.443 ' HE3' ' HB1' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.467 ' HD1' ' HA ' ' B' ' 202' ' ' ILE . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.669 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.475 ' HH ' HD13 ' B' ' 195' ' ' ILE . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.669 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.405 HG22 HG21 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.536 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . 0.447 ' C ' ' HG1' ' B' ' 249' ' ' THR . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.447 ' HG1' ' C ' ' B' ' 248' ' ' LEU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.469 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.58 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.58 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.463 HD11 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . 0.431 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.477 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.431 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.459 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.433 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.446 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.629 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.544 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . 0.491 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 14' ' ' ARG . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' B' ' 397' ' ' ASN . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG23 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.402 ' O ' HD21 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG22 HD13 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.1 mm100 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.468 ' C ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.602 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.602 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.485 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.487 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.421 HD13 HG22 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.562 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.486 ' HG3' HD11 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.436 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 343' ' ' ARG . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.59 HD21 ' HB2' ' B' ' 38' ' ' LYS . 12.1 t-20 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.405 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 397' ' ' ASN . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.419 ' HA ' HG23 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.468 ' HG2' ' C ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.545 HG22 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.483 ' O ' HG21 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.483 HG21 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.469 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . 0.462 HG22 HD13 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.459 ' C ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.597 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.597 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.432 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.494 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.515 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.462 HD13 HG22 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.434 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.518 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.417 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.62 HD21 ' HB2' ' A' ' 38' ' ' LYS . 12.7 t-20 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.439 ' HG2' HG22 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' N ' HG23 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.687 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 11.4 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.503 HG12 HG11 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.413 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.413 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.404 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 245' ' ' LEU . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 244' ' ' GLU . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.544 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 251' ' ' GLU . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 249' ' ' THR . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.437 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.423 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.503 HG11 HG12 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.476 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.408 HD11 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.476 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.431 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.532 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.408 ' HG3' HD11 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.426 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.595 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.833 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 28.0 t-20 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.413 ' O ' HG21 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.475 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.437 ' N ' HG23 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.475 ' O ' HG22 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.475 HG22 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.833 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.431 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.532 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.532 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.6 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.641 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' B' ' 81' ' ' LYS . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.513 HG12 HG11 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.417 HD11 ' HH ' ' B' ' 221' ' ' TYR . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . 0.417 ' HH ' HD11 ' B' ' 195' ' ' ILE . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.417 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.419 ' H ' ' HD3' ' B' ' 239' ' ' LYS . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' THR . . . . . 0.425 ' C ' ' H ' ' B' ' 251' ' ' GLU . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' B' ' 249' ' ' THR . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' SER . . . . . 0.616 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.616 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.513 HG11 HG12 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.411 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.432 HD11 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.519 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.432 ' HG3' HD11 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.41 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.501 ' O ' HG22 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . 0.454 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . 0.401 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 374' ' ' MET . . . . . 0.446 ' HE1' ' CZ ' ' B' ' 388' ' ' TYR . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . 0.446 ' CZ ' ' HE1' ' B' ' 374' ' ' MET . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.628 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.628 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.612 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.765 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 28.7 t-20 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . 0.472 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.528 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.502 ' O ' HG21 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.631 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.434 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.548 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.547 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.513 ' HA ' ' HD1' ' A' ' 205' ' ' HIS . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.513 ' HD1' ' HA ' ' A' ' 202' ' ' ILE . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . 0.663 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.458 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.425 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.663 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.547 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.916 0.388 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.524 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.524 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG21 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.518 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.587 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.514 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.44 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.571 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.571 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.444 ' O ' HG21 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.444 HG21 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.9 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.634 ' O ' HG21 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.634 HG21 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . 0.432 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.599 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . 0.566 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . 0.401 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . 0.563 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.469 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.469 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.711 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.711 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.563 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . 0.402 ' N ' HG13 ' B' ' 300' ' ' ILE . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . 0.452 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.551 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . 0.465 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.465 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . 0.521 ' O ' HG21 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.597 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . 0.521 HG21 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.526 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.417 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . 0.541 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.642 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.447 ' O ' HG22 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' O ' HG21 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.747 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HG2' HD13 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.568 ' O ' HG21 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.457 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.461 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.508 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.588 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.0 mm100 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.554 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 173' ' ' ASP . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 172' ' ' VAL . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.554 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.539 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.558 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.689 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.689 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.508 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.591 ' O ' HG21 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.591 HG21 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.471 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.409 ' HB3' ' HE2' ' B' ' 51' ' ' MET . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HG2' HD13 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' MET . . . . . 0.61 ' O ' HG21 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.548 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.61 HG21 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG21 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.537 HH12 HG21 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' B' ' 64' ' ' GLN . 3.9 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.51 HG21 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.471 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' B' ' 83' ' ' LYS . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.479 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' VAL . . . . . 0.413 HG12 HG12 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LEU . . . . . 0.56 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' THR . . . . . 0.625 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' TRP . . . . . 0.444 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' LYS . . . . . 0.531 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' ASP . . . . . 0.414 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.414 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.497 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' LYS . . . . . 0.497 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' PRO . . . . . 0.625 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' LEU . . . . . 0.469 HD11 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' LEU . . . . . 0.45 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' VAL . . . . . 0.413 HG12 HG12 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' GLN . . . . . 0.46 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 324' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.549 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . 0.451 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG22 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 354' ' ' VAL . . . . . 0.519 HG22 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 363' ' ' ASP . . . . . 0.404 ' O ' HG22 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 367' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 391' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 395' ' ' MET . . . . . 0.672 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 399' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 404' ' ' GLU . . . . . 0.425 ' O ' HG21 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 408' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 412' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 419' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 24' ' ' ILE . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.493 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' B' ' 317' ' ' GLN . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.402 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' HD11 ' A' ' 53' ' ' ILE . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.609 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.45 HG11 HG12 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.462 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.557 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.4 mm100 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 256' ' ' PHE . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.507 ' CB ' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.424 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.437 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -88.83 -28.79 20.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -77.36 0.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -79.98 8.22 7.44 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.771 -0.581 . . . . 0.0 111.54 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.16 43.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.922 0.391 . . . . 0.0 111.509 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 148' ' ' GLN . 70.2 m-85 -127.9 154.27 45.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -83.45 -2.35 90.16 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.3 160.05 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.73 141.72 58.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.551 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.551 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.45 HG12 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.544 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.537 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.533 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.428 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.74 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.508 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.495 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.407 HD13 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.402 ' O ' HG22 ' B' ' 28' ' ' VAL . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 24' ' ' ILE . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.405 ' HD2' HD11 ' B' ' 53' ' ' ILE . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.405 HD11 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.436 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.436 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.45 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.429 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.429 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.463 HG11 HG12 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.491 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' B' ' 256' ' ' PHE . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.431 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.439 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 57' ' ' ARG . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.455 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . 0.403 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.423 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.497 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -74.7 -37.32 62.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.17 -1.43 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -79.83 9.04 5.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.59 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -86.01 41.9 0.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.0 111.487 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.454 ' CZ ' ' HG3' ' B' ' 148' ' ' GLN . 64.9 m-85 -128.0 155.02 44.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.364 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.88 6.63 82.66 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.94 159.84 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.75 142.0 58.58 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.446 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.463 HG12 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.41 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.41 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.482 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.483 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . 0.448 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.556 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.548 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . 0.423 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.425 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.554 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.471 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . 0.471 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.731 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . 0.493 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.439 ' O ' HG21 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.439 HG21 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.491 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.656 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.46 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.44 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' HD13 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.499 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' HG12 ' A' ' 79' ' ' ILE . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 76' ' ' ILE . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.432 HG12 HD21 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.722 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.45 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.432 HD21 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.432 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.432 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -88.33 -41.29 12.96 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.85 21.15 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-O 121.345 0.593 . . . . 0.0 112.036 -175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -69.61 3.37 2.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -63.95 -36.6 84.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.277 175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.91 112.87 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.943 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.17 19.24 18.59 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.339 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.29 3.58 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.776 0.322 . . . . 0.0 110.196 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 69.81 -73.54 0.09 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.883 . . . . 0.0 112.073 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 261' ' ' GLY . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.402 ' H ' ' CG ' ' A' ' 260' ' ' ASP . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.461 HD23 HD11 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.491 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.441 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' A' ' 343' ' ' ARG . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.549 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.485 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.456 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.48 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.524 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.412 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.491 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.491 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.63 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.456 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.485 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.424 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.424 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.432 ' HD2' HD13 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.722 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.486 ' O ' HG22 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.418 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.441 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . 0.421 HG12 HD21 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.763 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . 0.421 HD21 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.497 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.497 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -87.91 -42.48 12.47 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 18.3 tt -85.59 23.02 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-O 121.31 0.576 . . . . 0.0 111.944 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -71.13 3.81 3.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -63.65 -37.14 86.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 110.401 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -84.35 119.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.701 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.38 11.68 65.04 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.378 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.49 6.43 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.139 0.176 . . . . 0.0 111.193 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 69.81 -77.7 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.755 0.659 . . . . 0.0 112.125 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.439 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.432 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . 0.413 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.464 HD23 HD11 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.455 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.514 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.563 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.451 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.41 ' O ' HG22 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.451 HG21 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' B' ' 346' ' ' VAL . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . 0.476 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.547 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.441 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.47 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.444 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' HA ' HH12 ' A' ' 45' ' ' ARG . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 HG21 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' CG ' ' HZ1' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.562 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.562 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.414 HG12 HD21 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.488 ' HB1' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.428 ' HE2' ' O ' ' A' ' 199' ' ' GLU . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.644 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.428 ' O ' ' HE2' ' A' ' 189' ' ' MET . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.431 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.542 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.542 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.423 ' HB3' ' HZ2' ' A' ' 238' ' ' LYS . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.29 -44.7 82.76 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.448 ' C ' ' H ' ' A' ' 255' ' ' ARG . 18.0 tt -81.36 -5.41 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 251' ' ' GLU . 23.0 ptmt -76.17 16.98 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.6 -0.687 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 253' ' ' ILE . 1.8 tpp180 -67.99 -21.17 65.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.715 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -70.8 -28.09 64.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 117.1 -15.19 13.5 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.592 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 25.7 t -84.58 149.22 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 -44.51 -72.75 0.05 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.56 0.537 . . . . 0.0 111.339 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.437 ' O ' HG21 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.409 HG12 HG21 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.41 ' CG1' HG13 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.509 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.463 HE21 HD13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.407 HE21 HG12 ' B' ' 62' ' ' VAL . 24.9 tm0? -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.491 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.482 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.426 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 355' ' ' ILE . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 351' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.523 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.598 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.545 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.42 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.408 ' HB ' ' H ' ' B' ' 20' ' ' ALA . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.408 ' H ' ' HB ' ' B' ' 19' ' ' ILE . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.513 ' O ' HG21 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.504 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.42 HG21 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.463 HD13 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.449 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.449 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.644 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.467 ' O ' HG21 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.467 HG21 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.437 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.504 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.437 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . 0.453 ' CG ' ' HZ1' ' B' ' 146' ' ' LYS . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.4 ' O ' ' HG3' ' B' ' 147' ' ' GLN . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.453 ' HZ1' ' CG ' ' B' ' 142' ' ' ASP . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' ' 143' ' ' THR . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . 0.426 HG12 HD21 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.448 ' HB1' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.677 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 208' ' ' GLY . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' B' ' 206' ' ' LYS . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.455 ' CD2' HD12 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.463 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.547 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.547 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' B' ' 238' ' ' LYS . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' B' ' 238' ' ' LYS . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' B' ' 254' ' ' LYS . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -66.47 -44.22 83.31 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' B' ' 255' ' ' ARG . 19.3 tt -79.42 -5.94 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 251' ' ' GLU . 22.9 ptmt -77.58 25.12 0.19 Allowed 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.325 -0.859 . . . . 0.0 111.505 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' B' ' 253' ' ' ILE . 4.1 tpp180 -73.33 -16.51 61.36 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.756 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.6 -9.35 59.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.66 -19.99 48.05 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.774 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.62 143.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 -41.41 -72.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.801 0.688 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.436 ' O ' HG21 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.436 HG21 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.416 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.416 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.474 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.54 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.465 HD12 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.509 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . 0.461 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.465 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.405 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.459 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.459 HG22 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.402 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.561 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.705 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' B' ' 256' ' ' PHE . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.68 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.429 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' HG11 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.575 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.409 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.63 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.5 ' HE1' ' O ' ' A' ' 199' ' ' GLU . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.5 ' O ' ' HE1' ' A' ' 189' ' ' MET . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.543 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.501 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.406 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.0 p-10 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.469 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -67.07 -46.79 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 13.6 tt -93.12 77.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.844 0.831 . . . . 0.0 111.595 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 256' ' ' PHE . 37.1 ttmt -138.42 -24.62 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.112 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 255' ' ' ARG . 72.8 ttp85 -83.65 19.12 1.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 254' ' ' LYS . 96.6 m-85 -116.75 -89.45 0.58 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.917 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -138.74 -83.19 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.743 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.18 163.13 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 0.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.12 149.33 49.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.097 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.485 ' O ' HG21 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.485 HG21 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.406 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.406 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.511 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.414 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.501 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.511 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.426 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.426 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.497 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 401' ' ' VAL . 20.9 t-20 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.438 ' O ' HG21 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.575 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.403 ' C ' ' H ' ' A' ' 430' ' ' GLN . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 428' ' ' MET . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.441 ' O ' HG22 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.434 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.504 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.554 ' HA ' ' HE ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.414 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.515 ' O ' HG22 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.515 HG22 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.443 HG12 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.61 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.552 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.552 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' MET . . . . . 0.482 ' HE1' ' O ' ' B' ' 199' ' ' GLU . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.426 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . 0.482 ' O ' ' HE1' ' B' ' 189' ' ' MET . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.475 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.42 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 6.0 p-10 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.469 ' HB3' ' HZ1' ' B' ' 238' ' ' LYS . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.515 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.46 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.06 -46.75 82.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -93.29 79.69 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.883 0.849 . . . . 0.0 111.403 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -137.41 -27.49 0.95 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.96 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -81.1 8.47 8.59 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.64 0.733 . . . . 0.0 109.463 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.4 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 97.3 m-85 -104.39 -81.65 0.52 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.766 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -147.43 -79.88 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.764 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.53 166.42 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.946 0.403 . . . . 0.0 111.939 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -73.25 149.24 42.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.98 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.502 ' O ' HG21 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.633 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.502 HG21 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . 0.439 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . 0.439 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.651 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.449 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.651 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.455 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . 0.416 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.408 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.445 ' HG3' HD12 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.455 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' HG22 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.564 HG22 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.575 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . 0.575 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.464 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.479 ' O ' HG21 ' B' ' 401' ' ' VAL . 20.5 t-20 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.454 ' O ' HG21 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.454 HG21 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.528 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.438 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.597 HG23 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' H ' HG23 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD1' ' HB3' ' B' ' 256' ' ' PHE . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB2' ' ND2' ' B' ' 397' ' ' ASN . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.48 ' O ' HG21 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG22 ' NH2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.564 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' NH1' ' HB3' ' B' ' 191' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.55 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.652 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 142' ' ' ASP . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.648 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.443 ' CG ' ' HZ1' ' A' ' 238' ' ' LYS . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.553 ' HB2' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.633 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.513 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.569 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.5 p-10 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.569 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.633 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HZ1' ' CG ' ' A' ' 167' ' ' ASP . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -75.79 -32.36 59.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.25 65.11 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 121.885 0.85 . . . . 0.0 112.759 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -129.53 7.35 5.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.029 0.919 . . . . 0.0 108.949 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -98.49 10.3 41.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.233 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.523 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 98.2 m-85 -117.99 -77.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.693 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 162.98 -14.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.012 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.04 131.79 22.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 122.536 0.335 . . . . 0.0 110.454 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.02 92.8 2.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.627 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.445 ' O ' HG22 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.411 ' CG1' HD23 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.408 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.422 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.49 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.41 ' HG2' HG23 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.529 ' HZ3' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.49 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.46 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.411 ' O ' HG21 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.588 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.527 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.452 HD21 ' HB2' ' B' ' 38' ' ' LYS . 18.7 t-20 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.535 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.593 HG23 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.593 ' H ' HG23 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 256' ' ' PHE . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.496 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HB2' HD21 ' A' ' 397' ' ' ASN . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.482 ' O ' HG21 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.44 HG22 ' NH2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.533 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.489 ' O ' HG22 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.489 HG22 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.412 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.412 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.4 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.61 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.428 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.528 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . 0.552 ' HB2' ' NH1' ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . 0.583 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.486 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.608 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.438 ' HB2' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.534 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.534 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.552 ' NH1' ' HB2' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -76.08 -38.76 56.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 15.6 tt -120.84 67.25 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 121.767 0.794 . . . . 0.0 112.728 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -129.95 1.47 4.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.851 0.834 . . . . 0.0 109.246 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -96.48 6.46 48.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.617 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.529 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 97.6 m-85 -110.32 -76.0 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.209 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 158.48 -12.12 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.367 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.7 130.95 26.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -141.36 104.51 4.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' SER . . . . . 0.511 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.511 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.427 ' O ' HG22 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . 0.413 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . 0.413 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.446 HG12 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . 0.473 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.442 HD21 HD11 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.44 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.428 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.433 HD12 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.459 ' NH1' HD12 ' B' ' 330' ' ' LEU . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.493 ' HZ3' ' HB2' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.459 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.433 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.415 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . 0.404 ' O ' HG22 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.415 ' O ' HG21 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.415 HG21 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.437 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.533 HG22 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . 0.412 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . 0.535 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.565 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.565 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.524 ' ND2' ' HB2' ' A' ' 38' ' ' LYS . 19.8 t-20 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.428 ' O ' HG21 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.454 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . 0.428 HG21 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 35' ' ' VAL . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 31' ' ' GLU . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.405 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.537 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HZ1' ' HB3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.412 ' O ' HD21 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.523 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.606 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.6 mm100 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.462 HD13 ' HH ' ' A' ' 221' ' ' TYR . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.427 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.434 ' HA ' ' HD1' ' A' ' 205' ' ' HIS . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.443 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.434 ' HD1' ' HA ' ' A' ' 202' ' ' ILE . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.526 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.467 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.462 ' HH ' HD13 ' A' ' 195' ' ' ILE . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.4 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.454 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.454 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.29 -42.94 78.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 256' ' ' PHE . 19.9 tt -96.7 35.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.734 0.778 . . . . 0.0 111.303 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 22.0 ptmt -71.2 -5.75 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.69 -6.8 55.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.393 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.413 ' HB2' HG12 ' A' ' 253' ' ' ILE . 10.5 t80 -75.52 141.05 43.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.85 83.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.083 -0.579 . . . . 0.0 114.077 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.66 133.22 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 117.02 0.41 . . . . 0.0 110.398 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 259' ' ' GLU . 3.3 mp0 -62.62 127.18 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.73 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' A' ' 285' ' ' ARG . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.442 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.449 HD11 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.421 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.521 ' HB2' ' NZ ' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HG3' HD11 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.509 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.433 HH21 ' HD2' ' A' ' 366' ' ' ARG . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.431 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.61 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' B' ' 38' ' ' LYS . 26.8 t-20 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.442 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.523 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.449 HD21 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.559 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.439 ' HA ' HD22 ' A' ' 397' ' ' ASN . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.421 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.433 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.559 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.457 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.427 ' CG ' ' HZ3' ' B' ' 81' ' ' LYS . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HZ3' ' CG ' ' B' ' 77' ' ' ASP . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.454 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . 0.449 ' O ' HD21 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.448 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.544 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.556 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.5 mm100 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . 0.405 HG21 HG22 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.443 ' HB1' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.475 HD13 ' HH ' ' B' ' 221' ' ' TYR . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.423 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.467 ' HA ' ' HD1' ' B' ' 205' ' ' HIS . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.443 ' HE3' ' HB1' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.467 ' HD1' ' HA ' ' B' ' 202' ' ' ILE . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.669 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.404 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.475 ' HH ' HD13 ' B' ' 195' ' ' ILE . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.669 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.405 HG22 HG21 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.536 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . 0.447 ' C ' ' HG1' ' B' ' 249' ' ' THR . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.447 ' HG1' ' C ' ' B' ' 248' ' ' LEU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' B' ' 254' ' ' LYS . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -91.53 -31.99 15.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' B' ' 256' ' ' PHE . 20.3 tt -104.52 32.32 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 121.761 0.791 . . . . 0.0 111.227 -175.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' B' ' 250' ' ' ALA . 22.7 ptmt -68.56 -4.78 16.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.66 -9.94 50.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.693 0.283 . . . . 0.0 111.211 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.452 ' HB2' HG12 ' B' ' 253' ' ' ILE . 10.2 t80 -73.55 146.94 44.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.25 -6.78 88.46 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.867 -0.683 . . . . 0.0 113.926 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.34 133.22 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 117.029 0.415 . . . . 0.0 110.222 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.99 125.43 24.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.436 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.469 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.58 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.58 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.634 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.463 HD11 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . 0.431 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.454 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.477 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.431 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.459 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.433 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.446 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.629 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.544 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.491 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 14' ' ' ARG . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' B' ' 397' ' ' ASN . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HA ' HG23 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.402 ' O ' HD21 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.403 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG22 HD13 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.1 mm100 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.468 ' C ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.602 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.602 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.485 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.485 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.487 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.497 ' HA ' ' CG2' ' A' ' 253' ' ' ILE . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -93.17 -38.75 11.4 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.497 ' CG2' ' HA ' ' A' ' 250' ' ' ALA . 20.1 tt -70.45 1.85 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.898 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -80.5 -19.07 46.7 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.855 -0.528 . . . . 0.0 112.385 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -71.07 -6.04 36.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.137 0.494 . . . . 0.0 111.593 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.11 -36.73 84.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.493 0.664 . . . . 0.0 109.637 176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.08 -17.47 56.01 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.394 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.59 132.77 69.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.62 112.83 18.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.609 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.421 HD13 HG22 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.562 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.486 ' HG3' HD11 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.436 ' HG3' HD12 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 343' ' ' ARG . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.458 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.547 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.59 HD21 ' HB2' ' B' ' 38' ' ' LYS . 12.1 t-20 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.544 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.405 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.59 ' HB2' HD21 ' A' ' 397' ' ' ASN . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.419 ' HA ' HG23 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.468 ' HG2' ' C ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.545 HG22 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.483 ' O ' HG21 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.483 HG21 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.446 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.469 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.413 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . 0.462 HG22 HD13 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.423 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.459 ' C ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.597 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.597 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.432 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.494 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.516 ' HA ' ' CG2' ' B' ' 253' ' ' ILE . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.45 -35.58 11.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.516 ' CG2' ' HA ' ' B' ' 250' ' ' ALA . 20.3 tt -70.89 -1.8 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.922 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -77.73 -20.69 53.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -73.17 -2.01 19.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.212 0.53 . . . . 0.0 111.646 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -64.74 -34.81 79.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 100.47 -14.89 59.17 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.312 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.55 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.14 113.24 13.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.515 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.462 HD13 HG22 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.454 HD11 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 310' ' ' GLU . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.454 ' HG3' HD11 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.434 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.466 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.518 ' O ' HG22 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.417 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.62 HD21 ' HB2' ' A' ' 38' ' ' LYS . 12.7 t-20 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.439 ' HG2' HG22 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.454 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' N ' HG23 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.687 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.687 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 11.4 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.503 HG12 HG11 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.413 ' HB1' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.413 ' HE3' ' HB1' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.404 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 245' ' ' LEU . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 244' ' ' GLU . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.544 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 251' ' ' GLU . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 249' ' ' THR . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.87 -13.75 13.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 250' ' ' ALA . 11.2 tp -75.29 -7.23 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 256' ' ' PHE . 21.5 ptmt -83.79 8.77 13.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.671 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -76.43 14.86 0.68 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.813 0.816 . . . . 0.0 109.853 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 254' ' ' LYS . 84.7 t80 -103.3 -34.23 8.85 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.401 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.96 -53.92 0.4 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.786 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.26 163.89 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -76.05 -90.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.278 0.361 . . . . 0.0 111.543 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.437 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.437 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.415 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.423 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.503 HG11 HG12 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.476 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.408 HD11 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.476 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.431 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.525 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.532 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.408 ' HG3' HD11 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.426 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.595 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.595 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.833 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 28.0 t-20 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.413 ' O ' HG21 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.475 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.437 ' N ' HG23 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.475 ' O ' HG22 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.475 HG22 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.833 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.431 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.532 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.532 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.6 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.641 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.417 ' HZ1' ' HB3' ' B' ' 81' ' ' LYS . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.513 HG12 HG11 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.417 HD11 ' HH ' ' B' ' 221' ' ' TYR . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.56 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . 0.417 ' HH ' HD11 ' B' ' 195' ' ' ILE . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.417 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.419 ' H ' ' HD3' ' B' ' 239' ' ' LYS . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' THR . . . . . 0.425 ' C ' ' H ' ' B' ' 251' ' ' GLU . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.438 ' HA ' HG22 ' B' ' 253' ' ' ILE . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' B' ' 249' ' ' THR . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -111.93 -14.34 13.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' B' ' 250' ' ' ALA . 11.2 tp -76.33 -5.47 7.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 120.967 0.413 . . . . 0.0 111.746 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' B' ' 256' ' ' PHE . 20.1 ptmt -86.72 10.06 16.94 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.806 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -75.78 25.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.801 0.81 . . . . 0.0 110.158 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' B' ' 254' ' ' LYS . 79.4 t80 -117.45 -35.86 3.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.551 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.72 -52.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.126 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.84 163.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 122.244 0.217 . . . . 0.0 110.482 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.56 -90.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' SER . . . . . 0.616 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.616 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.513 HG11 HG12 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.411 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.432 HD11 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.483 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.519 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.432 ' HG3' HD11 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG21 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.41 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.501 ' O ' HG22 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . 0.454 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . 0.401 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' MET . . . . . 0.446 ' HE1' ' CZ ' ' B' ' 388' ' ' TYR . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . 0.446 ' CZ ' ' HE1' ' B' ' 374' ' ' MET . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.628 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.628 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.612 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.765 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 28.7 t-20 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . 0.472 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.528 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.502 ' O ' HG21 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.631 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.434 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.548 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.476 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.432 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.547 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.433 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.513 ' HA ' ' HD1' ' A' ' 205' ' ' HIS . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.513 ' HD1' ' HA ' ' A' ' 202' ' ' ILE . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . 0.663 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.458 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.425 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.663 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.432 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.547 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.504 ' HA ' ' HB ' ' A' ' 253' ' ' ILE . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -96.49 -6.94 36.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.504 ' HB ' ' HA ' ' A' ' 250' ' ' ALA . 51.0 mt -94.04 9.94 4.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.088 0.947 . . . . 0.0 108.9 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -67.2 -14.64 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.627 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -69.83 -25.59 63.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 110.714 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.1 -33.94 77.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.692 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.37 -23.41 24.89 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.867 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.85 163.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 122.774 0.43 . . . . 0.0 109.89 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -73.5 147.21 44.26 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.949 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.425 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.524 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.524 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG21 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.58 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.507 ' O ' HG22 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.424 ' O ' HG21 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.518 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.587 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.44 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.493 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.514 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.44 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.571 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.571 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.444 ' O ' HG21 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.444 HG21 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.9 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.634 ' O ' HG21 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.634 HG21 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . 0.432 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.599 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . 0.566 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.401 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . 0.563 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.599 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . 0.411 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.469 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.469 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.711 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . 0.525 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.711 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.563 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.532 ' HA ' ' HB ' ' B' ' 253' ' ' ILE . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.34 -17.77 35.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' B' ' 250' ' ' ALA . 52.0 mt -87.51 11.52 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.951 0.881 . . . . 0.0 109.997 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -68.43 -16.33 63.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.309 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -69.09 -23.2 63.98 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.65 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.38 -35.27 80.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.355 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 93.87 -25.9 19.29 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.25 164.27 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -72.09 143.95 48.86 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . 0.402 HG13 ' N ' ' B' ' 301' ' ' ASP . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . 0.402 ' N ' HG13 ' B' ' 300' ' ' ILE . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.464 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.611 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . 0.452 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.551 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . 0.465 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.465 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . 0.521 ' O ' HG21 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.597 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . 0.521 HG21 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.526 ' O ' HG22 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.417 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . 0.541 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.642 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.447 ' O ' HG22 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' O ' HG21 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.747 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HG2' HD13 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.568 ' O ' HG21 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.457 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.461 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.508 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.588 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.0 mm100 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' CD ' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.554 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.402 ' HB ' ' H ' ' A' ' 173' ' ' ASP . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 172' ' ' VAL . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.554 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.591 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.21 -50.07 6.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.32 -4.05 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -64.86 -25.26 67.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.152 0.501 . . . . 0.0 111.308 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -90.56 -1.16 57.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.892 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.96 -19.26 61.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.142 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 149.15 -50.96 0.55 Allowed Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.535 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.33 161.88 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -75.64 103.76 5.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.99 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.539 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.412 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.558 ' HZ1' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.494 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.689 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.689 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.532 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.508 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.591 ' O ' HG21 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.749 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.591 HG21 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.471 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.409 ' HB3' ' HE2' ' B' ' 51' ' ' MET . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.533 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HG2' HD13 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' MET . . . . . 0.61 ' O ' HG21 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.548 ' O ' ' HG2' ' B' ' 57' ' ' ARG . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.61 HG21 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.51 ' O ' HG21 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.537 HH12 HG21 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' B' ' 64' ' ' GLN . 3.9 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.51 HG21 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.471 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' B' ' 83' ' ' LYS . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.479 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.413 HG12 HG12 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.56 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' THR . . . . . 0.625 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' TRP . . . . . 0.444 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.531 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ASP . . . . . 0.414 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.414 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.497 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' LYS . . . . . 0.497 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . 0.424 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . 0.548 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . 0.625 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' LEU . . . . . 0.469 HD11 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' B' ' 254' ' ' LYS . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -89.55 -50.62 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.2 -4.14 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' B' ' 250' ' ' ALA . 21.6 ptmt -62.11 -31.82 72.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.813 -0.554 . . . . 0.0 111.268 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -83.97 -3.14 57.76 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -69.73 -22.3 63.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.191 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.57 -57.08 0.38 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.22 162.95 39.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -72.66 109.51 6.34 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' LEU . . . . . 0.45 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . 0.413 HG12 HG12 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' ASP . . . . . 0.548 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.452 HD12 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' GLN . . . . . 0.512 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' GLN . . . . . 0.46 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.549 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . 0.451 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD12 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG22 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' VAL . . . . . 0.519 HG22 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' ASP . . . . . 0.404 ' O ' HG22 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' VAL . . . . . 0.404 HG22 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' MET . . . . . 0.672 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 404' ' ' GLU . . . . . 0.425 ' O ' HG21 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 408' ' ' VAL . . . . . 0.491 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 55' ' ' ALA . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 41' ' ' ILE . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 39' ' ' VAL . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' A' ' 45' ' ' ARG . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.429 HD12 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.534 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 143' ' ' THR . 89.2 mm-40 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HB2' HH11 ' A' ' 243' ' ' ARG . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.485 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.439 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.45 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 345' ' ' VAL . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 311' ' ' ILE . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 385' ' ' ILE . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 371' ' ' ILE . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.749 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.531 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' B' ' 55' ' ' ALA . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.482 HG23 HG12 ' B' ' 41' ' ' ILE . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.531 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.482 HG12 HG23 ' B' ' 39' ' ' VAL . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' B' ' 50' ' ' PRO . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' B' ' 45' ' ' ARG . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.407 HD12 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.455 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.42 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.407 HD23 HD21 ' B' ' 294' ' ' LEU . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.511 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.439 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.472 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.549 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ILE . . . . . 0.411 HG12 HD23 ' B' ' 237' ' ' LEU . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 191' ' ' GLN . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.411 HD23 HG12 ' B' ' 166' ' ' ILE . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.549 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.512 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' B' ' 248' ' ' LEU . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.452 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.429 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.407 HD21 HD23 ' B' ' 120' ' ' LEU . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.464 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' B' ' 321' ' ' ARG . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 336' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.437 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.561 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 355' ' ' ILE . . . . . 0.4 HD13 HD21 ' B' ' 403' ' ' LEU . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.409 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.742 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 400' ' ' ASN . . . . . 0.518 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 403' ' ' LEU . . . . . 0.4 HD21 HD13 ' B' ' 355' ' ' ILE . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.443 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.511 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.415 HH21 ' HD2' ' A' ' 13' ' ' ARG . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 55' ' ' ALA . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.449 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.501 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.776 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 243' ' ' ARG . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 240' ' ' VAL . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.56 HG12 HD23 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.738 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.534 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.438 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 158' ' ' VAL . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.552 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' B' ' 62' ' ' VAL . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 294' ' ' LEU . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.414 HG22 HG12 ' A' ' 385' ' ' ILE . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 371' ' ' ILE . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.493 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.467 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.423 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.489 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' B' ' 55' ' ' ALA . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.459 HD13 ' HE3' ' B' ' 51' ' ' MET . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.467 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.432 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.459 ' HE3' HD13 ' B' ' 32' ' ' LEU . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.738 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.489 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' B' ' 243' ' ' ARG . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.456 HG22 HG21 ' B' ' 240' ' ' VAL . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' B' ' 189' ' ' MET . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ILE . . . . . 0.576 HG12 HD23 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.776 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.576 HD23 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.506 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.456 HG21 HG22 ' B' ' 158' ' ' VAL . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' B' ' 149' ' ' ALA . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 275' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' B' ' 317' ' ' GLN . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' B' ' 334' ' ' ARG . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 337' ' ' PHE . . . . . 0.438 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' B' ' 344' ' ' ARG . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 294' ' ' LEU . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 365' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.427 HG22 HG12 ' B' ' 385' ' ' ILE . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 385' ' ' ILE . . . . . 0.427 HG12 HG22 ' B' ' 371' ' ' ILE . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.56 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 396' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.402 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 13' ' ' ARG . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 12' ' ' GLY . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 41' ' ' ILE . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.482 HD12 HE21 ' B' ' 317' ' ' GLN . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.504 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 53' ' ' ILE . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.582 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.565 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 240' ' ' VAL . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.478 HG12 HD23 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 183' ' ' SER . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 167' ' ' ASP . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.447 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.547 ' HB3' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.664 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.46 HD11 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.548 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.548 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.478 HD23 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 237' ' ' LEU . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.425 HG11 HG22 ' A' ' 158' ' ' VAL . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 . . . . . 0 C--O 1.239 0.507 0 N-CA-C 111.339 0.126 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 344' ' ' ARG . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 337' ' ' PHE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.551 HE21 HD12 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.422 ' HG2' HG21 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 319' ' ' ALA . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.51 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.418 ' HD3' ' OE1' ' A' ' 310' ' ' GLU . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 360' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 355' ' ' ILE . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 355' ' ' ILE . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.582 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.433 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.51 HG23 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.551 HD12 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.495 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.495 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' B' ' 50' ' ' PRO . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.664 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.438 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' B' ' 417' ' ' VAL . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.417 HG22 HG11 ' B' ' 240' ' ' VAL . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ILE . . . . . 0.498 HG12 HD23 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' B' ' 226' ' ' LEU . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' PHE . . . . . 0.466 ' HB2' ' HB1' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.698 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.467 HD11 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.48 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.55 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.55 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.498 HD23 HG12 ' B' ' 166' ' ' ILE . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' B' ' 237' ' ' LEU . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 158' ' ' VAL . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 302' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' B' ' 345' ' ' VAL . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 305' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.477 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.42 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.462 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 337' ' ' PHE . . . . . 0.48 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.42 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 302' ' ' VAL . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 355' ' ' ILE . . . . . 0.423 HD13 HD21 ' B' ' 403' ' ' LEU . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.4 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.573 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 397' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 403' ' ' LEU . . . . . 0.423 HD21 HD13 ' B' ' 355' ' ' ILE . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' B' ' 125' ' ' VAL . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.577 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.616 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD3' ' HB ' ' A' ' 186' ' ' VAL . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 HD23 ' A' ' 237' ' ' LEU . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.416 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 163' ' ' ARG . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.564 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 166' ' ' ILE . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.456 ' HG3' HD13 ' A' ' 311' ' ' ILE . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.553 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.432 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.572 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 401' ' ' VAL . 6.9 t30 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.437 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.407 ' CD2' ' H ' ' B' ' 109' ' ' PHE . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 106' ' ' SER . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.416 HG23 HG12 ' B' ' 41' ' ' ILE . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.517 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.419 ' HA ' ' HA2' ' B' ' 12' ' ' GLY . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.407 ' H ' ' CD2' ' B' ' 11' ' ' LEU . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.469 HG11 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.401 HG11 HG13 ' B' ' 286' ' ' VAL . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.623 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.569 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.569 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ILE . . . . . 0.497 HG12 HD23 ' B' ' 237' ' ' LEU . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' B' ' 217' ' ' PHE . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.441 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.497 HD23 HG12 ' B' ' 166' ' ' ILE . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.526 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.643 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 274' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' ARG . . . . . 0.459 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.401 HG13 HG11 ' B' ' 125' ' ' VAL . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.658 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.519 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.577 ' O ' HG23 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.579 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 397' ' ' ASN . . . . . 0.492 ' O ' HG23 ' B' ' 401' ' ' VAL . 6.4 t30 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 395' ' ' MET . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 401' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.462 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.61 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.663 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.519 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.473 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.654 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.425 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 5.1 p30 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.425 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.806 0.336 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 267' ' ' ARG . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.408 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.492 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.441 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.499 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.478 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.408 HH21 ' HD2' ' A' ' 366' ' ' ARG . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 401' ' ' VAL . 1.2 t30 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 397' ' ' ASN . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.562 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.634 HG22 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.634 ' H ' HG22 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.415 HG23 HG12 ' B' ' 41' ' ' ILE . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.415 HG12 HG23 ' B' ' 39' ' ' VAL . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.478 ' O ' HG22 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.478 HG22 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.565 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.545 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.404 HD21 HG21 ' B' ' 270' ' ' VAL . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.597 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ALA . . . . . 0.611 ' HB1' HH12 ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.494 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.624 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.539 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.624 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.611 HH12 ' HB1' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 271' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 269' ' ' GLU . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 275' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.477 HG13 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.445 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.436 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 329' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.468 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.417 ' HG3' HD13 ' B' ' 311' ' ' ILE . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' B' ' 344' ' ' ARG . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 355' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 381' ' ' PRO . . . . . 0.537 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 385' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.574 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 397' ' ' ASN . . . . . 0.411 ' O ' HG23 ' B' ' 401' ' ' VAL . 1.3 t30 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 401' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 397' ' ' ASN . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 417' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 73' ' ' ARG . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 286' ' ' VAL . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.618 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 143' ' ' THR . 86.9 mm-40 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 240' ' ' VAL . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.627 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.54 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 158' ' ' VAL . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 242' ' ' GLU . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.413 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 120.517 0.199 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 125' ' ' VAL . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.438 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.588 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.606 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.43 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.551 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.447 HD23 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.431 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.524 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 73' ' ' ARG . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.447 ' O ' HD23 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.407 HG11 HG13 ' B' ' 286' ' ' VAL . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' B' ' 143' ' ' THR . 86.8 mm-40 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.541 HG22 HG21 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.651 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 197' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.43 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.677 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.677 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.541 HG21 HG22 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.491 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' B' ' 251' ' ' GLU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' B' ' 249' ' ' THR . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.503 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.592 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 337' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' B' ' 311' ' ' ILE . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.602 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.406 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.539 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.584 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 353' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 356' ' ' ARG . . . . . 0.417 HH21 ' HD2' ' B' ' 356' ' ' ARG . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.634 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 404' ' ' GLU . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.461 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 41' ' ' ILE . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 39' ' ' VAL . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 24' ' ' ILE . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' HG22 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.421 ' O ' HD23 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG11 HD23 ' A' ' 350' ' ' LEU . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' THR . 87.8 mm-40 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.61 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.61 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.496 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.496 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 276' ' ' ARG . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 273' ' ' ASN . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 345' ' ' VAL . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.53 HD13 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.528 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.401 HH21 ' HD2' ' A' ' 321' ' ' ARG . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.53 ' HG3' HD13 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.528 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 302' ' ' VAL . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 360' ' ' LEU . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 355' ' ' ILE . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.556 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.646 ' HG2' HG21 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.547 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' HB1' ' B' ' 20' ' ' ALA . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.547 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 41' ' ' ILE . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' B' ' 53' ' ' ILE . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.467 ' HA ' HG22 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 66' ' ' VAL . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.472 ' O ' HG22 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.472 HG22 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.423 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 116' ' ' GLU . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.402 ' N ' HG12 ' B' ' 115' ' ' VAL . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' VAL . . . . . 0.498 HG23 HD11 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 143' ' ' THR . 85.6 mm-40 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' B' ' 240' ' ' VAL . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ILE . . . . . 0.412 HG12 HD23 ' B' ' 237' ' ' LEU . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.603 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.603 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.435 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.435 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' LEU . . . . . 0.412 HD23 HG12 ' B' ' 166' ' ' ILE . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' B' ' 164' ' ' VAL . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.515 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.622 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.534 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 273' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 276' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 282' ' ' ILE . . . . . 0.406 HD12 ' N ' ' B' ' 283' ' ' ARG . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 283' ' ' ARG . . . . . 0.406 ' N ' HD12 ' B' ' 282' ' ' ILE . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 302' ' ' VAL . . . . . 0.498 HG13 HG11 ' B' ' 345' ' ' VAL . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 310' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.404 HE21 HG21 ' A' ' 62' ' ' VAL . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' B' ' 321' ' ' ARG . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 329' ' ' ALA . . . . . 0.416 ' HA ' ' HG ' ' B' ' 332' ' ' LEU . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' B' ' 329' ' ' ALA . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.498 HG11 HG13 ' B' ' 302' ' ' VAL . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.456 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.632 HG21 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 371' ' ' ILE . . . . . 0.423 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.411 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.632 ' HG2' HG21 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.45 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.57 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.3 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 354' ' ' VAL . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.497 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 240' ' ' VAL . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.407 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 158' ' ' VAL . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.568 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.46 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.547 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.523 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.523 ' HG3' HD13 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.405 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.619 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 9.6 t30 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.422 ' O ' HG23 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.46 ' HG3' HH12 ' A' ' 283' ' ' ARG . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.503 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.47 HG22 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.47 ' N ' HG22 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.679 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.53 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 3.2 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.44 HG12 ' N ' ' B' ' 116' ' ' GLU . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLU . . . . . 0.44 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' B' ' 354' ' ' VAL . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.557 HG11 HG13 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.521 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.492 HG22 HG21 ' B' ' 240' ' ' VAL . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.492 HG21 HG22 ' B' ' 158' ' ' VAL . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' SER . . . . . 0.622 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.557 HG13 HG11 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.4 HD23 HD22 ' B' ' 298' ' ' ASN . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 298' ' ' ASN . . . . . 0.4 HD22 HD23 ' B' ' 294' ' ' LEU . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 303' ' ' PRO . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.455 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 365' ' ' GLU . . . . . 0.4 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 374' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' B' ' 374' ' ' MET . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 390' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 397' ' ' ASN . . . . . 0.616 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 9.5 t30 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.616 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.41 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.521 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 426' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 429' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 55' ' ' ALA . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 73' ' ' ARG . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.554 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.4 HG22 ' HD2' ' A' ' 168' ' ' PHE . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HD2' HG22 ' A' ' 166' ' ' ILE . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 235' ' ' ILE . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.679 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.444 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.679 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 213' ' ' ILE . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.558 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.916 0.388 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.45 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.444 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.525 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.525 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.584 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.401 ' HA ' HE22 ' A' ' 431' ' ' GLN . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 429' ' ' ASN . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' B' ' 55' ' ' ALA . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.636 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.544 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.635 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.635 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.41 ' O ' HG22 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 3.5 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.639 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ILE . . . . . 0.426 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' B' ' 354' ' ' VAL . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.445 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ALA . . . . . 0.41 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.575 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' B' ' 240' ' ' VAL . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 239' ' ' LYS . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 176' ' ' GLU . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 171' ' ' SER . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.488 HG22 HD11 ' B' ' 235' ' ' ILE . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.722 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLU . . . . . 0.538 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.722 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.488 HD11 HG22 ' B' ' 213' ' ' ILE . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 165' ' ' THR . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 164' ' ' VAL . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.575 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 323' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 334' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.503 ' O ' HG23 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 344' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 355' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 364' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 366' ' ' ARG . . . . . 0.429 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 368' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.639 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 397' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.456 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 407' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 411' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.751 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' GLU . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' A' ' 50' ' ' PRO . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 349' ' ' LEU . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' THR . 83.4 mm-40 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.626 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 240' ' ' VAL . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.438 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.438 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.41 ' O ' HG23 ' B' ' 53' ' ' ILE . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.626 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 145' ' ' ARG . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.492 HG13 HG11 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.555 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' B' ' 62' ' ' VAL . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.505 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.456 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.416 HH21 ' HD2' ' A' ' 343' ' ' ARG . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.403 HH11 ' CD1' ' B' ' 41' ' ' ILE . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' A' ' 366' ' ' ARG . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.695 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.487 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.555 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' MET . . . . . 0.609 ' O ' HG22 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' B' ' 50' ' ' PRO . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.609 HG22 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.575 HH12 HG23 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.487 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.512 HG22 HG23 ' B' ' 93' ' ' VAL . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 91' ' ' THR . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' B' ' 102' ' ' ASP . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 101' ' ' GLU . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.494 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 349' ' ' LEU . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' VAL . . . . . 0.528 HG11 HG13 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LEU . . . . . 0.575 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' TRP . . . . . 0.45 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' LYS . . . . . 0.549 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.461 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' GLY . . . . . 0.461 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.517 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' PRO . . . . . 0.661 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' LEU . . . . . 0.543 HD13 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 268' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' ARG . . . . . 0.418 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 272' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 275' ' ' GLU . . . . . 0.418 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 286' ' ' VAL . . . . . 0.528 HG13 HG11 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 307' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 311' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 312' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 315' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 317' ' ' GLN . . . . . 0.534 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 320' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 324' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.457 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 332' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 333' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 340' ' ' GLN . . . . . 0.55 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 341' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 343' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 343' ' ' ARG . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 345' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 346' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 349' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG23 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 353' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 354' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 363' ' ' ASP . . . . . 0.429 ' O ' HG23 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 367' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 391' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 393' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' B' ' 393' ' ' GLU . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 395' ' ' MET . . . . . 0.678 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 399' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 408' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 412' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 55' ' ' ALA . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 41' ' ' ILE . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 39' ' ' VAL . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' A' ' 45' ' ' ARG . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.429 HD12 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.534 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 143' ' ' THR . 89.2 mm-40 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 256' ' ' PHE . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HB2' HH11 ' A' ' 243' ' ' ARG . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.485 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.439 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.45 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -88.83 -28.79 20.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -77.36 0.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -79.98 8.22 7.44 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.771 -0.581 . . . . 0.0 111.54 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.16 43.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.922 0.391 . . . . 0.0 111.509 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 148' ' ' GLN . 70.2 m-85 -127.9 154.27 45.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -83.45 -2.35 90.16 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.3 160.05 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.73 141.72 58.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 345' ' ' VAL . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 311' ' ' ILE . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 385' ' ' ILE . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 371' ' ' ILE . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.749 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.531 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' B' ' 55' ' ' ALA . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.482 HG23 HG12 ' B' ' 41' ' ' ILE . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.531 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.482 HG12 HG23 ' B' ' 39' ' ' VAL . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' B' ' 50' ' ' PRO . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' B' ' 45' ' ' ARG . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.407 HD12 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.455 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.42 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.407 HD23 HD21 ' B' ' 294' ' ' LEU . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.511 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLN . . . . . 0.473 ' HG3' ' CZ ' ' B' ' 256' ' ' PHE . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.439 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.472 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.549 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ILE . . . . . 0.411 HG12 HD23 ' B' ' 237' ' ' LEU . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 191' ' ' GLN . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.411 HD23 HG12 ' B' ' 166' ' ' ILE . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.549 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.512 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' B' ' 248' ' ' LEU . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -74.7 -37.32 62.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.17 -1.43 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -79.83 9.04 5.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.59 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -86.01 41.9 0.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.0 111.487 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' B' ' 148' ' ' GLN . 64.9 m-85 -128.0 155.02 44.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.364 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.88 6.63 82.66 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.94 159.84 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.75 142.0 58.58 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.452 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.429 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.407 HD21 HD23 ' B' ' 120' ' ' LEU . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.464 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' B' ' 321' ' ' ARG . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.437 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.561 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ILE . . . . . 0.4 HD13 HD21 ' B' ' 403' ' ' LEU . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.409 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.742 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 400' ' ' ASN . . . . . 0.518 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 403' ' ' LEU . . . . . 0.4 HD21 HD13 ' B' ' 355' ' ' ILE . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.443 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.511 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.415 HH21 ' HD2' ' A' ' 13' ' ' ARG . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 55' ' ' ALA . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.501 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.776 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 243' ' ' ARG . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 240' ' ' VAL . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.56 HG12 HD23 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.738 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.534 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.438 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 158' ' ' VAL . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -88.33 -41.29 12.96 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 253' ' ' ILE . 18.2 tt -85.85 21.15 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-O 121.345 0.593 . . . . 0.0 112.036 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -69.61 3.37 2.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 8.1 mpt_? -63.95 -36.6 84.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.277 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.91 112.87 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.943 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.17 19.24 18.59 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.339 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.29 3.58 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.776 0.322 . . . . 0.0 110.196 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 69.81 -73.54 0.09 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.883 . . . . 0.0 112.073 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.552 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' B' ' 62' ' ' VAL . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 294' ' ' LEU . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.414 HG22 HG12 ' A' ' 385' ' ' ILE . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 371' ' ' ILE . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.493 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.423 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.489 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 255' ' ' ARG . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' B' ' 55' ' ' ALA . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.459 HD13 ' HE3' ' B' ' 51' ' ' MET . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.467 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.432 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.459 ' HE3' HD13 ' B' ' 32' ' ' LEU . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.738 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.489 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' B' ' 243' ' ' ARG . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.456 HG22 HG21 ' B' ' 240' ' ' VAL . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' B' ' 189' ' ' MET . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ILE . . . . . 0.576 HG12 HD23 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.776 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.576 HD23 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.506 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.456 HG21 HG22 ' B' ' 158' ' ' VAL . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' B' ' 149' ' ' ALA . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -87.91 -42.48 12.47 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.418 ' O ' HG12 ' B' ' 253' ' ' ILE . 18.3 tt -85.59 23.02 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-O 121.31 0.576 . . . . 0.0 111.944 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -71.13 3.81 3.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -63.65 -37.14 86.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 110.401 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -84.35 119.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.701 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.38 11.68 65.04 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.378 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.49 6.43 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.139 0.176 . . . . 0.0 111.193 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 69.81 -77.7 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.755 0.659 . . . . 0.0 112.125 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' B' ' 317' ' ' GLN . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' B' ' 334' ' ' ARG . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' PHE . . . . . 0.438 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' B' ' 344' ' ' ARG . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 294' ' ' LEU . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.427 HG22 HG12 ' B' ' 385' ' ' ILE . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' ILE . . . . . 0.427 HG12 HG22 ' B' ' 371' ' ' ILE . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.56 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 396' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.402 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 13' ' ' ARG . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 12' ' ' GLY . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 41' ' ' ILE . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.482 HD12 HE21 ' B' ' 317' ' ' GLN . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.504 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 53' ' ' ILE . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.582 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.565 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 240' ' ' VAL . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.478 HG12 HD23 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 183' ' ' SER . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 167' ' ' ASP . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.447 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.547 ' HB3' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.664 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.46 HD11 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.548 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.548 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.478 HD23 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 237' ' ' LEU . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.425 HG11 HG22 ' A' ' 158' ' ' VAL . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.29 -44.7 82.76 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 255' ' ' ARG . 18.0 tt -81.36 -5.41 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 251' ' ' GLU . 23.0 ptmt -76.17 16.98 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.6 -0.687 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 253' ' ' ILE . 1.8 tpp180 -67.99 -21.17 65.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.715 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -70.8 -28.09 64.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 117.1 -15.19 13.5 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.592 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 25.7 t -84.58 149.22 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 -44.51 -72.75 0.05 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.56 0.537 . . . . 0.0 111.339 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 344' ' ' ARG . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 337' ' ' PHE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.551 HE21 HD12 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.422 ' HG2' HG21 ' B' ' 62' ' ' VAL . 1.0 OUTLIER -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 319' ' ' ALA . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.51 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.418 ' HD3' ' OE1' ' A' ' 310' ' ' GLU . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 360' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 355' ' ' ILE . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 355' ' ' ILE . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.582 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.433 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.51 HG23 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.551 HD12 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.495 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.495 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' B' ' 50' ' ' PRO . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.664 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.438 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' B' ' 417' ' ' VAL . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.417 HG22 HG11 ' B' ' 240' ' ' VAL . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ILE . . . . . 0.498 HG12 HD23 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' B' ' 226' ' ' LEU . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' PHE . . . . . 0.466 ' HB2' ' HB1' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.698 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.467 HD11 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.48 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.55 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.55 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.498 HD23 HG12 ' B' ' 166' ' ' ILE . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' B' ' 237' ' ' LEU . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 158' ' ' VAL . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 253' ' ' ILE . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' B' ' 254' ' ' LYS . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -66.47 -44.22 83.31 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' B' ' 255' ' ' ARG . 19.3 tt -79.42 -5.94 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 251' ' ' GLU . 22.9 ptmt -77.58 25.12 0.19 Allowed 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.325 -0.859 . . . . 0.0 111.505 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' B' ' 253' ' ' ILE . 4.1 tpp180 -73.33 -16.51 61.36 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.756 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.6 -9.35 59.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.66 -19.99 48.05 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.774 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.62 143.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 -41.41 -72.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.801 0.688 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' B' ' 345' ' ' VAL . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 305' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.477 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.42 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.462 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' PHE . . . . . 0.48 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.42 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 302' ' ' VAL . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 355' ' ' ILE . . . . . 0.423 HD13 HD21 ' B' ' 403' ' ' LEU . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.4 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.573 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 397' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 403' ' ' LEU . . . . . 0.423 HD21 HD13 ' B' ' 355' ' ' ILE . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' B' ' 125' ' ' VAL . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.577 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' B' ' 256' ' ' PHE . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' B' ' 256' ' ' PHE . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.616 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD3' ' HB ' ' A' ' 186' ' ' VAL . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 HD23 ' A' ' 237' ' ' LEU . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.416 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 163' ' ' ARG . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.564 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 166' ' ' ILE . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -67.07 -46.79 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 13.6 tt -93.12 77.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.844 0.831 . . . . 0.0 111.595 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 256' ' ' PHE . 37.1 ttmt -138.42 -24.62 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.112 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 255' ' ' ARG . 72.8 ttp85 -83.65 19.12 1.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 254' ' ' LYS . 96.6 m-85 -116.75 -89.45 0.58 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.917 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -138.74 -83.19 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.743 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.18 163.13 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 0.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.12 149.33 49.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.097 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.456 ' HG3' HD13 ' A' ' 311' ' ' ILE . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.553 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.432 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.572 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 401' ' ' VAL . 6.9 t30 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.437 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.407 ' CD2' ' H ' ' B' ' 109' ' ' PHE . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 106' ' ' SER . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.416 HG23 HG12 ' B' ' 41' ' ' ILE . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.517 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.419 ' HA ' ' HA2' ' B' ' 12' ' ' GLY . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.407 ' H ' ' CD2' ' B' ' 11' ' ' LEU . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.469 HG11 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.401 HG11 HG13 ' B' ' 286' ' ' VAL . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.623 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.569 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.569 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ILE . . . . . 0.497 HG12 HD23 ' B' ' 237' ' ' LEU . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' B' ' 217' ' ' PHE . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.441 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.497 HD23 HG12 ' B' ' 166' ' ' ILE . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.526 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.06 -46.75 82.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -93.29 79.69 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.883 0.849 . . . . 0.0 111.403 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -137.41 -27.49 0.95 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.96 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -81.1 8.47 8.59 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.64 0.733 . . . . 0.0 109.463 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 97.3 m-85 -104.39 -81.65 0.52 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.766 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -147.43 -79.88 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.764 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.53 166.42 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.946 0.403 . . . . 0.0 111.939 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -73.25 149.24 42.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.98 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.643 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ARG . . . . . 0.459 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.401 HG13 HG11 ' B' ' 125' ' ' VAL . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.658 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.519 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.577 ' O ' HG23 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.579 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 397' ' ' ASN . . . . . 0.492 ' O ' HG23 ' B' ' 401' ' ' VAL . 6.4 t30 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 395' ' ' MET . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 401' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.462 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' B' ' 256' ' ' PHE . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.61 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.663 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.519 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.473 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.654 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.425 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 5.1 p30 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.425 ' HG ' ' OD1' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -75.79 -32.36 59.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.25 65.11 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 121.885 0.85 . . . . 0.0 112.759 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -129.53 7.35 5.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.029 0.919 . . . . 0.0 108.949 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -98.49 10.3 41.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.233 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.528 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 98.2 m-85 -117.99 -77.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.693 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 162.98 -14.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.012 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.04 131.79 22.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 122.536 0.335 . . . . 0.0 110.454 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.02 92.8 2.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.627 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 267' ' ' ARG . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.408 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.492 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.441 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.499 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.478 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.408 HH21 ' HD2' ' A' ' 366' ' ' ARG . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.406 ' O ' HG23 ' A' ' 401' ' ' VAL . 1.2 t30 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 397' ' ' ASN . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.562 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.634 HG22 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.634 ' H ' HG22 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' HB3' ' A' ' 256' ' ' PHE . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.415 HG23 HG12 ' B' ' 41' ' ' ILE . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.415 HG12 HG23 ' B' ' 39' ' ' VAL . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.478 ' O ' HG22 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.478 HG22 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.565 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.545 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.404 HD21 HG21 ' B' ' 270' ' ' VAL . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.597 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ALA . . . . . 0.611 ' HB1' HH12 ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.494 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.624 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.539 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.624 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.611 HH12 ' HB1' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -76.08 -38.76 56.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 15.6 tt -120.84 67.25 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 121.767 0.794 . . . . 0.0 112.728 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -129.95 1.47 4.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.851 0.834 . . . . 0.0 109.246 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -96.48 6.46 48.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.617 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.532 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 97.6 m-85 -110.32 -76.0 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.209 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 158.48 -12.12 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.367 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.7 130.95 26.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -141.36 104.51 4.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 271' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 269' ' ' GLU . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.477 HG13 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.445 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.436 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 329' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.468 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.417 ' HG3' HD13 ' B' ' 311' ' ' ILE . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' B' ' 344' ' ' ARG . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 355' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 381' ' ' PRO . . . . . 0.537 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.574 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 397' ' ' ASN . . . . . 0.411 ' O ' HG23 ' B' ' 401' ' ' VAL . 1.3 t30 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 401' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 397' ' ' ASN . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 417' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 73' ' ' ARG . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 286' ' ' VAL . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.618 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 143' ' ' THR . 86.9 mm-40 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 240' ' ' VAL . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.627 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.54 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 158' ' ' VAL . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 242' ' ' GLU . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.413 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.29 -42.94 78.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 256' ' ' PHE . 19.9 tt -96.7 35.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.734 0.778 . . . . 0.0 111.303 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 22.0 ptmt -71.2 -5.75 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -89.69 -6.8 55.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.393 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.463 ' HB2' HG12 ' A' ' 253' ' ' ILE . 10.5 t80 -75.52 141.05 43.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.85 83.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.083 -0.579 . . . . 0.0 114.077 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.66 133.22 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 117.02 0.41 . . . . 0.0 110.398 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 3.3 mp0 -62.62 127.18 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.73 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 125' ' ' VAL . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.438 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.588 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.606 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.43 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.551 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.447 HD23 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.431 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.524 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 73' ' ' ARG . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.447 ' O ' HD23 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.407 HG11 HG13 ' B' ' 286' ' ' VAL . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' B' ' 143' ' ' THR . 86.8 mm-40 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.541 HG22 HG21 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.651 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.43 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.677 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.677 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.541 HG21 HG22 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.491 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' B' ' 251' ' ' GLU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 254' ' ' LYS . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' B' ' 249' ' ' THR . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -91.53 -31.99 15.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' B' ' 256' ' ' PHE . 20.3 tt -104.52 32.32 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 121.761 0.791 . . . . 0.0 111.227 -175.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' B' ' 250' ' ' ALA . 22.7 ptmt -68.56 -4.78 16.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.66 -9.94 50.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.693 0.283 . . . . 0.0 111.211 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.5 ' HB2' HG12 ' B' ' 253' ' ' ILE . 10.2 t80 -73.55 146.94 44.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.25 -6.78 88.46 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.867 -0.683 . . . . 0.0 113.926 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.34 133.22 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 117.029 0.415 . . . . 0.0 110.222 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.99 125.43 24.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.436 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.503 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.592 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' B' ' 311' ' ' ILE . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.602 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.406 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.539 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.584 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 353' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 356' ' ' ARG . . . . . 0.417 HH21 ' HD2' ' B' ' 356' ' ' ARG . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.634 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 404' ' ' GLU . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.461 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 41' ' ' ILE . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 39' ' ' VAL . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 24' ' ' ILE . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' HG22 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.421 ' O ' HD23 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG11 HD23 ' A' ' 350' ' ' LEU . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' THR . 87.8 mm-40 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.61 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.61 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.496 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.496 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.513 ' HA ' ' CG2' ' A' ' 253' ' ' ILE . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -93.17 -38.75 11.4 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 250' ' ' ALA . 20.1 tt -70.45 1.85 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.898 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -80.5 -19.07 46.7 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.855 -0.528 . . . . 0.0 112.385 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -71.07 -6.04 36.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.137 0.494 . . . . 0.0 111.593 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.11 -36.73 84.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.493 0.664 . . . . 0.0 109.637 176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.08 -17.47 56.01 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.394 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.59 132.77 69.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.62 112.83 18.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 276' ' ' ARG . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 273' ' ' ASN . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 345' ' ' VAL . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.53 HD13 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.528 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.401 HH21 ' HD2' ' A' ' 321' ' ' ARG . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.53 ' HG3' HD13 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.528 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 302' ' ' VAL . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 360' ' ' LEU . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 355' ' ' ILE . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.556 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.646 ' HG2' HG21 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.547 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' HB1' ' B' ' 20' ' ' ALA . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.547 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 41' ' ' ILE . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' B' ' 53' ' ' ILE . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.467 ' HA ' HG22 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 66' ' ' VAL . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.472 ' O ' HG22 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.472 HG22 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.423 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 116' ' ' GLU . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.402 ' N ' HG12 ' B' ' 115' ' ' VAL . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' VAL . . . . . 0.498 HG23 HD11 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 143' ' ' THR . 85.6 mm-40 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' B' ' 240' ' ' VAL . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ILE . . . . . 0.412 HG12 HD23 ' B' ' 237' ' ' LEU . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.603 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.603 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.435 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.435 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' LEU . . . . . 0.412 HD23 HG12 ' B' ' 166' ' ' ILE . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' B' ' 164' ' ' VAL . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.515 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' B' ' 253' ' ' ILE . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.45 -35.58 11.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' B' ' 250' ' ' ALA . 20.3 tt -70.89 -1.8 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.922 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -77.73 -20.69 53.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -73.17 -2.01 19.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.212 0.53 . . . . 0.0 111.646 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -64.74 -34.81 79.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 100.47 -14.89 59.17 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.312 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.55 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.14 113.24 13.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.622 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.534 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 273' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' ILE . . . . . 0.406 HD12 ' N ' ' B' ' 283' ' ' ARG . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ARG . . . . . 0.406 ' N ' HD12 ' B' ' 282' ' ' ILE . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' VAL . . . . . 0.498 HG13 HG11 ' B' ' 345' ' ' VAL . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.404 HE21 HG21 ' A' ' 62' ' ' VAL . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' B' ' 321' ' ' ARG . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' ALA . . . . . 0.416 ' HA ' ' HG ' ' B' ' 332' ' ' LEU . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' B' ' 329' ' ' ALA . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.498 HG11 HG13 ' B' ' 302' ' ' VAL . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.456 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.632 HG21 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 371' ' ' ILE . . . . . 0.423 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.411 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.632 ' HG2' HG21 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' B' ' 255' ' ' ARG . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.45 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.57 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.3 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 354' ' ' VAL . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.497 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 240' ' ' VAL . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.407 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 158' ' ' VAL . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.568 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.87 -13.75 13.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 250' ' ' ALA . 11.2 tp -75.29 -7.23 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 256' ' ' PHE . 21.5 ptmt -83.79 8.77 13.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.671 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.413 ' HA ' ' HB3' ' B' ' 22' ' ' ASP . 2.3 mpt_? -76.43 14.86 0.68 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.813 0.816 . . . . 0.0 109.853 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 254' ' ' LYS . 84.7 t80 -103.3 -34.23 8.85 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.401 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.96 -53.92 0.4 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.786 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.26 163.89 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -76.05 -90.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.278 0.361 . . . . 0.0 111.543 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.46 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.547 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.523 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.523 ' HG3' HD13 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.405 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.619 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 9.6 t30 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.422 ' O ' HG23 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.46 ' HG3' HH12 ' A' ' 283' ' ' ARG . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.503 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.47 HG22 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.47 ' N ' HG22 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 255' ' ' ARG . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.679 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.53 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 3.2 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.44 HG12 ' N ' ' B' ' 116' ' ' GLU . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.44 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' B' ' 354' ' ' VAL . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.557 HG11 HG13 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.521 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.492 HG22 HG21 ' B' ' 240' ' ' VAL . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.492 HG21 HG22 ' B' ' 158' ' ' VAL . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' B' ' 253' ' ' ILE . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -111.93 -14.34 13.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' B' ' 250' ' ' ALA . 11.2 tp -76.33 -5.47 7.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 120.967 0.413 . . . . 0.0 111.746 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' B' ' 256' ' ' PHE . 20.1 ptmt -86.72 10.06 16.94 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.806 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 3.5 mpt_? -75.78 25.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.801 0.81 . . . . 0.0 110.158 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' B' ' 254' ' ' LYS . 79.4 t80 -117.45 -35.86 3.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.551 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.72 -52.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.126 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.84 163.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 122.244 0.217 . . . . 0.0 110.482 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.56 -90.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' SER . . . . . 0.622 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.557 HG13 HG11 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.4 HD23 HD22 ' B' ' 298' ' ' ASN . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 298' ' ' ASN . . . . . 0.4 HD22 HD23 ' B' ' 294' ' ' LEU . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 303' ' ' PRO . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.455 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 365' ' ' GLU . . . . . 0.4 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' B' ' 374' ' ' MET . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 390' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 397' ' ' ASN . . . . . 0.616 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 9.5 t30 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.616 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.41 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.521 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 426' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 55' ' ' ALA . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 73' ' ' ARG . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.554 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.4 HG22 ' HD2' ' A' ' 168' ' ' PHE . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HD2' HG22 ' A' ' 166' ' ' ILE . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 235' ' ' ILE . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.679 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.444 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.679 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 213' ' ' ILE . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.558 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.532 ' HA ' ' HB ' ' A' ' 253' ' ' ILE . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -96.49 -6.94 36.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 250' ' ' ALA . 51.0 mt -94.04 9.94 4.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.088 0.947 . . . . 0.0 108.9 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -67.2 -14.64 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.627 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -69.83 -25.59 63.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 110.714 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.1 -33.94 77.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.692 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.37 -23.41 24.89 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.867 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.85 163.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 122.774 0.43 . . . . 0.0 109.89 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -73.5 147.21 44.26 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.949 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.45 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.444 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.525 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.525 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.584 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.401 ' HA ' HE22 ' A' ' 431' ' ' GLN . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 429' ' ' ASN . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' B' ' 55' ' ' ALA . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.636 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.544 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.635 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.635 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.41 ' O ' HG22 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 3.5 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.639 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ILE . . . . . 0.426 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' B' ' 354' ' ' VAL . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.445 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.41 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.575 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' B' ' 240' ' ' VAL . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 239' ' ' LYS . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 176' ' ' GLU . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 171' ' ' SER . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.488 HG22 HD11 ' B' ' 235' ' ' ILE . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.722 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLU . . . . . 0.538 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.722 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.488 HD11 HG22 ' B' ' 213' ' ' ILE . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 165' ' ' THR . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 164' ' ' VAL . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.575 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ALA . . . . . 0.56 ' HA ' ' HB ' ' B' ' 253' ' ' ILE . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.34 -17.77 35.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' B' ' 250' ' ' ALA . 52.0 mt -87.51 11.52 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.951 0.881 . . . . 0.0 109.997 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -68.43 -16.33 63.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.309 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -69.09 -23.2 63.98 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.65 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.38 -35.27 80.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.355 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 93.87 -25.9 19.29 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.25 164.27 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -72.09 143.95 48.86 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 323' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 334' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.503 ' O ' HG23 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 344' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 355' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' ARG . . . . . 0.429 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 368' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.639 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 397' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.456 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 407' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 411' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.751 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' GLU . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' A' ' 50' ' ' PRO . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 349' ' ' LEU . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' THR . 83.4 mm-40 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.626 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 240' ' ' VAL . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.438 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.438 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.41 ' O ' HG23 ' B' ' 53' ' ' ILE . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.626 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 145' ' ' ARG . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.21 -50.07 6.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.32 -4.05 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -64.86 -25.26 67.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.152 0.501 . . . . 0.0 111.308 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -90.56 -1.16 57.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.892 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.96 -19.26 61.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.142 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 149.15 -50.96 0.55 Allowed Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.535 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.33 161.88 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -75.64 103.76 5.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.99 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.492 HG13 HG11 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.555 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' B' ' 62' ' ' VAL . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.505 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.456 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.416 HH21 ' HD2' ' A' ' 343' ' ' ARG . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.403 HH11 ' CD1' ' B' ' 41' ' ' ILE . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' A' ' 366' ' ' ARG . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.695 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.487 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.555 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' MET . . . . . 0.609 ' O ' HG22 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' B' ' 50' ' ' PRO . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.609 HG22 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.575 HH12 HG23 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.487 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.512 HG22 HG23 ' B' ' 93' ' ' VAL . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 91' ' ' THR . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' B' ' 102' ' ' ASP . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 101' ' ' GLU . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.494 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 349' ' ' LEU . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.528 HG11 HG13 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.575 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' TRP . . . . . 0.45 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.549 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.461 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLY . . . . . 0.461 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.517 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' PRO . . . . . 0.661 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' LEU . . . . . 0.543 HD13 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -89.55 -50.62 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.2 -4.14 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.11 -31.82 72.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.813 -0.554 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -83.97 -3.14 57.76 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -69.73 -22.3 63.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.191 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.57 -57.08 0.38 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.22 162.95 39.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -72.66 109.51 6.34 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' ARG . . . . . 0.418 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' GLU . . . . . 0.418 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' VAL . . . . . 0.528 HG13 HG11 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 307' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 312' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 315' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' GLN . . . . . 0.534 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 320' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 324' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.457 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 333' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' GLN . . . . . 0.55 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 341' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 343' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 343' ' ' ARG . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 345' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 349' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG23 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 353' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 354' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' ASP . . . . . 0.429 ' O ' HG23 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 391' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 393' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' B' ' 393' ' ' GLU . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 395' ' ' MET . . . . . 0.678 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 399' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 408' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 55' ' ' ALA . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 41' ' ' ILE . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 39' ' ' VAL . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' A' ' 45' ' ' ARG . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.429 HD12 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.534 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.4 mm100 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HB2' HH11 ' A' ' 243' ' ' ARG . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.485 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.439 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.45 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 . . . . . 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 345' ' ' VAL . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 311' ' ' ILE . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 385' ' ' ILE . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 371' ' ' ILE . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.749 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.531 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' B' ' 55' ' ' ALA . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.482 HG23 HG12 ' B' ' 41' ' ' ILE . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.531 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.482 HG12 HG23 ' B' ' 39' ' ' VAL . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' B' ' 50' ' ' PRO . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' B' ' 45' ' ' ARG . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.407 HD12 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.455 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.42 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.407 HD23 HD21 ' B' ' 294' ' ' LEU . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.511 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.439 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.472 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.549 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . 0.411 HG12 HD23 ' B' ' 237' ' ' LEU . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 191' ' ' GLN . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.411 HD23 HG12 ' B' ' 166' ' ' ILE . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.549 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.512 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' B' ' 248' ' ' LEU . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.452 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.429 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.407 HD21 HD23 ' B' ' 120' ' ' LEU . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.464 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' B' ' 321' ' ' ARG . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.437 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.561 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . 0.4 HD13 HD21 ' B' ' 403' ' ' LEU . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.409 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.742 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . 0.518 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . 0.4 HD21 HD13 ' B' ' 355' ' ' ILE . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.443 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.511 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.415 HH21 ' HD2' ' A' ' 13' ' ' ARG . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 55' ' ' ALA . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.449 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.501 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.776 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 243' ' ' ARG . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 240' ' ' VAL . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.56 HG12 HD23 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.738 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.534 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.438 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 158' ' ' VAL . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 . . . . . 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.552 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' B' ' 62' ' ' VAL . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 294' ' ' LEU . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.414 HG22 HG12 ' A' ' 385' ' ' ILE . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 371' ' ' ILE . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.493 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.467 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.423 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.489 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' B' ' 55' ' ' ALA . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.459 HD13 ' HE3' ' B' ' 51' ' ' MET . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.467 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.432 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.459 ' HE3' HD13 ' B' ' 32' ' ' LEU . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.738 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.489 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' B' ' 243' ' ' ARG . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.456 HG22 HG21 ' B' ' 240' ' ' VAL . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' B' ' 189' ' ' MET . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . 0.576 HG12 HD23 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.776 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.576 HD23 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.506 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.456 HG21 HG22 ' B' ' 158' ' ' VAL . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' B' ' 149' ' ' ALA . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' B' ' 317' ' ' GLN . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' B' ' 334' ' ' ARG . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . 0.438 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' B' ' 344' ' ' ARG . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 294' ' ' LEU . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.427 HG22 HG12 ' B' ' 385' ' ' ILE . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . 0.427 HG12 HG22 ' B' ' 371' ' ' ILE . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.56 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.402 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 13' ' ' ARG . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 12' ' ' GLY . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 41' ' ' ILE . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.482 HD12 HE21 ' B' ' 317' ' ' GLN . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.504 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 53' ' ' ILE . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.582 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.565 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 240' ' ' VAL . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.478 HG12 HD23 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 183' ' ' SER . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 167' ' ' ASP . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.447 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.547 ' HB3' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.664 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.46 HD11 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.454 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.548 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.548 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.478 HD23 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 237' ' ' LEU . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.425 HG11 HG22 ' A' ' 158' ' ' VAL . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 . . . . . 0 C--O 1.239 0.507 0 N-CA-C 111.339 0.126 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 344' ' ' ARG . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 337' ' ' PHE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.551 HE21 HD12 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.467 HE21 HG11 ' B' ' 62' ' ' VAL . 24.9 tm0? -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 319' ' ' ALA . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.51 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.418 ' HD3' ' OE1' ' A' ' 310' ' ' GLU . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 360' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 355' ' ' ILE . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 355' ' ' ILE . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.582 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.433 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.51 HG23 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.551 HD12 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.495 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.495 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' B' ' 50' ' ' PRO . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.664 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.438 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' B' ' 417' ' ' VAL . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.417 HG22 HG11 ' B' ' 240' ' ' VAL . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . 0.498 HG12 HD23 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' B' ' 226' ' ' LEU . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . 0.466 ' HB2' ' HB1' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.698 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.467 HD11 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.48 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.55 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.55 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.498 HD23 HG12 ' B' ' 166' ' ' ILE . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' B' ' 237' ' ' LEU . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 158' ' ' VAL . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' B' ' 345' ' ' VAL . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.477 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.42 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.462 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . 0.48 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.42 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 302' ' ' VAL . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . 0.423 HD13 HD21 ' B' ' 403' ' ' LEU . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.4 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.573 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . 0.423 HD21 HD13 ' B' ' 355' ' ' ILE . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' B' ' 125' ' ' VAL . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.577 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.616 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD3' ' HB ' ' A' ' 186' ' ' VAL . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 HD23 ' A' ' 237' ' ' LEU . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.416 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 163' ' ' ARG . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.564 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.41 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.0 p-10 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 166' ' ' ILE . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.456 ' HG3' HD13 ' A' ' 311' ' ' ILE . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.553 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.432 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.572 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 401' ' ' VAL . 20.9 t-20 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.437 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.407 ' CD2' ' H ' ' B' ' 109' ' ' PHE . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 106' ' ' SER . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.416 HG23 HG12 ' B' ' 41' ' ' ILE . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.517 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.419 ' HA ' ' HA2' ' B' ' 12' ' ' GLY . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.407 ' H ' ' CD2' ' B' ' 11' ' ' LEU . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.469 HG11 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.401 HG11 HG13 ' B' ' 286' ' ' VAL . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.623 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.569 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.569 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . 0.497 HG12 HD23 ' B' ' 237' ' ' LEU . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' B' ' 217' ' ' PHE . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.441 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.406 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 6.0 p-10 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.497 HD23 HG12 ' B' ' 166' ' ' ILE . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.526 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.643 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . 0.459 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.401 HG13 HG11 ' B' ' 125' ' ' VAL . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.658 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.519 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.577 ' O ' HG23 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.579 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.492 ' O ' HG23 ' B' ' 401' ' ' VAL . 20.5 t-20 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 395' ' ' MET . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.462 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' ' ND2' ' B' ' 397' ' ' ASN . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.61 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.663 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.519 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.473 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.654 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.575 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.5 p-10 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.575 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.806 0.336 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 267' ' ' ARG . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.408 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.492 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.441 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.499 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.478 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.408 HH21 ' HD2' ' A' ' 366' ' ' ARG . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.523 HD22 ' HB2' ' B' ' 38' ' ' LYS . 18.7 t-20 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 397' ' ' ASN . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.562 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.634 HG22 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.634 ' H ' HG22 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.523 ' HB2' HD22 ' A' ' 397' ' ' ASN . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.415 HG23 HG12 ' B' ' 41' ' ' ILE . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.415 HG12 HG23 ' B' ' 39' ' ' VAL . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.478 ' O ' HG22 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.478 HG22 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.565 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.545 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.404 HD21 HG21 ' B' ' 270' ' ' VAL . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.597 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . 0.611 ' HB1' HH12 ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.494 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.624 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.539 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.624 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.611 HH12 ' HB1' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 269' ' ' GLU . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.477 HG13 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.445 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.436 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.468 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.417 ' HG3' HD13 ' B' ' 311' ' ' ILE . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' B' ' 344' ' ' ARG . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . 0.537 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.574 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' A' ' 38' ' ' LYS . 19.8 t-20 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 397' ' ' ASN . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HA ' HD21 ' B' ' 397' ' ' ASN . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 73' ' ' ARG . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 286' ' ' VAL . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.618 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.6 mm100 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 240' ' ' VAL . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.627 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.54 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 158' ' ' VAL . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 242' ' ' GLU . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.413 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 120.517 0.199 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 125' ' ' VAL . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.438 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.588 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.606 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' B' ' 38' ' ' LYS . 26.8 t-20 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.43 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.551 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.447 HD23 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 397' ' ' ASN . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.431 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.524 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 73' ' ' ARG . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.447 ' O ' HD23 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.407 HG11 HG13 ' B' ' 286' ' ' VAL . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.5 mm100 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.541 HG22 HG21 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.651 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.43 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.677 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.677 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.541 HG21 HG22 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.491 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' B' ' 251' ' ' GLU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' B' ' 249' ' ' THR . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.503 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.592 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' B' ' 311' ' ' ILE . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.602 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.406 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.539 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.584 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . 0.417 HH21 ' HD2' ' B' ' 356' ' ' ARG . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.634 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 38' ' ' LYS . 26.6 t-20 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 404' ' ' GLU . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.461 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HB2' HD22 ' B' ' 397' ' ' ASN . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 41' ' ' ILE . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 39' ' ' VAL . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 24' ' ' ILE . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' HG22 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.421 ' O ' HD23 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG11 HD23 ' A' ' 350' ' ' LEU . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.1 mm100 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.61 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.61 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.496 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.496 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 276' ' ' ARG . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 273' ' ' ASN . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 345' ' ' VAL . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.53 HD13 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.528 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.401 HH21 ' HD2' ' A' ' 321' ' ' ARG . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.53 ' HG3' HD13 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.528 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 302' ' ' VAL . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 360' ' ' LEU . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 355' ' ' ILE . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.556 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.659 HD22 ' HB2' ' B' ' 38' ' ' LYS . 12.1 t-20 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.646 ' HG2' HG21 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.547 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' HB1' ' B' ' 20' ' ' ALA . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.547 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 397' ' ' ASN . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 41' ' ' ILE . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' B' ' 53' ' ' ILE . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.467 ' HA ' HG22 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 66' ' ' VAL . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.472 ' O ' HG22 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.472 HG22 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.423 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 116' ' ' GLU . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.402 ' N ' HG12 ' B' ' 115' ' ' VAL . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . 0.498 HG23 HD11 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' B' ' 240' ' ' VAL . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . 0.412 HG12 HD23 ' B' ' 237' ' ' LEU . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.603 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.603 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.435 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.435 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . 0.412 HD23 HG12 ' B' ' 166' ' ' ILE . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' B' ' 164' ' ' VAL . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.515 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 . . . . . 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.622 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.534 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . 0.406 HD12 ' N ' ' B' ' 283' ' ' ARG . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . 0.406 ' N ' HD12 ' B' ' 282' ' ' ILE . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . 0.498 HG13 HG11 ' B' ' 345' ' ' VAL . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.404 HE21 HG21 ' A' ' 62' ' ' VAL . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' B' ' 321' ' ' ARG . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . 0.416 ' HA ' ' HG ' ' B' ' 332' ' ' LEU . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' B' ' 329' ' ' ALA . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.498 HG11 HG13 ' B' ' 302' ' ' VAL . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.456 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.632 HG21 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . 0.423 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.411 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.686 HD22 ' HB2' ' A' ' 38' ' ' LYS . 12.7 t-20 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.632 ' HG2' HG21 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.45 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.766 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.57 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 11.4 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 354' ' ' VAL . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.497 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 240' ' ' VAL . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.407 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 158' ' ' VAL . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.568 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.46 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.547 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.523 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.523 ' HG3' HD13 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.405 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.619 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.832 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 28.0 t-20 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.422 ' O ' HG23 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.46 ' HG3' HH12 ' A' ' 283' ' ' ARG . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.503 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.47 HG22 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.47 ' N ' HG22 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.832 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.53 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.6 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.44 HG12 ' N ' ' B' ' 116' ' ' GLU . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . 0.44 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' B' ' 354' ' ' VAL . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.557 HG11 HG13 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.521 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.492 HG22 HG21 ' B' ' 240' ' ' VAL . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.411 ' HG2' HE21 ' A' ' 56' ' ' GLN . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.492 HG21 HG22 ' B' ' 158' ' ' VAL . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . 0.622 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.557 HG13 HG11 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.4 HD23 HD22 ' B' ' 298' ' ' ASN . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . 0.4 HD22 HD23 ' B' ' 294' ' ' LEU . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 303' ' ' PRO . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.455 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . 0.4 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' B' ' 374' ' ' MET . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.766 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 28.7 t-20 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.616 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.41 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.521 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 55' ' ' ALA . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 73' ' ' ARG . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.554 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.4 HG22 ' HD2' ' A' ' 168' ' ' PHE . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HD2' HG22 ' A' ' 166' ' ' ILE . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 235' ' ' ILE . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.679 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.444 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.679 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 213' ' ' ILE . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.558 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.916 0.388 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.45 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.444 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.525 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.525 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.584 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.401 ' HA ' HE22 ' A' ' 431' ' ' GLN . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 429' ' ' ASN . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' B' ' 55' ' ' ALA . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.636 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.544 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.635 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.635 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.41 ' O ' HG22 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.9 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.639 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . 0.426 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' B' ' 354' ' ' VAL . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.445 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . 0.41 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.575 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' B' ' 240' ' ' VAL . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 239' ' ' LYS . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 176' ' ' GLU . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 171' ' ' SER . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.488 HG22 HD11 ' B' ' 235' ' ' ILE . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.722 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . 0.538 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.722 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.488 HD11 HG22 ' B' ' 213' ' ' ILE . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 165' ' ' THR . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 164' ' ' VAL . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.575 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.503 ' O ' HG23 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . 0.429 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.639 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.456 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.751 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' GLU . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' A' ' 50' ' ' PRO . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 349' ' ' LEU . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.0 mm100 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.626 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 240' ' ' VAL . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.438 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.438 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.41 ' O ' HG23 ' B' ' 53' ' ' ILE . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.626 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 145' ' ' ARG . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.239 0.508 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.492 HG13 HG11 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.555 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' B' ' 62' ' ' VAL . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.505 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.456 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.416 HH21 ' HD2' ' A' ' 343' ' ' ARG . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.403 HH11 ' CD1' ' B' ' 41' ' ' ILE . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' A' ' 366' ' ' ARG . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.695 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.487 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.555 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' MET . . . . . 0.609 ' O ' HG22 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' B' ' 50' ' ' PRO . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.609 HG22 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.575 HH12 HG23 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 64' ' ' GLN . 3.9 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.487 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.512 HG22 HG23 ' B' ' 93' ' ' VAL . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 91' ' ' THR . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' B' ' 102' ' ' ASP . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 101' ' ' GLU . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.494 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 349' ' ' LEU . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' VAL . . . . . 0.528 HG11 HG13 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LEU . . . . . 0.575 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' TRP . . . . . 0.45 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' LYS . . . . . 0.549 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.461 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . 0.461 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.517 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' PRO . . . . . 0.661 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' LEU . . . . . 0.543 HD13 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' ARG . . . . . 0.418 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' GLU . . . . . 0.418 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' VAL . . . . . 0.528 HG13 HG11 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' GLN . . . . . 0.534 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 324' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.457 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 332' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 333' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' GLN . . . . . 0.55 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 343' ' ' ARG . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG23 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 353' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 354' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 363' ' ' ASP . . . . . 0.429 ' O ' HG23 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 367' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 391' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 393' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' B' ' 393' ' ' GLU . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 395' ' ' MET . . . . . 0.678 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 399' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 408' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 412' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 120.796 0.332 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -118.94 138.13 53.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.864 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.64 133.08 68.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.945 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -138.05 130.02 28.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.29 131.36 51.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.3 mm-40 -112.56 165.59 12.1 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.037 0.446 . . . . 0.0 111.349 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 m -119.58 128.75 54.19 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.316 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 p -82.4 -66.11 0.93 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.083 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -157.2 125.17 5.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.95 -107.71 2.12 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.939 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.1 4.12 49.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.067 0.461 . . . . 0.0 110.577 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -72.57 138.46 26.15 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.016 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -127.22 155.93 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.921 0.391 . . . . 0.0 111.203 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 38.1 ttm180 -134.4 133.87 41.04 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.85 -99.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 m 42.46 90.5 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -105.16 129.66 57.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 t -101.02 117.72 35.59 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.294 0.568 . . . . 0.0 111.122 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.1 pt -137.63 172.56 14.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.182 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.11 154.86 38.5 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.672 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.23 -36.71 75.92 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.169 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.29 -46.03 89.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.126 0.488 . . . . 0.0 111.314 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -64.36 -41.32 96.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.66 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 28' ' ' VAL . 96.8 mt -63.49 -44.62 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.895 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -55.94 -50.21 71.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.541 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.0 m -66.6 -46.82 74.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.584 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.21 94.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 55' ' ' ALA . 93.7 t -64.16 -42.77 96.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 52' ' ' ASN . 98.3 mttt -58.78 -48.11 82.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.195 0.521 . . . . 0.0 110.583 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -65.43 -42.96 91.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.072 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.56 -45.43 65.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -62.76 -42.36 99.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.1 -34.03 66.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.312 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.19 -41.63 97.01 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.56 -42.61 93.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.869 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.21 -36.78 80.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.13 -38.16 90.04 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -55.9 -41.66 74.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 41' ' ' ILE . 18.0 m -97.81 4.25 9.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.447 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.518 ' NH1' ' HB2' ' B' ' 400' ' ' ASN . 85.0 mmt-85 58.38 58.66 3.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.735 0.814 . . . . 0.0 113.14 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.496 HG12 HG23 ' A' ' 39' ' ' VAL . 42.4 mm -114.24 -13.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.356 0.598 . . . . 0.0 110.287 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.31 -33.58 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.71 -6.14 58.44 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.764 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -100.27 4.22 44.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.359 0.599 . . . . 0.0 109.863 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' A' ' 50' ' ' PRO . 55.3 ttt85 -90.42 118.01 29.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.672 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -94.82 -2.42 50.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.416 0.627 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.85 24.38 64.69 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -65.94 -43.47 87.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.065 0.933 . . . . 0.0 111.158 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -110.66 120.18 44.46 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' A' ' 45' ' ' ARG . 39.9 Cg_exo -57.32 140.52 93.25 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.221 1.947 . . . . 0.0 110.488 175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.6 tpt -63.08 -35.15 79.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 -173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.62 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 27.9 p-10 -63.68 -37.21 86.49 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.429 HD12 ' HD2' ' A' ' 50' ' ' PRO . 72.7 mt -63.61 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.566 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.27 -28.53 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.997 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -63.83 -40.64 97.1 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.243 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 17.5 pt20 -89.87 16.72 7.65 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.329 0.585 . . . . 0.0 111.129 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' B' ' 193' ' ' ARG . 61.7 mtp180 -114.15 -56.65 2.37 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.016 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -99.88 1.55 42.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 111.72 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.95 -33.85 88.36 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.599 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.56 86.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.702 0.287 . . . . 0.0 111.383 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.9 m -64.23 -42.66 96.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.626 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.1 p -93.64 11.98 3.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.651 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -59.36 -43.7 92.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.662 -175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.71 -42.99 85.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.189 0.518 . . . . 0.0 110.429 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.69 -34.81 79.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.486 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 62' ' ' VAL . 70.6 t -60.65 -41.89 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.774 0.321 . . . . 0.0 110.346 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.33 -40.8 91.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -40.64 98.05 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.905 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.73 -42.14 95.45 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.41 . . . . 0.0 110.636 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.16 -40.28 95.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.602 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 34.5 ttm -59.7 -45.92 90.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.63 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -61.86 -48.24 81.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.745 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -71.04 -41.12 71.22 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -65.06 -39.98 94.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.82 -46.49 89.27 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' ILE . 15.4 tt -66.15 -39.45 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.68 0.276 . . . . 0.0 111.231 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.55 -42.68 98.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.171 0.51 . . . . 0.0 110.628 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -41.95 93.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.529 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -70.66 -25.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 94.0 mt -65.93 -44.01 92.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 111.385 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -80.16 -26.17 39.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.782 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -92.36 -6.06 50.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.013 0.435 . . . . 0.0 110.5 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.48 58.89 3.9 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 mt -114.96 121.95 68.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.28 103.26 37.77 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.722 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 14.7 Cg_exo -68.91 147.48 68.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.797 2.331 . . . . 0.0 112.303 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.45 97.4 10.45 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.95 -101.67 2.52 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.945 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.7 135.88 26.86 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.653 0.263 . . . . 0.0 111.135 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.29 158.04 41.27 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.985 2.457 . . . . 0.0 112.087 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 m -114.08 121.45 43.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -97.42 -21.12 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t 47.15 84.93 0.19 Allowed Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -85.6 145.2 9.14 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.564 2.176 . . . . 0.0 112.042 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.7 -167.72 23.49 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.148 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -70.35 138.65 51.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.81 0.338 . . . . 0.0 110.701 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -105.45 125.79 51.39 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.116 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.42 140.19 39.71 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -85.99 115.97 23.93 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.61 -3.79 56.33 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.999 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -122.02 -167.0 1.47 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.719 0.295 . . . . 0.0 111.316 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.53 177.86 7.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.104 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -142.3 142.58 32.54 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.09 129.87 48.79 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.534 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.3 p90 -140.74 148.16 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -125.25 114.47 18.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.797 0.332 . . . . 0.0 111.185 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.12 120.34 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.922 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -82.43 122.92 28.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -153.59 157.24 39.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.76 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -103.07 161.46 13.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.13 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.17 163.59 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 97.4 m-85 -126.17 140.47 37.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.543 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 98.6 Cg_endo -94.75 -166.53 0.13 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.271 2.647 . . . . 0.0 112.218 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -136.84 156.96 47.81 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.25 160.03 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 120.742 0.306 . . . . 0.0 111.168 -175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.03 133.86 55.52 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.5 mt -86.71 120.82 28.41 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.181 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -141.46 148.62 39.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.724 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 19.99 78.08 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.519 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.778 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.1 mp0 -67.44 -24.61 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.34 5.6 22.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.981 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.0 mt -89.68 115.58 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.389 0.614 . . . . 0.0 110.782 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -107.41 125.03 50.71 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.075 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.49 HG11 HG13 ' A' ' 286' ' ' VAL . 72.0 t -119.46 129.23 75.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 120.736 0.303 . . . . 0.0 110.444 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -98.39 128.11 44.63 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 78.5 tttt -109.68 101.25 45.78 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.965 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -75.15 125.78 9.44 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.244 1.963 . . . . 0.0 110.999 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.5 mm -98.01 115.22 37.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.24 163.3 37.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.818 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.78 161.52 31.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.33 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.1 t -99.37 120.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.8 p -88.4 168.17 12.88 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 120.926 0.393 . . . . 0.0 111.27 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -30.35 71.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.959 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.69 86.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -63.89 -37.68 88.3 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.5 -44.23 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.849 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.36 -45.87 80.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.915 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.42 99.29 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.42 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.84 -41.79 91.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.004 0.43 . . . . 0.0 110.951 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 93.0 mt -62.75 -43.89 97.63 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.31 -39.12 93.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.564 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.1 m -61.4 -45.66 93.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.865 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.4 mt -63.07 -39.42 94.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.832 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.6 mmm180 -62.87 -38.34 90.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.466 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -77.61 -13.55 59.88 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.4 mm100 -66.32 -41.36 89.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.636 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 256' ' ' PHE . 86.5 mm-40 -108.13 144.27 35.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 243' ' ' ARG . . . -170.97 157.24 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.726 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.8 m -95.58 131.01 42.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.616 0.246 . . . . 0.0 110.6 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 28.3 p90 -76.64 137.84 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.316 0.579 . . . . 0.0 112.249 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -139.97 129.21 23.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.632 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -74.36 136.75 42.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.619 0.247 . . . . 0.0 110.896 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -157.29 171.32 20.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -135.44 130.91 35.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.756 0.312 . . . . 0.0 110.474 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.06 -114.14 0.62 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.464 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -94.66 171.87 8.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.925 0.393 . . . . 0.0 111.354 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.84 134.25 63.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.944 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -85.3 -164.24 0.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.435 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.11 -16.89 19.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 110.68 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HB2' HH11 ' A' ' 243' ' ' ARG . 1.2 pm0 -125.48 29.4 6.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.204 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.485 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 70.8 m-20 -80.24 174.99 11.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.347 0.594 . . . . 0.0 112.191 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -110.39 122.45 47.72 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.09 160.99 39.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 87.7 m -114.12 116.87 29.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 74.4 mt -121.25 119.36 58.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.766 -176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -94.75 112.34 24.08 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.62 160.2 39.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.162 0.506 . . . . 0.0 111.683 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.8 m -129.32 132.98 47.23 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.021 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.4 106.06 3.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.619 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 m -114.32 126.17 54.71 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.1 t -72.98 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.506 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -103.5 -4.45 23.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.247 0.546 . . . . 0.0 110.29 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.82 28.41 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.782 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -157.95 141.61 15.54 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -81.23 145.4 30.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -103.47 -177.1 3.27 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.65 -41.49 90.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -101.32 -166.69 27.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.518 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.68 25.2 58.94 Favored Glycine 0 CA--C 1.508 -0.374 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.804 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -107.58 114.08 27.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -125.44 150.79 46.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.891 0.377 . . . . 0.0 111.679 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.4 t -151.18 105.77 3.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.68 32.74 16.05 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.347 0.594 . . . . 0.0 110.603 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -73.63 126.74 30.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.69 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.67 125.2 52.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.249 0.547 . . . . 0.0 110.313 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.28 134.68 54.83 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.221 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.01 112.21 24.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.12 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.3 154.09 24.3 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.255 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 87.71 4.92 78.91 Favored Glycine 0 CA--C 1.501 -0.838 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.429 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -108.57 -2.29 18.96 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 111.436 0.162 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.13 37.75 95.0 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.764 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' B' ' 57' ' ' ARG . 66.7 mtp180 -85.44 -16.88 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.676 0.274 . . . . 0.0 111.351 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -113.45 -177.29 3.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.705 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.4 135.03 96.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.707 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.03 118.99 5.58 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.698 1.599 . . . . 0.0 110.458 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 108.74 -29.11 10.23 Favored Glycine 0 N--CA 1.437 -1.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.001 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.29 -49.31 74.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.93 0.395 . . . . 0.0 110.829 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.41 -9.42 59.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.162 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.439 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 4.5 m-20 -83.52 -41.01 18.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.611 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.94 -25.69 74.2 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.742 -0.663 . . . . 0.0 114.195 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 29.5 pt -85.19 -9.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -65.45 133.63 51.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.79 -4.72 68.9 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.3 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -88.26 146.13 25.5 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.964 0.382 . . . . 0.0 111.027 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -79.34 154.05 29.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.735 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.4 44.25 0.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.911 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.26 18.64 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.119 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.57 139.2 54.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.398 0.599 . . . . 0.0 111.702 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -99.46 122.28 42.33 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 212' ' ' THR . 78.2 t80 -110.52 -49.0 3.09 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 80.5 m 74.12 104.6 0.07 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.195 0.521 . . . . 0.0 110.313 -174.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.4 tp -119.22 139.85 45.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.98 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.56 120.08 23.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.446 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.62 128.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 34.6 m -109.97 126.17 53.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.812 0.339 . . . . 0.0 110.715 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 92.1 m-85 -92.14 141.07 24.75 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.2 150.32 74.74 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.604 2.203 . . . . 0.0 112.554 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.45 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 17.1 mm-40 -57.89 -32.25 67.52 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.381 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -93.45 27.9 2.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.929 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -75.83 140.51 42.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.032 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -62.6 -24.38 67.54 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.14 114.57 27.13 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -60.99 -34.81 75.38 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.53 -6.35 53.3 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.907 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -120.42 -18.56 7.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.6 ptmt -66.76 123.54 20.42 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 111.738 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.62 19.59 79.19 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.141 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -111.38 141.64 44.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.12 0.486 . . . . 0.0 110.943 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.88 96.16 6.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.52 158.76 15.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.438 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -115.92 124.54 50.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.52 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 212' ' ' THR . 76.5 m-85 -106.36 119.72 40.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.536 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -61.26 -49.41 77.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.19 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 60.86 94.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 123.545 0.528 . . . . 0.0 111.4 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.2 -48.34 10.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.252 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 68.05 155.39 0.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.186 0.595 . . . . 0.0 112.565 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -170.76 -40.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.333 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -123.54 128.83 50.31 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.177 -0.327 . . . . 0.0 111.51 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 67.1 t -133.95 131.71 56.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -126.58 141.32 51.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.485 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -82.93 140.38 32.85 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.127 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 149' ' ' ALA . 36.3 mtm180 -101.51 103.26 14.13 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.04 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -89.36 162.51 15.76 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.821 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.4 mt -50.15 129.41 23.3 Favored Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 123.357 0.411 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.7 143.44 80.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.341 2.027 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.94 113.64 2.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.644 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 42.1 tp -82.58 17.09 1.88 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.669 0.747 . . . . 0.0 110.65 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -93.36 14.32 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.124 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.45 3.13 4.54 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.465 0.706 . . . . 0.0 111.854 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -73.03 -70.1 0.38 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.195 0.521 . . . . 0.0 110.96 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -88.83 -28.79 20.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.387 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -77.36 0.88 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -175.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -79.98 8.22 7.44 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.771 -0.581 . . . . 0.0 111.54 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.16 43.52 1.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.922 0.391 . . . . 0.0 111.509 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 148' ' ' GLN . 70.2 m-85 -127.9 154.27 45.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -83.45 -2.35 90.16 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.3 160.05 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -64.73 141.72 58.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.219 0.533 . . . . 0.0 111.63 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.59 143.93 34.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.626 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 77.15 -33.42 1.51 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 115.578 0.991 . . . . 0.0 115.578 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.8 p -56.14 105.44 0.19 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.388 0.594 . . . . 0.0 112.322 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.48 -46.18 93.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.027 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -39.74 88.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.333 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.88 -41.26 97.54 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.6 tp -62.48 -47.1 85.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.621 0.248 . . . . 0.0 110.747 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 -65.6 -38.62 90.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.589 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.58 97.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.79 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.571 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 37.2 tp10 -66.77 -39.58 87.9 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.528 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 266' ' ' LEU . 71.9 t -64.68 -43.4 96.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.82 0.343 . . . . 0.0 110.315 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 9.3 tpt180 -58.87 -47.53 84.59 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.652 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 13.0 ptmt -65.56 -41.31 93.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.566 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -66.36 -43.04 87.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 98.3 mmm -65.17 -45.77 83.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 58.9 mt-10 -69.56 -32.1 70.68 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.89 -45.32 95.06 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.149 0.499 . . . . 0.0 110.535 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.27 -23.75 40.54 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 64.5 tp -63.68 -43.15 97.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.85 -47.22 86.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.868 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 m -63.58 -43.33 97.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.503 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.1 91.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 41.0 pt -65.34 -41.65 91.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -64.73 -36.15 83.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.228 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -60.12 -43.06 95.91 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 121.277 -0.169 . . . . 0.0 110.989 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -65.23 -41.31 94.5 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.941 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.49 HG13 HG11 ' A' ' 125' ' ' VAL . 55.4 t -61.47 -46.39 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.063 0.459 . . . . 0.0 110.127 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.23 -43.75 98.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.541 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.7 t -61.23 -42.44 98.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -62.33 -42.92 99.78 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.4 -45.31 80.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.203 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.2 -45.48 96.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.673 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -67.68 -38.13 83.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.875 0.369 . . . . 0.0 110.29 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.57 -41.25 97.18 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.173 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.51 -48.61 31.84 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.8 -45.85 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.908 0.385 . . . . 0.0 111.783 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -64.41 -37.54 87.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.241 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.94 18.51 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -133.26 113.37 12.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.493 0.187 . . . . 0.0 110.997 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.0 156.73 21.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -134.27 150.39 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.93 112.3 14.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.221 0.534 . . . . 0.0 110.221 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 345' ' ' VAL . 57.8 t -101.16 133.72 20.79 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.982 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.75 142.0 97.89 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.276 1.984 . . . . 0.0 111.507 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.15 77.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.051 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.84 -47.82 76.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.121 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.75 -41.88 99.41 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.888 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.9 mt -64.49 -42.57 95.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.254 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -57.25 -46.19 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.551 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 44.3 m -59.96 -41.57 92.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.161 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -61.23 -36.35 79.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.655 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 307' ' ' ILE . 68.3 mt -63.3 -42.7 97.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.226 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 37.0 t70 -60.5 -44.08 96.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.95 -45.01 99.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.076 0.465 . . . . 0.0 109.995 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.06 -41.64 99.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.881 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 50.1 mtm180 -62.84 -43.76 97.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.587 0.232 . . . . 0.0 110.828 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 2.0 mmm-85 -63.36 -42.69 98.9 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 121.08 0.467 . . . . 0.0 109.885 -178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.462 HE21 ' HB3' ' A' ' 317' ' ' GLN . 0.6 OUTLIER -69.16 -40.26 78.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.966 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.64 94.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.543 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.97 81.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -63.15 -41.17 99.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.671 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.9 mtm180 -86.86 -1.78 58.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -98.83 -20.52 16.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.255 0.55 . . . . 0.0 109.87 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 171.8 -52.8 0.18 Allowed Glycine 0 N--CA 1.434 -1.481 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.946 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 118.73 106.84 2.28 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.278 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -162.96 94.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.66 141.29 58.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.8 ttmp? 75.68 -39.2 0.38 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.196 0.998 . . . . 0.0 112.799 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -65.16 -22.82 66.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.243 0.544 . . . . 0.0 109.816 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.54 -21.81 40.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.277 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.16 -30.33 69.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.754 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -78.1 -13.65 59.79 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.878 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.25 145.89 89.51 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.81 133.89 60.95 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.017 2.478 . . . . 0.0 113.219 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 311' ' ' ILE . 31.2 ttt85 -70.14 -42.11 72.99 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.937 -1.028 . . . . 0.0 113.034 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.75 -32.61 71.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 60.5 mt -64.2 -36.0 82.63 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.859 0.361 . . . . 0.0 111.646 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.2 m-85 -101.4 -20.2 15.26 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.81 -32.73 74.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.667 0.27 . . . . 0.0 111.608 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.16 -53.68 41.24 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.167 0.508 . . . . 0.0 109.778 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.8 pt20 -67.77 -30.4 69.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.386 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.08 89.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.6 tttt -60.49 -42.29 96.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.099 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -61.11 -41.59 96.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.636 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 27.4 mtp180 -63.49 -44.24 94.95 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.863 0.364 . . . . 0.0 110.391 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 65.9 t -66.07 -44.68 91.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.001 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.519 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 70.3 t -61.23 -45.96 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.697 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.4 t -62.31 -44.93 99.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 0.0 110.276 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.14 -43.41 99.45 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.27 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 84.8 mt -63.97 -42.55 97.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.264 . . . . 0.0 110.656 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.9 mt -62.57 -47.01 85.73 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.51 -42.2 92.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.039 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.55 98.74 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.48 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -69.54 -37.74 77.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.951 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 350' ' ' LEU . 83.2 t -60.98 -44.88 99.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.34 0.59 . . . . 0.0 109.474 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.58 -44.36 99.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.705 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 29.7 ttp85 -70.8 -46.98 61.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -65.03 -44.07 90.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.787 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -89.83 5.63 45.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.831 -0.168 . . . . 0.0 110.776 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 39.89 61.38 1.48 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.095 0.958 . . . . 0.0 112.32 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.59 146.1 40.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.237 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -104.41 149.58 25.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -79.31 104.43 9.93 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.3 t70 -82.8 116.08 21.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.178 0.513 . . . . 0.0 112.025 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 364' ' ' GLU . 5.6 mm-40 -65.26 -34.54 78.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.454 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.425 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 58.6 mm-40 -64.23 -43.36 95.17 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -61.89 -44.24 97.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.474 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 85.1 t -64.54 -44.74 96.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -60.83 -43.39 98.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.31 -42.21 99.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.426 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.26 -40.6 96.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 110.772 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 385' ' ' ILE . 95.8 mt -63.51 -43.42 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.23 -44.68 96.88 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.75 -43.07 90.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.904 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 52.8 ttp -66.59 -42.18 87.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.223 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.2 66.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.611 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 t -65.66 -14.87 62.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.212 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.99 -10.06 59.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.5 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -105.43 164.58 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.57 -43.93 95.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.949 0.404 . . . . 0.0 110.743 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -119.97 97.08 49.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.616 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.8 -22.98 42.22 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.637 2.225 . . . . 0.0 112.644 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -63.31 -47.84 80.55 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.24 -34.56 68.37 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.219 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.36 -44.97 97.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.18 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 371' ' ' ILE . 95.7 mt -63.1 -43.43 98.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-O 121.035 0.445 . . . . 0.0 109.94 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.08 -37.38 85.64 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.482 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -60.1 -45.56 92.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.791 0.329 . . . . 0.0 110.604 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.01 -37.54 87.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.499 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 20.4 m -80.63 -13.36 59.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 0.0 110.916 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -77.55 -43.27 32.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.511 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.13 123.95 41.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.895 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -62.77 -39.63 94.78 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.907 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -62.04 -43.79 98.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.594 0.235 . . . . 0.0 110.52 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.4 -40.8 97.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.768 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.749 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 95.2 mtp -60.84 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -73.43 -41.21 63.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.201 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -62.88 -40.36 97.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.024 0.44 . . . . 0.0 110.148 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -71.01 -24.19 62.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.815 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.749 ' HG3' ' O ' ' A' ' 395' ' ' MET . 83.5 mtt-85 -62.42 -38.87 91.37 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.62 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.531 ' HB2' ' NH1' ' B' ' 40' ' ' ARG . 92.7 m-20 -64.04 -28.35 69.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.691 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.98 -51.34 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.25 0.548 . . . . 0.0 109.923 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.59 86.25 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.329 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.3 tp -64.34 -37.68 88.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.6 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 408' ' ' VAL . 38.4 tt0 -61.53 -40.48 94.81 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.86 -41.27 91.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.142 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.89 -41.12 97.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.565 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.72 97.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 97.9 t -63.64 -45.28 97.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.48 -37.22 86.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.74 87.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.094 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 99.4 t -67.22 -44.28 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 89.7 mt -62.95 -32.79 74.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.781 -177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.96 70.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -106.77 -6.13 17.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.89 163.95 14.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.713 0.292 . . . . 0.0 110.677 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.58 100.27 13.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.913 0.387 . . . . 0.0 110.629 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 70.3 t -105.7 122.2 58.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.722 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 10.2 t -116.33 131.5 56.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 120.949 0.404 . . . . 0.0 110.719 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.5 mt-10 -97.32 125.3 41.83 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.112 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -124.68 125.24 43.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.65 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 42.5 mt-10 -73.2 122.62 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.1 p -133.94 153.31 51.85 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.914 0.388 . . . . 0.0 111.649 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 18.4 m -80.45 152.93 28.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.99 -41.75 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.108 0.48 . . . . 0.0 110.234 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -60.04 -34.3 73.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.355 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.7 -43.42 96.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.755 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.95 -17.99 59.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.4 ttt -70.44 -19.36 62.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -75.21 79.66 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 110.691 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -116.77 32.52 6.1 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.921 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -70.48 90.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 O-C-N 124.079 0.862 . . . . 0.0 110.73 -177.279 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.717 0.294 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.66 137.63 41.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.17 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.9 m -119.61 150.68 22.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.047 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.7 m -151.35 140.82 21.56 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.993 0.425 . . . . 0.0 111.095 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 6.9 p -151.75 120.22 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -105.73 168.29 9.21 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.015 0.436 . . . . 0.0 111.817 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.0 m -120.46 128.43 53.15 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.741 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.1 p -82.65 -56.69 3.71 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.906 0.384 . . . . 0.0 110.547 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -168.72 121.89 0.83 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.466 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.86 -115.31 6.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.088 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 11' ' ' LEU . 6.4 mp -93.53 5.09 52.77 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.207 0.527 . . . . 0.0 110.478 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.44 132.74 14.97 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.745 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -122.82 157.02 33.36 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.85 0.357 . . . . 0.0 111.239 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -133.05 133.74 43.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.379 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.04 -99.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.4 m 42.02 90.05 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.89 129.56 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 5.7 t -102.22 116.77 33.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.325 0.583 . . . . 0.0 111.036 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -134.82 169.83 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.943 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 152.02 40.77 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.008 0.432 . . . . 0.0 111.748 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.6 -35.93 71.07 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.232 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.63 -41.39 97.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.084 0.468 . . . . 0.0 111.183 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -68.0 -41.03 82.87 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.426 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.7 -47.22 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -52.03 -50.07 62.15 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.037 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.7 m -69.05 -46.42 67.9 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.86 -41.7 95.47 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.408 HG11 ' HB1' ' B' ' 55' ' ' ALA . 93.9 t -64.3 -42.48 95.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.588 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' B' ' 52' ' ' ASN . 95.8 mttt -58.98 -48.15 82.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.055 0.455 . . . . 0.0 110.559 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.6 m -64.64 -44.16 91.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.023 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.21 -45.24 66.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.05 -42.36 99.69 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.57 -33.58 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -64.06 -41.4 97.37 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.42 -42.61 93.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.865 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.22 82.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.352 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.17 -38.96 92.93 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.524 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -56.28 -42.42 77.45 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.063 0.459 . . . . 0.0 110.756 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.482 HG23 HG12 ' B' ' 41' ' ' ILE . 19.0 m -95.23 0.26 10.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.601 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.531 ' NH1' ' HB2' ' A' ' 400' ' ' ASN . 84.7 mmt-85 61.48 60.24 1.72 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.811 0.844 . . . . 0.0 113.128 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.482 HG12 HG23 ' B' ' 39' ' ' VAL . 45.5 mm -117.06 -13.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.315 0.579 . . . . 0.0 110.265 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -65.76 -33.99 77.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.401 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.86 -4.68 48.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.901 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.48 1.49 38.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.326 0.584 . . . . 0.0 109.952 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.443 HH12 ' HA ' ' B' ' 50' ' ' PRO . 47.6 ttt85 -87.09 112.61 22.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -88.94 -8.0 54.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.6 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.3 39.52 12.55 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -41.51 26.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.156 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.92 122.06 37.99 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.443 ' HA ' HH12 ' B' ' 45' ' ' ARG . 38.5 Cg_exo -57.55 140.01 91.99 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.118 1.878 . . . . 0.0 110.448 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.1 tpt -63.07 -35.89 81.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.877 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.679 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 25.2 p-10 -63.52 -37.8 88.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.4 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.407 HD12 ' HD2' ' B' ' 50' ' ' PRO . 69.8 mt -63.27 -44.35 99.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.553 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 m -71.61 -28.73 32.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.974 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.408 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -64.01 -40.5 96.48 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.925 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.679 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 7.1 pt20 -87.95 21.14 2.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.377 0.608 . . . . 0.0 111.214 177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 193' ' ' ARG . 65.1 mtp180 -121.03 -59.41 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.849 174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -96.9 -1.93 44.87 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.608 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -34.68 90.06 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.584 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.46 84.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.737 0.303 . . . . 0.0 111.613 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.64 -41.23 98.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.782 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.6 p -94.76 11.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.824 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -58.83 -43.54 90.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.093 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.28 -42.84 87.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 0.0 110.466 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.11 -35.05 79.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.444 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.0 t -60.47 -42.69 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.53 -40.5 91.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.894 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.79 -40.87 98.89 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.864 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.34 -41.45 93.91 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.807 0.336 . . . . 0.0 110.904 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.76 -40.43 95.11 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 36.8 ttm -59.44 -45.27 92.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.599 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 48.9 m -62.38 -50.12 72.83 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.934 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -70.36 -41.19 73.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -65.58 -39.52 91.72 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -61.46 -46.24 90.89 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.4 tt -65.52 -39.45 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.111 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.31 -43.02 99.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.14 0.495 . . . . 0.0 110.759 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -42.3 96.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.828 -0.623 . . . . 0.0 112.35 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -71.59 -25.29 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.434 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.4 mt -65.93 -44.28 92.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.06 0.457 . . . . 0.0 111.435 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -80.16 -26.75 39.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.854 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.62 -9.04 48.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 55.69 67.07 1.06 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.455 ' O ' ' HD3' ' B' ' 86' ' ' PRO . 85.6 mt -121.04 124.55 72.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -104.8 102.02 32.55 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 120.555 0.217 . . . . 0.0 110.81 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' B' ' 84' ' ' ILE . 15.5 Cg_exo -68.39 145.69 66.18 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.767 2.311 . . . . 0.0 111.883 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.81 95.45 9.85 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.81 -97.6 2.21 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.866 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.01 135.19 23.99 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-O 120.767 0.317 . . . . 0.0 111.415 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.52 158.77 36.13 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.886 2.391 . . . . 0.0 112.2 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 12.2 m -115.12 125.24 53.24 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -101.03 -23.07 14.58 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 t 46.96 87.01 0.12 Allowed Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -87.84 149.53 7.18 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.457 2.105 . . . . 0.0 111.784 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -109.33 -163.08 19.93 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.016 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.64 137.42 44.17 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.717 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -104.18 123.91 48.16 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.504 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -106.53 127.85 53.64 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp -73.78 119.05 17.46 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.99 -9.38 58.09 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.297 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -118.86 -164.34 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.694 0.247 . . . . 0.0 111.367 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.47 179.79 6.5 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.28 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -143.13 145.31 32.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 87.9 m -127.45 130.01 48.51 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.52 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.6 p90 -142.88 149.76 38.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 41.6 m -128.26 116.39 19.79 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.341 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 44.5 t -91.68 118.84 37.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.016 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.66 119.5 24.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.37 159.87 44.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.379 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -104.27 162.75 12.94 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.848 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 162.56 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.237 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -125.95 138.91 33.01 Favored Pre-proline 0 N--CA 1.466 0.334 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.302 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -95.58 -169.66 0.16 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.232 2.621 . . . . 0.0 111.859 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -136.22 160.7 37.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.383 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 116' ' ' GLU . 16.8 t -133.59 162.88 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-O 120.814 0.34 . . . . 0.0 111.209 -174.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.42 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.6 mt-10 -117.49 134.62 54.65 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' B' ' 354' ' ' VAL . 82.3 mt -89.78 116.99 28.3 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.257 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -140.45 145.81 37.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.686 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.13 20.53 69.75 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.532 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.407 HD23 HD21 ' B' ' 294' ' ' LEU . 87.3 mt -65.63 -40.8 92.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.125 0.488 . . . . 0.0 110.786 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 0.8 OUTLIER -69.8 -18.04 63.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.817 -178.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.66 3.65 43.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.31 -178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.08 113.88 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.235 0.54 . . . . 0.0 110.751 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.43 125.47 51.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.255 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.489 HG11 HG13 ' B' ' 286' ' ' VAL . 96.9 t -118.86 127.81 75.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.612 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -97.18 130.64 44.4 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.511 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.9 tttt -112.06 100.82 50.31 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.565 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.88 125.36 9.86 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.258 1.972 . . . . 0.0 110.937 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -97.91 114.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -132.6 162.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.91 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.81 162.92 29.39 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.546 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.68 126.83 52.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 66.3 p -95.07 168.76 10.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.155 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.3 -30.35 71.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.966 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.43 80.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.914 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -64.11 -39.91 95.07 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.532 0.682 . . . . 0.0 109.546 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.16 -44.63 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.274 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.52 -45.16 89.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.65 -42.89 99.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.459 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -65.23 -40.96 94.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.713 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 95.2 mt -62.89 -43.52 98.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.005 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.92 -40.8 98.7 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.917 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 94.7 m -60.97 -45.46 94.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.978 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.38 -39.13 93.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.896 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.7 mmm180 -63.58 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.705 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -74.95 -15.92 60.66 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.1 mm100 -66.47 -40.93 89.62 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . 0.473 ' HG3' ' CZ ' ' B' ' 256' ' ' PHE . 86.0 mm-40 -106.77 140.89 38.9 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' B' ' 243' ' ' ARG . . . -169.12 157.62 7.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.071 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 15.2 m -94.25 132.83 38.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.552 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -78.68 135.63 37.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.188 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -138.26 122.39 18.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.429 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.05 133.92 46.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.34 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.439 ' CE ' ' HB2' ' B' ' 242' ' ' GLU . 64.0 pttt -152.64 174.64 13.72 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.37 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.19 121.69 19.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.104 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.32 -124.64 1.38 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.803 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.34 168.3 13.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.881 0.372 . . . . 0.0 111.492 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.88 132.62 63.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.989 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -85.89 -161.83 0.67 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.232 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -99.14 -16.39 18.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.88 0.371 . . . . 0.0 110.937 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.472 ' HB2' HH11 ' B' ' 243' ' ' ARG . 0.9 OUTLIER -127.35 29.16 5.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.187 -176.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.549 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 65.9 m-20 -79.43 173.3 12.72 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.227 0.536 . . . . 0.0 111.727 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -109.52 124.07 50.47 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.59 160.3 40.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 93.9 m -114.49 116.1 28.31 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 173.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . 0.411 HG12 HD23 ' B' ' 237' ' ' LEU . 68.1 mt -121.47 119.34 58.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.933 -176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -94.76 114.75 26.69 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -137.6 165.07 27.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.163 0.506 . . . . 0.0 111.874 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 40.6 m -131.67 135.79 47.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.661 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -89.92 103.81 3.05 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.604 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 38.1 m -112.42 123.29 49.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 25.7 t -69.47 -90.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.662 0.268 . . . . 0.0 111.443 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -108.21 -20.6 13.09 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.39 0.614 . . . . 0.0 110.025 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 28.77 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.867 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -156.08 136.44 13.08 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.08 142.41 38.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -100.85 -175.15 2.8 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.262 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.59 -39.58 88.62 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -102.99 -161.92 25.65 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.08 62.85 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.67 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.98 117.63 34.63 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.14 147.56 52.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.853 0.358 . . . . 0.0 111.468 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 14.0 t -150.1 110.39 4.18 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 63.75 32.45 13.61 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.103 0.478 . . . . 0.0 110.092 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.77 124.56 27.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.53 121.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.272 0.558 . . . . 0.0 110.294 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 64.2 tp -117.64 133.79 55.58 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.109 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.37 115.16 26.98 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.044 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.1 mtp -83.98 152.85 24.22 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.315 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 89.83 1.09 77.38 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.693 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' B' ' 193' ' ' ARG . 97.9 mt-30 -104.08 -0.89 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.499 0.19 . . . . 0.0 111.097 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.01 38.58 96.24 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.305 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' B' ' 191' ' ' GLN . 62.6 mtp180 -86.01 -20.32 29.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.655 0.264 . . . . 0.0 111.599 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.9 mmt -110.45 177.92 4.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.685 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.0 mm -61.0 133.76 92.63 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.836 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.91 115.61 2.25 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.964 1.776 . . . . 0.0 110.815 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 111.75 -30.0 8.12 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.065 -177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -62.39 -49.58 74.95 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.91 0.385 . . . . 0.0 110.739 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.66 -9.62 58.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.153 0.501 . . . . 0.0 111.095 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.478 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 7.7 m-20 -83.9 -38.42 21.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.238 176.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -69.9 -23.82 76.75 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.926 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.5 pt -88.01 -6.75 10.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.96 0.38 . . . . 0.0 111.772 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -66.36 129.55 40.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.721 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 98.62 -4.18 59.61 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.661 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -90.63 147.84 23.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.188 0.494 . . . . 0.0 111.041 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -78.95 156.36 28.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.994 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.62 53.69 1.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.05 0.452 . . . . 0.0 111.43 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 173.36 32.03 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.737 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -132.65 129.93 39.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.23 0.538 . . . . 0.0 111.314 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -90.36 116.77 28.57 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' B' ' 212' ' ' THR . 75.6 t80 -107.66 -49.03 3.3 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.5 m 74.38 104.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.357 0.598 . . . . 0.0 110.8 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.5 tp -119.08 140.07 44.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.158 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -77.44 124.84 28.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.7 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.61 126.33 72.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 52.7 m -107.74 123.77 49.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.922 0.391 . . . . 0.0 110.609 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 97.8 m-85 -89.41 140.71 28.52 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 37.6 Cg_exo -58.93 151.72 63.35 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.672 2.248 . . . . 0.0 112.603 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.409 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 49.3 mm-40 -58.04 -35.33 71.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.709 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.75 34.77 1.46 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.691 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -77.92 141.4 39.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -62.44 -25.21 67.85 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.29 114.15 26.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' B' ' 336' ' ' LEU . 40.6 tt0 -59.84 -37.3 78.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.02 0.438 . . . . 0.0 111.903 -176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -75.27 -5.71 46.01 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -120.75 -20.84 6.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.6 ptmt -65.2 124.56 22.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.237 0.541 . . . . 0.0 111.911 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.72 22.78 78.63 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.87 140.47 49.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.911 0.386 . . . . 0.0 111.122 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.01 93.56 4.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.403 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -92.14 163.98 13.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.385 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.53 128.54 54.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 212' ' ' THR . 74.3 m-85 -108.54 118.95 38.11 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.59 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -61.4 -50.03 74.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.221 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.8 mm 62.14 100.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.614 0.571 . . . . 0.0 111.536 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -86.04 -52.52 5.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.142 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.411 HD23 HG12 ' B' ' 166' ' ' ILE . 95.6 mt 69.95 153.69 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.3 0.64 . . . . 0.0 112.095 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -168.85 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -127.75 130.03 48.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.521 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 63.4 t -134.16 130.54 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.576 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -122.96 142.44 50.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.158 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.549 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 35.4 tt0 -84.86 135.54 34.04 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.205 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.512 ' HB3' ' CB ' ' B' ' 149' ' ' ALA . 36.4 mtm180 -97.62 105.45 17.6 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.052 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -90.15 159.94 16.51 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.551 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 82.1 mt -47.83 131.9 11.48 Favored Pre-proline 0 C--O 1.236 0.36 0 O-C-N 123.308 0.38 . . . . 0.0 111.263 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.41 143.91 83.93 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.426 2.084 . . . . 0.0 111.719 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.83 112.32 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.591 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' B' ' 248' ' ' LEU . 40.6 tp -81.09 20.21 0.83 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.618 0.723 . . . . 0.0 110.504 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 10.9 p -96.74 12.48 31.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.503 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.27 0.64 3.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.394 0.678 . . . . 0.0 111.651 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.08 -79.69 0.07 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.248 0.547 . . . . 0.0 110.006 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -74.7 -37.32 62.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.788 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 16.5 tt -70.17 -1.43 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -79.83 9.04 5.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.511 -0.743 . . . . 0.0 111.59 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -86.01 41.9 0.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.0 111.487 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' B' ' 148' ' ' GLN . 64.9 m-85 -128.0 155.02 44.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.364 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -86.88 6.63 82.66 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.94 159.84 26.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.75 142.0 58.58 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.339 0.59 . . . . 0.0 111.375 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.45 143.99 29.04 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.435 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.91 -33.07 1.93 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 115.429 0.931 . . . . 0.0 115.429 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.6 p -58.47 107.9 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.258 0.529 . . . . 0.0 112.311 -177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.61 -46.78 91.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.305 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.85 -38.8 83.61 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.507 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.07 -41.12 98.63 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.993 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.452 ' O ' HG23 ' B' ' 270' ' ' VAL . 61.1 tp -62.58 -46.45 88.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.483 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -65.5 -39.51 91.97 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.568 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.08 -42.8 99.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.852 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 34.7 tp10 -67.46 -38.29 84.24 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.997 0.427 . . . . 0.0 110.429 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.2 t -64.98 -43.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 120.855 0.359 . . . . 0.0 110.315 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.31 -47.76 84.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.596 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.8 ptmt -65.04 -43.44 92.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.647 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -65.23 -42.54 93.29 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 93.1 mmm -65.64 -45.58 82.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.724 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -70.13 -33.25 71.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -59.99 -45.64 92.07 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.385 0.612 . . . . 0.0 110.449 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -82.36 -20.84 36.45 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.55 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 65.0 tp -65.44 -42.62 92.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.61 -46.29 89.41 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.809 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.1 m -62.98 -42.39 99.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.057 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.91 -47.78 84.82 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 37.2 pt -65.12 -41.86 92.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.111 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -64.19 -36.72 84.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.309 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.58 -42.4 96.62 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.09 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.94 -41.78 95.22 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.814 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.489 HG13 HG11 ' B' ' 125' ' ' VAL . 54.3 t -61.39 -45.72 98.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.113 0.482 . . . . 0.0 110.012 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.429 ' O ' HG12 ' B' ' 291' ' ' ILE . 88.4 tttt -62.59 -44.89 95.17 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.783 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 38.6 t -61.34 -41.69 97.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.329 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -61.78 -43.59 98.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.731 0.3 . . . . 0.0 110.746 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.42 -43.18 77.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.429 HG12 ' O ' ' B' ' 287' ' ' LYS . 34.0 mm -64.1 -45.8 95.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.426 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -67.29 -38.08 84.44 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.195 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.04 -41.43 97.99 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.063 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.407 HD21 HD23 ' B' ' 120' ' ' LEU . 91.7 mt -72.48 -48.61 39.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.34 -45.4 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 121.199 0.523 . . . . 0.0 111.546 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -64.92 -38.07 89.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.003 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -121.55 115.77 23.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 0.0 111.128 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -105.73 157.03 17.72 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -138.34 147.85 25.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.29 118.05 20.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 79.9 t -107.98 133.31 20.54 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.123 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.62 142.03 96.76 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.348 2.032 . . . . 0.0 111.427 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.09 79.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.201 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.08 74.84 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.78 -42.39 99.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.6 mt -65.44 -42.13 92.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.0 109.599 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -56.11 -47.28 78.4 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.48 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 33.5 m -61.7 -41.62 97.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.533 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -61.23 -35.54 77.49 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.507 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 96.6 mt -62.78 -43.02 98.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.029 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 34.7 t70 -60.28 -44.78 95.04 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.397 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.72 -44.5 97.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.283 0.563 . . . . 0.0 109.905 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.63 -42.13 99.41 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.73 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 56.2 mtm180 -63.09 -43.77 97.57 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.996 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 2.7 mmm-85 -62.98 -42.76 99.93 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.531 . . . . 0.0 109.948 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.464 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -69.05 -40.88 78.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.974 179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.69 94.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.6 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.12 -36.16 82.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.38 -41.74 96.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.68 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' B' ' 321' ' ' ARG . 48.7 mtm180 -83.99 -5.22 59.18 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -95.8 -17.33 21.25 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.328 0.585 . . . . 0.0 109.837 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 168.25 -55.96 0.22 Allowed Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.897 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 123.01 113.74 2.14 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.041 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -169.86 95.73 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.08 142.63 58.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.421 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.487 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.99 -38.34 0.34 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.991 0.916 . . . . 0.0 113.084 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 25.9 tm0? -65.48 -21.98 66.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.208 0.528 . . . . 0.0 109.897 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -57.35 -20.31 28.28 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.355 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.67 -32.54 72.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.3 -4.43 50.76 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.966 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.85 147.04 97.82 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 122.17 -0.331 . . . . 0.0 111.567 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.46 132.07 48.45 Favored 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.955 2.436 . . . . 0.0 112.704 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.8 ttt180 -70.9 -41.6 71.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.625 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -59.91 -32.72 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' B' ' 224' ' ' GLU . 72.1 mt -63.44 -38.44 91.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.926 0.393 . . . . 0.0 111.455 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -97.68 -23.63 15.86 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.65 -34.84 79.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -50.37 64.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.144 0.497 . . . . 0.0 109.968 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 11.8 pt20 -70.21 -29.93 66.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.324 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.26 86.56 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.889 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.437 ' O ' HG23 ' B' ' 346' ' ' VAL . 88.9 tttt -59.64 -42.12 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.108 0.48 . . . . 0.0 110.311 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -61.27 -41.32 96.74 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.583 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 29.4 mtp180 -63.84 -44.35 93.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.054 0.455 . . . . 0.0 110.254 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 78.3 t -65.41 -45.15 93.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.845 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 75.9 t -61.73 -46.2 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.761 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.58 -44.48 99.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.46 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.04 -43.35 99.55 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.099 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 85.3 mt -63.93 -42.49 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.627 0.251 . . . . 0.0 110.777 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.561 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.7 mt -62.61 -46.78 86.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.43 -41.88 93.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.01 99.71 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.456 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.98 -37.54 81.63 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.795 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 350' ' ' LEU . 83.4 t -61.15 -45.01 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . 0.4 HD13 HD21 ' B' ' 403' ' ' LEU . 97.1 mt -63.35 -43.94 98.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.039 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -71.37 -47.4 56.58 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 33.2 m -64.15 -44.65 91.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.825 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.68 7.49 36.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 36.27 61.74 0.76 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.23 1.012 . . . . 0.0 112.569 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.8 146.1 38.05 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.631 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -103.03 148.32 25.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -77.53 102.55 6.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.409 ' O ' HG23 ' B' ' 367' ' ' VAL . 18.9 t70 -79.54 114.71 18.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.124 0.488 . . . . 0.0 111.988 -173.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.44 -36.6 84.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.333 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -62.43 -43.66 98.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 109.774 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -61.58 -43.66 98.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.271 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.474 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.5 t -64.66 -45.26 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.07 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -61.06 -43.6 98.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.434 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.59 -43.0 99.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.569 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.64 -41.03 98.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 0.0 110.669 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 367' ' ' VAL . 78.1 mt -63.53 -43.98 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.176 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.36 -44.7 96.73 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.01 -41.1 87.26 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.556 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 60.6 ttp -65.76 -41.71 91.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.238 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.61 -16.46 61.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.653 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.3 t -74.06 -5.82 43.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -92.88 9.18 36.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.354 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -122.57 162.82 21.11 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.21 -49.72 76.77 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.617 0.246 . . . . 0.0 111.337 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.29 100.1 45.35 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.744 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.71 -22.61 57.13 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.461 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -61.87 -49.78 74.84 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.16 -33.43 67.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.473 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.04 -45.19 97.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.84 0.352 . . . . 0.0 110.747 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.79 -43.55 97.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.85 -35.7 80.65 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -59.38 -45.2 92.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.697 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.09 -36.83 84.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.436 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 17.2 m -82.05 -10.35 59.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.049 0.452 . . . . 0.0 110.863 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -79.85 -44.95 19.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.053 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -95.95 123.69 39.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.772 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.49 -38.85 92.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.239 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -63.2 -42.2 99.27 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.875 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.2 -40.56 96.5 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.494 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.742 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 93.0 mtp -61.19 -48.44 81.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.46 -42.85 67.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -62.55 -40.77 97.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.143 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -69.67 -27.62 65.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.096 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' B' ' 395' ' ' MET . 85.1 mtt-85 -60.81 -37.77 83.11 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 120.571 0.224 . . . . 0.0 110.501 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . 0.518 ' HB2' ' NH1' ' A' ' 40' ' ' ARG . 93.3 m-20 -62.74 -36.08 81.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.423 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 99.5 t -62.53 -48.46 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.061 0.458 . . . . 0.0 110.077 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.73 -39.11 77.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.552 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . 0.4 HD21 HD13 ' B' ' 355' ' ' ILE . 38.8 tp -64.09 -37.66 88.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.704 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.443 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -60.84 -40.11 91.61 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -59.19 -42.44 90.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.283 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -64.75 -40.88 96.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.741 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.3 98.37 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.443 HG23 ' O ' ' B' ' 404' ' ' GLU . 98.0 t -64.14 -44.54 97.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.448 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.43 -38.41 89.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.7 92.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.05 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.39 -44.63 86.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 92.0 mt -62.6 -35.71 80.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -27.99 62.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.912 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -113.58 2.06 15.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.44 162.8 13.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.64 0.257 . . . . 0.0 110.468 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.56 97.24 11.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.052 0.453 . . . . 0.0 110.521 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.54 127.58 56.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.8 t -123.4 131.25 53.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.832 0.349 . . . . 0.0 110.318 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.511 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 66.6 mt-10 -96.5 129.38 43.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.996 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -125.51 126.44 44.87 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.351 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -73.44 122.34 21.97 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -133.94 153.32 51.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.135 0.493 . . . . 0.0 111.708 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.8 m -81.36 151.71 27.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -58.87 -41.18 86.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.067 0.461 . . . . 0.0 109.997 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -57.87 -39.24 77.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.061 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -62.66 -45.46 92.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.133 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 42.3 tp -70.92 -24.62 62.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.06 0.457 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.1 ttt -65.72 -22.04 66.58 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.247 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.09 90.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.091 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -123.0 33.92 5.27 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.618 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -75.26 86.49 2.47 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.654 -178.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -75.85 140.34 42.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.572 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.83 155.17 40.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.64 134.91 18.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.708 0.289 . . . . 0.0 111.071 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.02 120.9 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 21.4 mm-40 -104.94 159.61 15.67 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 m -119.13 130.09 55.38 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.79 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -91.06 -64.12 1.17 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.789 0.328 . . . . 0.0 111.574 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -160.09 125.86 4.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.77 4.24 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.764 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -96.32 6.3 49.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.861 0.362 . . . . 0.0 111.376 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.21 140.2 21.91 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.097 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.415 HH21 ' HD2' ' A' ' 13' ' ' ARG . 6.6 mpt_? -129.51 162.42 28.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 26.8 ttm180 -132.78 131.21 40.86 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 108.959 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.3 t -92.59 -87.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.837 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m 33.55 88.55 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.87 118.97 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -95.26 111.88 23.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.149 0.499 . . . . 0.0 111.074 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.0 pt -132.3 177.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.033 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -71.85 156.23 39.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.64 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.76 75.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -59.89 -46.29 89.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.968 0.414 . . . . 0.0 111.054 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -72.85 -30.21 63.82 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.495 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 20' ' ' ALA . 83.7 mt -62.1 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 116.796 -0.183 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 46.4 mt-10 -66.51 -45.92 77.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.055 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -59.58 -45.65 91.24 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.54 98.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 111.118 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' HB1' ' A' ' 55' ' ' ALA . 86.9 t -68.13 -41.16 83.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.607 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 99.8 mttt -54.74 -48.44 72.57 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.244 0.545 . . . . 0.0 109.698 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.4 m -65.3 -43.95 89.49 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.141 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.35 -52.2 49.45 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.87 -42.33 99.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.3 -36.8 78.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.3 -43.12 95.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.488 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.09 -42.76 92.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.585 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.68 92.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.894 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 42' ' ' ASP . 85.6 mttt -65.95 -35.68 81.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.651 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -59.02 -36.16 74.5 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.215 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -97.29 5.06 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.023 0.44 . . . . 0.0 111.485 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 59.93 32.89 21.39 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.697 0.799 . . . . 0.0 112.412 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.6 mm -95.54 -11.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.322 0.582 . . . . 0.0 110.811 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' CG ' ' HG2' ' A' ' 37' ' ' LYS . 13.4 p-10 -64.79 -33.42 75.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.515 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.8 -3.58 59.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.895 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -104.87 6.93 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.207 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.8 ttt-85 -85.89 119.13 25.87 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.528 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -77.04 -22.39 53.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.196 0.522 . . . . 0.0 110.011 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 83.31 2.43 90.32 Favored Glycine 0 C--O 1.223 -0.566 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.059 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.99 -42.5 97.18 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 117.282 0.541 . . . . 0.0 111.509 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.81 109.88 60.68 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 53' ' ' ILE . 39.3 Cg_exo -59.17 143.37 99.79 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.716 2.278 . . . . 0.0 112.397 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 tpt -65.1 -39.13 92.72 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 22.6 p-10 -64.95 -32.5 74.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.278 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.501 HG23 ' CZ ' ' A' ' 57' ' ' ARG . 8.9 mt -63.32 -46.61 95.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.8 m -70.7 -29.13 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.157 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -61.71 -42.87 99.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.309 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 10.8 pt20 -95.28 12.59 28.48 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.776 ' CZ ' ' HG2' ' B' ' 193' ' ' ARG . 99.5 mtt180 -123.83 -40.93 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.549 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -106.76 -0.0 23.82 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.49 -25.03 72.61 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.324 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.48 -41.09 89.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.728 0.299 . . . . 0.0 111.32 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 16.8 m -63.88 -40.99 97.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -94.97 9.5 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.367 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -59.53 -41.88 91.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.709 0.29 . . . . 0.0 111.094 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.15 -46.95 86.7 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.314 0.578 . . . . 0.0 110.557 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -65.96 -36.28 82.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.082 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 62' ' ' VAL . 86.1 t -61.94 -42.92 96.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 110.337 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.61 -41.05 96.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -39.74 97.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.651 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.62 -41.08 98.32 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.93 0.395 . . . . 0.0 111.135 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.57 -41.75 97.85 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.1 ttp -61.75 -44.04 97.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.133 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.87 -47.89 82.97 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.603 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -70.83 -38.84 73.25 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -65.59 -36.16 82.92 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -59.05 -47.65 84.46 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.207 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 20.0 tt -66.97 -36.69 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 121.001 0.429 . . . . 0.0 110.535 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.69 -47.0 87.29 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.82 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.9 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -67.98 -37.64 78.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.4 -44.65 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.783 0.325 . . . . 0.0 111.387 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.98 -36.19 67.05 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.0 0.39 56.71 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 9.0 mmpt? 64.34 42.95 4.95 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.377 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.46 126.93 52.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -114.26 96.9 44.2 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.62 142.53 90.05 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.796 2.331 . . . . 0.0 112.544 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.52 91.88 7.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.216 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.39 -123.33 6.55 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.384 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.92 126.97 27.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.8 142.99 78.61 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.497 2.132 . . . . 0.0 111.571 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 m -96.37 116.92 29.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.007 0.432 . . . . 0.0 110.736 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -104.31 122.6 45.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.54 93.06 35.44 Favored Pre-proline 0 C--N 1.313 -0.988 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.882 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -88.3 147.93 6.47 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.604 2.202 . . . . 0.0 112.132 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.84 -170.82 38.69 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.03 130.1 36.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.076 0.465 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -89.23 130.67 35.6 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.659 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -116.79 141.83 47.71 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.0 tp -78.83 113.04 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.095 0.474 . . . . 0.0 110.809 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.03 -0.9 54.91 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -124.99 -179.16 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.38 . . . . 0.0 111.479 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.63 156.66 39.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.637 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -120.58 138.15 54.03 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.901 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 m -124.13 134.12 53.42 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.712 0.292 . . . . 0.0 111.476 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -142.98 156.39 44.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.0 m -131.31 138.38 49.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.282 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.44 126.94 69.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -92.79 134.01 35.48 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -152.07 157.7 41.99 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 111.721 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -85.14 165.55 17.35 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.515 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.2 162.14 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.204 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -128.4 127.5 23.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.77 160.82 1.45 Allowed 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 123.189 2.593 . . . . 0.0 111.603 173.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.04 156.4 18.79 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.471 HG11 HD23 ' A' ' 350' ' ' LEU . 97.1 t -125.71 139.4 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -108.82 123.45 49.06 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.05 128.47 36.3 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.035 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -139.77 154.42 47.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.941 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.43 16.83 80.42 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.725 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.05 -39.95 90.54 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.017 0.437 . . . . 0.0 111.062 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -71.54 -17.28 62.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.886 -178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.54 3.15 45.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.384 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.03 114.7 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.996 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -110.01 126.16 53.67 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.654 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 66.0 t -120.88 130.17 74.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.797 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.5 137.64 33.39 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -113.32 98.87 47.74 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.349 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.63 129.45 11.8 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.994 1.796 . . . . 0.0 110.95 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.1 mm -101.51 114.01 39.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.803 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.47 161.04 41.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.307 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.32 164.41 30.16 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.521 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -93.04 126.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.5 p -99.58 172.47 7.27 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.088 0.471 . . . . 0.0 111.295 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.475 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.19 90.2 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.767 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.19 -39.9 95.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.928 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.7 t -61.95 -46.89 95.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.684 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -37.33 85.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.85 -43.28 99.42 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.76 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 27.0 ttt -67.13 -40.24 86.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 0.0 110.534 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 93.6 mt -62.18 -42.53 99.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.958 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.41 -42.51 96.14 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.554 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 93.9 m -63.02 -44.59 95.54 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.404 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.53 -40.82 98.01 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -61.77 -39.34 91.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -65.41 -31.46 72.57 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.315 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.7 mm100 -70.7 -13.23 61.99 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -110.39 130.85 55.47 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 243' ' ' ARG . . . -176.05 163.5 2.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.882 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 84.8 m -112.19 136.59 51.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 242' ' ' GLU . 43.1 p90 -80.62 140.24 35.83 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -133.35 148.67 51.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.885 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.09 135.9 36.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.887 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.9 pttt -146.9 165.05 30.96 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.181 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -132.22 101.68 5.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 176.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.79 -140.16 3.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.605 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -87.31 166.72 14.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.887 0.375 . . . . 0.0 111.603 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 HG22 HG21 ' A' ' 240' ' ' VAL . 60.7 t -91.62 128.33 43.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.024 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.04 -171.29 2.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.337 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -94.61 1.19 55.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.376 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.37 48.09 1.04 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 0.0 111.398 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -102.44 169.27 8.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.264 0.554 . . . . 0.0 112.226 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.11 108.62 20.17 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.55 153.37 17.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.195 0.522 . . . . 0.0 112.309 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.3 m -113.04 118.03 33.66 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.56 HG12 HD23 ' A' ' 237' ' ' LEU . 86.6 mt -123.8 129.95 74.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.04 110.62 21.6 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 171.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.03 153.01 42.52 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.435 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.6 m -126.94 134.07 50.49 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.12 103.01 2.65 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.571 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -113.59 144.62 42.58 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.48 -80.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.442 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -117.56 -38.67 3.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.137 0.494 . . . . 0.0 110.1 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -159.39 19.23 0.26 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.784 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -148.55 146.31 28.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -89.84 141.48 28.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -94.3 -175.93 3.81 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.851 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.12 -35.28 76.62 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.18 -172.27 25.16 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.84 28.35 35.16 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.836 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.2 112.26 25.32 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -151.14 145.59 25.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.884 0.373 . . . . 0.0 111.33 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.6 t -123.15 -77.74 0.6 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.86 77.0 3.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.309 0.576 . . . . 0.0 109.449 176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -104.63 123.19 47.14 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.026 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -93.72 116.41 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.486 0.66 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.23 130.58 56.95 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.809 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.21 115.46 29.16 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.413 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 92.9 mtp -81.47 148.3 29.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.48 49.87 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.522 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.89 -2.24 58.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.598 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.5 58.72 8.12 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.738 ' HG2' ' CZ ' ' B' ' 57' ' ' ARG . 33.5 mtp85 -97.21 -16.83 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.898 0.38 . . . . 0.0 110.341 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.6 mmt -119.45 168.95 10.46 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.984 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.15 134.7 84.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.16 131.87 41.19 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.117 1.878 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.71 -36.12 4.61 Favored Glycine 0 N--CA 1.433 -1.545 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.8 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -64.49 -51.83 60.96 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 111.144 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -85.96 -6.16 59.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.195 0.522 . . . . 0.0 110.837 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.92 -29.15 21.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.991 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.47 -12.57 72.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -95.89 -0.83 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 117.319 0.559 . . . . 0.0 111.613 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 56.7 mtpt -66.08 135.29 54.41 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.395 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 85.89 19.75 57.14 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.299 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -111.48 166.66 10.94 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.408 0.604 . . . . 0.0 110.507 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -90.76 159.21 16.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 110.672 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.39 94.25 6.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.227 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 122.32 29.93 1.26 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.227 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.1 135.11 55.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.88 0.372 . . . . 0.0 110.492 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -90.33 121.88 32.73 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -111.14 -44.83 3.51 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 52.5 m 71.46 101.11 0.06 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.267 0.556 . . . . 0.0 110.431 -175.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -118.43 142.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.37 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -88.49 115.46 26.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.671 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 73.4 t -111.56 124.27 68.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 26.3 m -100.43 119.08 37.93 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 94.7 m-85 -85.86 138.78 35.09 Favored Pre-proline 0 C--N 1.313 -0.99 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 35.0 Cg_exo -60.13 148.33 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.276 1.984 . . . . 0.0 112.309 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.534 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 64.2 mm-40 -58.17 -30.71 66.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.369 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -92.3 23.6 3.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.933 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -75.33 143.23 43.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 122.297 -0.252 . . . . 0.0 110.732 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -65.5 -26.01 67.73 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.63 119.58 33.5 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.247 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 42.1 tt0 -61.82 -34.93 76.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.885 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.3 p-10 -75.32 -2.47 28.45 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.028 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.0 mt -127.37 -28.99 2.75 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -59.89 125.28 23.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.5 23.67 77.53 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.124 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -125.81 147.62 49.37 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.976 0.417 . . . . 0.0 111.29 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.87 102.72 11.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.585 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.38 151.56 19.68 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.152 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.92 116.06 31.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.282 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 212' ' ' THR . 86.6 m-85 -102.94 119.89 39.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.56 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.48 74.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.816 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.4 mm 63.44 83.97 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.93 -42.82 72.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 166' ' ' ILE . 74.5 mt 62.99 167.22 0.13 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.342 0.591 . . . . 0.0 112.235 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -165.62 -47.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.684 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.438 ' HB3' ' OE2' ' A' ' 241' ' ' GLU . 68.6 mmtt -134.99 144.75 47.56 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.574 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 158' ' ' VAL . 57.5 t -136.55 97.28 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.758 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 239' ' ' LYS . 7.1 mp0 -91.59 157.29 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 30.1 tt0 -108.73 177.26 4.83 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 149' ' ' ALA . 52.4 mtm180 -123.25 146.17 48.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.837 0.351 . . . . 0.0 110.638 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -139.71 170.75 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.65 129.33 94.24 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.93 163.25 26.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.451 2.767 . . . . 0.0 113.037 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.71 96.86 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.113 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.59 -8.94 58.72 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.84 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 2.9 m -80.24 59.1 3.26 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 65.56 -47.38 0.38 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 173.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -47.76 -53.01 16.57 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -88.33 -41.29 12.96 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.516 -0.473 . . . . 0.0 111.712 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 253' ' ' ILE . 18.2 tt -85.85 21.15 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 CA-C-O 121.345 0.593 . . . . 0.0 112.036 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -69.61 3.37 2.48 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 8.1 mpt_? -63.95 -36.6 84.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.277 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -85.91 112.87 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.943 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -84.17 19.24 18.59 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.339 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.29 3.58 7.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.776 0.322 . . . . 0.0 110.196 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 69.81 -73.54 0.09 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.883 . . . . 0.0 112.073 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.4 t70 66.8 -167.24 0.21 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 78.02 -3.59 60.87 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.614 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.5 p -85.67 136.09 33.5 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 120.865 0.364 . . . . 0.0 110.315 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 85.0 t -65.42 -44.42 94.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -66.32 -40.44 89.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.843 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -67.73 -43.56 84.07 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.817 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 57.0 tp -62.29 -45.07 94.93 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.409 0.283 . . . . 0.0 111.234 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -66.01 -38.58 88.82 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.099 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -40.15 94.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.364 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 44.0 tp10 -66.03 -39.32 90.08 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.138 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 72.1 t -64.47 -42.49 95.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.775 0.322 . . . . 0.0 110.227 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.45 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 8.5 tpt180 -57.9 -47.95 81.31 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.5 ptmt -66.6 -40.93 89.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.594 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -64.94 -44.79 88.31 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 97.7 mmm -65.39 -45.12 85.27 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 56.5 mt-10 -70.56 -30.75 67.55 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.74 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -59.14 -45.1 91.84 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.052 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -86.55 -20.19 28.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.6 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.18 -43.04 96.34 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.27 -46.51 89.59 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.925 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.3 m -61.77 -41.56 97.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.18 99.51 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.92 -44.51 98.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.423 0.63 . . . . 0.0 109.53 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -64.75 -42.43 95.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.576 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -63.63 -38.58 91.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.426 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.62 -44.21 96.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.02 -45.46 86.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.243 0.544 . . . . 0.0 110.63 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.88 -46.41 90.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.548 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 29.0 p -62.9 -42.31 99.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -64.11 -47.6 79.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.954 0.407 . . . . 0.0 110.896 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.76 -48.07 73.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.171 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.12 -45.02 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -65.86 -44.71 84.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.67 93.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.127 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.586 HD22 HD13 ' A' ' 350' ' ' LEU . 2.0 tt -62.91 -47.29 83.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.146 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.88 -42.3 88.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.414 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -62.22 -30.47 71.11 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.939 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.59 -23.91 22.98 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -121.43 105.23 10.31 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.763 0.316 . . . . 0.0 111.684 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -117.22 134.29 54.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.36 155.19 10.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.117 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -64.89 138.1 58.17 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 110.119 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.1 t -113.69 132.16 22.71 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.829 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.13 139.26 83.02 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.258 1.972 . . . . 0.0 111.347 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.16 82.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.077 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.71 86.89 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.206 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.32 -44.07 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 311' ' ' ILE . 66.8 mt -65.56 -45.25 93.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.587 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.68 -47.6 83.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.223 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.0 m -62.49 -44.23 96.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.143 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -68.53 -29.68 68.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 94.6 mt -62.63 -42.51 96.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.658 0.266 . . . . 0.0 110.412 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 21.4 t70 -61.05 -41.46 96.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.344 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.83 -44.65 99.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.039 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.58 -40.21 96.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.758 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.552 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 82.0 mtm180 -63.92 -37.52 87.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.154 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 32.8 mmt180 -59.7 -45.65 91.47 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.23 -40.33 77.99 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.871 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.17 96.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.647 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.63 81.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.353 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.0 tm0? -63.33 -42.84 98.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.664 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' A' ' 321' ' ' ARG . 48.5 mtm180 -83.66 -16.8 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.82 -41.03 68.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.568 0.699 . . . . 0.0 109.362 174.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' B' ' 61' ' ' SER . . . -176.39 -55.39 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.072 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' B' ' 62' ' ' VAL . . . 130.77 114.25 1.64 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.532 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -173.82 100.74 0.11 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.16 145.17 56.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.258 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.488 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.7 ttmp? 75.68 -26.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 0.0 112.726 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.4 -20.09 62.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.314 0.578 . . . . 0.0 109.761 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.38 65.62 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.837 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -26.77 68.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.964 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -92.92 1.35 57.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.649 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 80.3 mt -74.35 141.45 77.07 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 50.1 Cg_exo -55.31 130.64 41.71 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.021 2.48 . . . . 0.0 113.319 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -66.73 -41.57 87.68 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -60.58 -23.95 65.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.96 -40.76 97.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.28 1.22 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.979 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -60.0 -45.44 92.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.67 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.51 -40.88 73.25 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.07 -41.21 97.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.627 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.96 -41.61 90.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.25 -46.45 89.74 Favored 'General case' 0 CA--C 1.523 -0.065 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.922 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -61.08 -43.12 99.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.557 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.9 mtp-105 -65.48 -42.1 92.6 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.6 t -64.36 -46.69 92.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.494 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 94.2 t -62.38 -46.28 96.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.765 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.49 -43.98 98.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.22 -43.29 98.61 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.102 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.96 -42.85 97.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.911 0.386 . . . . 0.0 110.638 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 294' ' ' LEU . 96.7 mt -63.2 -45.28 92.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.878 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.89 -39.22 90.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.258 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.05 94.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.611 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.46 -35.33 80.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.857 0.36 . . . . 0.0 110.224 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 350' ' ' LEU . 99.6 t -60.74 -43.51 95.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.1 mt -61.01 -45.34 98.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.821 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -68.93 -44.8 72.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 111.068 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.6 m -64.73 -45.24 87.34 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.26 6.03 44.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 55.13 39.83 31.62 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.453 0.47 . . . . 0.0 111.158 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.86 145.14 53.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 148.96 52.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.305 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.29 111.87 5.48 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.7 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -86.42 112.04 21.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.841 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 368' ' ' LYS . 57.2 mm-40 -61.03 -37.05 81.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.784 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -60.39 -47.32 86.6 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -60.98 -44.79 96.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.909 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.32 -46.79 92.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.354 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 364' ' ' GLU . 75.8 mmtt -63.41 -42.99 98.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.095 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.35 99.48 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.779 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.94 -38.28 90.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.884 0.373 . . . . 0.0 110.792 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.414 HG22 HG12 ' A' ' 385' ' ' ILE . 91.7 mt -62.44 -42.49 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.68 -45.92 81.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.431 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -41.65 91.6 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.88 -45.52 89.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.29 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.77 -25.15 62.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.058 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -66.19 -14.58 62.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.04 -0.57 55.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.873 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.53 170.98 7.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.512 0.196 . . . . 0.0 110.982 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -58.43 -50.13 74.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.766 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.63 110.29 17.45 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.49 -24.33 36.44 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.358 2.039 . . . . 0.0 113.021 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -64.26 -47.94 77.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.77 -35.87 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.94 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.2 t -67.17 -44.85 87.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.467 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.414 HG12 HG22 ' A' ' 371' ' ' ILE . 93.9 mt -63.57 -43.75 98.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.254 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 36.2 tt0 -67.07 -36.44 82.01 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.283 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.85 -46.43 89.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.389 . . . . 0.0 110.929 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -37.2 86.7 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.962 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.9 m -81.35 -12.3 59.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.179 0.514 . . . . 0.0 110.616 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 21.3 tptt -76.0 -41.98 49.53 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.465 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 22.0 t-20 -101.39 125.82 48.08 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.729 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -62.91 -38.38 90.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.493 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 44.7 tp10 -59.12 -45.88 89.75 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.081 0.467 . . . . 0.0 110.128 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.59 -41.44 98.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.734 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 399' ' ' ARG . 90.9 mtp -63.01 -40.94 99.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 399' ' ' ARG . 25.3 t70 -76.56 -52.99 8.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' ND2' ' HG3' ' B' ' 38' ' ' LYS . 14.2 t-20 -66.21 -43.65 86.11 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.59 -33.95 76.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.713 0.768 . . . . 0.0 109.717 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 395' ' ' MET . 28.2 ttm-85 -60.04 -39.92 87.62 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.613 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.59 -34.18 77.65 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.389 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 95.2 t -62.68 -46.95 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.25 92.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.907 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 48.9 tp -63.59 -39.0 93.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.068 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 408' ' ' VAL . 40.8 tt0 -58.64 -42.49 88.43 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 12.5 mm-40 -63.93 -40.25 96.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.079 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.3 -39.45 94.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.577 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.49 -39.19 93.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.644 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.6 t -64.09 -42.95 97.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.559 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 79.9 mt-10 -58.5 -43.67 89.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.691 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.901 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.95 -45.94 93.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.407 . . . . 0.0 110.793 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.16 -37.11 85.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.821 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.69 -27.64 65.03 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -116.89 9.6 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.697 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.1 161.53 13.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.563 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.66 109.3 13.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 74.0 t -117.18 131.84 68.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.112 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -127.89 133.86 49.34 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.123 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -90.19 113.05 24.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -117.28 109.55 16.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.432 -174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 49.1 mt-10 -73.92 121.5 21.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.765 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 4.8 p -136.52 158.25 44.88 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 25.5 p -88.76 167.1 13.58 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.723 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -60.97 -43.5 98.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.127 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.21 -40.45 90.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.27 -50.6 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.107 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.92 -28.84 58.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.17 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.5 ttt -61.17 -36.62 80.32 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.817 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 431' ' ' GLN . 90.5 m-20 -37.16 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.028 0.83 . . . . 0.0 113.054 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.9 29.68 16.64 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.475 ' OE1' ' HB3' ' A' ' 429' ' ' ASN . 19.7 mp0 -69.42 100.72 1.42 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.228 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.152 0 O-C-N 124.021 0.826 . . . . 0.0 111.892 178.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -74.15 136.04 42.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.461 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 155.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.073 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -146.68 128.32 15.16 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.959 0.409 . . . . 0.0 111.736 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.08 119.77 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.734 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 14.3 mm-40 -103.8 160.1 15.07 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.1 m -119.87 128.01 53.26 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -89.14 -68.3 0.78 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -155.64 125.3 6.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.586 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.82 -111.57 4.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.785 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.7 2.41 56.3 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.904 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.0 139.77 24.77 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.115 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.423 HH21 ' HD2' ' B' ' 13' ' ' ARG . 5.0 mpt_? -129.6 161.1 31.32 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.517 0.327 . . . . 0.0 110.861 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.567 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 29.9 ttm180 -133.08 129.73 38.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -91.09 -85.66 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.836 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 19.9 m 32.79 89.11 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mp -99.52 118.79 46.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -96.08 113.59 25.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.85 0.357 . . . . 0.0 110.947 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 pt -132.68 -175.41 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.793 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.489 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -76.63 158.94 30.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 120.761 0.315 . . . . 0.0 111.596 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.61 84.17 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 255' ' ' ARG . 2.4 p-10 -57.95 -49.22 77.55 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 p -70.6 -32.06 69.28 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.556 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 20' ' ' ALA . 90.6 mt -62.54 -46.16 97.06 Favored 'Isoleucine or valine' 0 C--N 1.343 0.284 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.945 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 43.9 mt-10 -65.86 -45.55 81.72 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.048 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.4 m -60.39 -45.5 93.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.24 97.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.795 0.331 . . . . 0.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.478 HG11 ' HB1' ' B' ' 55' ' ' ALA . 94.0 t -67.41 -41.16 85.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.768 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 99.7 mttt -55.54 -47.96 75.5 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.195 0.522 . . . . 0.0 109.67 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -65.46 -44.14 88.16 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.112 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.51 -51.09 60.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.206 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.459 HD13 ' HE3' ' B' ' 51' ' ' MET . 90.8 mt -62.74 -42.41 99.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.05 -36.62 77.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -64.22 -43.74 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.013 0.435 . . . . 0.0 110.299 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 96.1 t -65.69 -42.75 93.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.48 94.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.94 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HG2' ' CG ' ' B' ' 42' ' ' ASP . 96.9 mttt -65.66 -35.87 82.01 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.543 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.467 ' HG3' ' ND2' ' A' ' 397' ' ' ASN . 58.6 tttt -58.04 -39.6 78.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.093 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.25 0.96 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.829 0.347 . . . . 0.0 111.842 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 63.46 32.65 14.21 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.806 0.842 . . . . 0.0 112.41 177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.83 -12.75 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.224 0.535 . . . . 0.0 110.951 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 12.4 p-10 -64.8 -32.97 74.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.808 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.94 -3.25 55.25 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.985 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -105.51 6.55 32.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.0 110.202 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.432 ' NH2' ' HA2' ' B' ' 47' ' ' GLY . 47.1 ttt-85 -85.09 117.67 24.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.738 -175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -77.03 -18.73 57.93 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.991 0.424 . . . . 0.0 110.263 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' B' ' 45' ' ' ARG . . . 80.75 2.03 89.75 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.213 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.39 -41.24 96.78 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.291 0.546 . . . . 0.0 111.611 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -103.25 108.79 60.12 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' B' ' 53' ' ' ILE . 38.3 Cg_exo -59.19 143.45 99.76 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.874 2.383 . . . . 0.0 112.345 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.459 ' HE3' HD13 ' B' ' 32' ' ' LEU . 4.8 tpt -64.98 -39.22 93.15 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 22.6 p-10 -65.15 -31.54 72.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.229 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' B' ' 57' ' ' ARG . 9.8 mt -63.64 -45.84 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.833 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.47 -28.55 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.179 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -61.82 -41.76 98.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.285 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.5 pt20 -96.88 11.22 36.62 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.738 ' CZ ' ' HG2' ' A' ' 193' ' ' ARG . 98.7 mtt180 -121.97 -40.17 2.54 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.634 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -109.05 0.13 19.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.099 0.476 . . . . 0.0 110.717 175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.61 -24.4 72.53 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.267 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.27 90.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.578 0.228 . . . . 0.0 111.31 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 15.8 m -63.25 -42.58 99.2 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.484 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.5 p -93.4 10.28 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.42 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -59.6 -41.7 90.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.833 0.349 . . . . 0.0 110.796 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.92 -47.8 81.71 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.643 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -64.66 -36.37 84.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.869 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.2 t -61.9 -43.35 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.794 0.331 . . . . 0.0 110.467 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.77 -41.24 97.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.45 -39.29 96.76 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.673 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.99 -41.34 97.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.739 0.304 . . . . 0.0 111.133 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.44 -41.68 97.58 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.6 ttp -61.45 -43.56 98.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.136 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -61.95 -49.31 76.65 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.571 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -69.92 -38.53 76.28 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -66.01 -35.89 81.8 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.809 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.6 -48.24 82.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.4 tt -67.0 -36.23 76.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.376 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.427 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 16.0 t70 -61.89 -46.12 90.78 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.315 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' B' ' 81' ' ' LYS . . . -67.33 -41.71 84.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.776 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -66.46 -35.69 75.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.041 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.59 -44.48 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.635 0.255 . . . . 0.0 111.299 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 16.3 ptpt -74.24 -35.75 63.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.782 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -89.11 2.93 53.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.678 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.9 mmpt? 62.2 37.06 14.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.677 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.43 127.14 45.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.944 0.402 . . . . 0.0 110.878 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.04 97.94 46.59 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.455 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.67 143.25 92.05 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.687 2.258 . . . . 0.0 112.502 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.79 89.79 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.991 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.48 -129.41 9.74 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.113 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.25 127.76 28.48 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.2 142.94 82.22 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.55 2.167 . . . . 0.0 111.441 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 25.5 m -97.97 116.99 31.3 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.17 0.51 . . . . 0.0 110.835 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -105.33 123.77 48.42 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 41.1 t -116.73 93.15 40.25 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-O 120.939 0.399 . . . . 0.0 110.685 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -88.81 149.17 5.94 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 122.595 2.197 . . . . 0.0 112.106 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.03 -168.41 37.71 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.57 130.73 35.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.112 0.482 . . . . 0.0 110.991 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -87.33 134.98 33.49 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.533 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -122.24 147.75 45.83 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.579 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.86 110.12 18.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.115 0.483 . . . . 0.0 110.5 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.64 -0.9 49.09 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.588 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.39 178.51 5.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.001 0.429 . . . . 0.0 111.502 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.58 151.21 42.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.668 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -115.0 137.0 52.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.765 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.8 m -123.81 135.01 53.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.746 0.308 . . . . 0.0 111.345 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -143.4 157.32 44.55 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 29.5 m -132.92 143.13 49.28 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.89 130.21 69.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.908 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -93.43 126.22 38.45 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 56.2 p90 -148.3 156.64 42.78 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.908 0.385 . . . . 0.0 111.945 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -87.63 165.76 15.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.437 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.37 163.54 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.264 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -127.44 130.5 23.7 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -96.23 161.23 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.259 2.639 . . . . 0.0 111.497 173.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -106.52 157.51 17.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.489 HG11 HD23 ' B' ' 350' ' ' LEU . 73.6 t -124.15 138.81 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.61 117.08 33.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.61 125.87 35.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.164 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -139.09 154.54 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.472 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.6 16.78 79.83 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.475 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.18 -40.11 93.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.988 0.423 . . . . 0.0 111.263 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -71.52 -15.98 62.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.218 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.97 3.64 45.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.397 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 92.4 mt -88.65 114.19 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.196 0.522 . . . . 0.0 110.032 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -105.13 129.04 53.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.06 129.34 74.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -94.56 135.87 35.51 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 83.8 tttt -112.27 97.66 40.19 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.439 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.91 130.55 13.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.063 1.842 . . . . 0.0 111.008 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.6 mm -103.27 114.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.6 m -133.81 162.42 39.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.574 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.05 167.91 20.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.29 117.49 45.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -92.12 172.57 8.34 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.209 0.528 . . . . 0.0 111.888 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.75 -36.09 79.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.12 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.9 -37.32 86.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.728 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -63.5 -41.06 98.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.966 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 97.4 t -61.56 -45.97 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.624 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.72 -38.34 87.55 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.386 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.56 -44.32 98.13 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.819 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 26.8 ttt -67.09 -39.78 86.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.652 0.263 . . . . 0.0 110.726 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 93.6 mt -62.16 -42.21 99.05 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.07 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.7 -43.84 93.93 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.801 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 20.0 m -62.59 -44.11 97.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.589 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.33 -40.06 95.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.374 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 10.5 mmm180 -62.52 -37.18 85.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.971 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -72.38 -19.18 61.66 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.3 mm100 -81.56 -8.7 59.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -116.83 129.38 56.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' B' ' 243' ' ' ARG . . . -175.72 161.42 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.597 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 87.0 m -108.36 138.06 45.28 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.545 0.338 . . . . 0.0 110.124 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 44.3 p90 -81.54 138.68 35.4 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -132.96 147.32 52.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.027 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -75.81 138.63 41.28 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.563 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 61.2 pttt -150.29 167.93 25.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -136.13 110.06 8.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -143.44 7.28 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.426 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -83.71 163.54 20.18 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 0.0 111.611 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.456 HG22 HG21 ' B' ' 240' ' ' VAL . 48.5 t -89.26 131.12 37.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.457 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -92.47 -168.52 1.99 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.634 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -95.42 -2.71 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.796 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' B' ' 189' ' ' MET . 14.8 pt-20 -144.14 40.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.01 0.433 . . . . 0.0 111.601 -176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -93.4 169.22 10.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.443 0.64 . . . . 0.0 112.608 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -107.8 107.79 18.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.2 m -114.55 155.09 15.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 121.256 0.55 . . . . 0.0 112.14 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -115.35 119.01 34.85 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . 0.576 HG12 HD23 ' B' ' 237' ' ' LEU . 84.1 mt -125.77 128.37 72.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.08 111.28 22.0 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 170.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -143.7 155.54 44.24 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.183 0.516 . . . . 0.0 111.484 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 33.4 m -128.9 134.58 48.31 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.554 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.17 105.58 2.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.508 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -114.31 144.67 42.88 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.75 -81.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.324 . . . . 0.0 110.339 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -112.53 -42.94 3.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.326 0.584 . . . . 0.0 109.535 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -158.15 17.1 0.31 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.157 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -138.94 142.83 38.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.63 143.97 26.91 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -99.68 -176.69 3.34 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.648 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -61.63 -36.34 80.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.08 -175.09 31.78 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.495 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.2 25.81 46.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.153 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -103.65 105.47 15.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.27 152.88 37.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.9 0.381 . . . . 0.0 111.307 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 19.0 t -130.74 -78.18 0.53 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -92.8 72.31 4.88 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.455 0.645 . . . . 0.0 109.753 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -101.59 121.57 42.24 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.944 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.3 m -92.21 115.63 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.477 0.656 . . . . 0.0 110.488 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 57.2 tp -114.56 130.42 56.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.682 -178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.42 115.75 29.98 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.886 0.374 . . . . 0.0 110.226 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' B' ' 161' ' ' GLU . 92.5 mtp -81.59 148.73 28.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.786 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.72 64.35 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.793 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -95.53 0.62 53.27 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.41 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 64.84 59.52 8.0 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.776 ' HG2' ' CZ ' ' A' ' 57' ' ' ARG . 18.8 mtp180 -98.23 -20.55 17.18 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.921 0.391 . . . . 0.0 110.647 -177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.7 mmt -117.22 171.0 8.24 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.96 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.02 135.01 83.93 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.589 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.11 131.41 39.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.998 1.799 . . . . 0.0 110.961 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.68 -36.02 4.67 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.856 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.14 -51.78 65.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.992 0.396 . . . . 0.0 111.095 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.94 -14.95 53.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.071 0.462 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 8.0 m-20 -77.71 -39.96 42.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.232 0.539 . . . . 0.0 110.793 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -65.69 -31.26 79.37 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.165 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.3 pt -83.25 -4.53 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 56.9 mtpt -62.91 129.93 42.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.733 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.41 5.37 61.91 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.973 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -96.0 167.29 11.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.372 0.586 . . . . 0.0 111.407 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.32 158.35 16.6 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.79 96.05 4.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.761 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.481 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -130.27 130.54 44.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.239 0.52 . . . . 0.0 110.615 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -85.4 122.61 29.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -111.67 -46.25 3.27 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.402 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 62.2 m 71.48 102.14 0.07 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.194 0.521 . . . . 0.0 110.266 -175.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.9 tp -119.77 143.49 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.073 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.46 116.47 25.6 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.521 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 73.2 t -113.1 121.3 65.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 29.0 m -98.71 120.02 38.43 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 120.907 0.385 . . . . 0.0 110.533 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 90.1 m-85 -86.02 139.37 34.72 Favored Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -59.76 148.46 87.98 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.27 1.98 . . . . 0.0 112.133 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.417 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 33.2 mm-40 -59.03 -29.88 67.6 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.368 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.41 16.7 7.13 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.991 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -70.54 142.3 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.861 -0.524 . . . . 0.0 111.469 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -65.49 -24.85 67.25 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -96.42 118.39 32.85 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.85 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.461 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 44.1 tt0 -63.78 -31.68 72.94 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.974 0.416 . . . . 0.0 111.919 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -77.08 3.01 13.43 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.622 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.5 mt -132.53 -32.47 1.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.461 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.9 ptmt -57.29 128.02 34.9 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.31 19.78 77.74 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.201 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -125.69 144.55 50.56 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.002 0.43 . . . . 0.0 111.359 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -107.08 107.83 19.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.578 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.89 149.58 21.72 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.085 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -103.85 113.35 26.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -101.37 118.69 37.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.97 -48.42 76.51 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.845 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 63.44 87.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 123.615 0.572 . . . . 0.0 111.174 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -76.38 -43.45 40.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.508 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.576 HD23 HG12 ' B' ' 166' ' ' ILE . 72.2 mt 65.36 169.64 0.2 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.276 0.56 . . . . 0.0 112.081 -176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -165.67 -47.23 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.4 177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.506 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 65.5 mmtt -135.53 144.24 46.19 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.416 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.456 HG21 HG22 ' B' ' 158' ' ' VAL . 58.1 t -135.39 99.48 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.005 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.506 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 5.6 mp0 -93.24 159.25 15.35 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 32.7 tt0 -113.27 169.21 9.11 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.459 ' HB3' ' HB1' ' B' ' 149' ' ' ALA . 58.9 mtm180 -113.88 146.42 40.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.818 0.342 . . . . 0.0 110.756 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -140.14 171.09 14.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.48 129.15 93.43 Favored Pre-proline 0 N--CA 1.469 0.49 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.48 162.37 22.13 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.49 2.793 . . . . 0.0 112.769 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -79.66 92.21 5.34 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.167 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 49.5 tp -80.4 -14.05 58.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.088 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 4.8 m -77.99 64.77 3.26 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 64.62 -52.0 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -47.3 -52.02 17.51 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -87.91 -42.48 12.47 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.952 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.418 ' O ' HG12 ' B' ' 253' ' ' ILE . 18.3 tt -85.59 23.02 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-O 121.31 0.576 . . . . 0.0 111.944 -175.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -71.13 3.81 3.23 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -63.65 -37.14 86.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.1 0.476 . . . . 0.0 110.401 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -84.35 119.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.701 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -87.38 11.68 65.04 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.378 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.49 6.43 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 122.139 0.176 . . . . 0.0 111.193 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 69.81 -77.7 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.755 0.659 . . . . 0.0 112.125 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 6.9 t70 66.26 -169.8 0.2 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.307 0.643 . . . . 0.0 109.52 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 79.04 2.68 87.42 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.005 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 13.0 p -92.15 135.81 33.68 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.298 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.75 -44.53 96.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.994 0.426 . . . . 0.0 110.572 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 1.5 pm0 -65.6 -43.0 90.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.9 -42.6 92.75 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.297 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.439 ' O ' HG23 ' B' ' 270' ' ' VAL . 58.5 tp -62.46 -45.59 92.36 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.667 0.27 . . . . 0.0 111.256 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -65.65 -39.58 91.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.37 -39.56 94.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 46.1 tp10 -66.23 -38.8 88.77 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.203 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 266' ' ' LEU . 69.3 t -64.1 -42.71 96.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.828 0.347 . . . . 0.0 110.271 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.9 tpt180 -58.55 -47.47 84.1 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.385 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.48 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 15.2 ptmt -66.92 -40.29 87.61 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.562 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -65.22 -44.32 88.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.747 0.308 . . . . 0.0 111.553 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.7 mmm -65.67 -44.31 86.65 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 67.3 mt-10 -69.9 -31.21 68.88 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 111.532 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -58.97 -45.26 90.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 110.383 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -87.7 -19.64 27.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.671 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.88 -43.18 96.82 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.2 -45.58 93.99 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.478 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -61.69 -41.49 97.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.31 -42.42 99.01 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.43 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.89 -44.47 98.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 109.802 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -65.16 -42.52 93.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.57 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -63.37 -39.79 95.49 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.752 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.9 -43.77 98.08 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.73 -45.15 88.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.136 0.493 . . . . 0.0 110.527 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.93 -46.71 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.694 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 20.9 p -62.76 -42.25 99.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -64.27 -46.58 83.1 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.959 0.409 . . . . 0.0 110.625 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.35 -48.07 74.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.904 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.31 -45.28 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -66.47 -44.07 83.74 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.263 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.29 -44.31 93.82 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.05 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 350' ' ' LEU . 1.9 tt -63.0 -47.09 84.61 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.817 0.342 . . . . 0.0 110.112 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.59 -42.44 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.301 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.66 -30.85 70.99 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.022 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.95 -36.5 19.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -110.28 107.14 16.79 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 0.0 111.83 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.75 129.12 56.33 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.974 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.2 tp -144.2 151.45 16.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.014 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.84 141.06 58.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 120.894 0.378 . . . . 0.0 110.355 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 31.0 t -116.55 131.33 23.93 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.14 138.99 85.14 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.233 1.956 . . . . 0.0 111.471 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.49 84.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.389 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.58 -42.9 89.08 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.46 -43.82 93.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 311' ' ' ILE . 67.2 mt -65.92 -45.2 91.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.598 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -58.51 -47.55 83.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.244 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 26.3 m -61.49 -43.74 98.32 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.851 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -68.84 -30.0 68.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 93.7 mt -62.23 -42.67 96.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.651 0.262 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.605 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 30.5 t70 -61.41 -41.37 97.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.812 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.5 -44.3 98.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.136 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.21 -40.27 95.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.627 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.58 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 80.8 mtm180 -64.21 -37.87 89.02 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 26.5 mmt180 -59.59 -45.22 92.55 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' B' ' 317' ' ' GLN . 0.5 OUTLIER -70.24 -40.09 74.65 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.144 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.15 96.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.64 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.18 79.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.373 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -63.78 -42.73 97.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.647 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -83.15 -16.63 45.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -72.55 -40.44 66.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.395 0.617 . . . . 0.0 109.556 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . -177.85 -57.03 0.07 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 132.35 114.87 1.61 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.715 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -173.69 101.35 0.11 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.68 146.39 54.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.3 ttmp? 75.8 -34.0 0.23 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.043 0.937 . . . . 0.0 112.763 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.26 -21.94 66.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 110.467 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.99 -24.42 62.74 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.875 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 49.9 tp -62.99 -31.1 72.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.91 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -87.18 -2.2 58.45 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.023 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.29 142.0 89.19 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.382 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -56.41 133.64 59.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.773 2.315 . . . . 0.0 112.88 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' B' ' 334' ' ' ARG . 28.0 ttt85 -66.33 -42.28 88.42 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.357 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 2.2 pm0 -59.84 -25.47 65.04 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.83 -40.53 97.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.848 0.356 . . . . 0.0 111.037 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . 0.438 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 35.6 m-85 -108.53 2.34 22.12 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -60.51 -46.86 88.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.052 0.453 . . . . 0.0 110.584 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.2 -40.61 74.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.59 -41.56 96.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.798 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -66.94 -41.77 86.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.428 ' O ' HG23 ' B' ' 346' ' ' VAL . 89.0 tttt -60.16 -45.69 92.22 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.886 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -61.37 -43.62 98.55 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' B' ' 344' ' ' ARG . 42.1 mtp-105 -65.18 -41.46 94.59 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.384 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 341' ' ' ALA . 90.5 t -64.32 -46.16 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.388 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.577 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 95.8 t -61.94 -46.65 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.555 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.26 -44.1 98.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.759 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.31 -43.43 98.58 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.035 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . . . . . . . . . 93.9 mt -63.76 -42.5 97.82 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 294' ' ' LEU . 97.5 mt -63.4 -45.47 90.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.854 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.97 -39.49 90.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.513 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.93 94.86 Favored Glycine 0 C--O 1.237 0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.573 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -66.34 -36.05 81.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.061 0.458 . . . . 0.0 109.907 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 350' ' ' LEU . 97.7 t -60.59 -43.1 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.92 -44.39 98.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.502 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -67.48 -46.62 72.44 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.02 0.438 . . . . 0.0 110.632 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 21.3 m -64.56 -44.63 90.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.602 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -89.8 5.88 44.13 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.868 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.22 41.08 31.75 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.535 0.522 . . . . 0.0 110.626 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.7 mt -70.05 142.08 52.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.483 . . . . 0.0 111.202 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.67 146.3 50.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.049 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.44 106.42 2.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.754 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 34.2 t70 -83.32 115.63 22.08 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.07 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -61.79 -35.49 78.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.192 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . 0.479 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 57.9 mm-40 -61.46 -46.56 89.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 110.569 -178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -61.79 -43.84 98.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.632 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.85 -47.55 87.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.38 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.06 -42.87 99.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.817 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.57 -42.83 99.84 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.586 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.38 -37.96 88.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.918 0.389 . . . . 0.0 110.984 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.427 HG22 HG12 ' B' ' 385' ' ' ILE . 93.5 mt -62.18 -41.99 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.304 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.19 -46.37 79.44 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -65.71 -41.4 92.34 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.253 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.9 ttp -63.65 -46.72 84.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.324 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.12 -25.35 63.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.192 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.2 t -66.26 -14.72 62.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.667 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -86.29 -1.69 57.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -109.65 168.42 9.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.844 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -56.45 -49.52 74.36 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.088 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -129.97 110.22 16.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 121.019 0.438 . . . . 0.0 110.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.9 -23.91 34.37 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.45 2.1 . . . . 0.0 113.23 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -63.87 -47.23 81.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -69.43 -36.03 76.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.074 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.23 -45.3 94.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.313 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . 0.427 HG12 HG22 ' B' ' 371' ' ' ILE . 95.8 mt -63.46 -44.51 98.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 120.703 0.287 . . . . 0.0 110.911 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.04 -35.51 78.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.654 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.01 -46.3 89.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.948 0.404 . . . . 0.0 110.715 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.62 -28.6 69.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.575 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 11.6 m -87.71 -7.56 57.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.071 0.463 . . . . 0.0 110.732 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -84.01 -35.25 24.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 15.1 t-20 -106.62 122.54 46.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.814 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.13 -37.68 88.19 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.676 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.56 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.6 tp10 -58.31 -46.27 86.46 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.227 0.536 . . . . 0.0 109.939 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.84 -41.33 97.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.707 177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' B' ' 399' ' ' ARG . 92.8 mtp -63.7 -39.75 95.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.436 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' B' ' 399' ' ' ARG . 15.1 t70 -78.0 -52.21 9.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -65.59 -43.71 88.88 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.38 -33.97 76.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.66 0.743 . . . . 0.0 109.456 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' B' ' 395' ' ' MET . 27.2 ttm-85 -60.36 -39.58 87.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.718 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.92 -37.64 87.81 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.963 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.2 -47.18 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.173 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.91 -40.46 95.11 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 48.3 tp -64.03 -38.85 92.59 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.179 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.402 ' O ' HG23 ' B' ' 408' ' ' VAL . 38.8 tt0 -57.28 -43.27 82.95 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.071 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -62.64 -40.22 96.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.036 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -63.48 -39.96 95.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.825 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.72 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.0 t -64.63 -43.22 96.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -60.78 -40.42 92.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.441 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.21 -41.41 97.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.51 -45.92 94.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.99 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.41 -27.75 69.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.336 -177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.54 -36.22 83.05 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.885 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -107.82 -1.33 20.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -90.67 160.65 15.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.816 0.341 . . . . 0.0 110.808 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.66 106.49 12.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 77.1 t -117.74 129.86 73.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.464 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -127.8 134.75 49.48 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.74 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.1 mt-10 -91.14 119.88 31.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.8 111.91 18.58 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.683 -173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.402 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 61.0 mt-10 -77.54 119.53 21.25 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.135 0.493 . . . . 0.0 111.461 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 17.8 p -134.76 159.82 40.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.198 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 72.1 p -87.28 166.52 14.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.921 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.32 -43.57 98.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.165 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -61.33 -39.75 91.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.991 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -56.71 -49.51 74.93 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.32 -28.52 56.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.219 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 26.8 ttt -61.75 -37.22 83.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.1 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -38.78 -74.65 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 O-C-N 124.127 0.892 . . . . 0.0 112.912 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 58.03 40.04 25.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -70.76 106.94 3.74 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.708 0.289 . . . . 0.0 110.512 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.141 -179.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.944 0.402 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -86.34 136.08 33.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 161.03 16.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.706 0.289 . . . . 0.0 110.291 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 17' ' ' ILE . 4.8 p -129.5 139.85 51.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.283 0.564 . . . . 0.0 112.026 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.11 114.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.891 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -105.42 159.97 15.5 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.079 0.466 . . . . 0.0 111.542 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.9 m -119.81 128.31 53.59 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.909 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 p -77.12 -63.56 1.34 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.222 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -168.63 102.41 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.24 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.06 -119.01 8.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.196 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.09 75.87 9.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.856 0.836 . . . . 0.0 110.61 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 13' ' ' ARG . . . -164.07 130.55 2.23 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.286 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HD2' ' C ' ' A' ' 12' ' ' GLY . 3.8 mpt_? -127.85 156.27 42.82 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.873 0.368 . . . . 0.0 111.08 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -134.7 121.77 21.27 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.31 -95.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.435 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m 46.79 95.17 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 4.3 mp -101.49 120.76 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 O-C-N 121.934 -0.479 . . . . 0.0 109.972 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -120.27 128.85 53.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.481 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.44 -90.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.283 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.67 158.26 31.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -39.42 75.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -65.31 -46.23 81.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.848 0.356 . . . . 0.0 111.542 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.2 p -67.47 -39.53 85.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.401 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.4 mt -64.64 -45.32 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.179 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 19.9 tp10 -52.29 -53.38 44.9 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.126 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.4 m -65.99 -45.87 80.07 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.39 90.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 24' ' ' ILE . 75.4 t -60.56 -45.94 96.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.7 mppt? -64.01 -44.15 93.47 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.564 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 m -62.98 -42.25 99.78 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.995 0.426 . . . . 0.0 111.391 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -64.36 -51.5 63.04 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.24 -41.22 99.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.24 -35.6 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.128 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -64.8 -41.27 95.93 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.191 0.519 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.88 -42.87 96.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.234 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.39 73.82 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.87 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.68 -42.1 98.07 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 120.677 0.275 . . . . 0.0 111.441 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.9 ttpt -62.63 -43.55 98.53 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.988 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 41' ' ' ILE . 23.3 m -83.85 -0.63 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.238 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.2 38.37 13.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.908 0.883 . . . . 0.0 111.826 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.482 HD12 HE21 ' B' ' 317' ' ' GLN . 36.7 mm -97.04 -17.32 6.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.897 0.38 . . . . 0.0 111.067 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -64.71 -33.08 75.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.553 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.4 -5.08 58.89 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.989 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.75 6.84 34.41 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.963 0.411 . . . . 0.0 110.489 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.504 HH12 ' HA ' ' A' ' 50' ' ' PRO . 58.0 ttt85 -93.05 120.51 33.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.026 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -92.35 -3.9 54.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.621 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.612 -0.722 . . . . 0.0 114.276 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -65.52 -46.31 80.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.28 0.54 . . . . 0.0 111.972 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.69 107.92 57.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.536 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 53' ' ' ILE . 50.2 Cg_exo -56.81 136.88 78.92 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.487 2.125 . . . . 0.0 111.022 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.3 tpt -64.97 -38.56 91.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.383 -172.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 26.7 p-10 -64.8 -36.51 84.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.871 0.367 . . . . 0.0 111.176 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 50' ' ' PRO . 70.6 mt -63.59 -40.05 87.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.327 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -77.33 -35.51 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.377 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.3 94.3 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.3 pt20 -91.84 9.33 33.23 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HD2' ' NH2' ' B' ' 193' ' ' ARG . 97.1 mtt180 -122.59 -45.44 2.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.618 178.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -105.1 2.99 29.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.898 0.38 . . . . 0.0 111.356 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.49 -25.04 69.82 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.262 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.8 92.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -62.05 -39.95 94.09 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.673 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -106.64 12.47 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.048 0.451 . . . . 0.0 111.163 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -59.07 -44.4 91.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.718 0.294 . . . . 0.0 111.334 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.5 -42.24 78.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.062 0.458 . . . . 0.0 110.661 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.96 -38.8 92.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 62' ' ' VAL . 92.8 t -61.74 -38.44 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.056 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -40.25 90.32 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 -40.72 98.74 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.993 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 73' ' ' ARG . 35.6 t70 -65.88 -38.62 89.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.814 0.34 . . . . 0.0 110.744 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.55 -43.76 96.88 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 ttp -61.63 -45.59 93.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.219 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.8 m -62.23 -46.81 87.19 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.037 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 15.0 mtm180 -69.74 -43.7 71.76 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.975 0.417 . . . . 0.0 111.362 -177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -66.72 -39.08 87.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -60.68 -46.57 89.83 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.1 tt -65.66 -41.35 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.417 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.46 -39.86 92.5 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.42 0.629 . . . . 0.0 110.64 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.2 87.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.234 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.4 pt -67.55 -27.62 39.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.349 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.39 -43.77 94.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -29.67 50.94 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -87.66 -5.27 58.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.032 0.444 . . . . 0.0 110.598 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? 60.01 41.55 17.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.198 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.6 mt -98.51 122.89 50.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.158 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -106.32 101.53 35.55 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.16 139.77 85.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.336 2.024 . . . . 0.0 111.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.71 95.67 10.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.427 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.28 -101.18 2.77 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.799 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.35 133.23 9.46 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.97 141.64 59.08 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.103 1.869 . . . . 0.0 110.702 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.9 m -82.15 115.81 21.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.21 0.529 . . . . 0.0 110.616 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 70.7 m-85 -90.6 98.01 11.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.237 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.65 103.39 23.96 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.044 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 63.5 Cg_endo -92.7 142.42 2.22 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 122.671 2.247 . . . . 0.0 112.0 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.63 -162.9 36.3 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.44 149.61 25.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 117.045 0.423 . . . . 0.0 110.296 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -117.92 126.53 52.53 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.991 0.424 . . . . 0.0 110.363 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.8 mttt -103.81 138.95 39.69 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.6 tp -68.13 110.71 4.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 111.632 -174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.83 -7.94 53.68 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.181 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -105.63 -170.86 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.847 0.356 . . . . 0.0 110.706 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.36 172.79 11.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.377 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.45 140.12 51.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.452 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.3 m -124.08 133.23 53.67 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.104 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.9 156.31 46.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.935 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -96.11 -73.8 0.58 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.6 t 68.45 98.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.133 0.573 . . . . 0.0 110.028 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -100.77 145.28 28.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.35 -174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -156.21 162.29 40.19 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.944 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 305' ' ' ALA . 21.4 mm-40 -98.65 166.51 11.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.15 0.58 . . . . 0.0 111.513 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.14 167.17 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 122.882 0.473 . . . . 0.0 111.677 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -104.02 149.74 37.54 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.09 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -99.04 -176.11 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 123.394 2.729 . . . . 0.0 112.564 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.82 138.37 52.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.453 HG22 HG12 ' A' ' 300' ' ' ILE . 47.9 t -123.9 138.19 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -111.35 140.7 45.72 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.452 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.17 129.88 36.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.643 0.258 . . . . 0.0 110.368 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -140.63 144.9 36.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.76 18.5 79.62 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 114.49 0.556 . . . . 0.0 114.49 175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.54 -42.91 99.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 117.055 0.428 . . . . 0.0 111.646 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 1.5 mp0 -69.28 -21.17 63.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.1 0.476 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -85.01 4.32 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.789 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.1 mt -82.29 115.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.444 0.64 . . . . 0.0 110.415 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.64 122.75 38.73 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.744 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.79 123.68 70.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.139 0.495 . . . . 0.0 111.622 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.5 130.18 55.27 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.582 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.7 tttt -109.26 100.42 40.94 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.012 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.66 123.11 7.81 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.316 2.01 . . . . 0.0 110.916 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.4 mm -96.52 114.15 32.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.3 m -132.96 161.29 41.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.454 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -132.54 166.01 23.06 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.714 0.293 . . . . 0.0 110.831 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.2 t -101.99 118.42 48.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.8 p -96.98 173.72 7.14 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.904 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -34.93 76.46 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.708 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.96 94.92 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.493 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.77 -42.63 97.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.67 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 92.1 t -64.32 -44.62 97.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.832 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.81 -45.15 90.63 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.5 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.53 98.7 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.642 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -65.2 -42.09 93.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.014 0.435 . . . . 0.0 110.415 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.1 -40.73 98.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.429 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 146' ' ' LYS . 20.0 t70 -58.23 -44.13 88.1 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.387 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 19.6 m -61.64 -46.13 91.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.57 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.63 -41.55 99.09 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.773 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -62.03 -42.44 99.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.734 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HE3' ' OE2' ' A' ' 161' ' ' GLU . 44.6 mttp -63.55 -38.56 91.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.5 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 143' ' ' THR . 28.9 mt-30 -60.39 -38.13 82.98 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -98.03 8.4 44.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 135.8 53.95 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.811 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.7 m -72.31 138.32 47.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.768 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 243' ' ' ARG . 19.5 p90 -94.08 144.42 25.5 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 176.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -138.18 131.28 30.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.788 0.328 . . . . 0.0 111.367 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.85 121.95 19.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.512 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -164.9 162.33 20.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.387 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.62 89.28 7.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -126.49 -117.79 2.16 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.64 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.69 -172.25 3.26 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 204' ' ' GLY . 46.4 t -119.64 123.8 71.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -99.84 -161.62 0.88 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.312 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.65 -28.69 15.22 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.565 ' OE2' ' HE3' ' A' ' 146' ' ' LYS . 1.2 pm0 -107.32 12.52 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.12 175.95 5.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.689 0.757 . . . . 0.0 112.9 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -119.9 124.91 47.19 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 240' ' ' VAL . 30.9 m -114.61 153.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.306 0.574 . . . . 0.0 112.335 -175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.0 m -113.35 94.03 4.68 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.478 HG12 HD23 ' A' ' 237' ' ' LEU . 70.5 mt -117.4 117.93 56.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.185 0.517 . . . . 0.0 112.243 -175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 183' ' ' SER . 12.9 p-10 -88.99 119.13 29.24 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.19 162.17 36.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.314 0.578 . . . . 0.0 111.739 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.6 m -124.62 131.34 53.48 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.406 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.53 101.58 2.37 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.128 -0.558 . . . . 0.0 114.314 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.8 m -98.7 131.97 44.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.3 t -70.44 -75.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-O 120.881 0.372 . . . . 0.0 110.434 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.86 -41.57 1.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.863 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -148.06 9.99 1.16 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.361 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.85 159.76 40.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.359 -0.238 . . . . 0.0 110.359 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -94.17 168.24 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.086 0.469 . . . . 0.0 111.107 -178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -120.62 -176.99 3.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.036 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.53 -39.22 90.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.07 -159.59 31.4 Favored Glycine 0 C--O 1.225 -0.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.644 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.33 37.99 46.67 Favored Glycine 0 C--O 1.225 -0.426 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.232 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.11 122.77 40.74 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 185' ' ' PHE . . . -139.64 145.72 38.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 167' ' ' ASP . 9.6 t -110.05 -45.51 3.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 109.871 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -117.44 -61.17 1.74 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.447 ' HB2' ' HB1' ' A' ' 182' ' ' ALA . 49.8 t80 52.66 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.269 1.028 . . . . 0.0 112.791 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.7 97.65 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.74 0.781 . . . . 0.0 110.596 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.0 tp -100.1 122.59 43.2 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.732 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.547 ' HB3' HH12 ' B' ' 57' ' ' ARG . . . -94.84 125.28 39.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.421 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 85.9 mtp -91.43 164.29 13.87 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.216 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.7 5.25 88.36 Favored Glycine 0 CA--C 1.499 -0.958 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.382 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -102.43 -3.65 26.66 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.81 0.338 . . . . 0.0 110.427 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.7 34.74 90.74 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.072 -0.585 . . . . 0.0 111.767 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.664 ' NH2' ' HD2' ' B' ' 57' ' ' ARG . 10.7 mtp180 -86.34 -19.4 29.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.75 -173.08 2.18 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.192 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.46 HD11 ' CD2' ' A' ' 217' ' ' PHE . 24.1 mt -69.24 135.66 89.05 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -55.73 125.52 19.38 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.306 1.337 . . . . 0.0 109.249 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 102.81 -27.37 20.55 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.862 -175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -73.53 -54.46 8.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.414 0.607 . . . . 0.0 110.737 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.01 -13.45 59.78 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.511 0.672 . . . . 0.0 110.13 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.422 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 14.1 m-20 -83.53 -31.31 26.49 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.694 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.76 -36.36 91.09 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.824 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.23 -15.93 17.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -63.62 128.69 36.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.707 0.289 . . . . 0.0 110.279 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.454 ' H ' ' HB ' ' A' ' 158' ' ' VAL . . . 97.58 -11.16 64.92 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.621 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -89.09 158.17 18.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.219 0.51 . . . . 0.0 111.355 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.82 153.09 19.8 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.797 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.21 25.16 0.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.15 25.91 1.58 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -136.36 134.08 37.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.873 0.368 . . . . 0.0 110.304 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -96.68 114.86 26.55 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.198 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -127.18 115.06 18.52 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 23.0 m -72.66 124.84 26.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 120.97 0.414 . . . . 0.0 110.514 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.09 130.3 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.074 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.34 108.75 20.86 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.05 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.0 137.13 56.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.163 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 23.5 m -98.13 129.91 44.91 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 120.83 0.348 . . . . 0.0 111.477 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' CD2' HD11 ' A' ' 195' ' ' ILE . 77.6 m-85 -74.47 147.05 84.62 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.456 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.01 151.74 83.12 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.608 2.205 . . . . 0.0 112.609 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.402 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 70.8 mm-40 -58.9 -38.03 77.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.772 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -91.49 35.27 0.94 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.043 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.96 138.61 39.76 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.16 -24.01 67.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -100.93 117.65 35.39 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.4 tt0 -63.81 -34.8 78.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.31 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.548 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.8 p-10 -67.5 -13.85 62.41 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.694 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.548 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.1 mt -119.45 -12.83 9.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 224' ' ' GLU . 22.9 ptmt -65.01 129.36 39.43 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.088 0.471 . . . . 0.0 112.045 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.78 29.11 74.38 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.535 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.53 143.89 45.64 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.846 0.355 . . . . 0.0 111.633 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -97.58 102.05 13.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.641 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.95 143.41 29.27 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.14 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -114.86 113.42 24.18 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.3 m-85 -98.36 125.46 43.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.661 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.23 -35.98 82.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.903 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 46.1 mm 63.66 92.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 123.63 0.582 . . . . 0.0 111.172 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -77.3 -56.75 4.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.48 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.478 HD23 HG12 ' A' ' 166' ' ' ILE . 82.1 mt 65.75 167.45 0.2 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.397 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 237' ' ' LEU . 0.1 OUTLIER 175.77 -40.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.583 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -133.59 122.7 23.91 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 120.906 0.384 . . . . 0.0 111.887 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.425 HG11 HG22 ' A' ' 158' ' ' VAL . 99.2 t -135.51 105.95 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -96.49 106.72 19.01 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.9 0.381 . . . . 0.0 110.977 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -63.82 139.58 58.78 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.577 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 151' ' ' TRP . 57.6 mtt180 -82.45 157.9 23.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.846 0.831 . . . . 0.0 112.871 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -141.9 161.62 37.53 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 74.8 mt -56.07 128.43 71.62 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 120.658 0.265 . . . . 0.0 111.536 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.55 158.2 47.88 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.388 2.725 . . . . 0.0 113.405 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -77.56 163.58 26.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.257 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.4 tp -95.16 33.87 1.48 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.922 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -68.54 -23.25 64.5 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 74.89 -33.13 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 254' ' ' LYS . 46.6 mt-10 -59.43 -45.9 90.24 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.929 0.395 . . . . 0.0 111.531 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.29 -44.7 82.76 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 255' ' ' ARG . 18.0 tt -81.36 -5.41 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 251' ' ' GLU . 23.0 ptmt -76.17 16.98 0.38 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.6 -0.687 . . . . 0.0 111.315 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 253' ' ' ILE . 1.8 tpp180 -67.99 -21.17 65.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.715 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -70.8 -28.09 64.38 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 117.1 -15.19 13.5 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.592 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 25.7 t -84.58 149.22 4.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 260' ' ' ASP . 1.7 mp0 -44.51 -72.75 0.05 Allowed 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.56 0.537 . . . . 0.0 111.339 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 259' ' ' GLU . 4.8 p-10 176.36 136.92 0.06 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.417 0.448 . . . . 0.0 110.93 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 66.92 -129.32 29.67 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 115.991 -0.549 . . . . 0.0 114.188 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.7 t 66.74 95.44 0.06 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.599 0.759 . . . . 0.0 111.304 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.86 -44.96 99.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.594 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 1.3 pm0 -66.53 -38.5 87.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.564 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.2 -44.02 91.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.115 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 270' ' ' VAL . 65.1 tp -61.98 -47.46 84.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.702 0.286 . . . . 0.0 110.888 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -65.59 -40.17 92.41 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -65.0 -43.29 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.133 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 38.7 tp10 -66.31 -40.12 89.76 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 266' ' ' LEU . 80.6 t -65.15 -44.11 95.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.295 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -60.64 -46.16 91.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.751 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 16.3 ptmt -62.63 -44.18 96.93 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.128 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -67.25 -40.51 86.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.12 -42.52 99.31 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.783 0.325 . . . . 0.0 111.611 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.34 -21.53 49.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -67.44 -45.07 77.11 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.586 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.66 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.22 -40.62 96.73 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -57.92 -46.7 84.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.7 m -62.85 -42.28 99.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.707 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.87 98.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.49 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.13 -45.39 98.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.109 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -66.28 -45.59 79.95 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.099 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.04 -41.62 95.05 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -63.38 -43.17 98.38 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.791 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.9 -41.66 82.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.213 0.53 . . . . 0.0 110.303 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.76 -47.46 84.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.433 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -62.28 -49.72 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.1 -47.42 71.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.878 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.7 -45.33 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -66.66 -38.72 87.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.694 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.57 -47.09 91.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.6 -44.72 93.19 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 94.6 t -65.68 -44.12 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.033 0.444 . . . . 0.0 111.412 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -63.96 -38.56 91.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.132 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.14 13.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -127.28 127.85 45.03 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.188 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.13 157.32 30.41 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.453 HG12 HG22 ' A' ' 115' ' ' VAL . 10.7 tp -135.17 151.44 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.58 136.34 56.24 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.366 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 345' ' ' VAL . 66.0 t -126.4 125.55 24.55 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.596 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 302' ' ' VAL . 16.5 Cg_exo -67.56 151.97 78.92 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.897 2.398 . . . . 0.0 111.782 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.47 -34.71 78.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.165 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.579 ' HB2' ' HG3' ' A' ' 110' ' ' GLU . . . -48.91 -54.64 14.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.03 -43.7 94.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.924 -177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 311' ' ' ILE . 83.7 mt -64.88 -46.61 91.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -63.58 -44.04 95.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.347 -175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 45.0 m -61.87 -43.5 98.73 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.6 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 344' ' ' ARG . 62.5 mm-40 -66.86 -30.34 70.49 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.366 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 307' ' ' ILE . 85.3 mt -61.99 -41.71 92.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 17.4 t70 -58.37 -42.57 87.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.495 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.16 -45.71 98.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.506 0.669 . . . . 0.0 109.646 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 340' ' ' GLN . 97.2 mt -63.86 -39.04 93.26 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.135 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.501 ' HG2' ' CE1' ' A' ' 337' ' ' PHE . 21.7 mtm180 -62.1 -38.5 89.12 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 25.3 mmt180 -60.98 -41.6 96.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.551 HE21 HD12 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -66.01 -47.95 72.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.749 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.8 97.3 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' A' ' 332' ' ' LEU . . . -63.93 -41.19 97.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.962 0.41 . . . . 0.0 110.719 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.467 HE21 HG11 ' B' ' 62' ' ' VAL . 24.9 tm0? -65.04 -45.66 84.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.415 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -69.39 -34.51 74.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.68 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.99 -44.66 94.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.241 0.543 . . . . 0.0 109.608 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -173.72 -70.66 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.48 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 154.79 109.43 0.33 Allowed Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -165.41 99.63 0.71 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 144.95 52.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.8 ttmp? 77.73 -34.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.058 0.943 . . . . 0.0 112.829 176.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -69.83 -17.1 63.37 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.405 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 315' ' ' ARG . . . -59.33 -27.18 65.67 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.682 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 66.4 tp -61.73 -37.96 86.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.842 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.57 18.34 4.01 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.753 -174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 319' ' ' ALA . 60.8 mt -80.65 153.38 73.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 122.196 -0.315 . . . . 0.0 110.92 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.25 133.37 54.72 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.508 2.138 . . . . 0.0 112.369 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.431 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.1 ttt85 -70.3 -40.3 74.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.774 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.0 -27.28 61.45 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.13 -39.0 93.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.946 0.403 . . . . 0.0 111.117 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 315' ' ' ARG . 27.8 m-85 -105.7 -14.03 15.38 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -55.69 -46.46 77.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.901 0.382 . . . . 0.0 111.421 -176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -68.88 -49.57 57.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.848 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.51 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.8 pt20 -69.2 -32.16 71.26 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.778 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.38 90.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 110.481 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.73 -39.06 92.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -61.23 -41.39 96.79 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.298 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.418 ' HD3' ' OE1' ' A' ' 310' ' ' GLU . 63.8 mtt180 -60.54 -46.81 88.81 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.33 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 58.6 t -64.94 -46.54 91.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.449 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.29 -46.84 95.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.285 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.49 -44.76 98.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.16 99.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.284 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.6 mt -63.7 -44.49 93.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.641 0.258 . . . . 0.0 110.739 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.3 mt -63.7 -44.82 92.51 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.28 -41.32 94.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.768 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.02 -42.6 98.45 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.047 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -69.26 -33.79 73.78 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.787 0.293 . . . . 0.0 111.244 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 350' ' ' LEU . 77.6 t -60.63 -43.94 95.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 360' ' ' LEU . 89.1 mt -62.95 -45.48 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.001 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -64.07 -51.37 64.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 99.7 m -61.01 -43.79 98.38 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -91.73 9.53 32.15 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.913 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 37.56 66.2 0.48 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.16 0.984 . . . . 0.0 112.625 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.422 ' HB2' HG23 ' A' ' 355' ' ' ILE . 83.3 mt -82.09 155.36 25.11 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.55 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.34 146.88 50.64 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.54 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.91 130.73 44.28 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.19 111.87 24.46 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -63.5 -37.7 88.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.894 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -65.13 -40.57 94.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.945 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -60.03 -43.26 95.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.241 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 89.0 t -64.55 -43.83 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.642 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -59.7 -44.71 93.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.675 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.1 99.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.87 -37.64 88.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.927 0.394 . . . . 0.0 111.015 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 92.8 mt -62.25 -42.64 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.098 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.87 96.59 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -63.42 -31.09 72.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.058 0.456 . . . . 0.0 110.477 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 53.8 ttp -83.53 -44.37 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.079 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -71.99 -14.25 61.84 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.7 p -81.2 -4.97 57.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.883 0.373 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.43 -0.69 57.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.581 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.1 164.06 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.833 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.98 -45.98 86.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.755 0.312 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -120.93 107.06 38.36 Favored Pre-proline 0 CA--C 1.513 -0.443 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.856 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.24 -26.24 12.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.137 1.891 . . . . 0.0 112.994 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -66.57 -47.59 72.31 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.57 -33.03 72.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 91.8 t -64.11 -46.04 94.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.185 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.07 -42.58 97.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.083 0.468 . . . . 0.0 109.856 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -59.39 -44.21 92.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.468 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -60.12 -45.07 94.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.501 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -42.6 97.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.427 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 15.6 m -68.58 -38.7 80.89 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.648 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -63.44 -43.06 98.48 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 17.4 t-20 -95.58 114.97 26.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.986 0.422 . . . . 0.0 111.343 -176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -62.04 -33.16 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.749 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 6.3 tp10 -59.26 -45.08 92.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.913 0.387 . . . . 0.0 110.31 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.24 -41.1 99.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.715 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.8 mtp -61.45 -47.94 83.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.793 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.43 -47.49 73.05 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.505 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 20.5 t-20 -63.72 -40.39 96.63 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.355 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.28 -32.69 74.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.715 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.3 mtt-85 -58.66 -40.67 84.15 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -63.62 -39.41 94.3 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.6 -49.43 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.84 79.51 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.748 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 355' ' ' ILE . 35.0 tp -64.93 -32.13 73.7 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.994 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 37.6 tt0 -55.5 -47.34 76.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.898 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 41.1 mt-10 -62.67 -40.96 98.72 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.498 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -62.61 -41.0 98.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.757 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.62 96.69 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 96.1 t -65.21 -43.89 95.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.42 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 86.8 mt-10 -59.94 -37.56 79.87 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.637 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.13 96.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.995 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.26 -43.6 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.04 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 65.4 mt -61.89 -33.1 73.6 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.426 -177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.43 -33.96 71.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.295 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -108.94 2.95 21.76 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.4 167.9 11.66 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.742 0.306 . . . . 0.0 110.368 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -86.01 104.12 15.33 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.064 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.56 129.79 66.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.185 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.1 t -126.06 134.82 51.29 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.94 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.582 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 63.2 mt-10 -99.23 130.98 45.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.112 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -134.84 125.76 27.47 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.894 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 47.3 mt-10 -70.28 122.31 19.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.98 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 5.3 p -136.55 156.23 48.86 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.005 0.431 . . . . 0.0 111.746 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 1.3 m -88.28 158.85 18.34 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -58.97 -43.92 91.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.9 -39.0 80.15 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.197 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -62.28 -44.69 95.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.413 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.4 -32.48 70.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.821 0.343 . . . . 0.0 110.998 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.93 -28.94 66.71 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.583 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -67.85 96.99 0.61 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.136 0.493 . . . . 0.0 110.251 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -123.34 34.48 5.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.545 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.21 98.08 3.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.34 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.391 177.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 120.787 0.327 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -82.17 135.84 35.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.082 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.46 159.79 20.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' B' ' 17' ' ' ILE . 9.2 p -131.08 137.75 49.25 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 121.081 0.467 . . . . 0.0 111.95 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.24 125.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.996 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 19.2 mm-40 -114.62 158.73 21.34 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.179 0.514 . . . . 0.0 111.61 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 96.5 m -120.3 127.99 52.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.436 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 p -76.31 -71.68 0.37 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 120.785 0.326 . . . . 0.0 110.849 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -157.88 108.33 2.18 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.883 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.21 -120.81 16.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.005 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.23 78.26 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.304 0.573 . . . . 0.0 110.211 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.63 126.26 1.43 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -121.38 157.55 30.24 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.346 0.593 . . . . 0.0 111.394 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 41.0 ttm180 -134.82 119.27 17.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.48 -91.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.242 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 44.6 m 45.01 93.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.433 ' HA ' ' OG ' ' B' ' 4' ' ' SER . 4.1 mp -101.24 120.81 51.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 47.4 p -124.03 130.75 53.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.596 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 38.6 mt -132.26 -89.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.78 0.324 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.14 158.45 36.35 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.841 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.44 -43.48 83.93 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.86 -44.43 89.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.856 0.36 . . . . 0.0 111.484 -177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.4 p -66.96 -41.85 86.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 28' ' ' VAL . 95.7 mt -64.86 -44.05 96.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.96 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' B' ' 29' ' ' LYS . 18.6 tp10 -51.33 -53.48 35.68 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.276 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 93.1 m -66.63 -45.67 78.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.843 0.354 . . . . 0.0 111.912 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 24' ' ' ILE . 75.0 t -60.15 -46.91 93.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' B' ' 25' ' ' GLU . 2.9 mppt? -63.68 -43.2 97.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 0.0 111.304 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.6 m -63.02 -43.95 97.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.681 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.82 -47.83 70.8 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.861 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -41.14 98.82 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.16 -35.54 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.774 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -64.75 -41.95 95.52 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.051 0.453 . . . . 0.0 110.52 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.9 -42.48 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.737 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -35.27 72.41 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.818 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.45 -42.18 98.65 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.645 0.26 . . . . 0.0 111.521 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.505 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 34.9 ttpt -63.17 -43.74 97.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.249 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.51 HG23 HG12 ' B' ' 41' ' ' ILE . 17.1 m -83.1 -1.46 5.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.054 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 62.69 39.37 11.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.682 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.551 HD12 HE21 ' A' ' 317' ' ' GLN . 45.5 mm -97.42 -18.99 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.065 0.459 . . . . 0.0 110.86 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -64.29 -32.04 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.44 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.82 -5.43 57.26 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.921 -0.582 . . . . 0.0 113.068 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -104.23 1.05 30.11 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.937 0.399 . . . . 0.0 110.621 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.495 HH12 ' HA ' ' B' ' 50' ' ' PRO . 57.3 ttt85 -86.87 123.43 32.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.851 -177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -94.95 -5.56 44.45 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 121.11 0.481 . . . . 0.0 110.707 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.6 7.9 86.82 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.703 -0.68 . . . . 0.0 114.491 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.05 -46.84 85.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 117.45 0.625 . . . . 0.0 112.089 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 t -103.28 107.52 55.92 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.495 ' HA ' HH12 ' B' ' 45' ' ' ARG . 50.2 Cg_exo -57.32 137.22 80.62 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.625 2.217 . . . . 0.0 111.028 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 9.5 tpt -65.51 -37.49 86.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.99 -172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 27.4 p-10 -63.48 -39.17 93.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.723 0.297 . . . . 0.0 111.236 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' B' ' 50' ' ' PRO . 79.4 mt -64.05 -37.43 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.572 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.33 -34.97 15.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.233 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.03 94.56 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 8.6 pt20 -92.43 10.9 28.08 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.664 ' HD2' ' NH2' ' A' ' 193' ' ' ARG . 98.0 mtt180 -121.68 -45.3 2.3 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.6 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.91 5.72 30.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.003 0.43 . . . . 0.0 111.563 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.75 -13.66 69.17 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.794 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.95 -38.35 64.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.674 0.273 . . . . 0.0 111.248 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -61.44 -42.14 98.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.258 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.4 p -106.01 13.78 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.069 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -58.27 -44.99 88.68 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.765 0.317 . . . . 0.0 111.245 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.35 -41.49 85.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -65.43 -37.97 88.48 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.667 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 62' ' ' VAL . 97.1 t -61.63 -39.16 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.83 -40.73 93.88 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.69 99.07 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.624 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' B' ' 73' ' ' ARG . 37.2 t70 -65.59 -38.43 89.48 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.719 177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.05 -43.56 98.71 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 53.1 ttp -61.5 -45.12 95.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.079 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 47.2 m -62.64 -46.94 85.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.199 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 69' ' ' ASP . 26.1 mtm180 -69.39 -45.15 69.98 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.155 0.502 . . . . 0.0 111.343 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -66.33 -39.76 89.45 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -60.69 -46.61 89.71 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 13.6 tt -65.73 -41.9 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.271 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.48 -37.33 84.86 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.258 0.551 . . . . 0.0 110.9 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.79 85.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.953 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 45.6 pt -68.11 -25.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.67 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -43.73 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.871 0.367 . . . . 0.0 110.729 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.57 35.26 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.011 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -86.55 -7.36 58.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? 60.0 38.86 20.57 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.176 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.438 ' HA ' ' OH ' ' B' ' 112' ' ' TYR . 73.2 mt -98.59 125.62 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.713 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -110.05 102.52 51.09 Favored Pre-proline 0 C--N 1.314 -0.957 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.8 139.77 82.01 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.493 2.128 . . . . 0.0 111.907 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.13 99.93 12.57 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.158 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.62 -104.44 3.18 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.447 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.33 134.26 10.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.51 136.51 39.81 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.899 1.733 . . . . 0.0 110.553 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -74.43 119.4 18.58 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.909 0.385 . . . . 0.0 110.16 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 62.8 m-85 -95.21 98.13 10.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.37 102.48 21.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 72.6 Cg_endo -91.5 142.49 2.87 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.81 2.34 . . . . 0.0 112.466 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.9 -163.5 36.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.717 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.39 136.04 34.03 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.776 0.322 . . . . 0.0 110.667 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -108.64 122.38 46.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.857 0.36 . . . . 0.0 110.469 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.7 mttt -100.28 148.04 25.1 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.06 105.02 4.34 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.152 0.501 . . . . 0.0 111.867 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.24 39.89 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.655 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 4.0 mp0 -100.97 -176.34 3.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.822 0.344 . . . . 0.0 110.806 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -83.01 171.06 14.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -124.89 145.95 49.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.088 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 90.6 m -126.02 135.67 52.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.583 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -145.5 155.99 43.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 15.3 m -97.4 -74.41 0.57 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t 66.46 95.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.61 0.719 . . . . 0.0 109.623 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.71 143.03 30.42 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.326 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.98 164.59 38.27 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' B' ' 305' ' ' ALA . 25.2 mm-40 -100.66 164.41 11.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.269 0.628 . . . . 0.0 112.09 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.63 167.76 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' B' ' 84' ' ' ILE . 56.8 m-85 -104.2 148.64 36.25 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.135 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -98.9 -173.31 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.401 2.734 . . . . 0.0 112.386 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.92 145.2 50.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' B' ' 349' ' ' LEU . 58.2 t -126.42 137.91 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 111.767 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -114.81 141.42 47.91 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.425 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 93.7 mt -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -139.82 144.06 37.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.34 21.86 78.32 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.05 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.05 -42.26 97.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.959 0.409 . . . . 0.0 111.601 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.03 -15.73 63.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.719 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.23 4.58 52.96 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.888 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 93.2 mt -84.19 109.08 17.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.359 0.599 . . . . 0.0 110.062 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -92.88 123.79 36.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.835 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' B' ' 417' ' ' VAL . 61.1 t -119.91 127.92 75.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.081 0.467 . . . . 0.0 111.785 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -109.61 134.77 51.55 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 74.5 tttt -114.62 96.42 43.7 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.941 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.52 133.41 24.11 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.065 1.843 . . . . 0.0 110.765 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.5 mm -103.93 115.46 45.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.94 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.19 161.37 41.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.695 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.43 164.94 26.32 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.78 0.324 . . . . 0.0 110.953 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.97 120.66 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.4 p -100.66 174.3 6.13 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.274 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.09 -36.63 82.3 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 120.976 0.417 . . . . 0.0 110.233 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.27 85.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.16 -43.06 96.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.296 0.569 . . . . 0.0 109.623 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.05 -44.76 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.096 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -59.14 -44.4 92.06 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.016 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.75 -42.02 99.69 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.445 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -65.81 -41.36 91.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.822 0.344 . . . . 0.0 110.706 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.65 -41.39 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.67 -40.26 91.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.815 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -62.05 -45.67 92.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.343 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.94 -40.62 98.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.411 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -61.37 -44.43 97.17 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.998 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -63.65 -38.65 91.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.695 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -59.83 -36.43 76.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.066 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -98.84 7.16 46.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.29 136.27 55.59 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.805 0.336 . . . . 0.0 110.753 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 21.6 m -74.88 140.32 43.76 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.383 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.49 ' HA ' ' HA ' ' B' ' 243' ' ' ARG . 11.3 p90 -96.71 142.79 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.604 177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -134.8 130.16 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.886 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -72.05 119.53 16.36 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.385 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -163.78 165.31 23.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.161 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.84 99.32 11.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -138.51 -119.28 1.72 Allowed Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.837 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -138.31 -171.94 3.16 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.713 0.292 . . . . 0.0 110.464 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.417 HG22 HG11 ' B' ' 240' ' ' VAL . 47.3 t -120.34 119.67 60.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.19 -158.79 0.69 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -98.67 -24.1 15.19 Favored 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.95 10.86 22.24 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -71.15 176.53 4.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.751 0.786 . . . . 0.0 112.877 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -120.4 127.34 52.19 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.09 155.49 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 m -113.97 94.74 4.96 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . 0.498 HG12 HD23 ' B' ' 237' ' ' LEU . 76.3 mt -117.23 119.22 61.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.107 0.48 . . . . 0.0 111.972 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' B' ' 183' ' ' SER . 14.2 p-10 -92.01 117.44 29.83 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -140.05 161.71 36.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 121.404 0.621 . . . . 0.0 112.113 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.3 m -124.98 129.12 49.69 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.266 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.01 112.36 3.48 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.138 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 37.1 m -110.37 133.33 53.37 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.86 -77.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.981 0.419 . . . . 0.0 110.477 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -122.14 -41.44 2.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.746 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -151.02 5.26 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.21 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -142.67 154.5 44.4 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -88.95 161.34 16.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' B' ' 226' ' ' LEU . 22.8 p90 -112.2 -177.5 3.18 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.511 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.51 -36.2 83.14 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -99.91 -166.0 29.19 Favored Glycine 0 C--N 1.318 -0.424 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.48 36.45 20.13 Favored Glycine 0 CA--C 1.509 -0.297 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.858 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -118.9 115.27 24.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.765 0.317 . . . . 0.0 110.307 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 185' ' ' PHE . . . -132.5 149.52 52.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.991 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' B' ' 167' ' ' ASP . 5.8 t -113.67 -43.97 3.24 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -117.41 -62.9 1.51 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . 0.466 ' HB2' ' HB1' ' B' ' 182' ' ' ALA . 51.3 t80 55.48 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.703 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -84.85 97.47 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.716 0.77 . . . . 0.0 110.813 178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.42 122.69 42.89 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.408 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 57' ' ' ARG . . . -95.28 123.15 38.64 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.252 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.06 166.22 14.02 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.578 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.61 5.29 89.61 Favored Glycine 0 CA--C 1.499 -0.927 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.391 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -103.0 -1.82 28.65 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.765 0.317 . . . . 0.0 111.122 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.63 28.84 74.01 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.298 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.698 ' NH2' ' HD2' ' A' ' 57' ' ' ARG . 11.3 mtp180 -80.1 -28.56 39.03 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.38 179.88 4.14 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 120.819 0.343 . . . . 0.0 110.875 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.467 HD11 ' CD2' ' B' ' 217' ' ' PHE . 22.5 mt -64.29 133.6 95.7 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.09 124.0 15.19 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.358 1.372 . . . . 0.0 109.228 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.11 32.34 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.133 -175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -79.9 -58.83 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.263 0.532 . . . . 0.0 109.971 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.2 -22.86 61.97 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.514 0.673 . . . . 0.0 109.774 176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -79.83 -16.22 55.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.408 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.94 -28.02 35.9 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.149 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 21.3 pt -78.35 -15.15 13.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -64.57 129.11 38.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.93 1.52 63.18 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.944 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -104.05 149.85 24.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 117.375 0.587 . . . . 0.0 110.757 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.75 152.49 25.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.951 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.52 23.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.789 0.328 . . . . 0.0 111.804 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.22 25.37 2.04 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.261 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.81 138.88 45.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.974 0.416 . . . . 0.0 110.851 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -99.81 112.86 25.08 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.114 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -125.33 108.98 12.24 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 18.8 m -68.47 124.66 24.15 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 tp -110.2 128.84 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 121.234 0.54 . . . . 0.0 110.722 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -96.76 109.56 22.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 6.0 t -132.83 139.64 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.748 0.309 . . . . 0.0 110.728 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 17.8 m -102.4 129.3 48.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 111.499 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.467 ' CD2' HD11 ' B' ' 195' ' ' ILE . 77.4 m-85 -74.7 146.6 83.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.125 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.18 151.91 82.38 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.647 2.231 . . . . 0.0 112.397 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.48 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 61.1 mm-40 -59.19 -36.47 75.41 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.75 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -91.73 32.2 1.13 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.945 -176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -73.86 138.53 44.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.242 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -64.53 -22.55 67.0 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -101.79 117.69 35.37 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' B' ' 227' ' ' LYS . 44.9 tt0 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.345 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.55 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.7 p-10 -66.72 -13.02 60.83 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.55 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -120.44 -9.11 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' B' ' 224' ' ' GLU . 22.1 ptmt -69.1 129.82 40.96 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 121.223 0.535 . . . . 0.0 112.28 -176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 65.31 31.49 80.65 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.732 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -118.91 145.75 45.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.855 0.359 . . . . 0.0 111.487 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -99.76 97.53 8.45 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.05 23.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.193 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -118.38 110.64 17.71 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.383 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' B' ' 212' ' ' THR . 86.4 m-85 -95.81 124.21 39.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.677 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.6 -35.37 80.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.099 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 46.8 mm 64.39 93.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 123.806 0.691 . . . . 0.0 111.403 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -79.82 -56.23 4.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.788 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.498 HD23 HG12 ' B' ' 166' ' ' ILE . 84.7 mt 64.95 170.83 0.2 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' B' ' 237' ' ' LEU . 0.1 OUTLIER 171.97 -40.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.594 176.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -133.14 119.75 20.34 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.958 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.417 HG11 HG22 ' B' ' 158' ' ' VAL . 78.0 t -133.75 116.26 23.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -107.4 111.0 23.11 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.139 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.1 138.72 58.48 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.276 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' B' ' 151' ' ' TRP . 53.4 mtt180 -80.36 155.45 27.18 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.886 0.85 . . . . 0.0 112.826 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.33 158.21 44.55 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 114.538 -1.21 . . . . 0.0 107.922 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 80.9 mt -55.21 130.73 68.88 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-O 120.542 0.21 . . . . 0.0 111.474 -177.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.7 156.98 56.56 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.331 2.688 . . . . 0.0 113.476 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.08 159.41 28.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 33.8 tp -90.64 40.44 1.02 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.423 0.63 . . . . 0.0 109.349 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 21.0 p -76.15 -23.49 54.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' B' ' 253' ' ' ILE . . . 72.82 -31.77 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' B' ' 254' ' ' LYS . 43.8 mt-10 -57.76 -49.98 74.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.016 0.436 . . . . 0.0 111.262 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -66.47 -44.22 83.31 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' B' ' 255' ' ' ARG . 19.3 tt -79.42 -5.94 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -170.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 251' ' ' GLU . 22.9 ptmt -77.58 25.12 0.19 Allowed 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.325 -0.859 . . . . 0.0 111.505 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' B' ' 253' ' ' ILE . 4.1 tpp180 -73.33 -16.51 61.36 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.756 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -82.6 -9.35 59.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.66 -19.99 48.05 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.774 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.62 143.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' B' ' 260' ' ' ASP . 1.4 mp0 -41.41 -72.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.801 0.688 . . . . 0.0 111.266 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 259' ' ' GLU . 4.1 p-10 174.31 143.04 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.626 0.579 . . . . 0.0 110.849 175.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 63.42 -127.95 38.06 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 114.095 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 32.1 t 65.73 94.33 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.256 0.622 . . . . 0.0 110.735 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.67 -43.96 97.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.424 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -40.38 88.98 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.552 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.4 -43.43 94.95 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.425 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.433 ' O ' HG23 ' B' ' 270' ' ' VAL . 64.2 tp -61.49 -48.54 80.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.685 0.278 . . . . 0.0 110.902 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -66.26 -39.75 89.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.684 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.95 -44.26 93.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.927 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.488 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 43.1 tp10 -65.82 -39.8 91.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.958 0.409 . . . . 0.0 110.48 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 266' ' ' LEU . 72.5 t -64.3 -44.33 97.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.411 177.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.6 -46.46 90.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.803 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.3 ptmt -62.46 -46.38 88.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.333 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -66.14 -40.19 90.41 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.3 mmm -62.56 -43.88 97.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.034 0.445 . . . . 0.0 111.022 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.59 -23.56 59.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.101 0.477 . . . . 0.0 110.622 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -66.92 -45.03 79.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.151 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -72.61 -26.89 61.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.722 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.61 -41.54 97.6 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.84 -47.37 85.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.817 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 18.7 m -62.53 -42.61 99.64 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.003 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.73 -40.69 95.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.017 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.44 -45.15 98.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.048 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -66.04 -45.17 82.39 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.004 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.09 -41.27 95.17 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -63.21 -43.33 98.43 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.672 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.25 -42.16 81.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.9 tttt -58.17 -47.36 83.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.578 -178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 54.9 p -63.21 -36.95 85.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -63.66 -48.36 77.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.9 -47.48 68.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.992 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 287' ' ' LYS . 48.5 mm -63.6 -47.03 93.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -66.03 -37.78 86.75 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.773 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.71 84.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.234 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 -44.2 95.06 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.11 -43.53 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 111.518 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -65.6 -36.95 85.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.786 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.84 -48.81 9.66 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -124.92 143.97 50.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.681 0.276 . . . . 0.0 111.023 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -135.17 168.55 18.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.44 150.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 123.162 0.289 . . . . 0.0 110.588 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -65.77 133.54 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.161 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' B' ' 345' ' ' VAL . 59.3 t -124.15 126.45 25.57 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.644 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 19.3 Cg_exo -65.87 150.35 85.85 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.06 2.507 . . . . 0.0 112.146 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -63.1 -33.39 75.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.973 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . 0.606 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . . . -51.98 -52.28 51.52 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.17 -43.33 95.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.761 -177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.477 ' O ' HG13 ' B' ' 311' ' ' ILE . 71.9 mt -65.11 -47.37 88.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.264 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.61 -43.36 99.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.288 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 25.2 m -61.51 -44.14 97.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.46 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.42 ' OE1' ' HD3' ' B' ' 344' ' ' ARG . 70.9 mm-40 -66.63 -30.75 71.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 0.0 111.127 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 91.9 mt -62.5 -42.45 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.816 178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.4 t70 -58.55 -43.66 89.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.546 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.33 -45.71 98.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 121.335 0.588 . . . . 0.0 110.029 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' B' ' 340' ' ' GLN . 95.6 mt -63.69 -38.62 91.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.886 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 24.2 mtm180 -62.06 -38.27 88.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 25.9 mmt180 -60.75 -42.13 96.79 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.482 HE21 HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -65.71 -46.29 79.52 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.326 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.89 96.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.25 96.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -65.68 -44.47 86.16 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.927 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 56.4 mtm180 -76.35 -25.98 55.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -65.9 -44.08 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.223 0.535 . . . . 0.0 109.597 175.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.73 -64.69 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.656 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 148.11 112.23 0.66 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.325 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -170.46 100.56 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.25 146.42 52.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.305 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.462 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.6 ttmp? 75.88 -33.62 0.23 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.941 0.896 . . . . 0.0 112.89 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -70.38 -13.85 62.32 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.233 0.539 . . . . 0.0 110.263 175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -60.68 -28.08 68.34 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.395 177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.46 -38.33 89.36 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.281 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.99 10.26 12.36 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.875 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 66.0 mt -73.89 158.3 86.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 122.311 -0.243 . . . . 0.0 110.852 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.82 143.77 99.44 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 122.483 2.122 . . . . 0.0 111.806 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 28.6 ttt85 -83.92 -35.1 24.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.312 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 2.2 pm0 -58.53 -30.14 66.86 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.27 -39.25 92.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . 0.48 ' CE1' ' HG2' ' B' ' 315' ' ' ARG . 26.8 m-85 -106.31 -12.51 15.67 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -58.37 -44.61 88.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.852 0.358 . . . . 0.0 111.207 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -70.59 -46.83 62.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 0.0 111.781 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.5 pt20 -71.5 -31.74 67.44 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.16 90.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.94 0.4 . . . . 0.0 110.173 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.17 -41.18 96.32 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.85 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -60.67 -41.9 96.01 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.499 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.42 ' HD3' ' OE1' ' B' ' 310' ' ' GLU . 63.5 mtt180 -60.36 -46.74 88.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.25 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' B' ' 302' ' ' VAL . 60.0 t -64.09 -46.63 93.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.325 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.61 -46.37 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.272 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.94 -44.79 99.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.566 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.47 -42.63 99.81 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.058 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' B' ' 115' ' ' VAL . 95.8 mt -63.75 -43.72 95.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.729 0.3 . . . . 0.0 110.73 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.3 mt -63.79 -45.48 89.53 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.428 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.13 -40.32 90.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.198 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.64 99.64 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 113.16 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -68.89 -34.3 75.2 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.811 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 350' ' ' LEU . 76.3 t -60.92 -43.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . 0.423 HD13 HD21 ' B' ' 403' ' ' LEU . 96.7 mt -62.23 -44.21 98.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.81 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -65.31 -49.85 67.91 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.464 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 97.6 m -62.02 -44.65 96.26 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.25 9.82 27.11 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.933 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.83 57.65 1.84 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.147 0.979 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.81 152.96 33.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.774 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.12 147.21 49.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.627 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.22 119.23 13.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -91.61 114.81 27.45 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.332 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -64.84 -36.1 83.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.389 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.72 -41.31 96.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.278 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -59.46 -43.54 93.19 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.201 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.4 ' O ' HG13 ' B' ' 371' ' ' ILE . 67.2 t -65.77 -42.47 92.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.512 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.87 -43.44 90.85 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.453 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.18 -42.41 99.41 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.281 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.42 -37.65 88.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.961 0.41 . . . . 0.0 111.075 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.4 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.0 mt -61.9 -42.8 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.242 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.73 -40.65 95.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -66.56 -29.36 69.41 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.065 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 52.9 ttp -83.32 -45.93 13.19 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.148 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -73.05 -13.12 61.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 17.4 p -78.79 -6.63 56.46 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.074 0.464 . . . . 0.0 111.101 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.73 0.65 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.653 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -118.09 159.24 23.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.961 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.6 -45.08 95.32 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.728 0.299 . . . . 0.0 111.437 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -125.3 103.28 29.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.597 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.44 ' O ' HG13 ' B' ' 385' ' ' ILE . 56.1 Cg_endo -72.43 -22.53 21.41 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.204 1.936 . . . . 0.0 112.758 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.3 -46.36 83.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -71.89 -33.46 68.36 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.675 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 87.1 t -62.32 -46.89 95.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.43 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . 0.44 HG13 ' O ' ' B' ' 381' ' ' PRO . 72.0 mt -65.16 -41.67 92.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.309 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -56.84 -46.06 81.96 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.245 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -60.17 -44.67 94.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.674 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.19 -37.8 84.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.169 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 22.4 m -78.44 -29.66 47.13 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -67.62 -39.98 84.69 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 19.9 t-20 -99.07 117.85 34.49 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.901 0.382 . . . . 0.0 111.598 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -63.04 -34.79 78.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.057 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.573 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 5.8 tp10 -58.27 -46.07 86.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.0 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.4 -41.35 98.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.8 mtp -62.32 -46.84 86.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.73 -47.69 68.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.05 0.453 . . . . 0.0 111.453 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 20.6 t-20 -63.99 -40.21 95.86 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.613 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.26 -33.92 76.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.735 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.4 mtt-85 -60.77 -37.76 82.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.008 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -69.83 -20.32 63.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.918 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 60.4 t -80.59 -52.43 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.973 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.5 -37.74 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . 0.423 HD21 HD13 ' B' ' 355' ' ' ILE . 38.0 tp -65.42 -28.65 69.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.432 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 34.0 tt0 -57.6 -45.89 84.75 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.575 0.226 . . . . 0.0 110.576 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 51.4 mt-10 -63.37 -42.22 98.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.856 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.31 -40.39 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.981 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.51 -42.06 96.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.143 0.497 . . . . 0.0 110.514 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.594 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 90.0 t -65.29 -43.96 95.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.599 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 80.5 mt-10 -60.2 -36.27 77.26 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.152 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.39 96.5 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.241 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 99.6 t -66.64 -43.82 90.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.927 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 81.4 mt -62.66 -37.95 88.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.767 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.52 -29.25 64.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.977 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -110.73 8.26 22.47 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.34 159.88 15.02 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.73 0.3 . . . . 0.0 110.509 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.92 104.81 10.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.247 0.546 . . . . 0.0 110.028 178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' B' ' 125' ' ' VAL . 75.6 t -113.49 129.36 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.492 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 5.4 t -123.56 131.73 53.7 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.276 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.577 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 42.2 mt-10 -94.21 128.43 40.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.717 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -132.13 124.61 29.47 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.981 0.42 . . . . 0.0 111.327 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.434 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 47.9 mt-10 -70.8 122.17 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.182 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.9 p -137.87 155.63 48.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 4.2 m -87.22 159.17 18.93 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -58.79 -45.04 90.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.844 0.354 . . . . 0.0 110.777 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -60.55 -39.23 87.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.986 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -60.13 -45.54 92.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.062 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 40.6 tp -72.91 -28.41 62.45 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.913 0.387 . . . . 0.0 111.227 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -62.83 -22.15 66.45 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -73.68 95.01 2.28 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.218 0.532 . . . . 0.0 110.378 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -123.32 41.44 3.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.134 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.97 100.0 6.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.605 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.18 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -85.75 127.93 34.66 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.72 133.17 57.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 120.882 0.372 . . . . 0.0 110.446 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 m -137.09 146.77 45.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.84 0.352 . . . . 0.0 111.044 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.83 119.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 71.2 mm-40 -99.52 166.11 11.31 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.44 -176.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 m -123.81 135.49 53.81 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.863 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 p -100.28 -64.59 1.03 Allowed 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.726 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -156.99 126.56 6.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.665 0.269 . . . . 0.0 111.149 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.01 -114.11 6.3 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.238 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.48 0.15 49.89 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.147 0.498 . . . . 0.0 110.488 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 106' ' ' SER . . . -72.17 139.07 27.58 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.943 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -128.85 167.27 17.59 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.822 0.344 . . . . 0.0 110.778 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 31.3 ttm180 -129.29 116.32 18.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -71.45 -86.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 123.133 0.271 . . . . 0.0 110.391 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 22.91 83.01 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.16 125.18 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 m -95.43 112.37 24.09 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.112 0.482 . . . . 0.0 110.899 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.3 pt -137.98 177.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.086 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' B' ' 256' ' ' PHE . . . -62.32 148.5 44.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.018 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.16 91.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.629 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' B' ' 256' ' ' PHE . 20.0 p-10 -65.28 -40.14 93.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.956 0.408 . . . . 0.0 110.288 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -62.95 -42.42 99.81 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.216 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 28' ' ' VAL . 95.9 mt -63.73 -44.08 98.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.012 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.3 tp10 -52.27 -51.34 59.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.6 m -63.47 -43.61 96.82 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.976 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.91 98.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.737 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.2 t -63.15 -43.57 98.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.916 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 80.5 mttt -55.77 -53.13 60.47 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.435 0.636 . . . . 0.0 110.303 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.6 m -65.76 -43.83 87.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.581 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -72.07 -43.84 64.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.4 mt -64.13 -41.65 97.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.5 p -68.36 -28.85 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.21 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.616 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 52.3 t30 -62.89 -44.21 96.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.323 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.17 -42.36 88.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.445 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.53 70.74 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.938 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HE2' ' HA ' ' A' ' 34' ' ' ASN . 57.1 mtmt -62.57 -44.26 96.77 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 110.784 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -65.42 -42.37 92.57 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.404 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.7 m -82.48 7.93 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.198 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 40' ' ' ARG . 0.7 OUTLIER 57.12 38.49 29.06 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.602 0.761 . . . . 0.0 112.028 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' HG3' ' B' ' 317' ' ' GLN . 38.0 mm -103.82 -19.73 6.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.435 ' OD1' ' HA ' ' A' ' 37' ' ' LYS . 10.9 p-10 -65.93 -27.87 68.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.94 -15.44 67.08 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.522 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -95.21 4.29 53.72 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.823 0.344 . . . . 0.0 110.633 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -90.8 95.45 10.14 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.208 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -80.08 -3.54 49.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.129 0.49 . . . . 0.0 111.909 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.98 78.85 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 116.083 1.193 . . . . 0.0 116.083 170.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -64.41 -41.88 96.37 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.347 1.074 . . . . 0.0 111.756 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.38 117.72 65.22 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 120.964 0.411 . . . . 0.0 110.987 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.04 138.34 81.35 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.188 1.925 . . . . 0.0 111.143 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.9 tpt -64.21 -37.77 88.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.749 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -67.17 -16.13 64.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.697 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.73 -44.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.162 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -68.78 -32.58 55.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.604 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.06 90.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.946 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -96.06 7.19 47.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -97.73 -55.95 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 111.017 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' HA2' ' B' ' 323' ' ' GLY . 83.3 m-85 -113.69 11.0 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.057 0.456 . . . . 0.0 111.684 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.12 -32.22 83.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.442 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.69 81.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 p -67.76 -33.2 74.38 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.6 p -102.13 8.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.191 0.52 . . . . 0.0 110.759 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.07 -45.04 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.529 -174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.8 -42.29 81.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.114 0.483 . . . . 0.0 110.942 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.64 -33.58 75.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.483 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 62' ' ' VAL . 95.0 t -62.08 -41.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -60.32 -40.84 92.01 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.949 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.59 -41.46 99.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.681 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -64.2 -41.2 97.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.884 0.373 . . . . 0.0 110.987 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.43 -41.99 98.05 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 48.4 ttm -61.6 -43.2 99.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.09 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 m -60.92 -50.15 74.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.538 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -70.53 -40.92 73.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.92 -40.65 95.38 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -61.07 -47.05 88.14 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.609 0.242 . . . . 0.0 111.593 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.42 -37.46 78.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.78 0.324 . . . . 0.0 111.199 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.75 -40.8 92.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.323 0.583 . . . . 0.0 110.489 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.06 93.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.403 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -69.79 -28.45 37.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.755 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.18 -44.79 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.888 0.375 . . . . 0.0 111.268 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -76.32 -29.39 57.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.389 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -93.97 -1.37 54.7 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.257 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? 58.59 45.88 15.53 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.405 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.4 mt -100.94 122.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.083 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -111.97 93.75 22.36 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.973 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 84' ' ' ILE . 23.4 Cg_exo -64.69 143.38 80.63 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.64 2.227 . . . . 0.0 112.324 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.35 101.19 11.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.52 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.77 -141.99 16.87 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.103 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.98 121.93 34.42 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.23 137.84 81.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.041 1.827 . . . . 0.0 110.693 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.6 m -103.91 120.15 40.41 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -99.49 -13.3 19.55 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.694 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 t 41.88 84.57 0.18 Allowed Pre-proline 0 N--CA 1.487 1.399 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.73 136.93 6.39 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.11 1.874 . . . . 0.0 111.84 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.42 -149.68 23.0 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.02 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.57 143.05 27.2 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.873 0.368 . . . . 0.0 110.798 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 62.4 t80 -119.64 130.43 55.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 96.9 mttt -108.85 137.82 46.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.56 114.78 7.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.972 0.415 . . . . 0.0 110.549 -177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.6 3.17 55.3 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.524 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 55.1 mt-10 -127.23 -168.35 1.87 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 110.804 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.95 164.41 21.52 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.481 0.658 . . . . 0.0 112.569 -178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 97' ' ' TYR . 27.5 t80 -122.28 134.91 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.356 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.1 m -112.3 130.9 55.79 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.071 0.462 . . . . 0.0 111.657 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -147.63 154.37 40.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.725 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 20.3 m -132.29 112.17 12.0 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -98.44 116.29 40.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -91.13 136.94 32.74 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.743 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -158.5 157.11 31.5 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.578 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -92.44 156.35 17.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.953 0.406 . . . . 0.0 111.884 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.38 162.63 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.577 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.05 143.73 49.76 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -99.57 -166.98 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.639 2.893 . . . . 0.0 112.703 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -119.89 162.52 19.01 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.935 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 116' ' ' GLU . 17.0 t -132.9 160.62 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.94 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' N ' HG12 ' A' ' 115' ' ' VAL . 46.2 mt-10 -124.46 127.96 48.28 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.1 mt -99.14 128.06 45.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.183 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -140.26 145.18 36.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.308 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.3 26.28 61.93 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.168 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.64 -43.8 92.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.947 0.403 . . . . 0.0 111.416 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -79.49 -5.97 55.96 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.519 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.56 3.89 51.08 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.111 0.481 . . . . 0.0 110.847 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.77 118.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.297 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.75 132.48 44.09 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.77 129.64 73.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 120.859 0.361 . . . . 0.0 111.428 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -93.28 130.59 38.96 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.707 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 80.8 tttt -116.97 98.55 52.16 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.07 126.27 9.82 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.115 1.877 . . . . 0.0 111.688 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 46.5 mm -101.69 110.93 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.56 161.75 40.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.697 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -131.93 157.8 43.08 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.285 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.6 117.83 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -83.35 169.29 15.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.226 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.07 -34.05 75.56 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.85 88.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.235 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -63.17 -45.96 89.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.428 0.632 . . . . 0.0 109.773 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.6 t -65.64 -42.22 92.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.859 177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -55.55 -47.22 76.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.474 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.76 92.36 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.11 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.4 tpt -62.77 -39.13 93.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.941 0.401 . . . . 0.0 110.475 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 95.6 mt -61.88 -43.05 99.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.939 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.18 -38.86 92.56 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.854 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.635 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 27.3 m -60.59 -45.26 94.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.989 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.05 -39.41 94.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.721 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -61.04 -41.46 96.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.123 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -67.08 -36.1 81.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.0 mm100 -61.37 -37.02 81.89 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -175.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -109.11 135.49 50.16 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -173.45 162.45 4.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.717 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.9 m -99.62 143.3 30.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.369 0.128 . . . . 0.0 110.836 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -76.36 136.33 39.52 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.212 0.529 . . . . 0.0 112.303 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -128.95 132.84 47.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.642 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.25 132.63 43.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 65.5 pttt -150.65 168.65 23.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.938 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -145.47 121.49 10.72 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 160.28 -90.93 0.11 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.944 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -121.75 175.85 6.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 111.537 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.87 134.4 56.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.456 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -87.28 -157.15 0.37 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.842 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -103.68 -10.94 17.97 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.813 0.34 . . . . 0.0 110.901 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.22 25.21 4.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.301 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -74.67 161.05 30.03 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.571 0.7 . . . . 0.0 112.241 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.401 ' HD3' ' HB ' ' A' ' 186' ' ' VAL . 3.6 tmm_? -102.91 110.31 22.18 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.712 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 m -107.32 117.19 33.43 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 HD23 ' A' ' 237' ' ' LEU . 76.0 mt -120.36 126.65 75.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.042 0.449 . . . . 0.0 112.054 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -97.44 115.65 28.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -136.43 155.11 50.47 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.237 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 60.8 m -124.89 130.01 51.53 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.011 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.07 91.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.93 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.8 m -105.41 122.95 47.03 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 18.1 t -68.23 -82.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.806 0.336 . . . . 0.0 110.994 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -110.27 -30.86 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.411 0.624 . . . . 0.0 109.616 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.16 26.81 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.063 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.01 141.22 22.25 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.52 149.97 21.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.416 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 18.8 p90 -102.5 -176.27 3.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.838 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -63.62 -33.26 75.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -98.96 -167.45 30.54 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.384 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.04 30.37 31.62 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.127 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -112.25 109.21 18.75 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -132.77 133.36 43.33 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.374 0.607 . . . . 0.0 112.359 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -141.49 121.44 13.64 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 63.62 33.24 13.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.925 0.393 . . . . 0.0 110.414 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -82.01 118.78 23.26 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 163' ' ' ARG . 18.5 m -93.54 120.53 43.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 121.541 0.686 . . . . 0.0 110.918 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 62.4 tp -110.75 128.57 55.79 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.847 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -94.02 106.71 18.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.046 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 91.1 mtp -76.59 153.52 35.25 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.201 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.17 -15.99 60.66 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.93 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 60.1 mt-30 -90.08 -9.24 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.52 30.32 62.41 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.266 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 20.5 mtp180 -68.1 -39.01 82.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.062 -0.569 . . . . 0.0 111.827 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 22.5 mmt -97.96 172.97 7.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.986 0.422 . . . . 0.0 111.796 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.93 134.18 87.16 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.006 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 118.35 4.51 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.217 1.944 . . . . 0.0 111.388 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.46 -24.14 14.31 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.303 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -75.43 -61.36 1.93 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 117.074 0.437 . . . . 0.0 110.792 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.16 -10.97 59.74 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-O 121.084 0.468 . . . . 0.0 110.951 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 203' ' ' LYS . 2.4 t70 -93.43 -23.67 18.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.182 0.515 . . . . 0.0 110.434 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.04 -7.64 80.2 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.261 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.79 -5.6 10.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 O-C-N 122.521 -0.399 . . . . 0.0 111.411 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 200' ' ' ASP . 40.4 mtpt -65.74 127.71 33.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.385 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.23 -6.95 40.01 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.527 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -92.47 166.75 12.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.017 0.408 . . . . 0.0 110.229 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -84.31 177.82 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.83 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.27 -7.67 52.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.94 76.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 119.488 -1.339 . . . . 0.0 113.054 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -149.47 132.3 16.05 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.732 0.301 . . . . 0.0 111.03 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.8 139.0 36.27 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.46 -41.12 1.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.66 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 25.7 m 74.0 108.19 0.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.242 0.544 . . . . 0.0 111.087 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.2 tp -121.34 137.37 55.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.036 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -81.51 116.22 21.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.181 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.9 113.65 44.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 230' ' ' ALA . 52.4 m -93.71 123.48 37.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.514 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 93.0 m-85 -89.77 137.07 28.66 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.821 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.88 150.69 82.21 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.592 2.194 . . . . 0.0 112.544 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.564 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 43.0 mm-40 -60.74 -31.34 70.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.005 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -88.52 15.63 7.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.963 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -72.24 138.25 47.37 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.795 0.331 . . . . 0.0 110.154 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -69.83 -19.5 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.36 113.88 26.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 41.7 tt0 -58.68 -43.32 89.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.41 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.0 p-10 -70.5 -3.76 19.47 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 96.2 mt -123.98 -27.56 3.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.564 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 21.9 ptmt -61.83 123.37 17.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.244 0.545 . . . . 0.0 112.14 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.1 6.3 89.51 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.426 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.12 0.486 . . . . 0.0 111.35 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 216' ' ' THR . . . -108.0 102.53 11.7 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.253 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -88.99 153.49 20.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.165 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.48 118.02 31.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.054 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 212' ' ' THR . 93.3 m-85 -105.83 120.34 41.46 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.477 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.43 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.818 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 47.4 mm 68.05 92.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.63 0.581 . . . . 0.0 110.858 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.33 -51.21 8.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.836 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.463 HD23 HG12 ' A' ' 166' ' ' ILE . 79.3 mt 62.04 172.31 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -169.53 -46.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.814 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.48 146.72 46.62 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 83.4 t -131.37 118.77 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.514 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -112.98 141.64 46.59 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.4 tt0 -91.37 161.55 14.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.137 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 11.8 ptp180 -116.24 133.98 55.42 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.5 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -141.94 164.5 30.0 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.44 129.21 52.08 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -92.39 -167.57 0.19 Allowed 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.528 2.819 . . . . 0.0 111.596 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.96 123.43 20.19 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.3 tp -90.02 25.48 2.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.579 0.704 . . . . 0.0 110.423 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 11.7 p -94.38 5.22 52.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.81 6.76 5.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.382 0.673 . . . . 0.0 112.478 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.37 -47.04 74.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.034 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -67.07 -46.79 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.255 0.55 . . . . 0.0 111.051 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 13.6 tt -93.12 77.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.844 0.831 . . . . 0.0 111.595 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 256' ' ' PHE . 37.1 ttmt -138.42 -24.62 0.95 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.112 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 255' ' ' ARG . 72.8 ttp85 -83.65 19.12 1.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 254' ' ' LYS . 96.6 m-85 -116.75 -89.45 0.58 Allowed 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.917 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -138.74 -83.19 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.743 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.2 m -130.18 163.13 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 0.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.12 149.33 49.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.097 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.9 -176.28 3.01 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.26 -148.38 19.13 Favored Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.587 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 32.0 t 65.18 97.5 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.174 0.512 . . . . 0.0 110.819 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 94.0 t -61.36 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.235 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -42.23 85.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.593 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.68 -43.01 95.04 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.289 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.2 tp -62.5 -45.24 93.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.474 0.137 . . . . 0.0 111.157 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.4 mtp85 -64.7 -40.12 94.82 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.344 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.55 -42.53 95.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.474 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.508 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 47.2 tp10 -67.21 -40.06 86.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 266' ' ' LEU . 89.7 t -65.38 -43.11 94.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.444 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -58.58 -46.68 86.43 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 14.5 ptmt -65.15 -42.94 93.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.784 0.326 . . . . 0.0 111.444 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -67.41 -38.39 84.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 93.0 mmm -62.12 -42.67 99.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.7 0.286 . . . . 0.0 110.376 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.36 -31.6 68.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.676 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -61.01 -47.52 86.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.64 -29.79 61.4 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.619 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.41 -41.04 96.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.77 -44.84 93.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.869 177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.8 m -63.67 -41.54 98.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.081 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.4 -49.58 76.75 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 32.4 pt -65.61 -41.58 90.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.92 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.22 -43.61 98.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.263 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 289' ' ' GLN . 10.0 ttm180 -64.68 -42.03 95.64 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.642 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.7 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.92 -44.93 94.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.787 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.2 t -61.63 -44.06 97.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.482 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 285' ' ' ARG . 49.7 mt-30 -62.96 -44.4 96.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.719 0.295 . . . . 0.0 110.955 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.95 -48.96 69.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.431 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.19 -45.22 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.533 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -65.82 -45.33 82.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.8 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.18 -43.9 88.23 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.201 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.67 -45.08 91.75 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.76 -43.67 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.949 0.404 . . . . 0.0 110.907 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -66.45 -11.62 52.96 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -105.91 -31.21 8.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -125.59 122.08 35.45 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.493 0.182 . . . . 0.0 111.493 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.17 146.97 39.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.3 tp -138.51 150.2 24.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.443 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.54 108.37 6.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.273 0.558 . . . . 0.0 110.416 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.53 130.7 27.46 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.296 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.74 137.17 57.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.27 1.98 . . . . 0.0 111.331 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.23 71.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.17 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.69 79.42 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.98 -41.65 97.46 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 111.213 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 311' ' ' ILE . 69.7 mt -63.12 -45.79 97.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.276 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.91 -47.82 79.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.311 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.7 m -61.71 -42.64 99.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -64.52 -31.86 73.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.729 0.3 . . . . 0.0 111.682 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.659 HG13 ' O ' ' A' ' 307' ' ' ILE . 65.1 mt -61.76 -42.22 93.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.907 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.59 -43.1 97.77 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.866 0.365 . . . . 0.0 110.85 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.47 -44.94 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.347 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.0 mt -64.03 -39.48 94.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.104 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 48.1 mtm-85 -61.67 -45.75 92.66 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.89 0.376 . . . . 0.0 110.526 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -64.34 -35.78 81.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.962 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.417 ' HG3' ' CD1' ' B' ' 41' ' ' ILE . 0.2 OUTLIER -61.16 -46.34 90.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.054 178.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.59 82.97 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.407 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.41 91.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 22.8 tm0? -64.25 -47.1 80.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.518 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -76.68 -22.76 53.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.837 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -71.72 -36.44 70.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.38 -35.0 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.545 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.99 85.06 1.47 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.665 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -141.06 104.11 4.59 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.944 0.402 . . . . 0.0 110.338 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -82.67 145.68 29.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 1.5 ttmp? 78.95 -39.5 0.23 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.168 0.987 . . . . 0.0 112.704 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -71.47 -19.53 62.2 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.11 -22.29 60.62 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.87 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.89 -38.26 87.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.02 -5.78 52.45 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.124 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 66.1 mt -63.89 134.2 95.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.624 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.517 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 50.2 Cg_exo -54.46 131.3 44.63 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.988 2.459 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.456 ' HG3' HD13 ' A' ' 311' ' ' ILE . 15.4 ttm180 -64.42 -40.5 95.88 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.536 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -58.35 -27.75 64.48 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.06 -40.05 96.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.739 0.304 . . . . 0.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.85 0.89 22.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.768 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -62.38 -39.23 92.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.76 0.314 . . . . 0.0 111.26 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.8 -47.41 53.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.687 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.553 ' HG3' HD13 ' A' ' 314' ' ' LEU . 8.3 pt20 -67.43 -30.83 70.68 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.267 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -65.7 -37.25 85.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 110.271 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.15 -42.98 99.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.505 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -64.13 -37.79 88.72 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.161 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 7.4 mmt85 -55.42 -55.91 26.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 56.9 t -68.12 -44.65 84.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.097 -176.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 90.1 t -62.09 -46.73 95.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.76 -44.3 98.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 120.652 0.263 . . . . 0.0 110.528 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -42.13 99.7 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.146 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 78.7 mt -63.84 -42.78 97.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.716 0.293 . . . . 0.0 110.827 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 354' ' ' VAL . 91.6 mt -62.82 -45.76 91.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.799 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.25 -41.37 97.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.21 -40.69 98.93 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.226 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.432 ' CD ' HH11 ' A' ' 356' ' ' ARG . 9.6 tp10 -70.16 -37.18 75.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 121.101 -0.239 . . . . 0.0 110.912 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 350' ' ' LEU . 95.9 t -60.77 -44.88 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.84 -44.22 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.713 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.432 HH11 ' CD ' ' A' ' 353' ' ' GLU . 27.7 ttp180 -70.34 -44.66 67.71 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.2 m -63.89 -45.18 90.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -90.18 2.44 55.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.544 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 53.81 58.04 5.47 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.504 0.502 . . . . 0.0 111.798 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.68 140.56 30.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.97 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 151.51 48.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.951 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.25 125.01 25.05 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.513 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 21.8 t70 -103.09 115.72 31.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.93 -36.39 83.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.38 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 37.1 mm-40 -62.65 -43.16 99.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.875 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -62.22 -44.31 96.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.542 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 89.3 t -65.04 -46.42 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -62.44 -42.07 99.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.996 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.28 -43.57 99.2 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.332 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.35 -37.63 87.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.79 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.42 -42.1 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.878 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -58.78 -41.56 86.95 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.651 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.99 -42.82 99.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.027 0.441 . . . . 0.0 110.028 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 54.3 ttp -64.03 -45.72 87.62 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.925 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.78 -27.82 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.077 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -64.2 -17.54 63.63 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.571 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.34 -0.34 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -112.51 162.89 15.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.858 -0.155 . . . . 0.0 110.616 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.12 -54.09 50.72 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.224 0.328 . . . . 0.0 111.259 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -121.58 107.99 35.86 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 110.628 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.572 ' O ' HG13 ' A' ' 385' ' ' ILE . 55.5 Cg_endo -69.89 -24.58 28.91 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.338 2.026 . . . . 0.0 112.482 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.56 -46.64 85.0 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -67.04 -36.82 82.92 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.571 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.48 -46.42 95.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 381' ' ' PRO . 68.6 mt -64.06 -44.02 97.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.159 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.12 -45.67 87.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.509 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.81 -45.26 94.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.089 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.37 -26.41 68.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.8 m -91.82 -9.03 44.94 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.854 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 14.1 tptt -80.68 -48.13 13.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.406 0.622 . . . . 0.0 110.679 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 23.5 t-20 -88.62 117.27 27.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.539 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.59 -35.91 81.05 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.51 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.7 tp10 -58.28 -46.89 85.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.064 0.459 . . . . 0.0 109.844 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.74 -39.08 93.04 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.037 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 391' ' ' ASN . 94.2 mtp -60.7 -45.32 94.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.09 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -34.86 63.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 110.934 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 401' ' ' VAL . 20.9 t-20 -60.51 -50.24 74.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.504 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.6 tpt -67.84 -34.16 76.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.579 0.704 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 48.4 ttm-85 -58.08 -44.85 87.8 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.928 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.64 -35.25 80.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.874 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 397' ' ' ASN . 74.8 t -64.74 -49.36 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.4 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.2 82.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.133 0.492 . . . . 0.0 111.673 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.0 -37.82 88.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.054 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -59.99 -42.87 95.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 110.277 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 14.6 mm-40 -61.25 -41.34 96.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.998 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -64.04 -40.51 96.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.85 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.954 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 404' ' ' GLU . 85.7 t -64.72 -43.34 96.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 46.5 mt-10 -61.57 -36.76 81.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.43 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.6 98.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.9 -43.92 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.0 mt -63.04 -29.42 70.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.006 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.68 -36.58 79.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.588 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -103.61 -11.27 17.81 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -82.39 152.58 26.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.023 0.439 . . . . 0.0 111.837 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -81.93 101.96 10.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.08 119.57 51.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.684 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.6 t -108.89 128.6 55.06 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.825 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.603 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 38.9 mt-10 -97.44 120.0 37.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.205 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -116.7 115.56 25.87 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.29 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.437 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 39.6 mt-10 -83.69 115.17 22.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.757 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -138.94 161.06 38.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.908 -177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 10.4 m -67.79 144.43 55.37 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.254 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -56.67 -39.36 73.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -57.41 -34.96 69.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.528 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.76 -39.2 93.44 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.071 0.462 . . . . 0.0 111.066 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 46.5 tp -71.05 -24.19 62.29 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.485 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.8 tpt -77.64 -5.0 48.86 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.223 0.535 . . . . 0.0 111.141 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -77.19 31.24 0.14 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.891 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -80.28 78.75 6.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.941 0.4 . . . . 0.0 110.936 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -108.08 -24.57 11.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.645 -178.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.809 0.337 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -90.4 129.42 36.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.95 134.15 55.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.057 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 46.4 m -143.79 132.32 22.28 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.755 0.312 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.8 123.15 17.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 56.9 mm-40 -99.41 163.94 12.31 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.347 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 54.0 m -121.16 134.29 55.21 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 p -98.18 -63.29 1.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -161.03 128.93 4.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 -116.11 8.53 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.364 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.407 ' CD2' ' H ' ' B' ' 109' ' ' PHE . 6.5 mp -96.6 1.72 51.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.214 0.53 . . . . 0.0 110.395 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 106' ' ' SER . . . -71.93 135.99 23.65 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.013 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -125.96 165.21 19.18 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 122.569 0.347 . . . . 0.0 110.615 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.4 ttm180 -128.24 118.58 23.56 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.8 t -75.35 -90.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 m 27.24 80.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.99 124.91 41.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 31.0 m -96.3 112.89 24.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.018 0.437 . . . . 0.0 110.671 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.77 177.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.74 148.24 43.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.122 0.487 . . . . 0.0 112.172 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.85 87.09 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.603 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -66.0 -39.55 90.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.092 0.472 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 48.9 m -64.64 -41.68 95.98 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.446 ' O ' HG23 ' B' ' 28' ' ' VAL . 92.0 mt -63.95 -43.84 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.552 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.653 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 5.5 tp10 -51.04 -53.53 32.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.137 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.9 m -64.6 -42.27 95.66 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.139 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.18 94.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.577 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 24' ' ' ILE . 98.3 t -64.19 -42.89 96.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.829 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.653 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 84.8 mttt -54.89 -52.55 62.51 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.3 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -68.95 -43.1 75.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.215 -174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.02 -45.77 69.66 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.51 -41.2 96.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.8 p -68.91 -27.88 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 120.981 0.42 . . . . 0.0 110.189 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 59.2 t30 -64.54 -43.29 94.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.995 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.59 -42.65 86.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.73 69.21 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.787 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 56.4 mtmt -62.11 -44.43 96.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.961 0.41 . . . . 0.0 110.641 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -65.5 -41.95 92.64 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.328 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.416 HG23 HG12 ' B' ' 41' ' ' ILE . 18.3 m -84.34 7.63 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' B' ' 40' ' ' ARG . 0.8 OUTLIER 58.39 39.15 25.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.48 0.712 . . . . 0.0 111.986 176.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.417 ' CD1' ' HG3' ' A' ' 317' ' ' GLN . 41.7 mm -103.76 -20.89 5.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 15.0 p-10 -64.43 -32.57 74.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.542 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.2 -20.13 62.54 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.123 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -91.89 3.47 55.1 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 120.668 0.271 . . . . 0.0 111.156 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 45.9 ttt-85 -89.45 99.55 12.53 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.637 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -84.64 2.61 40.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.108 0.48 . . . . 0.0 112.054 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 15.27 81.52 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 170.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -66.62 -39.84 88.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.411 1.105 . . . . 0.0 111.756 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 11.6 p -100.15 118.41 61.47 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-O 120.952 0.406 . . . . 0.0 110.817 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.34 136.87 70.92 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.268 1.978 . . . . 0.0 111.22 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . . . . . . . . . 11.0 tpt -64.16 -36.85 85.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.687 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -68.31 -15.99 63.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.566 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -83.78 -44.88 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.122 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 18.7 m -70.43 -30.45 42.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.577 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.18 -43.91 92.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.653 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.19 7.53 44.96 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -97.91 -56.78 2.4 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.364 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.82 11.07 20.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.051 0.453 . . . . 0.0 111.64 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.0 -33.58 87.61 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.28 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.8 85.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 5.3 p -66.96 -35.71 80.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.517 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.4 p -101.07 9.12 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.815 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -58.4 -44.89 89.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.707 -174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -69.72 -41.0 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.997 0.427 . . . . 0.0 110.869 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.929 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 62' ' ' VAL . 85.2 t -61.19 -41.04 87.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.87 0.367 . . . . 0.0 110.135 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.54 -40.62 92.23 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.835 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.46 -40.66 97.9 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.899 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.76 -40.65 95.63 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.946 0.403 . . . . 0.0 110.735 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.09 -42.1 98.87 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 47.6 ttm -61.49 -43.22 99.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.713 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -61.08 -49.17 78.41 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.484 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.76 -40.58 72.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -64.52 -40.12 95.04 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.997 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -61.43 -47.93 83.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.64 0.257 . . . . 0.0 111.572 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 20.1 tt -67.09 -37.66 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.038 0.446 . . . . 0.0 110.88 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.85 -41.47 95.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.255 0.55 . . . . 0.0 110.588 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.25 -41.39 94.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.376 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -68.21 -29.32 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.734 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.72 -44.54 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 111.114 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -79.33 -23.57 43.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.569 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -97.96 -0.21 45.21 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.679 -0.409 . . . . 0.0 111.1 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? 60.77 40.53 15.97 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.564 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.75 123.89 50.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -113.35 96.51 39.89 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.55 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.2 147.24 88.01 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.765 2.31 . . . . 0.0 112.607 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.84 25.99 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.11 -140.93 15.34 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.113 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.56 122.59 31.6 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 140.53 90.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.093 1.862 . . . . 0.0 110.856 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.2 m -107.32 121.48 44.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -99.65 -12.44 20.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t 41.55 83.5 0.2 Allowed Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.37 128.68 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.448 2.098 . . . . 0.0 111.858 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.35 -145.9 16.07 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.265 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -99.32 147.96 24.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.846 0.355 . . . . 0.0 110.58 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . 0.461 ' HB2' ' CD1' ' B' ' 103' ' ' PHE . 61.1 t80 -122.49 128.88 51.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.467 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 97.0 mttt -105.35 138.54 41.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 37.5 tp -69.64 111.47 5.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.041 0.448 . . . . 0.0 110.381 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.74 0.17 42.45 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.58 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 51.3 mt-10 -122.67 -172.53 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.588 0.232 . . . . 0.0 111.041 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.94 165.96 22.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.37 0.605 . . . . 0.0 112.352 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' B' ' 97' ' ' TYR . 27.4 t80 -123.39 135.0 53.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.696 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 38.7 m -112.95 129.66 56.4 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.914 0.387 . . . . 0.0 111.77 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -147.93 156.49 42.73 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.744 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.419 ' HA ' ' HA2' ' B' ' 12' ' ' GLY . 27.1 m -133.29 113.75 12.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.739 0.304 . . . . 0.0 111.593 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.4 t -97.75 114.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -89.73 135.93 33.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.598 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.407 ' H ' ' CD2' ' B' ' 11' ' ' LEU . 48.4 p90 -158.41 163.7 36.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.578 0.351 . . . . 0.0 110.648 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -98.18 157.94 15.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.787 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.96 161.49 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 98.7 m-85 -132.01 141.02 39.94 Favored Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 49.1 Cg_endo -97.94 -165.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.75 2.966 . . . . 0.0 112.33 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -123.19 166.99 14.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.652 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.469 HG11 HD23 ' B' ' 350' ' ' LEU . 15.3 t -134.34 161.14 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 120.753 0.311 . . . . 0.0 111.09 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -123.01 127.98 49.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 89.1 mt -99.17 127.45 45.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.115 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -138.99 148.59 43.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.176 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.83 25.55 69.24 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.405 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.34 -43.86 96.51 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.11 0.481 . . . . 0.0 111.751 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -81.14 -2.84 50.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.568 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.58 -0.28 57.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.488 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 82.7 mt -87.61 122.73 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.495 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -105.37 127.99 53.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.401 HG11 HG13 ' B' ' 286' ' ' VAL . 57.3 t -116.09 128.98 73.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.824 0.345 . . . . 0.0 110.978 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -94.82 127.53 40.89 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.826 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 77.3 tttt -111.59 96.94 34.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.09 132.9 17.28 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.844 1.696 . . . . 0.0 111.541 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 44.9 mm -106.39 112.8 41.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.18 161.17 41.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.533 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.3 167.14 20.37 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 120.694 0.283 . . . . 0.0 110.359 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.65 116.13 46.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -85.94 171.15 11.69 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.965 0.412 . . . . 0.0 110.911 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -61.86 -33.85 74.93 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.265 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.94 96.0 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.872 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -62.89 -44.16 96.85 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 109.911 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 91.6 t -66.96 -42.77 89.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.22 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.88 -45.1 86.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.922 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.32 -37.82 95.02 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.833 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.3 tpt -65.0 -38.93 92.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.863 0.363 . . . . 0.0 110.555 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -61.6 -42.89 99.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.362 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.58 -39.08 93.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.623 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 27.2 m -60.94 -44.63 96.96 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.131 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.31 -39.7 95.3 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -59.18 -43.97 92.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.786 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -65.78 -35.09 79.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.476 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -61.53 -39.69 91.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -175.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -106.9 137.94 44.01 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' B' ' 243' ' ' ARG . . . -174.89 166.37 3.61 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.631 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 64.5 m -105.31 141.37 36.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.531 0.205 . . . . 0.0 110.551 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -73.22 134.59 44.37 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -128.06 132.1 49.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.326 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.03 136.19 43.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.105 0.478 . . . . 0.0 112.203 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.569 ' NZ ' ' HG2' ' B' ' 159' ' ' GLU . 64.6 pttt -151.43 168.09 25.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -145.45 108.25 4.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 171.31 -100.98 0.16 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.75 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.76 168.51 9.29 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 111.788 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 56.6 t -106.86 133.2 52.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.175 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.569 ' HG2' ' NZ ' ' B' ' 154' ' ' LYS . 47.5 mm-40 -86.08 -148.53 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -115.32 -2.77 12.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.887 0.375 . . . . 0.0 110.974 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -139.25 26.0 2.42 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.574 -177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.44 160.42 30.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.553 0.692 . . . . 0.0 111.988 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -102.35 108.11 19.35 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.7 154.83 18.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.039 0.447 . . . . 0.0 111.811 -174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 17.4 m -107.74 117.02 33.02 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . 0.497 HG12 HD23 ' B' ' 237' ' ' LEU . 77.2 mt -120.84 127.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.826 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -96.61 118.75 33.76 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -139.73 154.78 47.53 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.009 -0.676 . . . . 0.0 112.599 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 46.1 m -121.67 132.1 54.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.973 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.68 87.64 1.56 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.818 -177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 30.7 m -104.89 123.07 47.08 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 35.0 t -65.75 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.835 0.35 . . . . 0.0 110.88 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.51 -36.78 8.26 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.0 24.77 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.886 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -146.08 140.6 26.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.44 150.58 21.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.928 0.394 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -105.31 -176.12 2.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.434 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.31 -33.98 77.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -95.26 -169.73 36.19 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.328 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 82.31 29.99 35.22 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.877 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -112.48 109.34 18.86 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.63 129.89 35.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.321 0.582 . . . . 0.0 112.367 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.1 m -136.25 120.57 17.97 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 63.87 31.53 13.9 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.568 0.543 . . . . 0.0 111.17 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -78.76 122.43 26.02 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.909 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.8 m -96.97 121.23 47.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.435 0.636 . . . . 0.0 110.95 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.28 130.52 55.64 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.64 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.56 107.61 19.8 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.927 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 90.3 mtp -77.52 153.61 33.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.188 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.11 -18.85 56.12 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.784 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.461 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 61.5 mt-30 -87.61 -10.53 51.19 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 121.179 -0.208 . . . . 0.0 111.337 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.32 42.36 57.19 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.327 -0.94 . . . . 0.0 110.951 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 48.3 mtp180 -84.93 -24.33 28.44 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.433 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.2 mmt -109.23 173.44 6.32 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.989 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.411 HG13 ' CE2' ' B' ' 217' ' ' PHE . 50.0 mm -59.77 135.21 89.68 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.803 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.72 130.0 35.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.831 1.687 . . . . 0.0 110.613 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.48 -26.94 22.7 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.243 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -74.24 -68.04 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.309 0.554 . . . . 0.0 110.821 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.28 -18.56 63.13 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.476 ' O ' ' HD3' ' B' ' 203' ' ' LYS . 2.3 t70 -88.25 -25.25 22.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.785 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.0 -10.34 78.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.592 -177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.3 pt -90.85 -6.1 10.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 O-C-N 122.37 -0.488 . . . . 0.0 111.284 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' B' ' 200' ' ' ASP . 44.8 mtpt -64.42 130.12 42.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.449 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.2 -6.94 47.12 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.325 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -92.55 168.38 11.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.885 0.342 . . . . 0.0 110.306 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -85.81 177.51 7.62 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.794 0.331 . . . . 0.0 110.839 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.01 -13.83 62.14 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.38 86.78 0.12 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.797 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.1 141.62 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -93.97 125.24 38.48 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -120.46 -43.09 2.52 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.871 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 42.1 m 75.04 114.32 0.06 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.338 0.589 . . . . 0.0 111.326 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -124.56 140.71 46.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.976 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -86.12 115.64 23.82 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.284 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 62.1 t -112.81 113.31 43.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 63.4 m -97.38 120.59 38.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.487 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 93.0 m-85 -86.82 139.65 33.04 Favored Pre-proline 0 N--CA 1.442 -0.859 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.22 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 26.3 Cg_exo -61.77 152.48 74.06 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.864 2.376 . . . . 0.0 112.825 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.441 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 30.3 mm-40 -60.76 -31.17 70.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.677 0.751 . . . . 0.0 109.349 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -84.55 10.45 10.96 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.488 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 11.9 t80 -70.46 136.7 49.71 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.02 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -67.49 -24.13 65.55 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -89.89 115.97 27.6 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 41.1 tt0 -61.75 -40.76 96.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -175.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.406 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 6.0 p-10 -70.88 -4.07 22.43 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 96.1 mt -123.92 -24.77 4.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.1 ptmt -63.78 125.47 24.46 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.258 0.551 . . . . 0.0 112.165 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.27 6.84 88.8 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.467 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -112.76 146.44 38.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.026 0.441 . . . . 0.0 111.578 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.39 103.86 13.1 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.277 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -91.56 154.5 19.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.321 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.12 124.02 49.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.303 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.9 m-85 -109.6 119.71 40.25 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.203 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.37 -39.17 93.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.48 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 47.9 mm 67.18 91.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 123.687 0.617 . . . . 0.0 110.803 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -82.32 -48.25 11.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.83 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.497 HD23 HG12 ' B' ' 166' ' ' ILE . 76.4 mt 63.53 175.85 0.16 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.82 -46.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.759 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.526 ' HB3' ' OE2' ' B' ' 241' ' ' GLU . 68.9 mmtt -138.43 146.9 42.71 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -132.32 111.1 17.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.001 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' B' ' 239' ' ' LYS . 6.2 mp0 -106.13 143.39 34.33 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 41.5 tt0 -93.55 162.0 14.14 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' B' ' 149' ' ' ALA . 13.0 ptp180 -113.93 136.74 52.56 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.251 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -140.44 161.74 36.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.59 128.61 58.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -90.56 -171.71 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.372 2.714 . . . . 0.0 111.715 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -70.39 120.61 16.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' B' ' 248' ' ' LEU . 36.2 tp -84.68 23.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.417 0.627 . . . . 0.0 111.001 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 8.1 p -91.55 6.96 43.63 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.345 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 66.97 9.05 6.57 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.355 0.662 . . . . 0.0 112.487 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.68 -50.71 56.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.911 0.386 . . . . 0.0 110.053 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.06 -46.75 82.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 12.7 tt -93.29 79.69 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.883 0.849 . . . . 0.0 111.403 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -137.41 -27.49 0.95 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.96 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -81.1 8.47 8.59 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.64 0.733 . . . . 0.0 109.463 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.422 ' HA ' ' CB ' ' A' ' 20' ' ' ALA . 97.3 m-85 -104.39 -81.65 0.52 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.766 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -147.43 -79.88 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.789 -1.196 . . . . 0.0 113.764 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.53 166.42 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.946 0.403 . . . . 0.0 111.939 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -73.25 149.24 42.94 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.98 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -114.57 -179.67 3.7 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 92.71 -149.19 19.43 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.868 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t 65.44 96.22 0.05 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 110.616 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.05 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.505 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.7 OUTLIER -66.74 -40.31 88.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.826 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.08 94.02 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.504 ' O ' HG23 ' B' ' 270' ' ' VAL . 56.4 tp -62.36 -45.99 90.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.393 0.139 . . . . 0.0 111.009 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.6 -41.62 96.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.274 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.643 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -64.22 -42.76 96.44 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.663 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.489 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.2 tp10 -66.4 -39.97 89.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.64 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 266' ' ' LEU . 92.3 t -64.6 -43.56 96.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.465 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -58.37 -46.36 86.47 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 11.9 ptmt -64.74 -41.97 95.53 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.556 0.217 . . . . 0.0 111.291 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -66.41 -40.01 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 270' ' ' VAL . 98.2 mmm -61.51 -44.34 97.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.764 0.316 . . . . 0.0 110.742 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.19 -31.56 69.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -61.53 -48.13 82.43 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.54 -30.83 63.32 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.96 -40.57 93.86 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.02 -44.9 94.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.793 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 22.7 m -63.63 -42.54 98.16 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.74 -49.36 77.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 31.2 pt -65.56 -41.56 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.8 0.333 . . . . 0.0 111.023 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -62.65 -40.52 97.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.681 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -60.85 -42.98 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.508 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . 0.459 ' HG2' ' NE2' ' B' ' 289' ' ' GLN . 11.5 ttm180 -65.11 -41.78 94.6 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.401 HG13 HG11 ' B' ' 125' ' ' VAL . 68.2 t -61.27 -46.12 97.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.133 0.492 . . . . 0.0 110.092 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.58 -43.5 96.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.85 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 39.4 t -61.7 -45.25 94.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.105 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . 0.459 ' NE2' ' HG2' ' B' ' 285' ' ' ARG . 49.6 mt-30 -62.29 -45.75 91.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.086 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.38 -49.55 73.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.71 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.04 -45.47 94.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -65.58 -44.31 87.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 110.707 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.82 80.82 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.226 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.96 -45.11 90.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.687 0.28 . . . . 0.0 110.295 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.61 -43.06 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.322 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.5 -15.78 63.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.232 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.76 -38.81 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.117 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -119.37 123.65 44.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.87 152.61 31.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.5 tp -142.18 152.03 18.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -72.31 114.5 10.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.56 127.37 31.6 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.854 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.74 131.73 34.51 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.219 1.946 . . . . 0.0 110.77 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.1 -26.89 68.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.111 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.11 -48.32 76.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.751 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 92.5 mt -64.48 -41.02 96.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.658 ' O ' HG13 ' B' ' 311' ' ' ILE . 96.6 mt -63.16 -44.31 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.204 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.19 -46.94 87.1 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 37.1 m -62.01 -42.74 99.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.906 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 51.0 mm-40 -62.96 -31.97 73.18 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.714 0.292 . . . . 0.0 111.421 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 307' ' ' ILE . 64.0 mt -62.11 -42.13 93.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.151 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.8 -43.25 98.38 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 110.747 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.2 t -61.67 -44.14 98.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.295 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.1 -40.06 96.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.326 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 22.0 mtm180 -61.77 -45.49 93.68 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.814 0.34 . . . . 0.0 110.378 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 -63.76 -35.79 81.73 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.419 ' HG3' ' CD1' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -60.99 -46.84 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.219 178.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.07 -41.95 81.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.661 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.14 90.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.701 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.428 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 22.9 tm0? -65.74 -41.84 91.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.681 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -85.76 -7.12 58.96 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.704 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -89.18 -31.14 18.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.235 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -179.04 -36.26 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.362 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 112.51 81.26 1.09 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.701 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -136.64 106.24 6.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.981 0.42 . . . . 0.0 110.727 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -83.69 144.26 29.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.171 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 77.11 -40.15 0.35 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.261 1.024 . . . . 0.0 112.982 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -69.31 -19.65 63.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.577 0.703 . . . . 0.0 109.401 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.18 -22.36 60.86 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.848 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.43 -37.76 84.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -77.44 -10.21 59.33 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.017 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.19 135.33 90.9 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.05 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.43 129.14 33.17 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.039 2.493 . . . . 0.0 113.453 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.519 ' HG3' HD13 ' B' ' 311' ' ' ILE . 21.9 ttm-85 -61.93 -41.3 97.79 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.345 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.18 -26.43 60.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.28 -39.89 94.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 111.291 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -107.7 -0.68 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.76 -174.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.81 -41.53 91.43 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.177 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.6 -49.85 56.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.491 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.487 ' HG3' HD13 ' B' ' 314' ' ' LEU . 7.4 pt20 -67.9 -29.33 68.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.674 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.6 90.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.425 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.99 -44.0 97.66 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -63.12 -37.32 86.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.96 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -57.7 -53.41 58.45 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 15.3 t -69.39 -45.02 79.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 92.1 t -62.39 -46.91 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.57 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.87 -44.47 98.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.683 0.278 . . . . 0.0 110.774 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.51 99.78 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.993 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.5 mt -63.85 -42.32 97.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.532 0.206 . . . . 0.0 110.806 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.577 ' O ' HG23 ' B' ' 354' ' ' VAL . 88.2 mt -62.95 -45.97 89.96 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.13 -41.48 97.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.83 99.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.246 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.45 -37.36 80.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.873 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 350' ' ' LEU . 92.5 t -60.27 -44.33 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.68 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.538 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -70.05 -44.57 68.91 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 41.3 m -63.44 -44.51 94.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 111.828 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.59 -0.24 57.05 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.409 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 53.29 45.82 27.7 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.506 0.504 . . . . 0.0 111.874 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.87 138.03 44.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.056 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.24 150.36 43.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.677 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.46 123.11 19.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -96.71 114.25 25.88 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.401 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -61.38 -37.71 84.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.683 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.57 -40.57 92.92 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.029 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -61.68 -44.36 97.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.182 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.579 ' O ' HG13 ' B' ' 371' ' ' ILE . 86.9 t -64.76 -47.2 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.185 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.11 -41.45 98.24 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.755 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.43 -43.18 99.42 Favored Glycine 0 C--O 1.236 0.233 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.41 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.85 -38.94 92.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 0.0 110.612 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 367' ' ' VAL . 65.6 mt -62.29 -41.98 93.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.009 177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -61.07 -38.45 86.27 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.746 -0.382 . . . . 0.0 112.022 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.7 -39.83 88.22 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.944 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 62.5 ttp -65.33 -44.41 87.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.755 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.69 -24.48 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.771 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.4 t -65.12 -16.87 63.95 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.774 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.42 4.18 53.11 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -113.53 162.27 16.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.561 0.219 . . . . 0.0 111.434 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.89 -46.3 78.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.943 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.33 112.07 14.18 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.69 -22.09 24.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.422 2.082 . . . . 0.0 112.873 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -65.45 -47.06 77.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.06 -35.45 78.25 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.687 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.48 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.84 -44.17 98.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.322 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.32 -44.45 83.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.482 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -61.85 -44.94 95.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.369 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.7 -28.47 69.62 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.705 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 19.6 m -92.11 -7.89 47.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.548 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -81.01 -45.8 16.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.383 0.611 . . . . 0.0 109.81 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 26.4 t-20 -92.1 118.69 31.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.57 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.93 -36.31 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.476 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 6.8 tp10 -57.61 -47.41 82.23 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.01 -38.65 91.64 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 391' ' ' ASN . 95.1 mtp -60.57 -46.21 91.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.384 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -73.54 -34.79 65.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.492 ' O ' HG23 ' B' ' 401' ' ' VAL . 20.5 t-20 -59.88 -50.78 72.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.252 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.2 tpt -68.67 -32.7 72.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.579 0.704 . . . . 0.0 109.763 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 395' ' ' MET . 59.5 ttm-85 -58.99 -42.57 90.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.873 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -78.41 -8.51 58.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 111.418 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 397' ' ' ASN . 97.2 t -85.23 -50.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.216 0.531 . . . . 0.0 109.652 175.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.09 83.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.88 -38.74 92.07 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.105 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.462 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.5 tt0 -58.45 -44.69 89.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.307 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -60.77 -40.07 91.14 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.978 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -64.12 -39.95 95.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.98 93.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.247 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 404' ' ' GLU . 95.7 t -63.89 -43.69 97.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -60.24 -37.29 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.297 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.24 98.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.842 0.353 . . . . 0.0 110.956 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.97 -43.44 85.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.068 0.461 . . . . 0.0 110.555 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.8 mt -63.16 -26.62 68.89 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.257 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.71 -35.77 80.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.719 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -105.04 -14.14 15.51 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.63 156.17 30.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.911 0.386 . . . . 0.0 111.723 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.46 100.81 11.58 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.35 119.91 51.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -112.53 129.21 56.43 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.06 0.457 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 40.2 mt-10 -95.25 126.02 40.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.356 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.54 116.82 23.79 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.704 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 43.5 mt-10 -86.34 115.53 23.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -136.67 159.32 42.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.902 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.4 m -69.08 143.12 54.31 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.496 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -54.78 -37.71 66.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -57.24 -36.97 71.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.157 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -61.44 -36.07 79.34 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.017 0.436 . . . . 0.0 111.378 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 51.2 tp -78.56 -16.5 57.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.977 0.418 . . . . 0.0 111.363 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -81.59 -5.47 58.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.362 0.601 . . . . 0.0 110.565 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -77.64 32.52 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.706 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -81.01 68.68 7.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 111.049 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.35 -5.94 21.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.066 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.55 -178.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.494 0.188 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -100.73 139.61 36.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.139 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.09 147.8 22.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.502 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 p -142.17 134.29 27.52 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.407 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.41 133.51 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 17.6 mm-40 -110.3 156.99 19.97 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m -118.96 125.71 50.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.2 p -87.69 -65.68 0.99 Allowed 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.675 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -154.37 117.37 4.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.1 -107.31 1.51 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.118 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.7 -30.25 51.74 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.462 0.305 . . . . 0.0 111.305 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.1 126.85 41.71 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.087 0.555 . . . . 0.0 111.084 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 34.5 ttm180 -122.17 136.56 54.93 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.07 -95.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.254 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m 50.59 96.95 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.86 128.74 58.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 122.038 -0.414 . . . . 0.0 109.89 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -111.49 119.74 39.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.451 0.643 . . . . 0.0 111.786 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 20' ' ' ALA . 1.9 mt -140.12 -164.39 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' H ' HG22 ' A' ' 19' ' ' ILE . . . -68.34 140.46 55.9 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.307 -0.246 . . . . 0.0 110.386 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.67 82.54 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.532 ' OD1' ' HB3' ' B' ' 256' ' ' PHE . 11.6 p-10 -64.55 -42.54 95.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.99 0.424 . . . . 0.0 110.423 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -67.03 -42.9 84.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 20' ' ' ALA . 77.5 mt -62.95 -47.34 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.958 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.5 tp10 -65.08 -36.78 85.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.985 0.421 . . . . 0.0 110.51 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 92.5 m -62.28 -42.23 99.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.95 88.24 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.985 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.14 -42.76 96.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 90.9 mttt -59.13 -45.83 89.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.572 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -65.35 -42.43 92.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.083 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.4 -40.98 81.1 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.0 mt -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.4 p -70.36 -28.42 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.381 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.63 -45.44 92.82 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.253 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.7 -42.25 89.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.989 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.97 -31.74 69.01 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.761 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.347 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' ' ND2' ' B' ' 397' ' ' ASN . 39.1 ttpt -64.21 -38.83 92.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.598 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 m -87.4 -1.51 8.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? 70.03 12.93 7.85 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.661 0.784 . . . . 0.0 112.018 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.56 -22.4 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.22 -25.72 67.82 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.604 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.81 -5.46 74.71 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.786 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -97.85 6.67 47.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 ttm-85 -96.87 112.02 23.96 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.633 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -88.52 -11.11 46.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.664 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.85 32.48 9.07 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 116.441 1.337 . . . . 0.0 116.441 171.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -75.58 -46.11 33.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.778 1.289 . . . . 0.0 110.795 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.9 p -99.79 105.75 36.38 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.56 139.83 91.44 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.692 2.261 . . . . 0.0 112.338 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.1 tpt -65.33 -36.38 83.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.138 -174.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -63.06 -34.54 77.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.983 0.421 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 57' ' ' ARG . 53.7 mt -66.78 -44.3 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 51' ' ' MET . 20.1 m -63.84 -41.09 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.95 97.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.61 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 11.2 pt20 -81.63 -0.77 43.98 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.61 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -126.18 -38.66 2.13 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -114.63 8.49 16.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.46 -15.8 79.17 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.111 -1.043 . . . . 0.0 111.738 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.51 90.81 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.7 p -66.76 -35.1 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.511 ' O ' HG23 ' A' ' 66' ' ' VAL . 7.9 p -104.8 12.83 7.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.59 -42.99 93.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.789 0.328 . . . . 0.0 111.127 -175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -64.52 -44.32 91.26 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.183 0.516 . . . . 0.0 110.507 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.94 -36.23 83.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.629 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 62' ' ' VAL . 88.2 t -60.98 -43.51 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 109.958 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.22 -39.49 92.96 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.41 -40.69 99.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.786 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.14 -42.36 96.82 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.086 0.469 . . . . 0.0 110.957 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.41 -41.12 96.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.509 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 64.7 ttp -60.32 -45.22 94.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -61.63 -51.06 70.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.793 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -70.89 -39.46 72.8 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -64.47 -40.38 95.58 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.31 -48.57 81.18 Favored 'General case' 0 CA--C 1.526 0.044 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.277 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 80' ' ' ILE . 18.4 tt -67.36 -39.02 81.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.13 -44.54 96.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.638 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.42 -42.97 78.15 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -69.94 -26.96 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 76' ' ' ILE . 95.3 mt -64.28 -44.69 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.868 0.366 . . . . 0.0 111.323 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -84.86 -17.24 38.59 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -91.59 -0.85 57.63 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.321 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.9 mmpt? 61.31 40.05 14.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.36 177.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 75.0 mt -100.49 121.48 51.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.133 0.492 . . . . 0.0 110.104 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -114.95 100.45 53.61 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.075 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.76 145.96 33.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.296 1.997 . . . . 0.0 111.779 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.67 121.47 35.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.635 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -132.74 11.27 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.051 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.33 124.35 26.86 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 137.63 80.6 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.908 1.739 . . . . 0.0 110.313 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 m -98.39 116.69 31.15 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.44 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 91.9 m-85 -96.86 125.74 41.51 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.03 95.46 12.8 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.086 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 36.7 Cg_endo -89.48 134.92 2.46 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.782 2.321 . . . . 0.0 111.695 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.43 -165.25 34.84 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.819 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -80.82 140.14 35.61 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.79 0.329 . . . . 0.0 110.435 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -102.33 127.16 49.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.171 0.51 . . . . 0.0 110.756 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 98.7 mttt -99.04 121.32 40.82 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.4 tp -66.34 108.71 2.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.031 0.443 . . . . 0.0 111.027 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.15 -23.59 9.16 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.682 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 4.4 mp0 -102.46 -165.27 1.16 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 110.816 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -88.4 172.75 9.15 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.804 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.6 136.13 54.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.274 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.6 m -118.73 129.38 55.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.507 0.67 . . . . 0.0 112.221 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -145.7 162.23 38.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.547 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.5 m -132.17 129.14 39.41 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.025 0.441 . . . . 0.0 111.898 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.38 124.08 58.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -98.22 130.21 44.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.959 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.03 169.8 9.16 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.4 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.74 164.59 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.19 137.77 23.71 Favored Pre-proline 0 N--CA 1.474 0.76 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.175 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -97.69 -168.81 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.397 2.731 . . . . 0.0 112.75 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -139.93 152.34 46.29 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.837 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.31 157.92 42.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -115.31 132.55 56.58 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.0 mt -91.56 123.83 35.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.135 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -135.78 152.3 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.029 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.56 20.94 79.75 Favored Glycine 0 C--O 1.228 -0.221 0 CA-C-N 116.009 -0.542 . . . . 0.0 113.646 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.96 -40.45 96.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.129 0.49 . . . . 0.0 111.009 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 3.8 mp0 -66.16 -18.43 65.34 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.002 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.39 2.11 53.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.163 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.3 mt -80.95 125.62 39.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.82 126.26 52.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.328 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 417' ' ' VAL . 73.5 t -128.12 129.76 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.624 0.249 . . . . 0.0 111.12 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -94.19 136.09 34.86 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.562 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.4 tttt -109.16 94.33 15.02 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.43 123.59 6.07 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.323 2.015 . . . . 0.0 111.476 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.13 116.34 43.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.824 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.3 160.9 41.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.776 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -132.08 164.34 26.45 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.836 0.351 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.08 120.57 48.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.6 p -86.96 168.26 13.52 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.918 0.389 . . . . 0.0 111.297 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -64.63 -32.5 74.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.26 0.553 . . . . 0.0 110.048 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.77 81.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.675 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -64.41 -35.35 80.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.35 0.595 . . . . 0.0 109.799 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.2 t -63.12 -43.13 98.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.234 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -58.41 -45.76 87.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.73 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.32 99.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.2 tpt -68.1 -43.23 78.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.528 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.412 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 87.9 mt -63.61 -43.33 97.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.708 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.01 -40.95 99.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 120.93 0.395 . . . . 0.0 110.911 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.663 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 95.0 m -61.55 -44.88 96.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.223 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.77 -40.39 97.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.937 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 10.6 mmm180 -63.5 -38.34 90.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.257 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -77.74 -11.69 59.9 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 143' ' ' THR . 14.8 mm100 -79.67 -12.11 59.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.754 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -132.62 118.5 19.25 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.95 0.405 . . . . 0.0 111.901 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 243' ' ' ARG . . . -160.57 154.79 23.19 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.093 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.1 m -89.03 149.69 23.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.756 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -96.84 152.51 18.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.261 0.553 . . . . 0.0 112.358 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.44 121.91 9.72 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.274 1.03 . . . . 0.0 109.501 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.79 134.91 50.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.7 pttt -146.14 163.43 35.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.245 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -124.17 110.32 14.53 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -178.08 -105.64 0.19 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.369 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.82 158.62 36.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.736 0.303 . . . . 0.0 110.961 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.57 129.01 40.4 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.894 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -94.3 -163.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.316 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.519 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -98.73 -0.07 43.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.647 ' O ' ' HD2' ' A' ' 243' ' ' ARG . 7.4 pt-20 -138.41 22.57 2.74 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 79.3 m-20 -87.48 174.64 8.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.366 0.603 . . . . 0.0 112.07 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -112.61 122.47 47.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 138.11 54.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 53.7 m -92.87 117.38 29.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.1 mt -125.35 125.53 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.465 0.65 . . . . 0.0 112.292 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -100.47 115.5 30.22 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.33 160.63 39.55 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.54 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.7 m -127.87 131.69 49.44 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.705 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.24 103.6 2.62 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.877 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.8 m -108.96 136.09 49.07 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.5 -92.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.238 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -120.16 -2.24 10.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.179 0.514 . . . . 0.0 110.397 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 167.86 14.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.291 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -152.84 144.34 23.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.06 146.88 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.299 0.374 . . . . 0.0 110.182 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -106.53 -175.51 2.82 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.79 -43.59 98.55 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -93.96 -174.07 39.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.762 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.66 33.29 31.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.707 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -115.53 108.87 17.01 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.02 142.22 47.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.763 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.3 t -100.39 -62.56 1.23 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.38 89.68 2.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -113.13 127.6 56.24 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.634 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 8.5 m -100.09 112.85 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.321 0.581 . . . . 0.0 110.402 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.93 133.46 46.67 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.596 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' NH1' ' A' ' 243' ' ' ARG . . . -103.91 117.78 35.13 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.495 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 90.6 mtp -83.96 152.53 24.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.637 -176.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 94.28 -22.91 34.27 Favored Glycine 0 CA--C 1.507 -0.461 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.116 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HB3' ' NH1' ' B' ' 57' ' ' ARG . 64.1 mt-30 -84.7 -6.73 59.37 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.937 -0.154 . . . . 0.0 110.926 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 71.65 64.5 2.7 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.473 ' HG2' ' HD3' ' B' ' 57' ' ' ARG . 17.7 mtp180 -106.77 -18.41 13.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 -177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 21.1 mmt -120.68 165.42 15.1 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.142 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.97 132.67 39.55 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.762 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -51.89 129.1 29.04 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.114 1.876 . . . . 0.0 111.34 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.43 -32.07 7.83 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.884 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -67.57 -51.97 44.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.152 0.476 . . . . 0.0 111.195 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.43 -7.39 59.64 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.427 0.632 . . . . 0.0 110.591 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.79 -22.64 20.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.187 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.67 -9.47 78.3 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.679 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.5 pt -99.77 0.22 10.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 O-C-N 122.427 -0.455 . . . . 0.0 111.196 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.6 mtpt -65.86 130.59 43.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.117 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.68 2.14 67.57 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.289 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -91.3 161.79 14.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.333 -0.51 . . . . 0.0 110.957 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.85 175.28 10.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.175 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.56 -0.04 40.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -155.65 54.56 0.41 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.471 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.97 138.77 52.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.05 0.453 . . . . 0.0 110.677 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -96.19 110.02 22.38 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.805 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -132.02 120.16 22.03 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.554 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 32.1 m -82.88 127.6 33.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.126 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 9.5 tp -116.9 142.17 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.517 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.654 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 3.5 m-20 -85.15 117.3 24.02 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 83.9 t -121.83 123.18 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 29.6 m -107.91 121.27 44.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 79.0 m-85 -83.04 144.62 47.77 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.683 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 25.2 Cg_exo -61.66 151.91 77.33 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 122.743 2.295 . . . . 0.0 112.324 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 48.4 mm-40 -63.12 -35.94 81.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.846 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.14 26.76 0.98 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.972 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 223' ' ' ALA . 9.6 t80 -78.12 134.45 37.69 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -70.68 -18.85 62.82 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 221' ' ' TYR . . . -92.14 108.17 19.75 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 43.7 tt0 -59.64 -37.34 78.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.575 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 5.5 p-10 -67.24 -11.39 57.32 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.125 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.575 ' HG ' ' ND2' ' A' ' 225' ' ' ASN . 97.8 mt -123.57 -17.39 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.0 ptmt -64.91 126.35 27.71 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.133 0.492 . . . . 0.0 112.069 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.52 8.54 80.96 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.633 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -105.25 144.42 32.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.006 0.431 . . . . 0.0 111.052 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.95 103.27 12.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.328 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -95.83 145.28 25.48 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.111 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 99.5 mttt -114.09 111.86 22.3 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.591 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.5 m-85 -91.32 130.22 37.21 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.52 92.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.66 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.1 mm 64.03 116.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-O 121.376 0.608 . . . . 0.0 111.85 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -99.21 -65.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.537 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.8 mt 70.33 140.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.607 0.763 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -162.61 -27.76 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.941 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 70.0 mmtt -130.66 135.98 48.37 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.46 99.28 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.397 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -100.9 122.77 44.05 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.508 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.544 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 42.3 tt0 -74.16 161.31 30.1 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.11 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 161' ' ' GLU . 68.2 mtt180 -110.84 147.56 34.27 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.156 0.503 . . . . 0.0 111.718 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.0 166.65 22.86 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.785 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -51.14 127.0 27.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 123.491 0.495 . . . . 0.0 112.12 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.66 151.51 63.97 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.828 2.352 . . . . 0.0 112.281 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.43 99.14 4.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.428 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 44.2 tp -83.75 3.37 33.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 1.3 m -68.07 -6.37 22.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.227 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 70.78 -9.85 0.78 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 124.076 0.95 . . . . 0.0 113.302 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.45 -36.86 85.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.091 0.472 . . . . 0.0 110.822 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -75.79 -32.36 59.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.994 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 17.8 tt -126.25 65.11 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 121.885 0.85 . . . . 0.0 112.759 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -129.53 7.35 5.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.029 0.919 . . . . 0.0 108.949 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -98.49 10.3 41.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.233 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.528 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 98.2 m-85 -117.99 -77.34 0.57 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.693 -177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 162.98 -14.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.012 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.04 131.79 22.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 122.536 0.335 . . . . 0.0 110.454 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.02 92.8 2.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.627 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -158.84 -157.06 0.57 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.97 -23.58 28.86 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.36 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 13.7 p -64.74 136.39 56.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.98 -48.77 87.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.1 OUTLIER -71.51 -41.23 69.49 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.783 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.29 -42.98 99.11 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.327 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 270' ' ' VAL . 47.5 tp -64.63 -42.73 95.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.536 0.208 . . . . 0.0 110.692 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 267' ' ' ARG . 49.2 mtp85 -64.07 -39.07 93.26 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.551 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.5 -42.55 98.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.29 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 272' ' ' LYS . 43.9 tp10 -65.74 -39.71 91.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.056 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 266' ' ' LEU . 75.9 t -65.55 -40.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.43 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.411 ' HE ' ' CD ' ' A' ' 275' ' ' GLU . 11.1 tpt180 -56.39 -47.19 79.48 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.135 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 269' ' ' GLU . 7.9 ptmt -65.3 -38.26 89.66 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.043 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.34 -45.17 88.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.3 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.2 mmm -67.02 -44.22 80.84 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.411 ' CD ' ' HE ' ' A' ' 271' ' ' ARG . 65.6 mt-10 -69.27 -30.91 69.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.382 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -59.62 -45.51 91.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.213 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -86.26 -23.08 26.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.608 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.59 -43.68 96.26 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -61.71 -47.31 85.87 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.9 m -63.48 -39.27 94.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.442 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.05 79.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.927 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.88 -39.6 77.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.191 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.408 HH11 ' CD ' ' A' ' 405' ' ' GLU . 13.6 tpt180 -60.94 -45.95 92.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -64.22 -39.96 95.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.796 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -61.07 -43.48 98.82 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' HD21 ' A' ' 412' ' ' LEU . 54.2 t -64.54 -43.37 96.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.125 176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.427 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.2 tttt -57.9 -49.43 76.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.884 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.6 m -61.42 -40.87 96.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.616 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.35 -45.79 91.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.888 0.375 . . . . 0.0 110.636 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.45 -47.29 70.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.588 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 287' ' ' LYS . 38.4 mm -63.67 -46.55 94.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.625 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -67.57 -44.44 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.734 0.302 . . . . 0.0 110.565 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.41 -44.21 97.13 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.44 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.8 OUTLIER -63.18 -47.46 82.51 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.562 0.22 . . . . 0.0 111.222 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 79.9 t -67.5 -44.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.022 0.439 . . . . 0.0 111.513 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -63.38 -30.52 71.64 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -90.44 -12.24 37.98 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.86 109.03 10.59 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.55 130.33 55.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.052 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.48 154.66 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.611 0.243 . . . . 0.0 110.592 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.95 119.17 15.75 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.88 132.66 20.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.57 134.77 60.11 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.209 1.94 . . . . 0.0 111.036 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.04 -35.12 79.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.985 -177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.2 -47.26 78.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.379 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.24 -42.37 99.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.215 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -64.27 -45.49 96.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.328 0.585 . . . . 0.0 110.356 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.12 -49.62 77.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.213 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.7 m -62.04 -42.77 99.53 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.78 -23.69 66.1 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 307' ' ' ILE . 94.1 mt -63.0 -40.85 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.639 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.492 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 21.5 t70 -57.34 -44.71 84.53 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.835 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.27 -44.81 99.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.981 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.0 mt -63.02 -39.82 95.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.271 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' A' ' 330' ' ' LEU . 66.4 mtm180 -61.78 -44.08 97.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.0 110.351 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -63.28 -39.77 95.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.991 0.425 . . . . 0.0 110.824 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -42.91 92.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.372 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.72 82.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.65 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.85 -37.24 86.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.348 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' B' ' 62' ' ' VAL . 22.9 tm0? -64.6 -38.69 91.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.126 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -88.71 2.48 53.28 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.238 0.542 . . . . 0.0 111.433 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -96.61 -37.81 10.21 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -177.71 -48.39 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.334 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 124.43 110.08 1.86 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.017 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -168.01 101.36 0.46 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.24 146.44 47.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.859 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.441 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.9 ttmp? 75.53 -39.71 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.842 0.857 . . . . 0.0 112.805 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -67.18 -20.46 65.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.447 0.642 . . . . 0.0 109.896 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.84 60.77 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.023 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.499 HD12 ' NH1' ' A' ' 315' ' ' ARG . 51.4 tp -59.78 -35.32 74.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.705 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -87.01 3.86 44.26 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.169 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.49 140.0 89.6 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.178 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.53 123.23 11.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.874 2.383 . . . . 0.0 113.161 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.408 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.2 ttt180 -64.39 -40.69 96.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.874 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.64 -32.48 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.136 -175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.92 -39.2 93.61 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.923 0.392 . . . . 0.0 111.489 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -102.44 -2.91 27.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.7 -44.0 97.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.869 0.366 . . . . 0.0 111.294 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.55 -46.0 64.39 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.934 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.478 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.0 pt20 -66.07 -37.38 85.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.555 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.11 -38.38 90.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 110.371 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -58.86 -47.86 83.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.489 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.413 ' O ' HG23 ' A' ' 347' ' ' VAL . 9.1 mmt85 -63.31 -41.75 98.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 41.4 mtp-105 -62.97 -42.02 99.71 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 96.1 t -64.87 -46.09 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.764 0.316 . . . . 0.0 111.173 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.32 -45.52 98.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 343' ' ' ARG . 83.1 t -61.78 -44.78 99.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.736 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.7 99.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 89.8 mt -63.79 -42.53 97.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.782 0.325 . . . . 0.0 110.703 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.1 mt -62.67 -44.14 97.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.16 -39.9 95.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.02 -39.96 97.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.301 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -66.54 -37.03 84.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.881 0.372 . . . . 0.0 110.118 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.6 t -60.56 -43.9 95.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.087 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.48 -48.02 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.147 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -71.42 -42.27 68.49 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.219 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 94.4 m -61.5 -45.15 95.43 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.425 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -92.65 8.44 39.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.037 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 41.79 52.17 4.09 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.987 0.804 . . . . 0.0 112.324 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.45 136.36 44.22 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.736 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.8 146.35 38.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.602 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -62.43 111.56 2.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.72 110.43 20.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.917 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.53 -34.16 77.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.677 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -63.59 -42.59 98.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.716 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.408 HH21 ' HD2' ' A' ' 366' ' ' ARG . 6.7 tpp180 -61.02 -43.86 98.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.299 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.82 -44.27 92.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.434 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -60.81 -45.03 96.0 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.68 -44.29 97.74 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.243 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 91.2 mt -65.02 -39.73 93.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.681 0.277 . . . . 0.0 111.401 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 84.3 mt -62.81 -43.84 99.1 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.148 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.35 -39.51 92.45 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.703 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.2 -44.03 93.2 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.954 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.9 ttp -66.11 -41.59 90.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.398 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.57 -23.76 67.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.869 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -69.43 -7.86 41.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.503 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.92 6.59 45.66 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.678 0.275 . . . . 0.0 111.494 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -119.72 165.47 14.48 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.636 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.61 -53.67 54.89 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.69 0.281 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -122.71 109.68 32.27 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.114 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 385' ' ' ILE . 45.3 Cg_endo -69.05 -27.99 29.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.455 2.103 . . . . 0.0 113.175 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.83 -46.52 81.57 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -174.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.98 -32.49 72.11 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.232 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.99 -44.43 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.053 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 381' ' ' PRO . 67.2 mt -62.44 -45.53 98.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.732 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.87 -35.43 78.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.609 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.69 -44.6 96.33 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.705 0.288 . . . . 0.0 110.734 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -62.54 -31.99 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.895 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.7 m -83.75 -6.79 59.52 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.787 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -92.49 -12.99 30.56 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.608 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.537 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 25.4 t-20 -128.86 115.7 18.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.673 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -64.44 -33.91 76.96 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.928 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.537 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 36.8 tp10 -60.48 -45.89 92.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 0.0 110.321 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.69 -37.77 88.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.535 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 93.1 mtp -60.16 -46.34 90.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.309 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -65.95 -40.04 90.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.041 0.448 . . . . 0.0 110.633 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.523 HD22 ' HB2' ' B' ' 38' ' ' LYS . 18.7 t-20 -59.66 -48.29 82.24 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.596 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.9 tpt -65.54 -39.85 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.1 mtt-85 -65.21 -38.83 91.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.286 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.8 -40.03 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.422 . . . . 0.0 110.362 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 397' ' ' ASN . 97.3 t -66.54 -46.95 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.578 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 405' ' ' GLU . . . -64.44 -36.85 85.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.799 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.53 -39.12 92.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.82 -37.86 80.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.139 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 402' ' ' ALA . 30.0 mm-40 -58.5 -47.48 83.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.379 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.27 -38.09 86.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.227 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -61.11 -44.25 97.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 98.1 t -64.17 -43.28 97.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.25 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -60.89 -39.22 88.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.28 95.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.871 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 407' ' ' ALA . 94.4 t -64.9 -44.56 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.503 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 96.9 mt -61.41 -33.9 74.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.691 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.21 -29.43 68.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.991 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -110.83 -26.23 9.45 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.1 42.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 111.047 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -81.75 107.35 14.41 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.1 t -123.63 134.98 64.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.825 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.3 t -129.82 142.22 50.72 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.562 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 53.1 mt-10 -90.67 113.76 25.91 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.389 0.614 . . . . 0.0 109.96 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -119.69 116.7 26.5 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.164 -175.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -76.72 128.93 35.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.596 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -140.78 155.72 46.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.99 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 17.9 p -89.55 163.38 15.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.97 -44.89 96.7 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.151 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.72 -40.88 96.61 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -58.29 -51.14 71.04 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.727 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 36.5 tp -68.29 -37.97 81.18 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.12 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 26.0 ttt -61.24 -27.28 68.33 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -44.52 -79.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 55.57 32.07 18.42 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.0 102.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.013 -178.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.542 0.21 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -101.01 140.47 35.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.997 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.6 m -120.35 143.22 32.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.644 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.8 p -135.48 141.6 45.37 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.892 0.377 . . . . 0.0 111.521 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -141.77 132.22 25.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 52.3 mm-40 -112.12 155.55 23.71 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.032 0.444 . . . . 0.0 111.632 -177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 59.5 m -117.17 126.83 53.41 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.7 p -87.99 -73.81 0.47 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.812 0.339 . . . . 0.0 111.226 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -145.31 114.52 7.05 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.23 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.08 -103.71 0.97 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.826 -0.625 . . . . 0.0 113.403 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.98 -29.72 28.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.556 0.343 . . . . 0.0 110.849 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.71 127.4 44.22 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.97 0.748 . . . . 0.0 114.97 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -123.51 144.68 49.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.111 0.564 . . . . 0.0 110.773 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 14' ' ' ARG . 37.1 ttm180 -118.57 137.33 53.31 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.24 -93.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.285 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m 47.99 93.28 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.65 128.66 52.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -112.49 122.78 48.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 111.561 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.634 HG22 ' H ' ' B' ' 20' ' ' ALA . 2.0 mt -142.2 -162.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.634 ' H ' HG22 ' B' ' 19' ' ' ILE . . . -68.34 142.46 55.49 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.83 -39.96 86.85 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' HB3' ' A' ' 256' ' ' PHE . 10.2 p-10 -63.55 -44.6 93.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.87 0.367 . . . . 0.0 110.721 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -64.67 -42.78 95.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.552 HG13 ' O ' ' B' ' 20' ' ' ALA . 79.5 mt -63.27 -46.59 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.441 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 2.6 tp10 -63.41 -40.44 97.19 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.603 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 27.7 m -62.53 -41.72 99.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.672 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.91 -39.06 90.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.639 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.421 HG23 ' O ' ' B' ' 24' ' ' ILE . 85.3 t -63.59 -42.83 97.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.688 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 89.8 mttt -58.84 -46.49 87.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.764 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.7 m -64.21 -42.93 96.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.116 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -68.32 -40.02 81.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.61 -42.61 99.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.532 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.7 p -71.67 -28.7 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.91 -45.88 91.77 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.265 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.05 -41.94 87.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.46 69.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.672 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.1 mttt -61.69 -42.13 98.52 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.911 0.386 . . . . 0.0 111.185 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.523 ' HB2' HD22 ' A' ' 397' ' ' ASN . 40.1 ttpt -64.04 -41.94 97.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.194 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.415 HG23 HG12 ' B' ' 41' ' ' ILE . 12.9 m -84.56 -3.14 7.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? 68.71 18.77 8.66 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.369 0.668 . . . . 0.0 112.158 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.415 HG12 HG23 ' B' ' 39' ' ' VAL . 47.9 mm -81.45 -19.54 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.963 0.411 . . . . 0.0 111.726 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -64.9 -30.42 71.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.065 0.46 . . . . 0.0 110.29 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.22 -6.27 64.57 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.816 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -97.41 8.35 44.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.554 . . . . 0.0 110.682 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -98.7 113.91 26.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.339 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -87.03 -15.76 37.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.014 174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 30.98 8.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -73.76 -43.81 57.96 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.29 1.045 . . . . 0.0 111.085 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.76 104.52 35.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.73 139.12 87.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.644 2.229 . . . . 0.0 112.464 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.478 ' O ' HG22 ' B' ' 54' ' ' VAL . 11.4 tpt -64.74 -36.05 83.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.218 -174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -65.08 -24.71 67.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.969 0.414 . . . . 0.0 110.611 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.409 HG23 ' HD2' ' B' ' 57' ' ' ARG . 49.5 mt -78.36 -42.15 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.469 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.478 HG22 ' O ' ' B' ' 51' ' ' MET . 18.2 m -64.21 -40.71 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.0 -41.19 97.56 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 57' ' ' ARG . 9.1 pt20 -81.77 -1.85 48.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.565 ' HG3' ' HG3' ' B' ' 56' ' ' GLN . 91.5 mtt180 -126.41 -40.3 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -114.28 9.88 17.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.31 -14.23 80.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.176 -1.012 . . . . 0.0 111.789 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.87 -40.94 87.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -65.78 -32.88 74.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.498 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.1 p -108.49 13.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.117 0.485 . . . . 0.0 110.932 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -59.37 -43.44 92.86 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.47 -44.91 89.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.809 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.69 -35.69 81.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 62' ' ' VAL . 76.9 t -60.81 -43.61 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.82 0.343 . . . . 0.0 110.146 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.11 -39.59 93.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.233 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.46 -41.16 99.38 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.852 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.13 -41.94 97.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.35 -41.45 97.08 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.382 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 63.7 ttp -60.03 -45.13 93.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.161 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -61.85 -50.77 70.94 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.753 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -71.84 -39.06 69.99 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -64.55 -39.1 93.13 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.38 -48.7 80.61 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.254 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -67.74 -38.57 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 120.975 0.417 . . . . 0.0 110.888 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.72 -43.72 98.31 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.772 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.6 -44.06 75.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.99 -27.01 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 76' ' ' ILE . 94.0 mt -64.27 -45.21 96.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.587 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -82.22 -21.56 36.33 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -90.42 0.62 57.21 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.9 0.381 . . . . 0.0 110.521 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.4 mmpt? 60.26 40.11 18.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.661 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 79.8 mt -99.95 117.33 44.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -109.34 101.09 44.23 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.28 144.02 22.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.007 1.805 . . . . 0.0 111.93 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.59 124.09 37.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.368 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.04 -150.33 32.15 Favored Glycine 0 N--CA 1.437 -1.233 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.617 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.58 126.98 29.42 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.59 140.98 93.96 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.007 1.805 . . . . 0.0 110.409 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 19.6 m -96.69 116.63 29.45 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.159 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.545 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 90.1 m-85 -97.53 123.41 41.39 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.58 97.45 16.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.358 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 60.0 Cg_endo -90.08 148.39 4.65 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.708 2.272 . . . . 0.0 112.006 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.87 -167.1 21.57 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.17 137.74 37.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.609 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -97.05 130.49 44.34 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.091 0.472 . . . . 0.0 110.651 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.85 120.87 41.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.45 107.65 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.128 0.49 . . . . 0.0 110.748 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.14 -21.1 9.53 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -109.57 -165.71 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.01 174.97 7.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.485 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -122.27 140.53 52.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.749 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 94.9 m -120.48 130.44 54.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.223 0.535 . . . . 0.0 111.887 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -147.97 159.66 43.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -131.72 131.2 42.84 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.047 0.451 . . . . 0.0 111.827 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 45.9 t -106.35 123.97 61.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -96.44 132.6 41.82 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.837 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -154.25 159.87 41.52 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -98.73 167.07 11.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.58 164.9 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -116.33 141.35 27.74 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -100.2 -168.36 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.447 2.764 . . . . 0.0 112.703 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.41 152.97 48.85 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 8.2 t -131.66 159.16 43.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -120.14 123.65 43.84 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 78.6 mt -84.74 126.87 33.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -136.49 153.94 50.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.13 22.32 77.29 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 116.073 -0.512 . . . . 0.0 114.084 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -40.78 96.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.187 0.518 . . . . 0.0 111.27 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 34.1 mp0 -70.81 -13.52 62.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.649 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.79 -0.13 57.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.529 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -79.04 125.19 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.222 0.534 . . . . 0.0 110.983 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.03 127.14 56.14 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.094 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 417' ' ' VAL . 98.4 t -128.59 125.75 64.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-O 120.76 0.315 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -93.02 137.5 32.33 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -108.55 95.02 15.09 Favored Pre-proline 0 N--CA 1.441 -0.92 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -78.27 121.41 5.26 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.1 mm -99.67 118.18 45.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.097 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.37 162.66 38.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.81 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -131.41 166.48 21.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 82.8 t -101.41 118.25 47.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.5 p -86.12 167.26 15.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.827 0.346 . . . . 0.0 111.517 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.97 -35.37 80.47 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.011 0.434 . . . . 0.0 110.453 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.7 81.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -64.04 -37.17 86.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.331 0.586 . . . . 0.0 109.619 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.08 -43.07 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.742 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -57.2 -46.99 82.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.2 -42.95 99.72 Favored Glycine 0 C--O 1.238 0.379 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.67 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 13.3 tpt -66.55 -43.05 86.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.875 0.369 . . . . 0.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.404 HD21 HG21 ' B' ' 270' ' ' VAL . 91.2 mt -63.29 -43.46 97.81 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.17 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.71 -43.05 99.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.023 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.621 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.6 m -61.8 -43.58 98.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.588 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.8 mt -61.86 -40.64 96.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.591 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 13.0 mmm180 -64.54 -37.27 86.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.27 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -77.84 -12.44 59.98 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.0 mm100 -78.94 -17.26 55.77 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.747 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -127.54 119.49 26.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.549 ' HB3' ' HD3' ' B' ' 243' ' ' ARG . . . -162.74 154.69 18.36 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.118 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -87.18 156.71 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 116.702 -0.227 . . . . 0.0 110.862 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 47.6 p90 -105.38 151.14 24.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -145.09 124.51 13.09 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.259 1.023 . . . . 0.0 109.435 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -69.16 137.51 53.39 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.712 0.291 . . . . 0.0 111.715 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 65.5 pttt -148.76 167.58 25.22 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.42 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -126.42 116.1 20.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 176.21 -115.51 0.53 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -117.76 156.14 28.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.584 0.23 . . . . 0.0 110.693 -178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 99.1 t -85.55 128.51 39.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -90.85 -165.42 1.35 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.028 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.597 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -97.52 -1.74 43.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.694 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' B' ' 243' ' ' ARG . 8.4 pt-20 -138.23 20.14 2.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.563 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 77.1 m-20 -83.9 173.49 11.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.513 0.673 . . . . 0.0 111.744 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -113.68 120.6 41.43 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.93 154.27 24.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.112 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 51.5 m -107.99 119.22 38.86 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 87.7 mt -129.44 126.7 63.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -101.07 109.95 21.91 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -128.89 160.71 31.79 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 53.1 m -127.68 132.21 49.7 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.527 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -87.2 103.83 2.91 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.772 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -109.27 132.39 54.17 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.16 -92.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.925 0.393 . . . . 0.0 110.34 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -117.55 12.94 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.415 0.626 . . . . 0.0 110.12 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.71 -14.51 0.7 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.757 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -122.01 141.98 50.79 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.19 154.32 21.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -113.74 -177.19 3.07 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.666 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.86 -41.86 88.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.851 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.24 -173.5 35.69 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.822 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.54 34.62 24.96 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.534 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -117.91 106.0 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.738 0.304 . . . . 0.0 110.29 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -130.16 138.95 50.89 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 44.0 t -97.44 -56.57 2.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.96 84.52 2.04 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -107.19 125.63 51.36 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.051 0.453 . . . . 0.0 110.998 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 6.6 m -97.59 115.24 36.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.229 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.33 130.33 53.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.657 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . 0.611 ' HB1' HH12 ' B' ' 243' ' ' ARG . . . -100.01 114.08 27.11 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.429 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.1 mtp -80.74 154.12 27.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.388 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.98 8.86 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.592 ' HB3' ' NH1' ' A' ' 57' ' ' ARG . 96.6 mt-30 -77.51 -9.13 58.74 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.22 65.36 2.55 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.494 ' HG2' ' HD3' ' A' ' 57' ' ' ARG . 18.4 mtp180 -106.94 -19.1 13.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.937 0.398 . . . . 0.0 110.578 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 21.5 mmt -119.27 163.47 17.08 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.04 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mm -52.1 131.83 40.84 Favored Pre-proline 0 C--O 1.237 0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.087 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.47 128.01 22.14 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.16 1.906 . . . . 0.0 111.292 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 109.69 -36.84 4.08 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.787 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -64.7 -51.1 64.26 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.921 0.36 . . . . 0.0 111.145 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.31 -6.02 59.34 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 110.932 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -90.63 -26.62 19.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.264 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.39 -11.82 77.14 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.6 pt -96.94 -1.08 10.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.164 0.482 . . . . 0.0 111.201 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 59.5 mtpt -66.19 127.66 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.432 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.05 2.26 62.52 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.294 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -90.12 164.85 14.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.99 0.395 . . . . 0.0 111.143 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -82.72 165.91 19.53 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.186 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.33 0.54 19.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.52 55.18 0.42 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.51 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -134.57 141.36 46.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.037 0.419 . . . . 0.0 110.694 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 71.9 mt-10 -95.06 116.18 28.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -135.99 119.7 17.21 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 24.6 m -81.18 130.81 35.19 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.75 140.95 44.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.239 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.624 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 5.4 m-20 -85.09 116.83 23.69 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.089 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.38 126.02 74.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -109.72 122.42 47.44 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' B' ' 218' ' ' PRO . 85.2 m-85 -87.54 143.6 34.25 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.307 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 27.0 Cg_exo -61.51 149.3 90.29 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.369 2.046 . . . . 0.0 112.187 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.433 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 26.5 mm-40 -60.88 -31.37 70.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.049 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.64 17.97 4.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.866 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 223' ' ' ALA . 15.1 t80 -69.53 136.07 50.9 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.176 -0.327 . . . . 0.0 110.383 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -71.17 -19.11 62.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' B' ' 221' ' ' TYR . . . -93.35 113.54 25.74 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 42.6 tt0 -61.16 -38.38 86.27 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 5.3 p-10 -67.85 -9.94 48.84 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.539 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 95.9 mt -125.61 -13.5 6.48 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 21.9 ptmt -69.87 126.1 28.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.888 -176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.75 4.28 81.47 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.602 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -104.09 146.57 28.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.057 0.456 . . . . 0.0 111.344 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.97 113.79 26.99 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -104.29 146.27 29.04 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.624 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 99.1 mttt -114.93 108.02 16.17 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.532 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' B' ' 212' ' ' THR . 91.0 m-85 -89.78 134.75 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.525 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.5 -39.71 81.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 48.1 mm 63.51 107.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.208 0.528 . . . . 0.0 111.653 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -91.0 -65.43 1.02 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.872 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 96.5 mt 71.32 150.9 0.1 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.433 0.693 . . . . 0.0 112.47 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -170.66 -37.0 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.681 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.89 135.04 53.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.276 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.0 97.41 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.181 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.03 125.37 41.41 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.004 0.431 . . . . 0.0 110.815 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 40.5 tt0 -74.98 157.87 34.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.466 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.611 HH12 ' HB1' ' B' ' 188' ' ' ALA . 52.0 mtt180 -106.76 141.98 37.13 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.441 0.638 . . . . 0.0 111.887 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -133.01 163.35 29.43 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.368 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 74.5 mt -51.17 128.39 30.05 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.45 0.469 . . . . 0.0 112.152 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -69.38 152.36 71.29 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 122.869 2.379 . . . . 0.0 111.953 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.43 96.62 4.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.037 0.446 . . . . 0.0 110.571 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 43.1 tp -83.76 3.36 33.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.418 0.627 . . . . 0.0 109.956 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 1.1 m -68.39 -3.9 12.78 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.567 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 71.5 -12.86 0.59 Allowed 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 124.166 0.986 . . . . 0.0 113.577 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.97 -35.68 80.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.886 0.374 . . . . 0.0 111.271 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -76.08 -38.76 56.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.103 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 15.6 tt -120.84 67.25 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 121.767 0.794 . . . . 0.0 112.728 -175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -129.95 1.47 4.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.851 0.834 . . . . 0.0 109.246 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -96.48 6.46 48.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.617 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.532 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 97.6 m-85 -110.32 -76.0 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.209 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 158.48 -12.12 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.367 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.7 130.95 26.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -141.36 104.51 4.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.206 0.526 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -166.15 -156.13 0.24 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.43 -0.804 . . . . 0.0 108.983 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -24.58 28.73 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.756 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . 0.515 ' HB2' ' OE1' ' B' ' 264' ' ' GLU . 17.8 p -65.93 132.4 48.53 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 91.8 t -62.38 -48.39 88.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' B' ' 262' ' ' SER . 0.2 OUTLIER -71.6 -39.44 70.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.905 0.383 . . . . 0.0 110.626 -179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.66 -42.08 97.44 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.186 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.0 tp -64.64 -42.86 95.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.612 0.244 . . . . 0.0 110.744 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -64.49 -39.01 93.0 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.666 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.1 -41.25 99.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.445 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' B' ' 272' ' ' LYS . 37.8 tp10 -66.84 -40.76 88.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.307 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 266' ' ' LEU . 84.1 t -64.98 -41.03 91.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.774 0.321 . . . . 0.0 110.33 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 9.3 tpt180 -56.19 -46.97 79.19 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.448 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' B' ' 269' ' ' GLU . 7.6 ptmt -65.92 -39.35 90.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.657 0.265 . . . . 0.0 111.02 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -64.62 -44.24 91.18 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.609 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.8 mmm -66.22 -43.94 85.23 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 48.8 mt-10 -70.0 -30.09 67.32 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 111.167 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -59.9 -45.07 93.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.332 0.587 . . . . 0.0 109.986 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.46 -25.32 31.28 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.594 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.55 -43.69 96.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.06 -47.64 85.42 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.958 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 16.5 m -63.39 -39.89 95.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.536 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.17 71.18 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.707 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 38.7 pt -68.49 -40.18 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.144 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -60.52 -45.79 92.53 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -64.61 -40.3 95.25 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.795 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -60.46 -43.17 97.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.739 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.477 HG13 HG11 ' B' ' 125' ' ' VAL . 53.9 t -64.13 -43.4 97.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.958 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . 0.492 ' O ' HG12 ' B' ' 291' ' ' ILE . 87.5 tttt -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.149 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 49.7 m -60.36 -43.01 96.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.269 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -62.17 -45.73 92.13 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.857 0.36 . . . . 0.0 110.804 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.53 -49.62 65.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.942 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 287' ' ' LYS . 50.9 mm -63.57 -47.96 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -65.18 -46.18 81.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.759 0.314 . . . . 0.0 110.644 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.96 -43.69 97.07 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.91 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.494 HD22 HD13 ' B' ' 350' ' ' LEU . 3.6 tt -63.48 -45.18 91.95 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.29 -43.07 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.096 0.474 . . . . 0.0 111.306 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -61.64 -31.01 71.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.881 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -91.63 -11.66 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.22 101.95 6.01 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.73 122.48 46.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.288 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -127.96 156.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.74 116.15 17.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.73 138.03 21.02 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.544 -175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.01 136.78 67.67 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.349 2.033 . . . . 0.0 111.032 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.33 -35.81 80.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.169 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.35 89.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.186 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.32 -43.2 99.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 0.0 111.171 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.445 ' O ' HG13 ' B' ' 311' ' ' ILE . 66.1 mt -64.84 -46.77 90.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.273 0.558 . . . . 0.0 110.265 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.85 -48.79 80.13 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.025 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.8 m -62.87 -43.47 98.7 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -67.22 -22.15 65.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 307' ' ' ILE . 92.1 mt -62.84 -41.12 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.666 0.269 . . . . 0.0 110.417 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.477 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 27.6 t70 -57.11 -44.92 83.72 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.48 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.93 -44.03 97.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.174 0.511 . . . . 0.0 109.663 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.452 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.3 mt -63.1 -39.64 95.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.781 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 50.5 mtm180 -61.21 -45.02 96.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.21 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -63.18 -39.16 93.85 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.964 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.66 -43.12 94.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.263 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.28 85.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.692 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.39 86.27 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.391 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -64.73 -39.03 92.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.353 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -89.02 4.9 46.7 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -101.01 -30.99 11.32 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 174.52 -45.9 0.14 Allowed Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.555 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 122.25 115.22 2.29 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.883 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -171.24 102.4 0.21 Allowed 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.35 145.58 45.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.192 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.436 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.8 ttmp? 75.15 -39.72 0.41 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.983 0.913 . . . . 0.0 112.801 176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -66.22 -22.87 66.35 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 109.865 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' B' ' 315' ' ' ARG . . . -59.01 -20.43 53.01 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.231 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.468 HD12 ' NH1' ' B' ' 315' ' ' ARG . 51.0 tp -60.2 -38.82 84.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.814 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -82.46 -0.98 48.81 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 50.4 mt -63.79 140.76 97.88 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.326 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -52.62 124.03 14.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.749 2.299 . . . . 0.0 112.746 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.417 ' HG3' HD13 ' B' ' 311' ' ' ILE . 38.5 ttt180 -66.04 -40.29 90.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.661 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.6 pm0 -54.81 -32.83 60.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.989 -175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -102.72 -2.97 27.19 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -58.84 -48.22 82.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 111.618 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -42.08 65.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -65.8 -36.82 84.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.414 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.33 -38.45 90.19 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.477 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 346' ' ' VAL . 62.9 tttp -58.83 -47.98 82.92 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.433 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.424 ' O ' HG23 ' B' ' 347' ' ' VAL . 11.9 mmt85 -63.18 -41.8 99.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.4 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.415 HH21 ' HD3' ' B' ' 344' ' ' ARG . 41.5 mtp-105 -63.1 -41.97 99.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 92.4 t -64.55 -45.18 96.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 342' ' ' LYS . 97.7 t -61.85 -45.72 98.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 343' ' ' ARG . 87.4 t -61.53 -44.96 99.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.9 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.59 -41.77 99.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 90.5 mt -64.14 -42.48 96.79 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 110.618 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.548 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.4 mt -62.44 -44.42 96.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 355' ' ' ILE . 92.7 mt -64.62 -39.75 94.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.103 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.79 97.68 Favored Glycine 0 C--O 1.237 0.321 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.203 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -65.81 -36.87 84.7 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.4 t -60.49 -44.22 95.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.86 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 351' ' ' LEU . 79.3 mt -59.76 -48.35 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.434 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 23.7 ttp-105 -71.11 -43.02 68.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.449 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 32.5 m -61.77 -47.28 85.9 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -91.54 8.53 36.11 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 38.67 66.09 0.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.078 0.951 . . . . 0.0 112.129 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.47 132.98 33.79 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.425 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 146.03 34.36 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.684 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.64 112.8 3.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.6 113.95 25.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.871 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -66.17 -35.92 81.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.853 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.09 -43.73 97.68 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.729 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -60.62 -42.85 97.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.406 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.52 -44.29 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.285 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -60.42 -45.28 94.2 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.51 -45.09 96.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.67 -39.59 93.94 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 85.1 mt -62.85 -43.45 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.44 -36.88 85.6 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.562 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.73 -45.18 83.63 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.965 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 63.2 ttp -66.29 -42.47 88.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.663 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.87 67.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.746 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 38.5 t -64.6 -15.63 61.41 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.934 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.21 4.7 41.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -115.8 168.08 10.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.18 -58.41 8.59 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.768 0.318 . . . . 0.0 110.713 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -120.86 107.33 38.18 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.061 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . 0.537 ' O ' HG13 ' B' ' 385' ' ' ILE . 48.4 Cg_endo -68.88 -24.52 33.79 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.63 2.22 . . . . 0.0 113.401 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.04 -47.45 80.14 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.21 -29.87 66.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.035 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.7 -44.84 98.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 381' ' ' PRO . 65.0 mt -62.56 -44.94 99.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 121.259 0.552 . . . . 0.0 110.501 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.97 -36.23 81.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.516 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.07 -44.91 96.67 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.47 -33.53 75.04 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 110.986 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.1 m -83.96 -5.35 59.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -92.72 -12.02 32.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.503 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 25.6 t-20 -130.37 117.29 19.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.702 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -65.16 -34.15 77.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.8 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.574 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 31.7 tp10 -59.49 -46.98 87.26 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.959 0.409 . . . . 0.0 110.106 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.65 -38.48 91.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.945 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 94.2 mtp -60.12 -46.01 91.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.426 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.73 -40.16 88.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.662 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' A' ' 38' ' ' LYS . 19.8 t-20 -58.57 -48.35 81.23 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.626 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 15.4 tpt -64.69 -40.36 95.24 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' B' ' 395' ' ' MET . 83.8 mtt-85 -65.22 -38.09 89.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.36 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.84 -39.43 94.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.985 0.421 . . . . 0.0 110.404 177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 397' ' ' ASN . 68.6 t -67.08 -46.9 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.097 0.475 . . . . 0.0 110.584 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.97 -37.33 87.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.124 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.48 -38.63 90.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.18 -38.43 86.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.181 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -58.53 -47.45 84.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.388 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.31 -38.51 90.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.999 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.437 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -61.65 -42.91 99.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 98.7 t -64.55 -43.24 96.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 110.149 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -60.05 -40.58 89.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.962 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.47 -41.13 96.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.437 HG23 ' O ' ' B' ' 407' ' ' ALA . 95.4 t -64.41 -44.86 97.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.414 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 98.0 mt -62.55 -29.42 70.56 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.542 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.99 -31.1 70.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.766 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -112.0 -20.24 12.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -71.37 151.14 44.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.929 0.395 . . . . 0.0 111.146 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -81.09 103.88 11.2 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' B' ' 125' ' ' VAL . 61.5 t -120.01 132.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.94 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 11.3 t -126.17 142.18 51.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.975 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -88.45 113.38 23.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -123.02 118.05 26.88 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -78.94 128.43 33.28 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.785 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -137.86 156.08 48.29 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.992 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 24.1 p -88.05 162.64 16.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -61.46 -44.56 96.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.74 0.305 . . . . 0.0 110.683 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -61.56 -40.35 94.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.063 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -57.4 -51.68 68.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.284 0.564 . . . . 0.0 110.697 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 35.7 tp -69.14 -37.69 78.43 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.262 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.87 -36.31 76.62 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.421 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -34.49 -82.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.148 0.905 . . . . 0.0 112.531 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 53.95 33.39 17.26 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -65.94 101.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.252 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.976 -179.16 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -111.03 125.25 53.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.807 0.337 . . . . 0.0 110.813 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.28 133.17 66.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.938 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 m -146.04 138.82 25.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.794 0.331 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.73 124.93 13.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.281 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 50.6 mm-40 -104.82 144.58 31.57 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.057 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -109.63 127.84 54.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -90.8 -64.18 1.17 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.647 0.26 . . . . 0.0 111.611 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -162.33 128.58 3.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.018 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.57 -109.25 2.52 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.259 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.8 mp -100.56 5.38 43.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.824 0.345 . . . . 0.0 110.869 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -83.35 136.08 14.63 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.435 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -128.99 157.5 41.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 111.101 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -129.04 132.7 47.51 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.1 t -95.56 -89.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.962 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 m 41.36 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.15 122.65 50.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.1 p -97.11 109.47 22.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.276 0.56 . . . . 0.0 112.093 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.2 pt -137.34 168.49 21.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.061 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.7 161.4 27.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.867 0.365 . . . . 0.0 111.656 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.43 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.785 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -57.91 -49.11 77.85 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.209 0.528 . . . . 0.0 111.215 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -72.5 -37.57 68.37 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.892 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.39 -45.58 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.576 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 tt0 -62.68 -46.33 88.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.22 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.0 m -62.69 -46.34 88.61 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.038 -176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.88 85.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.93 -43.17 96.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.705 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.589 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 55.2 mtmt -60.59 -44.47 96.2 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.652 0.263 . . . . 0.0 110.794 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.7 m -62.89 -43.7 98.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.854 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.95 -41.52 61.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.66 -42.27 98.68 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 14.6 p -65.35 -36.03 76.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.097 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -64.91 -41.4 95.6 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.65 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.63 -42.96 93.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.62 -33.81 71.97 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.992 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -64.41 -36.01 82.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.334 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HA ' HD21 ' B' ' 397' ' ' ASN . 40.7 ttpt -61.56 -43.42 98.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.742 0.306 . . . . 0.0 110.771 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.94 -5.2 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.518 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 61.28 63.5 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.961 0.904 . . . . 0.0 112.469 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 HD11 HH11 ' B' ' 344' ' ' ARG . 40.9 mm -124.41 -12.99 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.431 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -65.23 -34.27 77.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.808 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.95 -5.9 62.69 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.864 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -106.21 6.72 31.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.997 0.427 . . . . 0.0 110.233 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' NH2' ' HA2' ' A' ' 47' ' ' GLY . 49.6 ttt-85 -89.25 106.88 18.73 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.622 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -79.59 -12.16 59.85 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.265 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' HA2' ' NH2' ' A' ' 45' ' ' ARG . . . 78.16 23.54 65.75 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.718 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -63.54 -41.74 98.45 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 117.56 0.68 . . . . 0.0 110.107 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -103.25 122.53 44.91 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.39 141.04 94.63 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.285 1.99 . . . . 0.0 111.551 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' O ' HG22 ' A' ' 54' ' ' VAL . 9.1 tpt -66.91 -34.09 77.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.191 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 27.7 p-10 -62.25 -39.29 92.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.906 0.384 . . . . 0.0 110.678 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.46 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.9 mt -67.16 -43.7 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 51' ' ' MET . 23.7 m -64.15 -33.76 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.999 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.69 87.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.003 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 16.9 pt20 -92.48 8.98 36.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.956 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 67.4 mtt180 -103.76 -63.85 1.15 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.667 175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.61 1.97 51.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.95 80.85 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.822 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.08 -41.27 77.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.198 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.8 m -64.3 -40.23 95.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.9 p -99.55 12.81 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.109 0.481 . . . . 0.0 111.1 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -59.35 -44.31 92.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.688 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.17 -40.19 78.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 110.347 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.3 -36.04 82.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.151 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 62' ' ' VAL . 78.3 t -61.29 -42.76 94.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.91 -39.94 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.16 96.07 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.61 -41.2 98.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.827 0.346 . . . . 0.0 110.497 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.2 -41.91 97.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 54.6 ttp -60.79 -44.05 97.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.092 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -62.41 -49.95 73.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.855 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' A' ' 73' ' ' ARG . 56.9 mtm180 -70.98 -39.48 72.44 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -64.5 -38.94 92.76 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.779 -0.369 . . . . 0.0 111.735 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.89 -48.08 83.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.5 tt -66.45 -38.48 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.158 0.504 . . . . 0.0 110.704 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.59 -43.04 98.11 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.42 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . . . -69.15 -43.4 74.39 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.865 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.9 pt -65.96 -39.99 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.55 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -69.87 -31.85 69.91 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.409 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.55 -1.07 57.92 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.603 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? 62.02 36.57 15.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.39 127.78 58.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.957 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -110.23 110.43 58.36 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.705 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.57 156.52 53.76 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.807 2.338 . . . . 0.0 112.468 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.68 80.33 5.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.44 -86.9 1.31 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.379 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.77 126.63 19.0 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-O 120.512 0.196 . . . . 0.0 110.99 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 149.6 44.73 Favored 'Trans proline' 0 C--O 1.239 0.562 0 C-N-CA 122.866 2.377 . . . . 0.0 111.252 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.8 m -97.04 119.48 35.6 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.902 0.382 . . . . 0.0 110.805 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -100.03 115.3 29.4 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.3 102.42 43.71 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.895 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.13 152.32 9.54 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.573 2.182 . . . . 0.0 111.832 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -105.58 -174.61 24.0 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.33 131.89 37.21 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -98.91 127.14 44.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.935 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 99.7 mttt -107.72 131.21 54.67 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.4 tp -69.51 117.02 10.59 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 98.62 -2.43 58.8 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.191 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 48.5 mt-10 -120.12 -177.34 3.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.167 0.508 . . . . 0.0 112.085 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -77.99 162.01 27.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.979 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -129.44 136.98 50.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.034 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.7 m -125.46 132.24 52.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.018 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 52.5 p90 -139.16 159.6 41.77 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.7 m -130.95 146.21 52.28 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 11' ' ' LEU . 57.3 t -123.52 126.96 73.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.42 125.16 46.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.818 0.342 . . . . 0.0 110.52 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.81 158.27 43.94 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.035 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.33 176.82 6.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.36 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 p -136.92 151.89 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.032 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -122.64 124.37 26.72 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 120.454 0.169 . . . . 0.0 110.812 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.96 -173.01 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.21 2.606 . . . . 0.0 113.115 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -133.62 150.62 51.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.57 0.224 . . . . 0.0 110.522 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -120.23 133.62 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.879 0.371 . . . . 0.0 110.142 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.92 122.9 34.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.564 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -138.41 154.77 48.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.79 0.329 . . . . 0.0 110.878 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.45 19.5 73.82 Favored Glycine 0 CA--C 1.507 -0.45 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.684 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.84 -43.32 93.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.22 0.533 . . . . 0.0 111.003 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -73.9 -15.72 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.905 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.73 4.83 45.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.144 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -88.05 124.68 41.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.288 0.566 . . . . 0.0 111.317 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -113.16 133.79 54.87 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.243 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.457 HG11 HG13 ' A' ' 286' ' ' VAL . 71.8 t -124.78 129.12 73.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.452 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 128' ' ' PRO . 43.8 tt0 -98.42 128.62 44.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.9 tttt -108.13 97.24 20.89 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.804 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 126' ' ' GLU . 17.0 Cg_exo -67.57 126.48 14.87 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.474 2.116 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 48.1 mm -104.9 108.18 24.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.19 162.68 39.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.886 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -132.51 173.7 11.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.273 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.1 t -106.94 124.16 62.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.3 p -92.5 169.49 10.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.76 0.314 . . . . 0.0 111.067 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.46 -30.48 71.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.465 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.47 -40.38 96.95 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.336 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.51 -40.78 96.27 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.591 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.4 t -62.26 -45.48 98.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.524 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.65 -38.29 87.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.971 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.66 -42.98 98.55 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.557 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -66.58 -39.49 88.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.948 0.404 . . . . 0.0 110.398 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.0 mt -61.96 -44.23 97.19 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.522 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.59 -41.13 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.758 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.618 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 33.4 m -61.09 -46.41 90.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.637 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.99 -42.07 99.74 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -64.37 -39.57 94.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.483 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -66.47 -35.7 80.92 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.6 mm100 -58.23 -39.55 79.37 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -113.9 126.1 54.79 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.12 14.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.018 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.0 m -77.7 156.63 30.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -116.43 160.76 20.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -147.45 152.79 38.68 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -88.59 143.14 27.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.764 0.711 . . . . 0.0 112.29 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.8 pttt -145.89 176.12 9.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.815 177.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -144.47 120.64 10.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.134 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.63 -112.92 0.54 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.275 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.72 158.19 16.42 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.904 0.383 . . . . 0.0 111.738 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 240' ' ' VAL . 22.0 t -94.07 130.02 43.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.95 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -89.69 -150.28 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.605 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.627 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -115.24 8.95 15.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.724 0.297 . . . . 0.0 111.418 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -147.91 19.03 1.13 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.11 169.11 18.67 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.518 0.675 . . . . 0.0 112.349 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.8 tmm_? -105.7 123.6 48.19 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.32 157.72 40.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.66 -172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 m -113.9 115.09 27.15 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.1 mt -125.26 129.86 73.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -97.02 120.89 38.21 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -137.5 158.04 45.24 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.177 0.513 . . . . 0.0 111.683 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.1 m -127.75 131.95 49.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.454 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -79.22 80.87 1.48 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.665 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 57.7 m -99.66 129.13 45.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 24.5 t -77.04 -91.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.319 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -112.82 12.92 19.61 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.36 0.6 . . . . 0.0 109.976 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.25 -9.79 1.51 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.677 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -120.6 140.59 51.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -87.33 155.54 20.0 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.447 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 179' ' ' GLY . 41.5 p90 -114.69 176.88 4.86 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.896 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.45 24.38 0.05 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 177' ' ' PHE . . . -151.44 172.54 30.93 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.0 28.71 36.55 Favored Glycine 0 C--N 1.312 -0.797 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.577 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -101.68 108.34 19.84 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -120.71 155.06 34.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.232 0.539 . . . . 0.0 112.239 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.9 t -149.61 97.53 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.045 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 59.29 50.81 7.39 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.516 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.97 124.38 29.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.527 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.37 123.28 40.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.267 0.556 . . . . 0.0 110.512 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 48.7 tp -122.59 144.22 49.24 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.915 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.94 113.88 27.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.429 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.4 mtp -81.27 153.87 26.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.93 -17.29 59.57 Favored Glycine 0 CA--C 1.504 -0.648 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.786 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -92.5 -6.58 49.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.677 -0.261 . . . . 0.0 110.663 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.15 48.38 70.88 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.828 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -93.58 -6.7 46.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 17.9 mmt -117.51 177.33 4.79 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.193 0.521 . . . . 0.0 111.637 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.2 mm -57.33 132.2 81.2 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.3 126.65 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.4 1.4 . . . . 0.0 110.011 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 101.96 -31.07 9.13 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.34 -0.934 . . . . 0.0 111.729 -176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.24 -52.82 43.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.917 0.358 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.68 -7.41 59.65 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.219 0.533 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HB2' ' HA2' ' A' ' 197' ' ' GLY . 29.5 m-20 -87.92 -28.64 21.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.068 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.76 -17.36 78.85 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.366 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.91 -1.97 10.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 122.433 -0.451 . . . . 0.0 111.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 59.8 mtpt -68.52 114.61 7.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.479 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.7 -1.91 42.1 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.599 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -90.64 160.8 15.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 117.256 0.528 . . . . 0.0 111.12 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -85.09 153.69 22.54 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.914 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.47 80.21 1.93 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.913 0.387 . . . . 0.0 111.068 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 134.18 49.11 0.08 OUTLIER Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.239 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.92 125.09 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.994 0.426 . . . . 0.0 110.671 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -81.35 119.02 23.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -110.27 -44.86 3.66 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 60.5 m 73.25 111.63 0.06 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.316 0.579 . . . . 0.0 110.804 -175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.0 tp -120.16 140.06 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.542 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.54 ' OD1' ' HE2' ' A' ' 232' ' ' LYS . 11.8 m-20 -82.63 109.09 16.51 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.171 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 67.0 t -108.98 112.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 31.3 m -103.25 122.24 44.35 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 95.7 m-85 -84.71 141.28 38.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.135 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.36 150.95 77.74 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.474 2.116 . . . . 0.0 111.835 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 57.5 mm-40 -57.93 -36.08 72.0 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.768 -178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.98 37.72 1.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.615 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -77.99 141.29 39.03 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -60.03 -30.56 69.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.35 121.39 33.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.99 -40.27 97.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -73.46 -6.67 47.83 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.3 mt -115.67 -25.59 7.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.9 ptmt -63.74 122.88 17.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.336 0.589 . . . . 0.0 111.896 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.23 12.03 84.98 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.684 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -111.66 149.39 31.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.109 0.48 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -113.15 114.95 27.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.874 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -109.0 145.14 36.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.795 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 214' ' ' ASP . 99.6 mttt -112.68 118.69 35.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.246 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 212' ' ' THR . 96.8 m-85 -102.47 120.16 40.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.363 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.14 94.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.203 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 51.1 mm 69.42 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 123.662 0.601 . . . . 0.0 111.171 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -86.01 -60.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.95 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.8 mt 67.61 152.88 0.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.272 0.629 . . . . 0.0 112.559 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -162.3 -47.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.013 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -124.2 136.31 54.08 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.007 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 158' ' ' VAL . 59.6 t -138.08 107.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.25 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 13.0 mp0 -99.59 140.94 33.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.047 0.451 . . . . 0.0 111.038 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 39.9 tt0 -86.69 176.64 7.66 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.844 0.858 . . . . 0.0 109.797 -178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 242' ' ' GLU . 48.1 mtt180 -125.82 158.04 36.02 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 245' ' ' LEU . 36.3 tt0 -143.41 168.87 18.8 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.413 ' N ' ' HG2' ' A' ' 244' ' ' GLU . 90.7 mt -49.49 119.96 9.97 Favored Pre-proline 0 N--CA 1.464 0.273 0 O-C-N 123.326 0.391 . . . . 0.0 110.569 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.8 157.77 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.013 2.475 . . . . 0.0 113.117 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.91 89.94 1.11 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.597 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 36.3 tp -80.19 72.56 7.01 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.468 0.651 . . . . 0.0 111.163 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' A' ' 251' ' ' GLU . 5.0 m -155.11 17.86 0.42 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 62.69 25.23 15.0 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.052 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 249' ' ' THR . 57.6 mm-40 -67.76 -60.78 2.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.668 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -68.29 -42.94 78.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.373 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 256' ' ' PHE . 19.9 tt -96.7 35.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.734 0.778 . . . . 0.0 111.303 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 22.0 ptmt -71.2 -5.75 34.32 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 255' ' ' ARG . 0.0 OUTLIER -89.69 -6.8 55.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.393 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.463 ' HB2' HG12 ' A' ' 253' ' ' ILE . 10.5 t80 -75.52 141.05 43.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.85 83.76 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.083 -0.579 . . . . 0.0 114.077 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.66 133.22 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 117.02 0.41 . . . . 0.0 110.398 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 3.3 mp0 -62.62 127.18 30.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.73 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.16 171.84 8.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.286 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 84.75 -26.64 5.2 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 121.1 -0.571 . . . . 0.0 114.222 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.1 p -65.08 121.53 14.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.88 0.372 . . . . 0.0 110.816 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.85 -47.17 94.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.185 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.23 -40.43 71.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.656 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.57 90.91 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.375 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.3 tp -63.21 -43.48 98.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.539 0.209 . . . . 0.0 110.495 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.54 -40.83 98.02 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.366 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.71 -42.69 99.77 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.666 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.512 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 48.1 tp10 -68.19 -38.71 82.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.009 0.433 . . . . 0.0 110.57 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 266' ' ' LEU . 76.2 t -66.11 -43.32 92.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 O-C-N 122.264 -0.273 . . . . 0.0 111.022 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -59.35 -46.56 88.31 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.503 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.7 ptmt -63.91 -44.74 92.03 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.525 0.202 . . . . 0.0 111.357 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -66.51 -41.02 89.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.2 mmm -63.01 -43.1 99.69 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.806 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.89 -32.69 71.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.646 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.83 -47.39 86.59 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.91 -32.87 65.63 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.634 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.04 -42.84 99.6 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 109.945 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.54 -44.75 95.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.302 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 21.8 m -62.0 -39.81 93.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.027 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.86 95.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.657 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 90.7 mt -64.71 -45.62 94.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.897 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -66.87 -44.02 82.03 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.717 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -66.14 -41.31 90.63 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -66.05 -42.67 89.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.676 0.274 . . . . 0.0 111.224 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.457 HG13 HG11 ' A' ' 125' ' ' VAL . 54.9 t -62.22 -44.44 99.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.01 0.433 . . . . 0.0 109.965 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.64 -46.85 88.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.771 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 47.4 m -61.55 -41.15 96.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.158 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -59.72 -47.47 85.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.809 0.338 . . . . 0.0 111.438 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.56 69.06 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 0.0 111.694 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.8 mm -64.89 -44.32 96.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.938 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.64 -39.66 94.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.837 0.351 . . . . 0.0 110.498 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.52 -44.08 98.47 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.164 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 44.4 mt -63.83 -44.75 92.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.56 -43.93 86.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.407 . . . . 0.0 111.724 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -64.11 -37.43 87.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.464 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.2 -42.18 12.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -99.52 108.37 20.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.122 0.487 . . . . 0.0 112.305 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -109.22 127.15 54.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.012 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -135.79 154.38 34.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.534 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.01 134.69 49.8 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.88 132.39 23.69 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.33 135.02 55.24 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.373 2.049 . . . . 0.0 111.32 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.5 -34.68 78.82 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.76 -43.13 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.891 0.377 . . . . 0.0 111.149 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.17 -43.88 95.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -59.69 -41.15 90.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.596 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 m -62.22 -43.46 98.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.188 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -33.85 77.04 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.335 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.1 mt -62.26 -42.54 95.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.725 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.438 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 27.7 t70 -59.55 -43.59 93.48 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.779 0.323 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -45.21 99.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.043 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.8 mt -63.19 -41.46 99.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.507 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 47.7 mtm180 -61.66 -43.29 99.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.83 0.348 . . . . 0.0 110.896 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 67.0 mtt-85 -65.89 -37.47 86.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.069 0.461 . . . . 0.0 110.385 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.434 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -64.42 -44.05 92.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.114 177.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.6 91.24 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.475 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.676 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -65.45 -48.2 73.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.595 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -69.82 -35.55 74.88 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -66.11 -30.29 70.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.894 0.378 . . . . 0.0 111.356 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -176.57 -67.0 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.962 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 136.87 98.88 0.52 Allowed Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.505 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -161.64 100.78 1.17 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.46 143.44 57.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.177 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 0.5 OUTLIER 78.14 -28.96 0.16 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.855 0.862 . . . . 0.0 113.259 178.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -65.45 -22.7 66.78 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.701 0.763 . . . . 0.0 109.449 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.03 -24.59 58.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.953 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.21 -36.57 82.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.204 0.526 . . . . 0.0 110.664 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.54 -5.31 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.045 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.0 mt -68.48 146.6 97.87 Favored Pre-proline 0 N--CA 1.466 0.364 0 O-C-N 122.338 -0.226 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.6 Cg_exo -59.46 133.07 49.72 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.07 2.514 . . . . 0.0 113.58 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.7 ttm-85 -65.79 -43.55 88.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.517 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.1 pm0 -57.68 -32.57 67.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.6 -39.18 93.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.866 0.365 . . . . 0.0 111.45 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -103.45 -10.1 18.84 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -59.16 -45.14 91.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.857 0.36 . . . . 0.0 111.352 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -69.34 -48.61 60.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.977 0.418 . . . . 0.0 111.826 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.588 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.4 pt20 -66.76 -33.63 76.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.179 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.37 -44.48 91.25 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.165 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.58 -36.76 83.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.134 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -58.36 -46.76 85.66 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.547 177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.23 -41.06 90.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.468 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 98.0 t -62.71 -45.87 97.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 89.1 t -62.03 -45.91 97.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.488 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 343' ' ' ARG . 70.2 t -62.0 -44.6 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.15 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.93 -42.19 99.6 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.131 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 94.7 mt -63.12 -43.58 98.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.837 0.351 . . . . 0.0 110.219 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.572 ' O ' HG23 ' A' ' 354' ' ' VAL . 94.8 mt -63.85 -45.1 91.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.6 -40.99 96.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.106 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.79 -40.64 98.45 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.89 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.99 -34.79 77.2 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 120.677 0.275 . . . . 0.0 110.573 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 350' ' ' LEU . 76.5 t -60.55 -44.1 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.388 0.613 . . . . 0.0 109.37 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.33 -44.69 99.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.004 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -70.7 -45.17 65.48 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 30.2 m -63.72 -43.87 95.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -90.27 5.68 46.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.483 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 50.91 44.95 28.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.34 144.51 46.49 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.659 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -117.4 161.05 20.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.379 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -86.17 109.98 19.27 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 27.3 t70 -86.47 117.78 25.48 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.61 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -65.1 -36.05 83.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.51 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 40.6 mm-40 -63.2 -41.59 99.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.789 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 -61.8 -43.73 98.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.544 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.09 -43.22 92.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.916 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -59.5 -44.43 93.11 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.12 -41.59 99.7 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.353 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.51 -38.94 91.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.899 0.38 . . . . 0.0 110.96 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.3 mt -62.64 -42.43 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.261 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -56.64 -45.29 81.68 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.55 -46.05 91.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.62 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -65.97 -44.49 84.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.57 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.19 -37.23 85.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.308 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 34.0 t -64.66 -17.0 63.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -77.2 -10.92 59.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 0.0 111.506 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -100.81 169.84 8.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.276 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -59.85 -53.64 55.55 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.297 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 383' ' ' GLU . 32.0 t70 -123.8 107.87 30.98 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 0.0 110.55 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.44 -23.61 37.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.377 2.051 . . . . 0.0 112.872 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -63.55 -48.7 76.41 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.433 ' HG2' ' OD2' ' A' ' 380' ' ' ASP . 10.0 pt-20 -69.25 -35.76 76.45 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.443 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.03 -45.12 95.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.83 -43.89 97.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.14 -37.25 85.23 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.351 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -60.05 -44.07 94.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.726 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.04 -41.79 97.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.2 m -74.56 -13.8 60.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.147 0.498 . . . . 0.0 111.053 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -80.14 -24.22 40.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.217 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 395' ' ' MET . 23.7 t-20 -122.48 121.55 36.84 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.51 -38.17 90.13 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.02 -45.37 90.87 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.003 0.43 . . . . 0.0 110.096 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.45 -41.19 98.64 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.6 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.606 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 94.4 mtp -61.49 -45.97 91.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.052 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.71 -46.73 84.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 111.477 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' B' ' 38' ' ' LYS . 26.8 t-20 -62.96 -41.69 99.61 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.73 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.4 -39.75 95.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.495 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 395' ' ' MET . 92.2 mtt-85 -61.9 -40.57 95.89 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.741 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -63.41 -37.26 86.6 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.521 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.35 -49.15 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.994 0.426 . . . . 0.0 110.857 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.4 78.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.924 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.25 -40.48 96.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.514 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 408' ' ' VAL . 43.7 tt0 -61.43 -42.48 98.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.729 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -65.05 -38.55 91.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.018 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -64.66 -36.79 85.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.9 0.381 . . . . 0.0 110.261 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.66 94.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.192 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.69 -43.65 98.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.086 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -59.33 -42.87 92.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.939 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.75 99.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.247 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.75 -45.16 95.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.025 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.43 HD21 ' CG1' ' A' ' 286' ' ' VAL . 93.9 mt -62.46 -38.88 91.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.712 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.36 -26.19 67.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.043 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -108.0 -3.84 18.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -99.85 157.53 16.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.91 0.386 . . . . 0.0 110.828 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.62 97.9 9.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.954 0.407 . . . . 0.0 109.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 62.8 t -101.64 128.77 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.149 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -124.45 132.17 53.5 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.367 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.551 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 66.8 mt-10 -93.76 137.88 32.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.237 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -137.49 118.97 14.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.56 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 61.7 mt-10 -73.97 122.78 23.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.066 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.2 p -138.06 156.99 47.24 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.321 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.3 m -80.02 156.72 27.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -59.09 -41.97 89.34 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.132 0.492 . . . . 0.0 109.794 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.58 -39.33 76.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -63.23 -46.98 84.4 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 111.605 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.27 -28.95 64.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.174 0.511 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.08 -19.41 65.97 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.897 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.03 84.89 2.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.959 0.409 . . . . 0.0 110.152 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -118.28 44.72 2.17 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -74.15 90.98 2.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.927 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.506 0 CA-C-O 118.352 -0.832 . . . . 0.0 110.712 -178.353 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -102.86 128.61 49.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.701 0.286 . . . . 0.0 110.854 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.9 134.17 66.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.813 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 47.9 m -145.46 132.46 20.27 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.536 -0.465 . . . . 0.0 111.779 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p -141.12 124.15 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 21.4 mm-40 -108.13 149.09 28.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.798 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.6 m -108.69 126.2 52.72 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 11.0 p -90.57 -60.25 1.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.718 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -166.36 132.5 2.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.935 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.54 -113.59 5.38 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.237 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.447 HD23 ' O ' ' B' ' 107' ' ' VAL . 6.4 mp -98.8 8.28 45.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.878 0.37 . . . . 0.0 110.785 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -85.8 138.24 16.0 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -131.11 156.25 45.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.01 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 35.0 ttm180 -126.04 131.51 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.8 -88.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.891 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 m 40.44 84.09 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.628 0.771 . . . . 0.0 112.922 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 78.0 mt -97.59 121.93 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 2.2 p -96.02 110.03 22.33 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.265 0.555 . . . . 0.0 112.109 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.22 165.29 25.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.112 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.4 30.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.527 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.52 -30.84 67.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.972 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -58.11 -49.24 77.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.209 0.528 . . . . 0.0 111.2 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -72.53 -36.62 68.35 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.957 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 88.8 mt -62.64 -45.83 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.481 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 33.6 tt0 -61.84 -46.91 87.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.935 0.398 . . . . 0.0 110.175 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -62.63 -46.76 86.73 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.317 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.99 85.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.24 -43.29 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.706 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 53.2 mtmt -60.7 -44.31 96.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.835 0.35 . . . . 0.0 110.85 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.0 m -62.82 -43.71 98.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.013 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -74.99 -41.45 59.51 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.46 -42.36 98.65 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 15.0 p -65.2 -36.99 79.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.182 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -64.89 -40.85 95.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.483 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.44 -42.92 94.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.14 70.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.0 mttt -65.12 -35.54 81.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 0.0 110.81 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.487 ' HA ' HD21 ' A' ' 397' ' ' ASN . 40.5 ttpt -61.61 -44.71 96.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.622 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -87.4 -5.88 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.536 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 63.68 59.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 112.262 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.434 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.5 mm -122.47 -12.59 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.501 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -65.77 -33.75 76.59 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.711 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.91 64.44 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.736 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.27 8.28 33.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.079 0.466 . . . . 0.0 110.091 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -90.36 109.89 20.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -82.04 -10.85 59.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.89 24.82 70.94 Favored Glycine 0 C--O 1.224 -0.512 0 N-CA-C 114.538 0.575 . . . . 0.0 114.538 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -64.41 -43.31 94.79 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.527 0.663 . . . . 0.0 110.489 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 13.9 p -101.55 121.61 50.76 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.95 140.34 94.86 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.131 1.888 . . . . 0.0 111.786 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.431 ' O ' HG22 ' B' ' 54' ' ' VAL . 10.0 tpt -66.24 -34.5 78.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.146 -174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.612 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 27.4 p-10 -63.18 -39.37 94.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.096 0.474 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.451 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 83.9 mt -65.01 -43.62 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.102 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 51' ' ' MET . 22.4 m -65.02 -34.0 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.208 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.89 87.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 17.5 pt20 -91.2 8.31 36.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.791 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' B' ' 53' ' ' ILE . 66.0 mtt180 -104.47 -66.08 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.046 0.45 . . . . 0.0 111.059 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -96.01 3.26 53.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.185 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.26 84.43 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.43 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.62 78.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -63.85 -42.14 97.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.857 0.36 . . . . 0.0 111.875 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.524 ' O ' HG23 ' B' ' 66' ' ' VAL . 9.8 p -95.98 11.89 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.038 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -59.59 -44.23 93.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.243 -0.286 . . . . 0.0 111.473 -175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.62 -40.44 88.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.358 . . . . 0.0 110.54 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.07 -36.63 84.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.179 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' B' ' 62' ' ' VAL . 92.1 t -61.73 -42.22 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.105 0.479 . . . . 0.0 109.933 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.82 -39.68 92.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.78 -37.34 94.68 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.532 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.12 -42.02 99.45 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.077 0.465 . . . . 0.0 110.477 176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.45 -42.21 98.41 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 54.1 ttp -60.94 -44.64 96.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -50.65 70.63 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.91 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.405 HH21 ' HD2' ' B' ' 73' ' ' ARG . 56.4 mtm180 -70.42 -39.5 74.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -64.37 -39.04 93.1 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.56 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.54 -47.46 86.07 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.623 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.05 -39.52 84.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.896 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.71 -41.61 95.88 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 121.005 0.431 . . . . 0.0 111.038 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.6 -42.51 86.8 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 44.3 pt -67.95 -39.66 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.86 -44.37 98.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -33.77 73.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.633 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -89.0 0.39 56.7 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.2 mmpt? 61.51 37.35 16.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.586 0.354 . . . . 0.0 111.756 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.6 mt -103.74 127.21 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.035 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -109.41 109.68 60.16 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.676 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.01 154.04 57.79 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.771 2.314 . . . . 0.0 112.4 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.6 81.53 6.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.12 0.486 . . . . 0.0 111.876 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.85 -91.03 1.66 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.073 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.42 130.35 21.0 Favored Pre-proline 0 C--N 1.316 -0.887 0 O-C-N 122.832 -0.216 . . . . 0.0 110.767 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -74.78 143.31 29.68 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.252 1.968 . . . . 0.0 110.962 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.8 m -94.37 119.45 33.13 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.413 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -99.04 121.08 40.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.47 100.54 45.37 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.274 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -86.5 144.51 7.82 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 122.749 2.299 . . . . 0.0 112.07 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.58 -170.3 30.28 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.247 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.32 121.52 26.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -88.75 131.51 35.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.121 0.486 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' B' ' 101' ' ' GLU . 99.6 mttt -113.7 130.91 56.35 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.67 123.7 22.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.998 0.428 . . . . 0.0 110.386 -177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.23 -0.35 71.77 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.105 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 98' ' ' LYS . 47.1 mt-10 -122.49 -175.81 3.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.631 0.253 . . . . 0.0 110.964 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -83.37 167.12 17.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.319 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -131.52 135.01 46.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.249 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 71.5 m -122.97 132.11 54.01 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.113 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.47 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 51.1 p90 -139.47 159.46 42.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -131.81 149.81 52.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.634 0.254 . . . . 0.0 110.494 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.447 ' O ' HD23 ' B' ' 11' ' ' LEU . 56.6 t -123.31 125.52 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.337 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -92.65 119.76 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -149.45 158.78 44.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.84 175.07 7.02 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.669 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.21 152.84 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.973 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -125.69 121.54 24.56 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 120.604 0.24 . . . . 0.0 111.09 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.18 -172.44 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.366 2.711 . . . . 0.0 112.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.4 152.06 50.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.104 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.63 158.56 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.652 0.263 . . . . 0.0 110.35 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.18 134.54 54.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -92.33 121.43 33.81 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -137.79 150.21 47.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.085 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.93 18.48 69.82 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.501 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -43.45 95.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 111.719 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -74.01 -12.37 60.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.473 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.51 -0.98 57.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.456 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.81 124.69 39.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.319 0.581 . . . . 0.0 111.225 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.87 126.82 54.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.162 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.407 HG11 HG13 ' B' ' 286' ' ' VAL . 88.6 t -119.39 131.4 72.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 120.768 0.318 . . . . 0.0 111.304 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' B' ' 128' ' ' PRO . 40.4 tt0 -99.41 129.46 45.6 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 84.7 tttt -107.72 97.25 19.53 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' B' ' 126' ' ' GLU . 15.1 Cg_exo -68.43 125.28 12.64 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.391 2.061 . . . . 0.0 111.179 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 47.7 mm -103.99 110.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.2 163.04 38.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.094 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -132.31 167.16 20.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.362 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.9 121.1 53.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 67.7 p -87.46 169.52 12.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.175 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.06 -25.65 66.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.264 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.23 90.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.035 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.82 -39.15 93.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.376 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 94.8 t -63.1 -45.33 98.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.7 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.53 -41.42 97.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.386 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.88 -40.91 99.48 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.5 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 12.7 tpt -67.78 -39.91 84.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.841 0.353 . . . . 0.0 110.576 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.4 mt -62.21 -44.55 96.32 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.481 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.32 -40.06 96.27 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.572 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 96.7 m -61.71 -46.18 90.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.082 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.54 -41.78 98.44 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.047 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -64.47 -40.28 95.4 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.832 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -64.88 -34.25 77.95 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' B' ' 143' ' ' THR . 15.5 mm100 -61.45 -36.77 81.32 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -116.28 125.04 51.62 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.14 146.26 13.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.369 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 20.1 m -75.49 143.44 42.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.732 0.413 . . . . 0.0 111.292 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -103.22 158.06 16.58 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -145.9 145.77 30.83 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.241 1.016 . . . . 0.0 108.315 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -82.27 139.25 34.31 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 57.7 pttt -141.95 179.77 6.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.497 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -144.47 122.7 12.23 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.08 -122.5 1.47 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.883 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -88.26 160.89 17.48 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.541 HG22 HG21 ' B' ' 240' ' ' VAL . 47.2 t -98.75 132.03 44.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.736 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.05 -160.22 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.98 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.651 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . -107.72 9.89 29.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.738 0.304 . . . . 0.0 111.145 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -147.21 21.52 1.21 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.763 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -84.43 173.24 11.05 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.465 0.65 . . . . 0.0 112.67 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -110.29 122.86 48.68 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.5 38.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 43.2 m -114.5 116.63 29.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 91.5 mt -127.0 130.62 71.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -96.03 116.18 28.56 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 171.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.83 155.98 48.86 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.115 0.483 . . . . 0.0 111.969 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 68.5 m -128.5 132.3 48.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.325 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.09 85.53 1.39 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.657 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 53.3 m -103.65 128.97 50.89 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 20.8 t -80.06 -94.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.34 12.77 31.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.281 0.563 . . . . 0.0 110.288 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 139.05 -2.91 2.71 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.368 -178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -123.49 139.0 54.46 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -88.0 149.86 23.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 0.0 110.341 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -104.84 -174.37 2.52 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.038 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.66 -3.02 25.58 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -123.13 -176.36 14.81 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.24 29.81 52.33 Favored Glycine 0 C--N 1.319 -0.393 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.228 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -103.09 107.67 18.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -121.72 155.64 34.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.118 0.485 . . . . 0.0 112.215 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.6 t -151.58 97.12 2.34 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.108 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.35 45.68 8.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.298 0.571 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -76.65 125.71 29.72 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.493 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.4 121.51 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.416 0.627 . . . . 0.0 110.387 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.89 144.28 48.94 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.896 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.5 117.11 33.32 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.9 mtp -82.19 153.32 26.04 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.686 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.76 56.79 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.957 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -90.62 -7.86 51.62 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.954 -0.123 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.65 42.77 79.04 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.977 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -89.52 -7.79 54.18 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -118.21 176.49 5.2 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.209 0.528 . . . . 0.0 111.895 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.16 131.98 80.6 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.726 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.97 124.2 15.69 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.509 1.473 . . . . 0.0 110.102 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' B' ' 200' ' ' ASP . . . 104.05 -28.67 14.3 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.817 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.11 -53.49 19.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.017 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.64 -6.77 58.82 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 121.355 0.598 . . . . 0.0 110.28 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.43 ' HB2' ' HA2' ' B' ' 197' ' ' GLY . 30.9 m-20 -89.51 -23.97 21.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.014 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.32 84.65 Favored Glycine 0 C--O 1.227 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.172 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 pt -101.92 2.0 10.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.044 0.45 . . . . 0.0 111.212 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.651 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 58.1 mtpt -73.46 105.57 4.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.743 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.74 -7.13 25.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -85.92 160.17 19.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.943 0.372 . . . . 0.0 110.565 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -87.27 153.66 21.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.294 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.18 80.11 1.28 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.081 0.467 . . . . 0.0 111.624 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 133.16 52.12 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.027 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.68 132.56 21.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.758 0.313 . . . . 0.0 110.692 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -87.08 126.83 35.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -120.17 -44.57 2.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 31.7 m 73.16 108.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.962 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 tp -115.06 137.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.331 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.677 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 14.3 m-20 -81.57 110.16 16.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.84 117.17 54.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 27.0 m -105.81 123.14 47.48 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 96.9 m-85 -85.67 141.26 36.07 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 32.7 Cg_exo -60.51 150.42 81.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.408 2.072 . . . . 0.0 112.34 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 67.6 mm-40 -57.63 -32.79 67.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.139 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -101.43 36.93 1.9 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -76.65 144.72 39.3 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -62.15 -29.5 70.4 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.21 121.3 33.61 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.52 -36.1 82.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -79.16 -2.06 39.08 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.6 mt -118.49 -27.9 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 22.5 ptmt -62.52 122.29 15.41 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.921 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.9 15.55 81.54 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.456 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -118.05 146.81 43.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.0 111.173 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -111.82 123.78 50.96 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.538 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -117.65 144.84 44.82 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.458 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.677 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 89.5 mttt -109.83 121.62 45.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' B' ' 212' ' ' THR . 97.7 m-85 -103.56 118.26 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.852 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -64.3 -40.33 95.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.042 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 50.6 mm 71.77 106.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.713 0.633 . . . . 0.0 111.137 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.66 -62.0 1.57 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.902 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 95.7 mt 67.67 153.94 0.09 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.277 0.631 . . . . 0.0 112.337 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -163.87 -42.48 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -130.35 137.74 50.06 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.827 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.541 HG21 HG22 ' B' ' 158' ' ' VAL . 58.2 t -140.09 102.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.301 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -95.85 143.95 26.62 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.956 0.408 . . . . 0.0 111.082 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.552 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 36.4 tt0 -88.91 178.4 6.43 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 123.757 0.823 . . . . 0.0 110.166 -177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.491 ' H ' ' HG2' ' B' ' 242' ' ' GLU . 46.2 mtt180 -127.03 158.84 35.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -143.87 167.39 22.44 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 87.0 mt -48.58 119.04 7.56 Favored Pre-proline 0 N--CA 1.466 0.327 0 O-C-N 123.254 0.346 . . . . 0.0 110.706 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.22 157.06 54.54 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.881 2.387 . . . . 0.0 112.876 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.91 91.36 0.33 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.741 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 36.9 tp -81.49 72.02 8.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.472 0.653 . . . . 0.0 110.71 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' B' ' 251' ' ' GLU . 5.0 m -160.48 26.11 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.598 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 254' ' ' LYS . . . 58.33 21.76 8.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.982 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' B' ' 249' ' ' THR . 65.1 mm-40 -65.18 -44.52 88.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.973 0.416 . . . . 0.0 111.886 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -91.53 -31.99 15.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.068 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.5 HG12 ' HB2' ' B' ' 256' ' ' PHE . 20.3 tt -104.52 32.32 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 121.761 0.791 . . . . 0.0 111.227 -175.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' B' ' 250' ' ' ALA . 22.7 ptmt -68.56 -4.78 16.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.66 -9.94 50.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.693 0.283 . . . . 0.0 111.211 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.5 ' HB2' HG12 ' B' ' 253' ' ' ILE . 10.2 t80 -73.55 146.94 44.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.25 -6.78 88.46 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.867 -0.683 . . . . 0.0 113.926 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 60.6 t -126.34 133.22 69.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 117.029 0.415 . . . . 0.0 110.222 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -63.99 125.43 24.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.436 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.47 176.93 6.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.611 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 81.94 -25.99 3.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.04 -0.6 . . . . 0.0 114.164 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 13.5 p -66.14 124.27 22.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.03 0.415 . . . . 0.0 110.683 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.06 -47.46 90.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.937 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 1.1 pm0 -71.06 -40.6 71.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.994 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.41 93.16 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.301 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.416 ' O ' HG23 ' B' ' 270' ' ' VAL . 50.4 tp -63.72 -43.71 95.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.488 0.185 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -63.71 -41.04 98.15 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.39 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -62.69 -41.88 99.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.727 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.503 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 39.9 tp10 -68.11 -38.22 82.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.601 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.416 HG23 ' O ' ' B' ' 266' ' ' LEU . 76.4 t -66.43 -42.71 90.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.796 176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -58.57 -46.42 86.96 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.582 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 13.9 ptmt -64.28 -44.32 92.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.403 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -66.63 -42.11 87.27 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.8 mmm -63.51 -43.18 97.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.706 0.288 . . . . 0.0 111.415 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.58 -31.47 67.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.065 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -61.23 -47.46 85.97 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.61 -33.54 69.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.007 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 59.4 tp -61.62 -42.82 99.42 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.012 0.434 . . . . 0.0 110.055 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.49 -45.12 94.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.379 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 26.1 m -61.27 -40.81 95.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.888 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.62 98.3 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.325 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.86 -45.12 95.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.254 0.55 . . . . 0.0 109.66 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -66.77 -44.13 82.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.633 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -66.62 -40.95 89.03 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.19 -42.15 89.24 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.337 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.461 ' CG1' HD21 ' B' ' 412' ' ' LEU . 52.5 t -61.98 -44.35 98.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.152 0.501 . . . . 0.0 110.037 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -60.76 -46.67 89.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.491 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -60.93 -41.66 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.243 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -59.84 -47.45 85.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 111.473 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.14 -45.67 69.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.646 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.7 mm -64.74 -44.09 96.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.986 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.691 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.94 -43.24 99.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.137 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.78 -45.51 89.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.59 -44.07 86.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.849 -178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -64.79 -36.9 85.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.458 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.15 -38.43 16.43 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.088 0.47 . . . . 0.0 112.152 -176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -120.18 123.89 44.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.746 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 10.6 tp -133.53 158.51 42.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.647 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.21 137.84 55.12 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 42.4 t -121.48 128.4 25.67 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.39 131.42 38.34 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.359 2.04 . . . . 0.0 111.272 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.61 -35.47 81.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.288 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.18 77.69 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.48 -42.88 91.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.966 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.592 ' O ' HG13 ' B' ' 311' ' ' ILE . 64.0 mt -64.91 -44.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.85 -42.7 89.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 24.5 m -61.95 -41.74 98.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.268 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -66.11 -33.91 76.85 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.148 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 307' ' ' ILE . 62.6 mt -61.68 -43.35 96.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.062 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 27.8 t70 -59.84 -43.87 94.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.751 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.23 -43.85 97.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.264 0.554 . . . . 0.0 110.209 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' B' ' 340' ' ' GLN . 85.2 mt -62.87 -41.28 99.33 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.186 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 52.6 mtm180 -62.96 -39.98 96.32 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.503 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 28.4 mmt180 -60.48 -43.5 96.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -65.97 -44.48 84.81 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.025 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.02 95.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.541 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.31 87.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.668 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -66.27 -47.4 73.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -72.81 -28.9 62.84 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -71.19 -23.32 62.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.088 0.47 . . . . 0.0 111.008 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.433 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 175.12 -61.68 0.11 Allowed Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.603 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 62' ' ' VAL . . . 129.56 97.14 0.82 Allowed Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 120.092 -1.051 . . . . 0.0 113.158 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -161.18 103.69 1.28 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.36 146.77 54.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.904 -177.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.474 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 0.2 OUTLIER 77.12 -28.01 0.17 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.14 0.976 . . . . 0.0 113.169 176.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -66.91 -21.08 66.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.552 0.691 . . . . 0.0 109.365 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.69 -24.3 61.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.412 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.36 -36.46 82.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -83.58 3.9 30.58 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.581 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 77.4 mt -73.64 146.97 86.52 Favored Pre-proline 0 C--O 1.238 0.467 0 O-C-N 122.188 -0.32 . . . . 0.0 110.779 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 32.1 Cg_exo -59.29 133.08 50.24 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.923 2.415 . . . . 0.0 113.578 -177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' B' ' 338' ' ' GLU . 50.0 ttm-85 -66.58 -42.46 86.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -58.53 -32.26 68.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.97 -40.29 96.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.806 0.336 . . . . 0.0 111.821 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . 0.45 ' HB2' HG23 ' B' ' 311' ' ' ILE . 60.2 m-85 -102.85 -8.71 20.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.43 ' OE1' ' HD3' ' B' ' 334' ' ' ARG . 8.3 tp10 -59.82 -43.21 94.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.115 0.483 . . . . 0.0 111.156 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -68.69 -49.05 62.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.066 0.46 . . . . 0.0 111.514 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.602 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -67.93 -33.35 74.51 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.764 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -65.07 -43.78 91.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 110.24 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.29 -37.16 84.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.28 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.406 ' O ' HG23 ' B' ' 347' ' ' VAL . 13.7 mmt180 -59.04 -45.79 89.86 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.539 HH11 HD11 ' A' ' 41' ' ' ILE . 3.8 mtt180 -64.71 -42.97 94.89 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.775 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 84.3 t -62.15 -45.79 97.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.268 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 94.7 t -61.71 -45.62 98.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 110.227 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 343' ' ' ARG . 74.3 t -62.68 -45.08 99.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.604 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.66 99.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.156 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 93.3 mt -63.14 -43.86 97.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.27 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.584 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -63.92 -44.84 91.73 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.934 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.32 -41.02 97.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.163 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.03 99.43 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.843 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.33 -34.24 75.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.761 0.315 . . . . 0.0 110.534 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.5 t -60.38 -44.27 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.52 -44.35 99.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.702 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . 0.417 HH21 ' HD2' ' B' ' 356' ' ' ARG . 14.4 ttp180 -70.33 -44.68 67.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 27.0 m -64.08 -43.38 95.58 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -88.45 1.97 53.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 55.88 42.04 29.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.039 0.447 . . . . 0.0 111.052 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 93.8 mt -72.45 147.62 45.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.307 0.575 . . . . 0.0 111.407 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -122.23 159.89 26.37 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.37 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -88.43 102.36 14.81 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.82 117.95 21.91 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.747 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -65.63 -36.92 85.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -63.42 -39.11 93.62 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.017 0.436 . . . . 0.0 110.026 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . 0.406 HH21 ' HD2' ' B' ' 366' ' ' ARG . 9.6 tpp85 -61.0 -43.76 98.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.27 175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.3 t -66.54 -43.32 90.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.878 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.63 -43.82 93.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.16 99.42 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.397 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.45 -38.81 90.95 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.871 0.367 . . . . 0.0 110.944 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.38 -42.77 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.825 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.96 -43.67 86.59 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.89 -43.19 96.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.994 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.5 ttp -66.68 -43.74 83.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.912 0.387 . . . . 0.0 111.035 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.85 81.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.38 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 27.7 t -64.26 -15.75 60.72 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.901 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -79.94 -11.73 59.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.658 0.266 . . . . 0.0 111.521 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.02 166.94 11.03 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.678 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.2 -47.36 86.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.197 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.9 104.3 18.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.916 0.389 . . . . 0.0 110.7 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.89 -24.82 39.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.419 2.079 . . . . 0.0 113.053 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.73 -46.84 80.54 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.19 -36.59 79.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.954 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.46 -44.73 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.56 -43.49 98.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.941 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -66.02 -37.76 86.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.154 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.57 -43.62 93.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.771 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.69 -36.53 81.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.517 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 21.3 m -81.31 -9.69 59.71 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.167 0.508 . . . . 0.0 110.902 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -85.12 -21.23 29.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.835 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -124.77 121.28 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.5 -38.47 91.26 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.959 0.409 . . . . 0.0 110.079 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -62.87 -41.77 99.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.348 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.634 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.2 mtp -61.65 -46.54 89.33 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.55 -48.81 75.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.183 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.431 HD21 ' HA ' ' A' ' 38' ' ' LYS . 26.6 t-20 -62.53 -41.28 98.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.689 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.5 tpt -63.47 -39.06 93.45 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.577 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.634 ' HG3' ' O ' ' B' ' 395' ' ' MET . 90.1 mtt-85 -62.43 -40.27 96.02 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -63.81 -35.03 79.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.422 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.38 -50.05 78.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.788 0.328 . . . . 0.0 110.721 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -68.87 -37.82 79.31 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.809 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.16 -40.89 97.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.298 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.403 ' O ' HG23 ' B' ' 408' ' ' VAL . 42.5 tt0 -61.09 -43.22 99.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.618 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -63.97 -38.57 91.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.202 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -64.77 -37.56 88.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.626 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.26 96.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.236 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.403 HG23 ' O ' ' B' ' 404' ' ' GLU . 97.7 t -62.78 -43.91 99.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.123 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.53 -42.13 91.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.776 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.71 -41.58 98.06 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.84 -45.51 94.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.016 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.461 HD21 ' CG1' ' B' ' 286' ' ' VAL . 94.5 mt -62.58 -38.7 91.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.816 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.8 -28.66 68.94 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.937 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -112.09 7.84 19.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.23 156.66 19.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.008 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -82.13 103.93 12.1 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 60.7 t -108.0 127.88 63.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.23 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 4.9 t -121.1 129.83 53.48 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.151 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 60.7 mt-10 -94.87 130.42 41.48 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -132.1 121.54 23.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.524 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.5 mt-10 -76.56 125.8 29.87 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.953 0.406 . . . . 0.0 110.15 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 2.5 p -137.56 155.1 49.61 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.114 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 9.2 m -81.39 157.78 24.88 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.66 -41.32 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.096 0.474 . . . . 0.0 109.949 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -59.15 -40.78 86.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.442 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.4 -50.09 72.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.999 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.6 tp -67.08 -34.0 76.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.027 0.442 . . . . 0.0 110.941 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 27.8 ttt -62.34 -18.96 62.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.236 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -74.56 81.25 1.98 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 110.234 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -111.84 36.28 3.36 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.2 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -68.36 105.99 2.35 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.303 -178.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -78.96 135.96 37.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.038 0.447 . . . . 0.0 111.676 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.91 156.0 42.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.326 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.3 m -149.98 148.35 28.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.74 0.305 . . . . 0.0 111.371 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.87 133.68 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.357 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -108.75 159.35 16.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.7 m -118.02 126.94 53.28 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.971 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 p -85.93 -55.06 4.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.624 0.25 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -174.81 129.26 0.31 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.27 -110.96 3.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.761 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 107' ' ' VAL . 6.7 mp -95.34 1.81 54.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.622 0.369 . . . . 0.0 110.814 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.38 131.59 10.49 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.763 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -127.97 150.17 50.02 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.792 0.437 . . . . 0.0 109.881 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -120.62 125.89 48.89 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 t -90.5 -85.1 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m 25.56 87.46 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.6 123.2 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.5 p -87.0 105.34 17.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.21 -169.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.392 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -64.47 140.57 58.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.753 0.311 . . . . 0.0 111.313 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.95 89.01 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.378 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.9 -48.85 79.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.749 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -62.47 -42.75 99.7 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.373 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 20' ' ' ALA . 66.2 mt -62.04 -46.88 95.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 120.907 0.384 . . . . 0.0 110.757 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.4 tp10 -65.69 -35.64 81.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.515 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 99.3 m -62.08 -41.67 98.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.724 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.18 85.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -65.12 -43.38 95.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.598 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 88.0 mttt -53.81 -49.76 67.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.539 0.685 . . . . 0.0 109.662 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -63.38 -43.36 97.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.185 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -71.08 -39.44 72.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.895 -176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.79 -42.38 99.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.85 -33.4 61.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.336 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -63.08 -44.83 94.66 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.336 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.3 t -66.82 -43.16 89.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.483 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.22 -39.81 80.0 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.93 -177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.6 -38.76 92.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HB2' HD22 ' B' ' 397' ' ' ASN . 34.7 ttpt -64.35 -42.83 96.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.295 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 41' ' ' ILE . 27.8 m -89.82 4.69 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.013 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.57 53.46 3.31 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 39' ' ' VAL . 18.2 mm -105.88 -24.47 4.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.239 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -64.71 -31.67 73.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.867 0.365 . . . . 0.0 110.686 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.67 -10.44 71.5 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.95 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.04 -2.33 26.14 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.033 0.444 . . . . 0.0 110.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -86.8 110.87 20.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.269 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.35 -39.61 85.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.0 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.56 15.79 28.57 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.598 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.56 -47.2 84.91 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 54' ' ' VAL . 2.7 m -105.05 108.66 61.84 Favored Pre-proline 0 C--O 1.241 0.622 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.34 141.72 80.92 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.656 2.237 . . . . 0.0 111.63 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.491 ' HA ' HG22 ' A' ' 54' ' ' VAL . 10.4 tpt -61.64 -38.44 87.69 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.251 -172.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -62.74 -39.85 95.4 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.908 0.385 . . . . 0.0 110.777 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.6 mt -70.11 -42.18 79.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.365 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 51' ' ' MET . 32.9 m -68.73 -34.09 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.715 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.34 93.4 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -77.21 -1.09 27.71 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.764 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 53' ' ' ILE . 87.7 mtt180 -103.77 -64.21 1.12 Allowed 'General case' 0 C--N 1.345 0.394 0 CA-C-O 120.779 0.323 . . . . 0.0 111.272 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -94.22 -2.82 51.83 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.11 -27.02 69.82 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.741 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.97 97.46 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.582 0.23 . . . . 0.0 111.399 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 15.8 m -63.79 -42.23 97.78 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.99 0.424 . . . . 0.0 111.871 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' B' ' 323' ' ' GLY . 8.6 p -89.17 5.82 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.082 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.4 HH11 HG22 ' A' ' 24' ' ' ILE . 1.8 tpt180 -60.25 -42.79 96.06 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.572 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.57 -40.04 88.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.991 0.424 . . . . 0.0 109.869 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.56 -36.03 82.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.116 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.2 t -60.21 -42.26 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.95 -39.53 92.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.557 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.53 -37.42 94.75 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.31 -40.44 95.94 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.018 0.437 . . . . 0.0 110.186 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.41 -41.02 96.49 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.383 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 31.8 ttm -59.34 -46.24 89.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.889 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -61.68 -49.98 74.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.549 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' HG22 ' A' ' 76' ' ' ILE . 54.5 mtm180 -72.62 -36.48 68.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -65.58 -37.11 85.72 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.409 -0.517 . . . . 0.0 111.483 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -61.09 -45.72 93.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.265 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 73' ' ' ARG . 18.3 tt -65.54 -35.99 76.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.898 0.38 . . . . 0.0 110.591 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 81' ' ' LYS . 8.6 t70 -62.53 -48.36 79.86 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.77 -40.47 95.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.3 pt -66.91 -31.62 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.957 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.82 -44.35 96.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 111.237 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 77' ' ' ASP . 14.1 ptpt -78.51 -24.46 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.803 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -88.12 -7.48 56.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.596 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 8.2 mmpt? 61.53 40.62 13.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.446 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . 82.9 mt -100.26 124.23 53.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.867 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -108.78 102.67 49.02 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.901 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.66 141.16 84.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.601 2.2 . . . . 0.0 112.304 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.93 97.74 11.36 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.295 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.92 -109.85 3.85 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.865 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.52 135.97 24.75 Favored Pre-proline 0 C--N 1.315 -0.93 0 O-C-N 122.911 -0.17 . . . . 0.0 110.726 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.07 144.33 81.6 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.552 2.168 . . . . 0.0 111.255 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.3 m -98.12 120.13 37.99 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.822 0.344 . . . . 0.0 110.488 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.3 121.36 44.74 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.5 t -116.1 97.84 50.18 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.994 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -89.74 137.92 2.93 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.859 2.373 . . . . 0.0 111.976 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.62 -162.46 31.37 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.864 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.69 150.86 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.706 0.289 . . . . 0.0 110.588 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -116.14 119.46 35.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.007 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.45 129.25 41.28 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.57 107.33 2.05 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.909 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.05 -18.62 11.32 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.267 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -111.4 -170.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.963 0.411 . . . . 0.0 111.347 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.01 167.33 22.07 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.349 0.595 . . . . 0.0 112.576 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -120.94 135.04 55.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.199 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -112.17 128.0 56.1 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.918 0.39 . . . . 0.0 111.477 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -148.73 161.35 41.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.9 m -139.67 145.35 38.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.742 0.306 . . . . 0.0 110.921 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.421 ' O ' HD23 ' A' ' 11' ' ' LEU . 61.2 t -121.43 126.56 75.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.99 115.3 24.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.692 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -159.38 163.37 35.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.321 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -131.92 179.72 5.91 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.942 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.45 167.84 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' CE1' ' HA ' ' A' ' 84' ' ' ILE . 6.9 m-85 -108.29 148.61 37.93 Favored Pre-proline 0 N--CA 1.477 0.921 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.376 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -100.82 -176.46 0.15 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 123.469 2.779 . . . . 0.0 112.837 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -137.35 158.28 44.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.899 0.479 . . . . 0.0 109.742 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG11 HD23 ' A' ' 350' ' ' LEU . 23.4 t -131.34 158.15 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.015 0.436 . . . . 0.0 111.351 -176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.71 126.58 50.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.4 123.3 37.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -136.95 157.67 46.2 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.966 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.12 18.07 78.92 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.349 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.97 -40.99 95.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.441 . . . . 0.0 111.165 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -78.92 -6.51 56.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.677 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.52 3.41 55.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.941 0.401 . . . . 0.0 111.039 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.9 mt -85.88 123.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.15 130.51 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 75.7 t -126.32 130.28 71.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.01 0.434 . . . . 0.0 111.616 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -96.02 133.92 39.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -104.83 100.49 24.08 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.88 119.17 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.24 1.96 . . . . 0.0 111.416 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 47.8 mm -95.73 112.63 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG23 HD11 ' A' ' 278' ' ' LEU . 27.2 m -126.64 160.44 34.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.122 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.33 169.03 13.99 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.436 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.6 t -111.38 127.33 68.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.5 p -106.43 176.95 5.0 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.932 0.396 . . . . 0.0 111.183 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.88 -35.08 77.27 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.79 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.72 -40.36 94.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.969 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -64.32 -44.58 91.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.198 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 90.7 t -67.15 -43.69 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.395 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -60.81 -42.18 97.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.731 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.09 95.84 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.87 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 tpt -66.0 -37.95 87.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 0.0 110.55 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.6 mt -61.71 -40.21 94.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.614 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.22 -42.85 96.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 20.1 m -62.05 -42.76 99.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.579 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.52 -39.85 92.5 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.265 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -62.96 -37.18 86.04 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.907 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -72.95 -17.71 61.46 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 111.645 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' THR . 16.1 mm100 -69.6 -33.68 73.03 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -123.32 136.83 54.86 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.17 133.74 5.33 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.952 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.1 m -73.15 143.24 47.36 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 31.6 p90 -101.61 160.82 14.12 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -144.65 169.77 17.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.072 1.349 . . . . 0.0 108.893 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -101.36 136.48 41.13 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.83 174.77 11.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.625 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -142.39 126.28 17.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.898 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 155.1 -124.53 1.53 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.388 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.34 -178.23 4.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.656 0.265 . . . . 0.0 111.308 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.14 131.3 62.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.051 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -85.45 -158.79 0.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.405 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -112.16 10.36 20.22 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.958 0.409 . . . . 0.0 110.159 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -149.24 27.89 0.83 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.131 -174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.11 178.07 6.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.622 0.725 . . . . 0.0 112.525 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -119.96 123.6 43.92 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.67 163.68 34.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -172.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.2 m -116.96 121.28 40.96 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.59 128.67 68.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.342 -175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.46 99.83 10.79 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -123.15 156.45 35.01 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.2 m -127.86 133.12 49.34 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.234 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -80.43 94.08 1.49 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 m -108.12 126.74 53.12 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 23.9 t -73.07 -90.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 110.863 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -105.83 -34.27 7.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.255 0.55 . . . . 0.0 110.082 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.38 19.8 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.317 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -147.08 144.48 29.09 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.8 148.38 23.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.405 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -110.03 -175.88 2.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.08 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -60.34 -43.31 96.59 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -91.02 -178.28 43.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.664 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.73 20.59 65.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.653 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -103.19 103.83 13.91 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -133.87 151.89 51.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.134 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 40.9 m -143.55 117.59 9.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.036 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 t70 57.02 38.01 29.06 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.458 0.703 . . . . 0.0 110.6 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -84.73 125.74 32.79 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.856 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.7 m -86.18 127.58 40.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.318 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.8 tp -118.99 141.28 48.81 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.301 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.3 119.68 40.02 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.36 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 68.2 mtt -83.88 159.55 21.31 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.455 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.75 -17.12 56.31 Favored Glycine 0 CA--C 1.506 -0.492 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.271 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -95.32 -15.9 22.79 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.643 0.258 . . . . 0.0 110.371 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.81 73.28 0.69 Allowed Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' B' ' 57' ' ' ARG . 72.0 mtp180 -113.53 -8.29 13.35 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.673 -0.411 . . . . 0.0 112.023 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 20.0 mmt -114.64 175.7 5.37 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.85 0.357 . . . . 0.0 111.284 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.98 133.42 67.66 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.197 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.87 126.48 20.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.067 1.845 . . . . 0.0 111.697 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.07 -29.41 12.23 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.614 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -61.47 -49.21 77.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.069 0.434 . . . . 0.0 111.276 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -83.83 -9.58 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.915 0.388 . . . . 0.0 111.426 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.61 ' HA ' ' CD ' ' A' ' 203' ' ' LYS . 18.8 m-20 -92.05 -27.64 17.66 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.19 -10.51 85.39 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.528 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.5 pt -105.24 -0.14 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.61 ' CD ' ' HA ' ' A' ' 200' ' ' ASP . 52.9 mtpt -66.19 124.22 22.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.849 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.35 65.19 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.668 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -86.93 159.87 18.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.294 0.547 . . . . 0.0 111.419 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -81.31 148.58 29.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.385 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.95 79.55 2.83 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.811 0.339 . . . . 0.0 110.621 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.68 32.97 0.19 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.314 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.87 139.77 53.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.328 0.564 . . . . 0.0 110.024 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -99.5 106.47 18.49 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -130.0 111.99 13.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 33.3 m -87.51 129.75 34.96 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 7.9 tp -124.57 134.83 65.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.588 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -82.01 113.22 19.75 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.353 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -111.94 116.01 51.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.6 m -98.49 120.5 39.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 96.7 m-85 -84.68 140.0 38.0 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.402 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.49 151.43 75.14 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.568 2.179 . . . . 0.0 112.457 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.406 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 33.8 mm-40 -60.07 -22.74 63.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.309 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.86 19.95 15.15 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.148 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -67.85 140.1 56.56 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.65 0.262 . . . . 0.0 110.657 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -93.7 117.8 30.57 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.496 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 45.5 tt0 -62.91 -37.5 87.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 6.5 p-10 -70.78 -6.89 41.11 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 94.7 mt -123.23 -14.57 7.45 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.496 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.7 ptmt -70.99 116.07 10.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.487 0.661 . . . . 0.0 111.756 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.85 12.52 77.09 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.882 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.01 151.21 22.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.963 0.411 . . . . 0.0 111.246 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.44 104.54 13.3 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -97.44 145.83 25.81 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.317 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -112.08 114.88 27.99 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.985 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 212' ' ' THR . 97.0 m-85 -101.09 114.12 27.77 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.0 70.91 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 50.5 mm 68.02 136.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.401 0.619 . . . . 0.0 111.794 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -115.69 -68.71 0.9 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.778 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 99.1 mt 68.3 154.31 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.04 0.536 . . . . 0.0 112.018 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -169.21 -38.07 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.562 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -123.85 123.81 41.27 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.677 0.275 . . . . 0.0 111.404 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.0 t -128.97 118.07 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.12 162.7 12.71 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.028 0.442 . . . . 0.0 111.83 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -98.59 162.81 12.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.845 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -131.89 157.15 44.73 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.496 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -140.62 -176.03 4.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.496 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 72.9 mt -53.76 131.29 56.58 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.01 154.39 66.81 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.926 2.418 . . . . 0.0 111.914 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -73.43 131.69 42.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 52.0 tp -116.1 4.19 13.64 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 14.7 p -99.77 -4.46 30.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.153 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.513 ' HA ' ' CG2' ' A' ' 253' ' ' ILE . . . 57.93 60.57 2.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -106.11 -56.54 2.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.91 0.386 . . . . 0.0 110.153 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -93.17 -38.75 11.4 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.592 0.711 . . . . 0.0 109.283 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 250' ' ' ALA . 20.1 tt -70.45 1.85 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.898 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -80.5 -19.07 46.7 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.855 -0.528 . . . . 0.0 112.385 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -71.07 -6.04 36.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.137 0.494 . . . . 0.0 111.593 -177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.11 -36.73 84.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.493 0.664 . . . . 0.0 109.637 176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 101.08 -17.47 56.01 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.394 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.59 132.77 69.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.62 112.83 18.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -94.91 -172.26 2.66 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 85.69 -147.23 21.93 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.248 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t 63.66 108.34 0.03 OUTLIER 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 89.1 t -59.95 -47.95 89.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.828 0.347 . . . . 0.0 111.403 -175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 264' ' ' GLU . 0.5 OUTLIER -72.04 -39.27 69.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.776 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.7 83.85 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.826 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 270' ' ' VAL . 50.2 tp -63.38 -43.75 96.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.633 0.217 . . . . 0.0 110.812 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 43.6 mtp85 -62.63 -43.0 99.91 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.488 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.611 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -63.59 -42.75 98.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.538 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 43.9 tp10 -67.05 -40.24 87.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 266' ' ' LEU . 78.8 t -66.59 -41.9 89.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.622 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.27 -45.24 91.75 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.807 -0.179 . . . . 0.0 111.395 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 15.0 ptmt -66.68 -28.68 68.64 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.837 0.351 . . . . 0.0 111.143 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 276' ' ' ARG . 43.2 m-80 -81.27 -37.97 27.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.9 mmm -63.05 -42.91 99.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.767 0.318 . . . . 0.0 110.855 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -69.74 -31.01 68.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.366 0.603 . . . . 0.0 110.24 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 273' ' ' ASN . 19.4 ttm-85 -61.61 -46.58 89.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.571 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.61 -32.55 69.94 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.722 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.471 HD11 HG23 ' A' ' 130' ' ' VAL . 50.3 tp -60.48 -42.69 96.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.218 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.42 -47.64 85.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.748 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.2 m -66.39 -38.77 88.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.474 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.46 73.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.23 -36.73 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 0.0 110.915 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -60.83 -45.65 93.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.482 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -64.58 -37.49 87.74 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.079 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -60.44 -44.44 95.81 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.47 -43.88 96.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.054 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.66 -46.63 86.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.159 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.8 m -62.0 -41.89 98.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -63.22 -45.34 92.1 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.897 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.21 69.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.932 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.21 -45.74 95.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -66.43 -42.08 88.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.896 0.379 . . . . 0.0 110.659 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.76 -41.71 95.6 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.189 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -46.35 88.57 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.522 0.201 . . . . 0.0 110.884 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 83.2 t -65.59 -44.77 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.122 0.487 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -64.84 -34.44 78.37 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.079 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -83.34 -38.68 21.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -108.25 111.02 22.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.79 130.45 53.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.694 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -138.47 154.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.17 142.23 50.69 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 345' ' ' VAL . 50.5 t -121.77 123.11 27.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.76 140.14 72.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.851 2.367 . . . . 0.0 112.063 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.57 -35.69 81.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.296 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.23 -48.12 71.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.214 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.9 -41.15 97.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.35 -44.93 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.97 -43.05 95.34 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.2 m -61.97 -43.19 99.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.776 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -66.52 -33.54 75.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.61 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.53 HD13 ' HG3' ' A' ' 334' ' ' ARG . 95.3 mt -61.83 -41.94 92.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.19 -46.54 82.76 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.25 -43.83 98.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.91 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.528 HD13 ' HG3' ' A' ' 340' ' ' GLN . 95.4 mt -62.12 -41.2 98.0 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.043 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 22.0 mtm180 -61.82 -45.5 93.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.965 0.412 . . . . 0.0 110.362 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 33.8 mtt180 -64.12 -37.35 87.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.097 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.67 85.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.154 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.78 87.38 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.4 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.6 87.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.616 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -65.51 -45.71 82.47 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.464 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.401 HH21 ' HD2' ' A' ' 321' ' ' ARG . 46.4 mtm180 -71.23 -27.54 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.894 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.11 -23.91 61.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.155 0.502 . . . . 0.0 110.515 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.566 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 165.96 -47.92 0.27 Allowed Glycine 0 N--CA 1.433 -1.52 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.839 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.15 110.74 1.82 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.903 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -168.24 100.71 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -75.04 147.15 40.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.186 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 2.5 ttmp? 75.41 -34.42 0.25 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.113 0.965 . . . . 0.0 113.238 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -73.57 -14.14 61.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.672 0.748 . . . . 0.0 109.284 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.12 62.74 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.014 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.55 -37.14 80.28 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.588 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.37 12.93 9.01 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 62.3 mt -80.37 142.96 55.02 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 40.5 Cg_exo -56.28 126.44 22.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.733 2.289 . . . . 0.0 113.406 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.53 ' HG3' HD13 ' A' ' 311' ' ' ILE . 22.0 ttm-85 -64.75 -40.8 95.91 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.582 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -57.37 -32.18 66.51 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.56 -35.41 80.89 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.962 0.41 . . . . 0.0 111.095 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.39 -5.26 23.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.449 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.12 -44.29 95.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.291 0.567 . . . . 0.0 111.121 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -70.34 -46.6 63.85 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.794 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.528 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.7 pt20 -68.32 -30.24 69.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 344' ' ' ARG . . . -64.87 -36.65 85.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.565 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -44.48 96.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.016 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -62.84 -36.56 83.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.95 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 341' ' ' ALA . 8.9 mmt180 -56.18 -52.88 62.77 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.501 HG11 HG13 ' A' ' 302' ' ' VAL . 59.1 t -68.89 -44.0 81.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.456 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 92.8 t -61.67 -48.07 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.377 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.25 -45.31 96.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 120.806 0.336 . . . . 0.0 110.965 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.04 -42.49 99.73 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.074 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 48.2 mt -65.13 -41.7 94.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.116 -0.234 . . . . 0.0 111.04 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 354' ' ' VAL . 95.2 mt -61.94 -46.83 87.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.874 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 73.0 mt -66.91 -39.99 87.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.02 95.93 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.141 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.22 -32.17 73.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 350' ' ' LEU . 97.7 t -60.25 -44.52 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 360' ' ' LEU . 91.1 mt -62.42 -44.68 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.115 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -70.79 -47.83 57.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.918 0.39 . . . . 0.0 111.279 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -64.79 -45.41 86.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -92.14 4.6 52.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.757 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.71 61.31 3.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.574 0.546 . . . . 0.0 111.17 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 355' ' ' ILE . 89.4 mt -83.14 137.74 33.95 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.202 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 146.49 38.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.86 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.27 108.45 3.67 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 14.3 t70 -89.58 102.2 14.89 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.034 0.445 . . . . 0.0 111.151 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.07 -30.69 71.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.651 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 60.8 mm-40 -61.7 -45.98 91.64 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.967 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -61.63 -42.65 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.242 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 399' ' ' ARG . 88.6 t -63.74 -47.94 88.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.291 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.16 -41.86 99.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.79 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.87 -43.39 99.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.622 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.76 -34.67 78.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.733 0.301 . . . . 0.0 111.114 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 367' ' ' VAL . 89.3 mt -62.62 -43.11 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -58.66 -42.5 88.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.13 -42.46 99.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.012 0.434 . . . . 0.0 110.186 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 62.7 ttp -70.0 -43.45 71.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.889 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.65 -29.46 70.47 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.5 t -65.05 -14.75 61.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.699 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.4 5.25 46.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.51 168.47 9.37 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.515 0.198 . . . . 0.0 111.023 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.91 -46.2 88.5 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.443 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -134.17 108.64 11.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.649 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.18 -24.62 27.57 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.478 2.119 . . . . 0.0 113.175 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -64.72 -47.35 78.58 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.61 -35.38 77.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.127 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.5 -44.6 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.94 0.4 . . . . 0.0 110.73 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.25 -43.63 98.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.71 -40.94 88.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -61.18 -44.1 97.83 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.639 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -40.86 95.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.654 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -79.73 -6.28 56.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.225 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -89.64 -38.75 13.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.101 0.477 . . . . 0.0 110.934 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 26.3 t-20 -103.99 117.5 34.45 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.629 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.81 -34.7 78.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.556 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 12.4 tp10 -57.66 -44.34 85.63 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 109.688 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.2 -38.52 90.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.327 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 91.7 mtp -60.55 -44.6 95.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.77 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.83 -39.49 90.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.248 0.547 . . . . 0.0 110.175 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.659 HD22 ' HB2' ' B' ' 38' ' ' LYS . 12.1 t-20 -59.73 -50.38 74.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.512 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.8 -42.64 73.47 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.85 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.646 ' HG2' HG21 ' A' ' 367' ' ' VAL . 63.3 mtm180 -66.17 -37.7 86.27 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.42 -40.16 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.802 0.334 . . . . 0.0 110.698 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.3 t -66.05 -46.19 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.053 0.454 . . . . 0.0 110.173 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.78 94.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.149 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.67 -36.97 85.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -59.97 -38.81 83.61 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.996 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.18 -45.48 90.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -64.98 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.45 99.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.417 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 84.3 t -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.042 0.449 . . . . 0.0 110.089 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.44 -38.71 90.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.02 96.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.226 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.54 -43.33 90.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.704 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 95.6 mt -62.31 -27.42 69.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.084 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.47 -14.07 62.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -119.45 -36.41 3.36 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -68.31 151.26 47.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.306 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.89 107.03 5.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.08 125.61 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 4.7 t -125.88 125.4 42.76 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -89.54 129.32 36.03 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.435 0.636 . . . . 0.0 110.725 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -133.12 119.62 20.19 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.465 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 72.6 mt-10 -70.78 128.28 35.5 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.075 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.0 p -135.03 153.32 52.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 7.4 m -83.56 157.23 22.4 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.59 -43.04 93.83 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.976 0.417 . . . . 0.0 110.248 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -58.19 -40.54 81.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.477 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.32 -42.2 99.18 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.057 0.456 . . . . 0.0 111.191 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.84 -21.95 59.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.116 0.484 . . . . 0.0 110.933 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 20.0 ttt -81.07 -5.71 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.202 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.26 35.45 0.22 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.392 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -88.17 79.91 7.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.034 0.445 . . . . 0.0 110.608 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.84 1.66 46.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.192 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.115 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.954 179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -92.61 135.55 33.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.837 0.351 . . . . 0.0 111.572 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.12 155.6 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -152.09 146.86 25.85 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.582 0.229 . . . . 0.0 110.984 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -141.69 135.48 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.942 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 41.8 mm-40 -109.12 158.12 18.09 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 91.3 m -119.11 127.89 53.78 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.4 p -85.08 -61.1 1.85 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.78 0.324 . . . . 0.0 110.791 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -164.8 123.37 1.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.808 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.88 -108.17 2.21 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.49 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.58 -0.57 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.693 0.282 . . . . 0.0 111.319 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.78 133.91 12.21 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.652 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.0 154.14 46.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.566 0.347 . . . . 0.0 110.332 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 37.7 ttm180 -122.63 126.8 48.38 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.55 -83.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.84 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m 24.45 87.93 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.9 118.62 40.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -85.47 107.64 17.52 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 pt -146.11 -166.8 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.588 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.547 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -64.84 140.53 58.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.793 0.33 . . . . 0.0 111.408 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.58 88.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.465 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' HB1' ' B' ' 20' ' ' ALA . 2.4 p-10 -59.48 -48.65 80.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.642 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 43.9 m -63.26 -42.11 99.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.418 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.547 HG13 ' O ' ' B' ' 20' ' ' ALA . 66.3 mt -61.84 -47.33 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.561 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.5 tp10 -65.51 -37.39 86.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.481 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.471 ' HA ' ' HD2' ' B' ' 29' ' ' LYS . 99.9 m -61.91 -41.56 98.05 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.815 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.84 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.984 0.421 . . . . 0.0 109.994 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.27 -42.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.162 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 81.9 mttt -56.94 -46.81 81.83 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.654 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.7 m -64.41 -42.9 95.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.013 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' NH1' ' B' ' 73' ' ' ARG . 6.1 tp10 -70.98 -39.49 72.44 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.769 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.48 -33.51 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.036 0.446 . . . . 0.0 110.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -62.14 -45.65 92.51 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.412 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.92 -42.62 85.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.508 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.46 -39.35 79.68 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.849 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.69 -38.46 91.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' A' ' 397' ' ' ASN . 32.5 ttpt -63.0 -42.98 99.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.409 . . . . 0.0 110.632 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -89.13 7.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.953 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 60.94 45.43 9.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.129 0.572 . . . . 0.0 112.369 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 41' ' ' ILE . 11.0 mm -101.36 -24.23 4.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.543 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.7 -27.99 69.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.791 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -7.39 82.85 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.735 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.72 3.74 29.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.915 0.388 . . . . 0.0 110.85 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -90.42 113.17 25.03 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.65 -38.86 73.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.307 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.76 33.12 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.346 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -60.93 -48.32 82.34 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -106.6 109.04 62.86 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' B' ' 53' ' ' ILE . 51.7 Cg_exo -55.18 141.58 80.01 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.709 2.273 . . . . 0.0 111.699 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.467 ' HA ' HG22 ' B' ' 54' ' ' VAL . 10.7 tpt -61.16 -38.72 87.49 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.349 -172.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -63.15 -40.9 98.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.943 0.402 . . . . 0.0 110.619 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 57' ' ' ARG . 77.3 mt -67.65 -42.73 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.233 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' B' ' 51' ' ' MET . 29.6 m -67.88 -33.6 62.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.78 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.95 96.16 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.93 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -76.76 -2.63 34.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.566 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 193' ' ' ARG . 90.0 mtt180 -101.83 -62.46 1.25 Allowed 'General case' 0 C--N 1.347 0.485 0 CA-C-O 120.772 0.32 . . . . 0.0 111.619 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -96.15 0.41 51.21 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.67 -30.45 74.84 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.474 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.96 88.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 17.8 m -62.54 -43.05 99.78 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.369 . . . . 0.0 111.751 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 323' ' ' GLY . 9.3 p -89.69 4.78 5.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.904 -175.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.61 -42.66 93.12 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.521 -0.471 . . . . 0.0 111.228 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -66.6 -40.37 88.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.066 0.46 . . . . 0.0 110.235 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -65.48 -31.66 72.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.215 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.559 HG23 ' O ' ' B' ' 62' ' ' VAL . 84.4 t -60.47 -42.48 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.31 -39.59 91.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.596 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -39.66 98.18 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.618 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.87 -40.71 97.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.046 0.45 . . . . 0.0 110.538 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 66' ' ' VAL . 91.0 mt -61.1 -41.1 96.05 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 32.8 ttm -59.9 -46.03 90.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.076 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 39.5 m -61.48 -48.15 82.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.729 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.472 ' O ' HG22 ' B' ' 76' ' ' ILE . 52.5 mtm180 -73.98 -37.49 64.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -64.99 -37.38 87.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.503 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.72 -45.54 93.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.472 HG22 ' O ' ' B' ' 73' ' ' ARG . 18.2 tt -65.78 -36.49 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.41 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' B' ' 81' ' ' LYS . 9.9 t70 -61.35 -48.4 81.46 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 110.991 176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.04 95.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 pt -66.96 -30.16 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.45 HG13 ' O ' ' B' ' 76' ' ' ILE . 99.2 mt -65.74 -43.87 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 110.7 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' B' ' 77' ' ' ASP . 15.3 ptpt -79.33 -25.39 42.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.76 -176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -88.58 -5.87 57.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.135 177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 7.9 mmpt? 60.56 42.43 14.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.592 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.423 ' HA ' ' CE1' ' B' ' 112' ' ' TYR . 87.4 mt -102.29 123.55 55.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.56 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -107.0 102.88 45.27 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.973 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -62.69 139.89 77.77 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.307 2.005 . . . . 0.0 112.277 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.38 97.91 10.17 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.12 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.61 -113.56 4.75 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.158 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -132.71 130.57 21.71 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 24.3 Cg_exo -62.79 143.77 92.48 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.244 1.962 . . . . 0.0 111.433 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 29.9 m -99.13 118.29 35.54 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 0.0 110.479 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.74 122.05 45.59 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 48.4 t -116.25 97.31 49.45 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 120.589 0.233 . . . . 0.0 110.861 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -89.53 142.35 4.19 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.536 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -99.0 -147.5 22.05 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.456 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -100.88 146.31 27.5 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.482 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -109.71 121.94 46.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.2 135.29 39.36 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.7 tp -70.88 101.24 2.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.041 0.448 . . . . 0.0 111.521 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.42 -24.21 5.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.254 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -107.94 -167.97 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.483 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.3 170.5 16.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.528 0.68 . . . . 0.0 112.46 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -119.13 133.84 55.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.101 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 26.4 m -107.06 130.18 54.7 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.698 0.285 . . . . 0.0 111.413 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -152.53 160.16 43.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.849 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 58.6 m -139.37 145.92 39.57 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.64 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.24 126.86 75.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -91.94 118.16 30.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -165.17 161.3 19.36 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -120.36 -177.12 3.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.033 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.11 172.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' B' ' 84' ' ' ILE . 7.8 m-85 -112.01 146.64 35.23 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.24 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -100.09 -178.05 0.19 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 123.518 2.812 . . . . 0.0 112.67 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.6 157.1 46.58 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.589 0.355 . . . . 0.0 110.387 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.402 HG12 ' N ' ' B' ' 116' ' ' GLU . 18.3 t -130.79 160.73 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 120.77 0.319 . . . . 0.0 110.897 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.402 ' N ' HG12 ' B' ' 115' ' ' VAL . 49.2 mt-10 -125.78 131.55 52.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 82.3 mt -97.06 125.64 41.66 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.827 0.346 . . . . 0.0 111.551 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -138.56 158.55 44.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.12 77.78 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.573 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.56 -41.07 96.54 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.186 0.517 . . . . 0.0 111.128 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -81.0 -0.68 40.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.626 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.055 0.455 . . . . 0.0 110.613 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 79.3 mt -89.72 123.22 41.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.06 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -118.31 128.95 55.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 78.6 t -124.29 130.67 73.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 120.908 0.385 . . . . 0.0 111.71 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -94.8 132.4 39.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -106.44 99.82 26.5 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.11 118.81 5.37 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.088 1.859 . . . . 0.0 111.261 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 50.3 mm -94.66 114.59 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . 0.498 HG23 HD11 ' B' ' 278' ' ' LEU . 31.2 m -128.55 163.41 33.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.55 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -129.04 172.31 11.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.487 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 66.2 t -115.16 127.52 72.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 60.5 p -108.17 179.68 4.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.138 0.494 . . . . 0.0 111.387 -177.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.86 -35.19 79.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.185 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.52 98.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.362 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.74 -44.57 95.87 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.393 0.616 . . . . 0.0 110.008 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 92.9 t -66.73 -43.87 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.427 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -60.91 -42.89 98.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.045 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.95 98.19 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.939 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.38 -37.66 87.67 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' B' ' 137' ' ' VAL . 95.5 mt -62.44 -39.51 93.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.08 -40.31 93.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.567 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 30.4 m -62.74 -43.53 98.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.326 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.0 -39.4 92.12 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.53 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -62.7 -37.62 87.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.685 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.44 -14.03 61.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.87 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 143' ' ' THR . 14.5 mm100 -74.01 -29.94 62.2 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -126.94 135.98 51.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -161.97 136.68 7.01 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.863 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -73.81 141.45 46.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -99.47 158.86 15.44 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -143.84 169.4 17.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.826 1.25 . . . . 0.0 108.872 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -100.48 142.84 31.39 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.307 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' B' ' 242' ' ' GLU . 64.6 pttt -155.16 178.21 10.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.48 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -148.5 126.1 11.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.222 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.56 -112.93 0.54 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.835 -1.174 . . . . 0.0 113.411 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.32 178.86 4.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.677 0.275 . . . . 0.0 111.003 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.28 129.19 58.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.938 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -86.5 -165.17 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.09 6.95 36.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.882 0.373 . . . . 0.0 110.985 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.1 31.48 0.76 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.321 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -89.2 176.71 6.85 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.68 0.752 . . . . 0.0 112.649 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -118.77 124.78 48.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' B' ' 240' ' ' VAL . 27.0 m -131.16 163.47 36.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 25.9 m -117.75 118.81 33.09 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . 0.412 HG12 HD23 ' B' ' 237' ' ' LEU . 75.4 mt -127.7 127.39 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.338 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.47 106.11 18.35 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 171.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -128.32 157.41 41.04 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.009 0.433 . . . . 0.0 111.179 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 37.6 m -127.29 131.53 50.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.488 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' B' ' 176' ' ' GLU . . . -77.53 90.46 1.04 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.68 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -109.53 125.09 52.13 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.17 -91.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.603 0.24 . . . . 0.0 111.162 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -112.37 -4.37 14.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 0.0 110.083 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 159.36 32.34 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.055 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -163.69 137.75 5.79 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 170' ' ' GLY . 3.4 mp0 -82.83 156.41 23.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.664 0.269 . . . . 0.0 110.376 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -118.41 -173.84 2.55 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.848 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -58.55 -45.96 87.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -97.98 -174.58 33.32 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.093 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.58 21.83 57.34 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.959 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -104.62 109.06 20.82 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -134.56 152.44 51.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 54.2 m -145.9 116.04 7.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.971 178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.63 32.16 20.3 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.834 0.709 . . . . 0.0 110.481 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -80.58 126.52 31.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.689 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -90.46 128.19 42.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.511 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.6 tp -118.29 140.73 49.38 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.245 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.37 116.28 31.68 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.069 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 68.6 mtt -80.07 160.02 25.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.86 -26.0 14.43 Favored Glycine 0 CA--C 1.504 -0.614 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.258 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -84.65 -18.53 35.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.743 0.306 . . . . 0.0 110.457 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 70.78 72.36 0.9 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 63.9 mtp180 -114.05 -7.37 13.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 19.9 mmt -114.26 175.74 5.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.406 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.42 133.67 53.19 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.975 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.37 125.96 17.99 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.921 1.748 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 97.81 -26.39 23.48 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.749 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.99 -48.09 81.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.081 0.441 . . . . 0.0 111.364 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.3 -8.05 59.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.431 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.603 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 18.3 m-20 -91.82 -29.36 16.79 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.99 -10.06 86.49 Favored Glycine 0 CA--C 1.515 0.072 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.671 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.99 -0.41 10.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.888 0.375 . . . . 0.0 111.911 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.603 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 54.8 mtpt -68.32 116.24 8.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.246 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.92 0.43 56.23 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.554 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -86.54 162.65 17.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.237 0.518 . . . . 0.0 111.377 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -81.44 150.24 28.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.271 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.52 77.1 5.02 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.119 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 138.77 44.27 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.974 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -133.88 144.29 48.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.972 0.386 . . . . 0.0 110.591 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.11 106.84 19.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.641 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.94 107.89 9.01 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 28.1 m -86.73 129.2 34.96 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.704 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.6 tp -123.37 133.67 68.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.439 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.45 114.92 21.8 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.121 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.15 120.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 42.8 m -101.35 119.86 39.4 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 95.9 m-85 -83.66 145.77 48.29 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.017 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 217' ' ' PHE . 39.7 Cg_exo -60.89 148.77 91.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.504 2.136 . . . . 0.0 112.15 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.423 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 50.0 mm-40 -59.61 -29.0 67.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.665 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.04 25.87 5.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.262 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -68.2 139.98 56.08 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.759 0.314 . . . . 0.0 110.449 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -63.84 -23.2 67.26 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.81 118.85 37.15 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.3 tt0 -63.85 -34.08 77.13 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.435 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.2 p-10 -70.07 -9.19 54.63 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.435 ' HG ' ' ND2' ' B' ' 225' ' ' ASN . 98.3 mt -124.14 -13.7 7.2 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.0 ptmt -71.02 120.35 16.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.097 0.475 . . . . 0.0 111.209 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.36 11.62 83.1 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.612 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -107.7 150.59 26.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.973 0.416 . . . . 0.0 111.178 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -112.93 114.64 27.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.02 26.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.039 0.447 . . . . 0.0 111.557 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -112.97 112.15 23.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.231 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 212' ' ' THR . 96.5 m-85 -100.54 113.36 26.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.575 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.9 -41.31 74.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.058 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 68.77 135.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 O-C-N 123.736 0.648 . . . . 0.0 111.869 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -117.58 -62.43 1.56 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.006 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . 0.412 HD23 HG12 ' B' ' 166' ' ' ILE . 95.7 mt 65.65 166.48 0.19 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.099 0.56 . . . . 0.0 111.626 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -177.43 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.209 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -124.34 126.39 45.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.736 0.303 . . . . 0.0 111.375 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' B' ' 164' ' ' VAL . 40.1 t -129.28 120.22 50.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -106.14 161.3 14.63 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.854 0.359 . . . . 0.0 111.764 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.515 ' HB2' ' HD3' ' B' ' 154' ' ' LYS . 39.9 tt0 -99.05 164.51 12.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.582 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -134.14 152.92 52.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.56 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 18.3 tt0 -136.36 -174.53 3.72 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.56 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 66.5 mt -53.36 129.07 51.55 Favored Pre-proline 0 C--N 1.323 -0.567 0 C-N-CA 122.871 0.468 . . . . 0.0 112.233 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.49 154.51 68.69 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.985 2.457 . . . . 0.0 112.065 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.01 129.89 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.03 7.57 13.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 16.1 p -101.45 -4.8 26.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.31 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.53 ' HA ' ' CG2' ' B' ' 253' ' ' ILE . . . 59.71 56.75 3.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -103.34 -57.53 2.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.105 0.479 . . . . 0.0 110.687 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.45 -35.58 11.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.437 0.636 . . . . 0.0 109.349 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.53 ' CG2' ' HA ' ' B' ' 250' ' ' ALA . 20.3 tt -70.89 -1.8 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.922 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -77.73 -20.69 53.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 ttp85 -73.17 -2.01 19.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.212 0.53 . . . . 0.0 111.646 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -64.74 -34.81 79.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 100.47 -14.89 59.17 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.312 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.55 130.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.14 113.24 13.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.78 -170.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.67 -146.01 23.13 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.835 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.3 t 66.01 107.84 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.007 0.432 . . . . 0.0 109.983 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.2 -48.16 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.931 0.396 . . . . 0.0 111.143 -175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.5 OUTLIER -72.38 -39.64 67.85 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.59 179.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.5 -47.57 82.68 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.848 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.405 ' O ' HG23 ' B' ' 270' ' ' VAL . 53.4 tp -63.09 -43.91 97.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.644 0.222 . . . . 0.0 110.801 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 44.6 mtp85 -62.94 -42.48 99.82 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.575 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.622 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -63.91 -43.01 97.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.659 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.534 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 18.8 tp10 -66.05 -41.13 91.22 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.487 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 266' ' ' LEU . 77.6 t -66.74 -42.36 89.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.739 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -59.25 -46.51 88.3 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.535 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 12.5 ptmt -65.78 -31.21 72.06 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 276' ' ' ARG . 84.1 m-20 -79.13 -38.54 35.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 91.0 mmm -62.94 -43.38 98.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.986 0.422 . . . . 0.0 110.577 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.67 -29.79 66.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 110.196 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' B' ' 273' ' ' ASN . 37.2 ttm-85 -62.95 -46.64 86.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.611 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -71.31 -29.62 65.25 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.628 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.498 HD11 HG23 ' B' ' 130' ' ' VAL . 51.2 tp -60.43 -42.49 96.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.997 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.8 -45.95 90.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.979 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 34.4 m -68.72 -37.59 79.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.338 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.09 -51.39 70.22 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . 0.406 HD12 ' N ' ' B' ' 283' ' ' ARG . 2.8 pp -70.64 -32.23 48.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.147 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . 0.406 ' N ' HD12 ' B' ' 282' ' ' ILE . 14.9 tpt180 -62.9 -44.89 94.88 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -64.09 -38.26 90.41 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.807 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.34 -44.66 95.32 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.3 -43.47 95.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.84 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -57.84 -46.57 84.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.139 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 23.9 m -62.41 -43.06 99.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.684 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.21 -45.16 94.57 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.993 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 294' ' ' LEU . . . -65.15 -49.68 68.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.75 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 36.2 mm -64.9 -45.62 94.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -67.34 -43.33 81.8 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.523 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.3 -41.21 98.3 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.233 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 290' ' ' ALA . 0.5 OUTLIER -62.3 -45.58 92.62 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.557 0.218 . . . . 0.0 110.7 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.21 -44.81 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.043 0.449 . . . . 0.0 111.161 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.281 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -86.61 -30.04 22.11 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -118.65 109.86 16.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.026 0.441 . . . . 0.0 112.01 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -107.62 128.69 54.77 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.182 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -137.12 152.82 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -65.63 136.59 56.52 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.512 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . 0.498 HG13 HG11 ' B' ' 345' ' ' VAL . 61.5 t -119.57 122.45 29.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.776 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.7 142.87 72.14 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.954 2.436 . . . . 0.0 112.029 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.77 80.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.369 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.72 77.75 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.64 -40.87 96.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -44.27 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.24 -42.35 95.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.244 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 39.7 m -62.21 -43.71 98.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.526 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' B' ' 314' ' ' LEU . 64.4 mm-40 -65.91 -34.01 77.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.512 HD13 ' HG3' ' B' ' 334' ' ' ARG . 95.4 mt -62.05 -41.88 92.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.64 -46.55 84.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.847 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.34 -43.71 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.942 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.513 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.8 mt -62.26 -41.21 98.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.227 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.5 mtm180 -61.52 -45.16 95.37 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.977 0.418 . . . . 0.0 109.973 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -64.01 -38.74 92.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.121 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -45.71 91.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.934 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.86 -39.55 83.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.31 -38.04 87.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.661 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.404 HE21 HG21 ' A' ' 62' ' ' VAL . 22.4 tm0? -65.98 -44.54 84.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.243 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' B' ' 321' ' ' ARG . 44.4 mtm180 -73.04 -25.97 61.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.785 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -72.67 -24.99 61.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.977 0.418 . . . . 0.0 110.589 177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . 167.95 -51.67 0.23 Allowed Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.307 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 127.99 104.79 1.25 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.833 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -164.04 92.41 0.67 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.1 148.67 49.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.446 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 2.1 ttmp? 75.38 -33.18 0.23 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.439 1.096 . . . . 0.0 113.114 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -75.54 -11.25 59.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . 0.416 ' HA ' ' HG ' ' B' ' 332' ' ' LEU . . . -64.58 -16.01 61.99 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.926 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.21 -38.14 85.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.341 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -79.23 1.11 25.9 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.118 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.416 ' HG ' ' HA ' ' B' ' 329' ' ' ALA . 71.1 mt -73.73 142.69 80.69 Favored Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 121.94 -0.475 . . . . 0.0 110.762 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -56.95 126.87 23.61 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.696 2.264 . . . . 0.0 113.249 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' B' ' 311' ' ' ILE . 29.1 ttm-85 -65.02 -41.28 95.42 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.278 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -57.3 -31.91 66.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.0 -31.23 72.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.914 0.388 . . . . 0.0 111.403 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -106.92 -1.4 22.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.868 0.366 . . . . 0.0 111.08 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.21 -44.76 94.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.43 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -70.02 -44.74 68.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.37 . . . . 0.0 111.526 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.513 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.6 pt20 -69.21 -29.43 67.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.134 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' B' ' 344' ' ' ARG . . . -65.63 -37.63 87.11 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.733 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.01 -44.04 98.01 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.939 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -62.84 -35.78 81.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.186 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' B' ' 341' ' ' ALA . 9.0 mmt180 -56.32 -52.78 63.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.498 HG11 HG13 ' B' ' 302' ' ' VAL . 60.3 t -68.7 -44.29 82.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.595 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.474 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 93.3 t -61.71 -48.8 87.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.32 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.9 t -64.12 -45.05 97.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.17 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.33 97.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.39 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 47.3 mt -65.93 -40.52 91.48 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.425 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 354' ' ' VAL . 94.7 mt -61.66 -46.13 91.09 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.648 0.261 . . . . 0.0 110.491 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 76.4 mt -66.43 -40.49 89.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.029 0.443 . . . . 0.0 110.893 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.78 -37.52 94.8 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.079 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.86 -33.94 77.0 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 350' ' ' LEU . 99.1 t -60.42 -44.01 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.89 -44.7 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.814 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -70.91 -47.29 59.96 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.419 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 20.6 m -65.07 -44.21 89.69 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.38 6.3 45.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.668 0.27 . . . . 0.0 111.412 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.13 53.85 12.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.815 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.41 142.11 43.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.923 0.392 . . . . 0.0 110.229 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.68 148.22 41.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.021 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.93 110.0 4.2 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.456 ' O ' HG23 ' B' ' 367' ' ' VAL . 15.3 t70 -90.61 102.7 15.44 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.231 0.539 . . . . 0.0 111.112 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -64.95 -30.96 71.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.695 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.85 -47.07 86.72 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 110.314 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.3 -42.5 95.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.285 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.632 HG21 ' HG2' ' B' ' 399' ' ' ARG . 88.5 t -63.25 -47.88 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.62 -42.95 98.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.722 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.2 98.59 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.198 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.12 -37.11 84.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.897 0.379 . . . . 0.0 111.071 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . 0.423 HG13 ' O ' ' B' ' 367' ' ' VAL . 93.2 mt -62.69 -43.26 98.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.718 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.93 -39.0 87.74 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.98 -44.7 91.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.103 0.477 . . . . 0.0 110.144 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.4 ttp -67.49 -42.17 83.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.378 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.73 70.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.124 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 33.1 t -64.87 -16.67 63.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.811 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.52 -2.19 57.88 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -103.99 169.31 8.58 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 120.65 0.262 . . . . 0.0 111.076 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.69 -44.68 96.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.31 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -133.08 108.25 12.58 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.398 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.17 -24.85 22.97 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.403 2.069 . . . . 0.0 113.166 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.91 -47.89 76.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.96 -35.07 74.18 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.85 -44.65 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.39 -43.42 98.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -65.64 -41.0 93.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -61.37 -43.67 98.48 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.915 0.388 . . . . 0.0 110.786 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.2 -33.92 75.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.153 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 8.7 m -84.79 -7.83 59.04 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.991 0.424 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -87.98 -48.7 7.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 24.3 t-20 -91.57 116.06 28.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.72 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.19 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.567 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.411 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 29.9 tp10 -61.29 -42.67 99.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.13 -38.08 89.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.715 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.3 mtp -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.146 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.74 -41.14 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.212 0.53 . . . . 0.0 110.403 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.686 HD22 ' HB2' ' A' ' 38' ' ' LYS . 12.7 t-20 -60.51 -50.87 71.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.521 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -67.83 -43.67 79.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.883 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.632 ' HG2' HG21 ' B' ' 367' ' ' VAL . 67.5 mtm180 -67.03 -38.74 86.45 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.71 -40.14 96.22 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.066 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 66.9 t -65.26 -45.18 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.954 0.407 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.54 91.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.016 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.98 -37.68 88.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.72 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.74 -38.5 81.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -58.75 -46.0 88.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.074 0.464 . . . . 0.0 110.067 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -64.94 -37.8 88.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.822 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.31 99.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.167 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.426 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 95.7 t -64.61 -43.77 96.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.204 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.06 -38.61 89.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.231 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.12 -41.18 99.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.257 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.2 -42.88 91.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.502 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 95.7 mt -61.93 -26.57 68.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.034 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.06 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -119.68 -38.24 3.01 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -67.07 150.25 49.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.704 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.31 110.0 5.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.671 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.94 126.99 64.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.011 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 3.2 t -125.73 123.35 38.66 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.799 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.24 125.54 35.52 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.44 0.638 . . . . 0.0 110.305 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -131.8 114.07 14.27 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.387 -176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 50.1 mt-10 -69.49 129.85 40.85 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.601 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 16.9 p -134.32 153.39 51.91 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.46 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 13.4 m -79.82 154.7 28.26 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -57.94 -42.69 85.43 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.947 0.403 . . . . 0.0 110.685 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -60.23 -39.43 86.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.06 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.4 -39.49 90.91 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.243 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 45.0 tp -80.12 -14.55 58.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.024 0.44 . . . . 0.0 111.271 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 24.3 ttt -86.67 -2.72 58.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.369 0.604 . . . . 0.0 110.535 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.38 31.68 0.23 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.234 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -87.5 80.19 8.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.922 0.391 . . . . 0.0 111.224 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -96.15 -10.96 26.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.02 0.438 . . . . 0.0 110.941 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.539 -0.743 . . . . 0.0 110.333 -179.708 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 120.841 0.353 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -86.77 119.36 26.92 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.302 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.85 133.87 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.4 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -130.68 131.69 44.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.839 0.352 . . . . 0.0 111.382 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.71 127.06 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 16.1 mm-40 -106.79 157.8 17.47 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.879 0.371 . . . . 0.0 110.907 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -128.66 129.51 45.93 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.984 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -84.69 -58.25 2.79 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.7 0.286 . . . . 0.0 110.782 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -166.86 135.08 2.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.299 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.58 -120.81 21.95 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.367 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.04 2.87 56.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.985 0.422 . . . . 0.0 110.704 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.36 112.97 4.24 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.083 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -108.01 162.95 13.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.794 0.331 . . . . 0.0 111.193 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 36.6 ttm180 -136.77 134.38 37.01 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.3 t -90.13 -95.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.5 m 37.43 92.59 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.21 129.81 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 p -91.05 114.25 26.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.389 0.614 . . . . 0.0 112.46 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 20' ' ' ALA . 37.5 mt -137.81 172.59 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.522 ' N ' HG22 ' A' ' 19' ' ' ILE . . . -61.59 145.8 50.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.864 0.302 . . . . 0.0 110.53 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.36 -36.55 75.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.091 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' B' ' 255' ' ' ARG . 1.2 p30 -57.51 -48.52 79.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.88 0.371 . . . . 0.0 111.112 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -66.53 -43.65 84.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.78 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 28' ' ' VAL . 74.7 mt -62.14 -51.68 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -65.87 -36.83 84.54 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.465 -175.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.45 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 95.7 m -62.34 -43.24 99.27 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.16 -37.96 89.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.975 0.417 . . . . 0.0 110.462 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 24' ' ' ILE . 95.0 t -63.23 -41.97 94.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.649 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 85.7 mttt -55.72 -46.95 77.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.418 0.628 . . . . 0.0 109.455 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.7 m -67.62 -41.62 83.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.04 -41.3 77.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.752 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.35 -43.27 99.22 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.742 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 12.6 p -67.18 -32.8 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.317 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -63.88 -43.09 97.07 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.157 0.503 . . . . 0.0 110.361 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.27 -42.65 91.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.201 0.524 . . . . 0.0 109.84 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.69 74.64 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.313 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 98.0 mttt -66.25 -34.53 78.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.766 ' HA ' ' ND2' ' B' ' 397' ' ' ASN . 34.5 ttpt -63.89 -45.12 90.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.68 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.38 -13.49 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.54 0.686 . . . . 0.0 109.38 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 65.01 61.68 0.75 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.177 -1.374 . . . . 0.0 112.838 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 41' ' ' ILE . 48.2 mm -116.97 -2.17 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.005 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.87 -31.21 72.03 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.155 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.54 -6.09 65.31 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.454 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -98.47 -4.92 33.42 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.26 0.552 . . . . 0.0 109.635 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -83.4 114.75 21.66 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.824 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -94.16 -1.14 54.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.637 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.74 17.43 77.37 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.69 -0.687 . . . . 0.0 113.802 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -65.01 -38.54 91.25 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.853 0.326 . . . . 0.0 110.38 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.44 111.48 61.42 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 140.96 85.69 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.857 2.372 . . . . 0.0 112.379 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.57 ' O ' HG22 ' A' ' 54' ' ' VAL . 12.4 tpt -63.43 -37.38 87.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.454 -173.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 24.2 p-10 -62.4 -39.13 92.25 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.932 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.8 mt -64.61 -42.89 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 51' ' ' MET . 18.9 m -63.56 -38.8 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.933 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.15 93.73 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.84 0.352 . . . . 0.0 111.296 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 11.4 pt20 -86.81 10.14 16.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.708 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -110.08 -71.65 0.75 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.543 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -95.51 3.15 54.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.767 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -62.45 -33.78 87.38 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.55 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.19 79.27 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.9 m -60.86 -43.45 98.35 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.922 0.392 . . . . 0.0 111.859 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -100.89 12.32 6.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 5.2 tpt180 -56.86 -44.96 82.7 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.881 0.372 . . . . 0.0 111.109 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.79 -41.31 78.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.778 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.34 -20.02 61.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.272 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 62' ' ' VAL . 69.8 t -61.89 -41.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -60.84 -39.59 89.67 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.686 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.57 -43.08 98.56 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.097 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.88 -42.05 95.13 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.121 0.486 . . . . 0.0 110.55 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.34 -41.39 96.97 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 41.0 ttm -60.81 -43.33 98.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.935 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.2 m -60.66 -49.93 75.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.179 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -69.67 -39.22 77.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -64.77 -40.05 94.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.638 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.55 -48.35 82.16 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 111.449 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 80' ' ' ILE . 20.2 tt -66.67 -39.7 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.881 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.08 -39.76 90.29 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.74 -42.74 81.35 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.6 pt -64.47 -38.89 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.629 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 76' ' ' ILE . 70.4 mt -63.17 -45.75 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.286 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -35.02 65.16 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -87.16 2.23 50.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 10.6 mmpt? 65.96 40.18 4.21 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.874 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.93 128.75 59.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -117.23 98.94 52.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.16 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.11 144.11 74.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.812 2.341 . . . . 0.0 112.212 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.51 114.26 28.32 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.261 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.23 -132.28 11.19 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.445 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.94 117.72 32.12 Favored Pre-proline 0 C--N 1.319 -0.735 0 O-C-N 122.868 -0.195 . . . . 0.0 110.633 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.37 143.27 97.68 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.302 2.002 . . . . 0.0 110.941 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -115.13 127.11 55.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.73 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 43.46 80.67 0.28 Allowed Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -89.14 128.0 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.884 2.39 . . . . 0.0 111.353 175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.39 -166.41 41.85 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.818 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.12 151.28 29.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -115.98 121.81 43.37 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.832 0.349 . . . . 0.0 111.359 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.86 134.93 39.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.36 117.69 13.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.05 0.452 . . . . 0.0 110.66 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.11 -11.65 57.22 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.452 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -113.48 -171.57 1.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.92 0.391 . . . . 0.0 111.666 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.06 170.07 17.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.351 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -128.99 144.65 51.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.595 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.2 m -126.95 132.55 50.82 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.163 0.506 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -142.63 157.63 44.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.0 m -133.65 119.07 18.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.933 0.396 . . . . 0.0 111.294 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.4 t -99.33 114.14 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -79.02 125.67 29.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.269 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -150.99 164.78 35.59 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.58 171.49 7.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.391 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.16 151.7 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 120.671 0.272 . . . . 0.0 111.68 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -117.91 134.21 23.3 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.845 0.458 . . . . 0.0 111.126 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -94.74 -172.75 0.27 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.31 2.674 . . . . 0.0 112.869 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -128.85 155.77 44.71 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 116' ' ' GLU . 16.9 t -131.97 163.14 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-O 120.736 0.303 . . . . 0.0 110.684 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 115' ' ' VAL . 47.4 mt-10 -120.41 135.23 55.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 354' ' ' VAL . 80.7 mt -96.3 123.31 39.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.888 -177.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -140.76 144.69 35.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.137 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.52 25.25 75.99 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-N 115.836 -0.62 . . . . 0.0 114.18 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.18 -41.31 94.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.275 0.559 . . . . 0.0 110.875 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -72.21 -15.3 61.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.824 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.99 2.95 40.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.18 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.5 mt -93.77 112.62 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-O 121.176 0.513 . . . . 0.0 109.763 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -96.78 132.37 42.55 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.598 HG11 HG13 ' A' ' 286' ' ' VAL . 58.4 t -123.91 130.8 73.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.046 0.45 . . . . 0.0 111.239 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.11 135.88 39.15 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.503 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 79.0 tttt -115.32 91.14 27.17 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.068 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.78 136.52 53.81 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.402 2.068 . . . . 0.0 111.034 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.9 115.67 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.651 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 161.2 38.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.057 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -132.7 165.5 24.36 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.58 114.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 64.9 p -89.13 172.53 9.02 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.606 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.81 -35.85 81.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.442 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.23 91.59 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.281 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -63.31 -44.67 94.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.333 0.587 . . . . 0.0 109.89 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.8 t -66.83 -42.51 89.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.084 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -55.5 -48.29 74.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.204 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.16 -38.03 95.39 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.497 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 27.6 ttt -64.92 -39.81 94.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 94.7 mt -62.27 -41.61 98.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.926 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.22 -39.41 92.68 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 110.303 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 18.9 m -62.01 -42.76 99.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.016 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 140' ' ' MET . 85.0 mt -62.94 -38.24 90.26 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.273 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -60.34 -36.61 78.36 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.032 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -76.93 -12.74 59.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.128 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 143' ' ' THR . 13.1 mm100 -86.76 -10.43 53.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -125.65 133.87 52.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -165.33 159.35 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.545 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.568 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 25.6 m -95.15 165.53 12.37 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -92.43 143.09 26.72 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -147.87 164.95 32.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.512 1.125 . . . . 0.0 109.963 173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -125.33 141.73 51.91 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.819 0.343 . . . . 0.0 111.279 -177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -149.02 -178.98 6.67 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.395 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.12 122.28 10.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.959 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.4 -102.64 0.22 Allowed Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.741 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -114.32 174.18 6.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.07 0.462 . . . . 0.0 111.99 -176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 240' ' ' VAL . 48.1 t -107.78 132.94 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -85.87 -76.34 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . 172.89 -25.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.1 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -117.56 21.58 12.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 241' ' ' GLU . 4.0 m-20 -83.88 176.64 8.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.791 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -115.91 115.3 25.98 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.3 158.66 17.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.5 m -115.69 112.43 22.07 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.2 mt -127.76 128.59 69.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.86 113.69 25.94 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -130.15 155.47 46.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.983 0.42 . . . . 0.0 111.641 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.4 m -121.97 133.02 54.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.432 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.41 81.29 1.75 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.744 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 39.2 m -98.32 127.55 44.31 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 35.7 t -81.41 -86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.752 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -113.58 -31.65 6.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.2 21.38 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.313 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.26 147.15 27.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.605 0.241 . . . . 0.0 110.374 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -94.8 135.13 36.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -87.78 -178.81 6.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.637 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.59 -40.41 83.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -96.75 -171.88 34.49 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.803 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.4 22.82 55.86 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.489 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -106.2 111.01 23.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -123.34 146.27 48.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.361 0.601 . . . . 0.0 112.267 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.1 t -145.12 100.89 3.55 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.722 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 64.0 37.28 9.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.258 0.552 . . . . 0.0 111.253 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.61 125.27 28.71 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.602 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 m -96.94 121.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.402 0.62 . . . . 0.0 110.633 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 51.0 tp -114.38 136.77 52.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.483 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.36 112.27 24.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.795 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.1 mtp -83.73 148.8 26.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.355 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.4 -12.04 65.05 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.411 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -96.72 -1.46 46.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.362 0.125 . . . . 0.0 110.833 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 67.91 39.16 89.53 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.996 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -82.35 -24.52 34.48 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -105.21 177.01 4.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.788 0.328 . . . . 0.0 111.572 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -54.15 132.28 60.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.695 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -53.17 122.56 11.39 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.702 1.601 . . . . 0.0 110.284 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.19 -28.58 15.14 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.27 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -65.9 -50.53 64.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.047 0.423 . . . . 0.0 111.135 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -83.75 -5.97 59.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.189 0.519 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.88 -36.31 15.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.06 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.31 -33.45 85.04 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.645 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 32.7 pt -78.4 -7.37 10.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 61.6 mtpt -63.13 124.73 21.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.437 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.75 59.68 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.46 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -92.35 158.46 16.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.117 0.458 . . . . 0.0 111.678 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -82.12 153.98 25.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.742 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.6 31.42 0.19 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.789 0.328 . . . . 0.0 111.858 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -167.73 49.64 0.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.426 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -151.18 148.1 27.84 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.555 0.217 . . . . 0.0 110.929 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.67 124.98 50.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -131.1 113.78 14.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 38.8 m -78.12 127.85 32.92 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.9 tp -129.35 133.98 64.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.64 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.09 112.87 20.2 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.413 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -111.55 111.85 37.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.116 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 35.0 m -98.11 120.05 37.84 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 85.1 m-85 -85.98 144.48 39.15 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.937 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.41 149.21 87.48 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.625 2.217 . . . . 0.0 112.461 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.11 -32.32 72.88 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.533 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -84.8 16.26 3.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.222 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -72.22 138.56 47.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.966 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -64.0 -31.13 72.2 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -89.97 118.5 29.57 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.463 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 44.2 tt0 -62.8 -36.78 84.27 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.407 ' ND2' ' HG ' ' A' ' 226' ' ' LEU . 7.5 p-10 -69.86 -8.66 50.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.748 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 97.8 mt -121.39 -24.41 5.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 22.7 ptmt -62.88 122.41 15.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.378 0.608 . . . . 0.0 112.225 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.72 13.58 82.06 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.539 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -105.33 141.16 37.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.037 0.446 . . . . 0.0 111.011 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.89 96.13 5.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.059 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -97.25 145.6 25.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.082 -177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -104.79 115.7 30.75 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.668 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 212' ' ' THR . 82.4 m-85 -96.91 119.97 36.37 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.704 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.49 -37.52 77.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.289 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 49.0 mm 62.97 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.404 0.621 . . . . 0.0 111.124 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.64 -59.87 2.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.019 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.9 mt 65.33 161.18 0.13 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.962 0.505 . . . . 0.0 111.766 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -172.16 -49.78 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -135.0 138.3 43.84 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.651 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.471 HG21 HG22 ' A' ' 158' ' ' VAL . 67.0 t -132.43 131.62 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 4.2 mp0 -112.27 161.9 16.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -121.22 164.39 17.02 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -123.24 143.81 49.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.161 0.505 . . . . 0.0 110.826 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.36 168.01 10.22 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.234 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 84.6 mt -48.28 125.16 11.69 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 123.595 0.559 . . . . 0.0 110.615 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.568 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 58.6 Cg_endo -69.23 143.53 53.73 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.674 2.249 . . . . 0.0 113.205 -178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -83.77 117.46 23.27 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.645 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 36.1 tp -85.58 33.66 0.58 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.532 0.682 . . . . 0.0 110.718 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.34 9.71 22.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 253' ' ' ILE . . . 75.45 -27.71 0.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.736 0.814 . . . . 0.0 112.644 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -58.58 -50.03 75.28 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -112.87 -13.75 13.13 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 250' ' ' ALA . 11.2 tp -75.29 -7.23 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.896 0.379 . . . . 0.0 111.752 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 256' ' ' PHE . 21.5 ptmt -83.79 8.77 13.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.671 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.413 ' HA ' ' HB3' ' B' ' 22' ' ' ASP . 2.3 mpt_? -76.43 14.86 0.68 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.813 0.816 . . . . 0.0 109.853 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 254' ' ' LYS . 84.7 t80 -103.3 -34.23 8.85 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.425 -1.262 . . . . 0.0 109.401 177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.96 -53.92 0.4 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.786 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.26 163.89 36.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 53.5 mp0 -76.05 -90.27 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.278 0.361 . . . . 0.0 111.543 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 53.35 -93.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.524 0.73 . . . . 0.0 112.629 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 76.24 -4.06 49.97 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.92 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 264' ' ' GLU . 10.9 p -82.83 137.76 34.19 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.793 0.33 . . . . 0.0 110.375 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.3 -46.13 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.492 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.445 ' OE1' ' HB2' ' A' ' 262' ' ' SER . 0.9 OUTLIER -67.62 -41.37 84.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.043 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.76 -44.64 91.89 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.965 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' VAL . 59.8 tp -62.5 -44.59 96.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.562 0.22 . . . . 0.0 110.627 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -64.06 -41.35 97.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.47 92.94 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.9 -45.7 88.14 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.096 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 266' ' ' LEU . 70.3 t -64.17 -44.0 97.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -59.14 -45.79 90.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.061 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -68.41 -37.64 80.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.607 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.46 -39.27 81.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.906 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 91.2 mmm -63.39 -41.82 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.955 0.407 . . . . 0.0 110.583 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.63 -30.16 66.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.051 0.453 . . . . 0.0 110.237 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 45.6 ttm-85 -60.48 -46.04 91.56 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.475 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.57 -20.76 39.21 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.582 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.93 -42.22 98.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.45 -46.71 87.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.731 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.5 m -65.25 -39.92 93.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.007 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.46 69.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.793 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.58 -34.26 56.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.128 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.46 HH12 ' HG3' ' A' ' 409' ' ' GLU . 27.9 tpt180 -60.69 -45.43 94.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.449 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -64.96 -42.53 94.53 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -68.23 -38.08 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.415 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 125' ' ' VAL . 47.9 t -62.38 -43.84 98.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.463 0.649 . . . . 0.0 109.294 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.75 -46.53 89.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.443 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 78.1 p -62.59 -35.96 81.19 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -61.39 -45.97 92.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.068 0.461 . . . . 0.0 110.463 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.7 70.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.0 -45.3 97.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.945 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -67.07 -43.34 82.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.89 -41.67 98.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.4 -46.01 90.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.609 0.242 . . . . 0.0 110.542 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.88 -43.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.035 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -64.0 -34.01 77.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.046 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.53 -39.85 18.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -111.74 102.78 11.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -100.66 129.61 46.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.996 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 11.2 tp -135.75 146.47 29.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.872 0.368 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -74.25 126.65 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.772 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.69 135.52 19.77 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.583 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.77 138.65 75.79 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.535 2.156 . . . . 0.0 111.504 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.07 82.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.93 79.42 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.69 -40.02 95.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.891 0.377 . . . . 0.0 111.525 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.63 -43.89 98.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.593 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.22 -42.66 98.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.762 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -61.16 -43.05 99.49 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.827 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -66.01 -34.07 77.25 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.797 0.332 . . . . 0.0 111.76 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.53 -42.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.547 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 18.5 t70 -57.81 -44.18 86.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.898 0.38 . . . . 0.0 110.32 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.34 -44.11 98.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.523 HD13 ' HG3' ' A' ' 340' ' ' GLN . 73.7 mt -62.46 -42.1 99.23 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.75 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.547 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 80.8 mtm180 -62.12 -43.36 98.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 110.473 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -64.86 -42.46 94.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.5 OUTLIER -66.49 -45.0 81.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.304 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.71 -39.45 91.22 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.13 82.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.397 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.21 -47.02 81.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -72.82 -26.72 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.899 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -71.45 -39.32 71.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.292 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . -170.61 -35.11 0.03 OUTLIER Glycine 0 C--O 1.219 -0.798 0 C-N-CA 120.365 -0.922 . . . . 0.0 113.066 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 111.02 45.47 0.87 Allowed Glycine 0 C--O 1.223 -0.558 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.84 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 328' ' ' GLN . 26.6 t-20 -99.87 103.61 15.22 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.89 0.376 . . . . 0.0 110.244 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -82.35 144.76 30.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.342 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 72.62 -37.78 0.4 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.149 0.98 . . . . 0.0 112.911 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.84 -17.18 63.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.537 0.684 . . . . 0.0 109.2 176.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.2 64.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.466 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 52.8 tp -61.0 -37.97 84.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.283 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -78.17 -11.54 59.93 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.533 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.71 139.13 82.06 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.77 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.75 129.18 33.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.774 2.316 . . . . 0.0 112.876 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -65.74 -41.26 92.41 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.906 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -57.78 -30.07 65.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.53 -39.88 95.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.87 0.366 . . . . 0.0 111.03 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.34 -9.15 20.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -59.47 -41.32 89.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.891 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -68.26 -50.81 51.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.536 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.523 ' HG3' HD13 ' A' ' 314' ' ' LEU . 10.2 pt20 -67.87 -30.84 70.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -64.78 -42.49 95.05 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -59.87 -45.84 91.19 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.208 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -61.1 -44.17 97.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.04 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -65.31 -41.21 94.28 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.069 -0.653 . . . . 0.0 112.34 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 341' ' ' ALA . 84.3 t -63.62 -47.45 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.076 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 86.8 t -62.68 -47.34 93.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.161 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.75 -44.05 98.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.928 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.05 -43.22 99.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.1 mt -64.2 -42.56 96.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 0.0 110.6 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 354' ' ' VAL . 99.5 mt -62.71 -46.34 88.6 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.826 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.56 -40.94 93.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.245 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.19 -40.71 98.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.241 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -66.97 -36.96 83.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.872 0.368 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 350' ' ' LEU . 88.0 t -60.86 -44.2 97.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.38 -44.75 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.798 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -67.09 -48.63 67.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.958 0.409 . . . . 0.0 111.052 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 20.4 m -65.05 -45.42 85.45 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -87.57 4.01 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 57.68 40.37 26.59 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.371 0.42 . . . . 0.0 111.055 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.45 133.7 44.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.57 148.57 46.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.929 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.47 113.61 5.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -86.36 119.04 26.2 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.343 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.425 ' CD ' HH22 ' A' ' 399' ' ' ARG . 78.9 mm-40 -63.35 -36.27 83.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.03 -40.97 97.51 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.152 0.501 . . . . 0.0 109.697 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -60.94 -44.11 97.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.469 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 88.4 t -66.32 -45.31 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -61.91 -43.42 98.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.47 -41.44 99.78 Favored Glycine 0 C--O 1.237 0.292 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.86 -38.38 90.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.036 0.446 . . . . 0.0 110.792 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.48 -42.79 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.521 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.13 -44.15 97.78 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.54 -41.16 93.37 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.932 0.396 . . . . 0.0 110.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.405 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 51.2 ttp -65.19 -42.08 93.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.239 0.543 . . . . 0.0 110.717 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -27.44 68.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.61 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -16.3 63.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.313 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -85.92 1.07 51.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -115.97 158.17 23.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.761 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.32 -51.78 67.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.96 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.45 103.15 51.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.105 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.6 -22.18 38.47 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.447 2.098 . . . . 0.0 112.871 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.37 -47.62 81.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.11 -37.21 83.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.608 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.07 -46.85 92.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.636 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.25 -43.55 97.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.563 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 390' ' ' LYS . 41.3 tt0 -63.64 -44.22 94.48 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.17 -45.25 95.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.918 0.389 . . . . 0.0 110.912 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -39.55 93.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 24.7 m -84.29 -4.95 59.18 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.977 0.418 . . . . 0.0 111.176 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 386' ' ' GLU . 15.4 tptt -92.26 -39.95 11.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.192 0.52 . . . . 0.0 109.87 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.604 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 28.5 t-20 -96.96 115.56 27.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.939 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.68 -34.47 77.93 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.832 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.604 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 4.0 tp10 -55.07 -51.62 65.78 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.141 0.496 . . . . 0.0 110.251 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.24 -39.47 94.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.138 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.619 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 96.6 mtp -60.16 -46.56 89.26 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.528 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.25 -48.99 75.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.823 0.344 . . . . 0.0 111.509 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.832 ' ND2' ' HA ' ' B' ' 38' ' ' LYS . 28.0 t-20 -62.85 -42.08 99.6 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -177.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 13.8 tpt -64.81 -37.51 87.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.34 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.619 ' HG3' ' O ' ' A' ' 395' ' ' MET . 90.4 mtt-85 -60.88 -41.05 95.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -63.07 -39.6 95.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.962 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.67 -47.25 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.314 0.578 . . . . 0.0 110.132 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.29 91.49 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.63 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.5 tp -63.88 -38.75 92.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.989 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.422 ' O ' HG23 ' A' ' 408' ' ' VAL . 41.4 tt0 -59.62 -41.83 91.3 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 17.4 mm-40 -59.03 -43.62 91.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.507 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -63.0 -42.17 99.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -64.35 -43.12 95.56 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.274 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 404' ' ' GLU . 99.0 t -63.97 -43.84 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.46 ' HG3' HH12 ' A' ' 283' ' ' ARG . 89.0 mt-10 -63.22 -39.58 95.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.074 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.85 93.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.356 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.46 -45.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.946 0.403 . . . . 0.0 110.893 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -27.94 69.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.527 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.95 -37.08 78.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.24 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.32 -9.28 25.63 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.53 158.38 16.49 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.957 0.408 . . . . 0.0 111.293 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -82.63 100.95 10.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.828 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.93 113.27 42.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.5 t -111.32 132.78 54.13 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.503 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 71.5 mt-10 -91.72 139.34 30.77 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -131.33 117.58 19.12 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -72.72 117.49 14.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.957 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 3.7 p -132.67 161.37 34.12 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.287 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 72.3 p -84.31 161.92 20.27 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -62.15 -41.29 98.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.336 0.588 . . . . 0.0 109.799 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -59.99 -40.3 88.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.256 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -62.85 -42.45 99.75 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.906 0.384 . . . . 0.0 111.036 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.3 tp -71.31 -31.62 67.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.639 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 13.8 tpt -69.0 -11.8 61.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -72.94 71.23 1.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.35 0.595 . . . . 0.0 109.938 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.53 48.69 0.83 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.186 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -78.53 95.45 5.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.851 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.007 -178.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -75.18 122.85 24.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.988 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.72 139.75 48.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.091 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -134.65 137.99 44.09 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.864 0.364 . . . . 0.0 111.063 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -145.73 125.23 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 71.1 mm-40 -104.99 157.51 17.18 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.887 0.375 . . . . 0.0 110.995 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 88.1 m -130.54 130.09 43.66 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.148 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 10.7 p -86.95 -64.54 1.13 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 120.792 0.33 . . . . 0.0 111.119 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -158.58 130.49 6.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.811 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.28 -117.52 9.72 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.51 5.03 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.941 0.401 . . . . 0.0 110.883 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.76 110.95 3.22 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.356 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -106.94 161.17 14.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.102 0.477 . . . . 0.0 111.246 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 34.0 ttm180 -135.1 135.93 41.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.26 -95.08 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.051 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.9 m 37.46 91.49 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -102.73 129.64 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 33.2 p -91.71 112.41 24.33 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.47 HG22 ' N ' ' B' ' 20' ' ' ALA . 33.2 mt -135.33 170.63 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.47 ' N ' HG22 ' B' ' 19' ' ' ILE . . . -59.41 145.65 42.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.727 0.299 . . . . 0.0 110.589 177.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.68 -35.69 74.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.079 -176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 255' ' ' ARG . 1.2 p30 -58.26 -48.72 79.54 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.836 0.35 . . . . 0.0 111.219 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -66.13 -43.1 88.08 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.776 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.476 ' O ' HG23 ' B' ' 28' ' ' VAL . 74.9 mt -61.64 -51.63 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.681 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -65.58 -36.93 85.19 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.571 -175.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.2 m -62.13 -42.75 99.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.669 0.271 . . . . 0.0 111.142 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.33 90.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.771 0.32 . . . . 0.0 110.354 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 24' ' ' ILE . 92.0 t -63.29 -41.86 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.779 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.681 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 82.5 mttt -57.61 -45.53 85.22 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.232 0.539 . . . . 0.0 109.667 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 15.7 m -67.77 -40.45 84.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.69 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.31 -40.68 77.5 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.719 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.98 -42.86 99.95 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.662 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.34 -32.0 55.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.348 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -62.96 -46.16 89.04 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.158 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.82 -42.37 92.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.009 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.92 76.53 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.8 -34.36 76.61 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.832 ' HA ' ' ND2' ' A' ' 397' ' ' ASN . 38.2 ttpt -63.34 -45.37 91.53 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.534 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.74 -13.43 13.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 0.0 109.597 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 65.02 67.94 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 112.992 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' A' ' 317' ' ' GLN . 46.6 mm -122.19 -3.63 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.047 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -66.14 -30.57 71.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.143 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.43 -7.11 63.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.125 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -98.07 -2.89 39.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.333 0.587 . . . . 0.0 109.756 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -84.87 114.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -95.73 4.08 53.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.17 15.87 81.11 Favored Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.656 -0.702 . . . . 0.0 113.647 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -64.3 -42.95 96.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.84 0.32 . . . . 0.0 111.016 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.64 111.5 64.73 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.69 139.81 83.63 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.734 2.289 . . . . 0.0 112.168 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.53 ' O ' HG22 ' B' ' 54' ' ' VAL . 12.0 tpt -63.31 -36.93 85.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.294 -173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 23.4 p-10 -62.02 -40.07 94.43 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.681 -0.407 . . . . 0.0 111.059 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.62 -42.62 95.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.875 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.53 HG22 ' O ' ' B' ' 51' ' ' MET . 19.8 m -63.4 -38.43 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.979 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.78 -39.29 93.9 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.007 0.432 . . . . 0.0 111.309 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.6 pt20 -86.37 9.53 17.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.786 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -109.59 -71.2 0.77 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.452 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -96.31 3.38 53.03 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.823 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.42 -34.91 90.81 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.601 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.69 81.67 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 37.6 m -60.38 -42.74 96.49 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.629 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.652 ' O ' HG23 ' B' ' 66' ' ' VAL . 7.3 p -102.04 13.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.877 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.89 -44.58 86.8 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.259 -0.276 . . . . 0.0 111.36 -174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.64 -42.9 81.52 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.302 0.573 . . . . 0.0 110.347 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.0 -19.73 61.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.505 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' B' ' 62' ' ' VAL . 74.2 t -61.92 -42.08 93.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.04 -39.46 89.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.603 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.64 -43.4 99.04 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.068 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.27 -41.18 94.47 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.084 0.469 . . . . 0.0 110.494 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 42.1 ttm -60.23 -43.33 96.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.905 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.8 m -61.05 -48.86 79.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -69.73 -40.08 76.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -64.8 -39.63 93.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.086 -0.245 . . . . 0.0 111.513 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.18 -48.41 81.86 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 19.8 tt -66.39 -39.94 85.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.4 . . . . 0.0 111.09 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.3 -40.43 89.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.123 0.487 . . . . 0.0 110.808 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.81 87.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.521 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 41.1 pt -66.09 -36.72 78.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.488 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.21 -44.44 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.01 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.43 57.19 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -92.3 4.66 52.87 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 10.5 mmpt? 62.83 41.63 8.61 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.934 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 83.9 mt -107.13 127.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.725 0.298 . . . . 0.0 110.263 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -118.53 97.33 50.7 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.037 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.45 143.9 71.29 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.84 2.36 . . . . 0.0 112.459 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -102.19 111.79 24.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.71 -142.61 16.23 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.122 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.04 115.7 45.4 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 120.453 0.168 . . . . 0.0 110.578 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.63 141.55 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.405 2.07 . . . . 0.0 111.284 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 8.4 m -111.82 122.66 48.4 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.43 -5.05 40.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.542 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t 37.25 81.75 0.24 Allowed Pre-proline 0 N--CA 1.484 1.231 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -89.85 120.87 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.805 2.337 . . . . 0.0 111.074 175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.34 -168.55 36.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -78.13 149.71 33.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 0.0 110.719 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -111.43 129.58 55.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -109.37 130.64 55.49 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.5 112.57 5.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.892 0.377 . . . . 0.0 111.153 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.08 -2.04 47.62 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.651 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -123.72 -174.34 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.604 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.83 159.27 31.17 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -119.99 138.43 53.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.759 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 56.6 m -123.92 132.34 53.71 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.973 0.416 . . . . 0.0 111.871 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -141.71 157.66 44.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 42.6 m -130.95 119.08 21.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.951 0.405 . . . . 0.0 111.417 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 66.1 t -101.71 114.97 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.647 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -81.15 129.56 34.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.098 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.16 163.58 39.08 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.095 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.99 173.6 6.28 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.449 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.23 150.33 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 120.691 0.282 . . . . 0.0 111.516 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -116.51 135.48 22.91 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.93 -174.4 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.212 2.608 . . . . 0.0 112.325 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -129.01 155.68 45.01 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.44 HG12 ' N ' ' B' ' 116' ' ' GLU . 13.2 t -130.54 165.5 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 0.0 110.615 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.44 ' N ' HG12 ' B' ' 115' ' ' VAL . 47.8 mt-10 -124.6 136.64 54.12 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' B' ' 354' ' ' VAL . 77.5 mt -95.92 124.02 39.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.915 -176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -139.96 142.42 36.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.004 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.84 27.47 73.14 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.817 -0.628 . . . . 0.0 114.489 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.68 -42.14 91.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.318 0.559 . . . . 0.0 110.985 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' B' ' 121' ' ' GLU . 1.6 mp0 -70.93 -16.29 62.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.549 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.11 1.4 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.546 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 86.6 mt -92.49 111.55 24.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.224 0.535 . . . . 0.0 109.914 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -94.88 127.05 40.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.21 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.557 HG11 HG13 ' B' ' 286' ' ' VAL . 65.2 t -120.84 130.08 74.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.081 0.467 . . . . 0.0 111.546 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.64 135.89 41.36 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.521 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.7 tttt -115.1 91.87 28.99 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.019 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.17 134.71 43.7 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 111.123 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 50.5 mm -109.93 116.41 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.049 0.452 . . . . 0.0 110.473 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.89 163.09 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.028 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.12 161.69 33.75 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.711 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.44 114.85 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.1 p -88.94 173.69 8.35 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.283 0.564 . . . . 0.0 111.747 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.38 -34.32 76.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.975 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -62.37 -45.4 93.35 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.521 0.677 . . . . 0.0 110.113 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 89.0 t -66.56 -42.29 89.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.076 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -56.04 -47.55 77.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.916 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.01 -38.4 95.97 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.246 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' B' ' 144' ' ' LEU . 27.8 ttt -64.95 -39.55 93.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.803 0.335 . . . . 0.0 110.654 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.1 mt -61.83 -42.11 98.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.845 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.92 -39.5 94.76 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.878 0.371 . . . . 0.0 110.824 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' B' ' 147' ' ' GLN . 26.1 m -61.55 -42.38 98.75 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.11 178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 140' ' ' MET . 95.4 mt -62.07 -38.55 89.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.858 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -61.13 -38.01 84.83 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -75.43 -11.67 60.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 143' ' ' THR . 13.3 mm100 -88.32 -11.18 47.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -123.9 134.95 53.44 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -166.74 159.19 13.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.753 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . . . . . . . . . 23.6 m -93.78 166.02 12.4 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -95.34 143.92 26.32 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -147.41 163.28 36.98 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.927 1.291 . . . . 0.0 109.802 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.16 142.49 50.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -150.76 -178.21 6.44 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 120.935 0.398 . . . . 0.0 110.867 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -144.38 134.21 23.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.31 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 144.31 -104.55 0.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.732 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -120.01 168.86 10.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.956 0.408 . . . . 0.0 111.704 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.492 HG22 HG21 ' B' ' 240' ' ' VAL . 24.5 t -99.26 133.17 42.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -86.37 -75.11 0.4 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.472 ' HB2' ' HE3' ' B' ' 203' ' ' LYS . . . 173.84 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.274 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -116.72 20.12 14.16 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.319 0.58 . . . . 0.0 110.547 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.2 m-20 -84.61 174.49 9.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.846 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.93 115.72 27.37 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.47 158.65 18.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 22.5 m -113.69 114.28 26.17 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -128.05 126.81 66.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.169 0.509 . . . . 0.0 112.063 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -98.26 111.07 23.53 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -125.97 158.01 36.35 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.011 0.434 . . . . 0.0 111.842 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 38.2 m -124.6 130.21 52.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.331 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.09 84.36 1.56 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.677 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -105.33 124.52 49.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.6 -91.75 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.721 0.296 . . . . 0.0 111.007 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.78 -34.97 9.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.244 0.545 . . . . 0.0 110.042 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.83 31.53 0.1 Allowed Glycine 0 CA--C 1.503 -0.7 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -155.0 144.91 21.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -97.37 134.85 40.09 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.363 0.414 . . . . 0.0 110.011 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -91.08 -179.03 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.937 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.62 -35.88 77.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -98.44 -175.89 32.78 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.46 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.29 20.94 53.72 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.014 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -103.61 110.98 23.25 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.58 144.87 51.03 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.96 0.41 . . . . 0.0 111.83 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -146.0 102.45 3.64 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 65.57 36.83 6.3 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.189 0.519 . . . . 0.0 110.967 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -77.1 123.49 26.46 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.52 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.16 124.29 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.532 0.682 . . . . 0.0 110.326 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 51.9 tp -115.54 134.07 55.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.453 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.24 110.44 22.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.798 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.2 150.65 27.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.56 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.58 60.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.449 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -90.85 -2.6 57.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.348 0.118 . . . . 0.0 111.254 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.96 35.0 71.51 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.1 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.411 ' HG2' HE21 ' A' ' 56' ' ' GLN . 64.4 mtp180 -78.89 -27.65 43.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 18.7 mmt -103.11 176.33 5.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.818 0.342 . . . . 0.0 111.535 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.55 132.82 63.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.497 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.07 129.67 35.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.521 1.481 . . . . 0.0 110.175 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 98.03 -32.33 6.99 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.08 -176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.09 -48.95 74.14 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 117.021 0.41 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.58 -6.5 59.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.209 0.528 . . . . 0.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -90.57 -35.55 14.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.471 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -66.74 -34.88 88.74 Favored Glycine 0 C--O 1.228 -0.27 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.424 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 27.7 pt -75.67 -12.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' B' ' 160' ' ' ALA . 61.3 mtpt -60.16 124.89 21.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.366 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.23 3.89 60.01 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.338 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -97.54 160.46 14.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.084 0.442 . . . . 0.0 111.211 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -84.88 155.93 21.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.872 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.29 13.8 1.09 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.19 39.32 0.99 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.032 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.93 145.8 36.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 0.0 112.047 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -98.27 138.75 35.07 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.061 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -143.01 119.16 10.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 36.2 m -82.43 126.7 32.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.609 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.8 tp -129.76 134.28 63.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.803 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.61 110.15 18.02 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.135 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -110.83 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . 31.0 m -99.03 119.09 37.22 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 88.8 m-85 -83.13 145.82 50.03 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.78 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.34 149.89 83.39 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.722 2.281 . . . . 0.0 112.727 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 64.5 mm-40 -60.87 -34.26 74.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.483 0.659 . . . . 0.0 109.616 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.98 27.54 1.57 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.996 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.74 141.71 39.14 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.392 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 -67.96 -22.14 65.05 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.56 120.76 40.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 38.5 tt0 -62.2 -38.46 89.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' B' ' 226' ' ' LEU . 7.1 p-10 -68.38 -10.17 53.2 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.948 -177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 97.5 mt -119.42 -24.52 6.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' B' ' 224' ' ' GLU . 22.2 ptmt -64.58 124.87 22.99 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.415 0.626 . . . . 0.0 112.511 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 73.05 12.69 79.41 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.447 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.75 139.1 40.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.06 0.457 . . . . 0.0 111.344 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 216' ' ' THR . . . -108.92 101.28 10.38 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.88 144.39 30.59 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.317 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -104.74 111.66 24.47 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' B' ' 212' ' ' THR . 93.1 m-85 -91.03 133.29 35.43 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.142 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -84.24 -33.31 24.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . . . . . . . . . 49.5 mm 60.21 99.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.567 . . . . 0.0 111.164 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -81.49 -62.11 1.74 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.739 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 94.8 mt 66.05 154.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.025 0.53 . . . . 0.0 111.67 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -165.81 -48.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' B' ' 240' ' ' VAL . 6.1 tmtt? -133.61 137.6 45.52 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.922 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.492 HG21 HG22 ' B' ' 158' ' ' VAL . 57.3 t -130.16 131.95 65.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.033 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 4.1 mp0 -112.55 158.31 20.1 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -116.84 164.98 13.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -124.55 142.42 51.36 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 110.836 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -110.37 164.93 12.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.313 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 93.0 mt -48.04 128.42 12.0 Favored Pre-proline 0 C--N 1.339 0.125 0 O-C-N 123.578 0.549 . . . . 0.0 110.586 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.28 136.12 36.26 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.216 1.944 . . . . 0.0 112.761 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.88 114.2 19.6 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.93 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.62 65.83 8.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.534 0.683 . . . . 0.0 110.209 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.97 13.74 12.26 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.562 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.494 ' HA ' HG22 ' B' ' 253' ' ' ILE . . . 71.84 -28.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.89 -50.98 71.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -111.93 -14.34 13.51 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' B' ' 250' ' ' ALA . 11.2 tp -76.33 -5.47 7.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 120.967 0.413 . . . . 0.0 111.746 -175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' B' ' 256' ' ' PHE . 20.1 ptmt -86.72 10.06 16.94 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.806 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.421 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 3.5 mpt_? -75.78 25.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.801 0.81 . . . . 0.0 110.158 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' B' ' 254' ' ' LYS . 79.4 t80 -117.45 -35.86 3.88 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.551 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.72 -52.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.126 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -133.84 163.5 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 122.244 0.217 . . . . 0.0 110.482 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.56 -90.34 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 48.62 -96.53 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.776 0.83 . . . . 0.0 112.947 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.21 -1.91 78.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.449 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . 0.622 ' HB2' ' OE2' ' B' ' 264' ' ' GLU . 8.6 p -79.1 136.43 37.14 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.47 -48.24 87.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.128 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.622 ' OE2' ' HB2' ' B' ' 262' ' ' SER . 0.3 OUTLIER -69.77 -39.09 76.88 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.963 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.34 -44.33 93.65 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.995 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . . . . . . . . . 57.0 tp -63.1 -43.59 98.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.678 0.275 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 62.7 mtp85 -63.84 -41.73 97.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.511 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.29 92.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.925 0.393 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' B' ' 272' ' ' LYS . 47.9 tp10 -65.3 -44.63 87.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.064 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 76.5 t -64.72 -44.04 96.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.67 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.81 -46.05 88.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.666 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' B' ' 269' ' ' GLU . 40.7 pttt -67.21 -39.56 86.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.462 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -67.23 -39.52 86.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.846 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 90.5 mmm -63.08 -42.27 99.59 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.759 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.39 -30.08 66.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.505 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -60.76 -46.33 90.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.639 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -79.64 -19.77 48.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.462 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 56.2 tp -62.7 -41.29 99.05 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.88 -47.52 85.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.716 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 17.1 m -64.13 -39.94 95.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.918 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.36 70.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.12 -38.01 73.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.114 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -59.73 -45.01 93.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.479 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -64.73 -43.31 93.8 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -67.6 -39.42 84.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.382 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.557 HG13 HG11 ' B' ' 125' ' ' VAL . 50.9 t -61.57 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.22 -45.93 92.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.862 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -62.27 -34.98 77.6 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -63.61 -47.4 81.57 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.967 0.413 . . . . 0.0 110.471 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.68 -43.15 76.73 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.408 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.49 -45.36 95.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.812 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -67.15 -43.26 82.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.094 0.473 . . . . 0.0 110.206 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.9 -40.83 98.72 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.197 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.4 HD23 HD22 ' B' ' 298' ' ' ASN . 0.5 OUTLIER -62.34 -46.27 89.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.708 0.29 . . . . 0.0 110.584 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.06 -43.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -61.41 -38.16 86.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.035 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.18 -46.94 11.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . 0.4 HD22 HD23 ' B' ' 294' ' ' LEU . 52.8 m-80 -98.96 100.88 12.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 112.138 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.51 125.11 49.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.211 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.1 tp -132.62 148.84 31.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.754 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.25 122.12 23.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.963 0.411 . . . . 0.0 109.947 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' B' ' 303' ' ' PRO . 61.5 t -101.61 133.17 20.97 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.736 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 302' ' ' VAL . 38.9 Cg_exo -61.87 140.19 83.93 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.56 2.173 . . . . 0.0 111.29 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.48 -35.58 79.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.41 -46.39 76.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.38 -40.91 98.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.707 0.289 . . . . 0.0 111.467 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 63.8 mt -63.75 -43.71 98.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.831 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.17 -43.65 92.12 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.899 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 50.1 m -62.11 -43.0 99.79 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.893 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -66.0 -32.73 74.39 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . . . . . . . . . 95.8 mt -62.43 -42.25 94.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.822 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' B' ' 315' ' ' ARG . 29.7 t70 -60.62 -42.04 96.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.39 -44.32 98.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.802 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' B' ' 340' ' ' GLN . 80.5 mt -63.01 -42.4 99.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.58 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' B' ' 312' ' ' ASP . 59.9 mtm180 -62.76 -43.78 97.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -64.36 -42.25 96.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.32 -43.95 84.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.025 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.22 -40.61 90.43 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.0 -36.3 83.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.26 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.506 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.9 tm0? -64.1 -49.11 73.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.591 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -67.7 -36.78 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -60.64 -45.12 95.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.955 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -167.82 -34.22 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.307 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 113.08 64.46 0.46 Allowed Glycine 0 C--O 1.222 -0.623 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.169 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -119.71 103.73 9.64 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.839 0.352 . . . . 0.0 110.236 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -83.19 144.58 29.71 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.106 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? 72.32 -39.08 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.262 1.025 . . . . 0.0 112.724 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -18.74 64.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.131 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -61.45 -22.93 65.49 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.502 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.87 -38.12 87.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.51 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -78.01 -8.69 58.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.888 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.81 143.04 91.69 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.857 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.48 129.97 38.03 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.896 2.397 . . . . 0.0 113.004 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -68.06 -41.33 82.13 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.751 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.8 pm0 -59.02 -31.62 68.99 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.69 -39.65 94.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.769 0.319 . . . . 0.0 111.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -103.0 -5.09 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -41.97 99.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 -178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.4 -51.94 51.81 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.359 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.496 ' HG3' HD13 ' B' ' 314' ' ' LEU . 9.1 pt20 -67.14 -30.52 70.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.655 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.448 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.22 -43.89 96.83 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.738 0.304 . . . . 0.0 110.242 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.3 -44.71 95.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.314 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -61.18 -44.24 97.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.157 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' B' ' 314' ' ' LEU . 11.2 mtm180 -65.2 -40.93 94.85 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 119.994 -0.682 . . . . 0.0 112.444 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 99.0 t -63.49 -47.34 92.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.045 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 90.6 t -63.61 -47.46 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.307 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.68 -44.22 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.69 0.281 . . . . 0.0 110.739 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.99 -42.86 99.93 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 82.6 mt -64.74 -42.79 94.93 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.646 0.26 . . . . 0.0 110.842 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' B' ' 354' ' ' VAL . 95.6 mt -62.66 -46.17 89.42 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.814 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.2 -40.71 94.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.08 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.65 -41.68 99.0 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.531 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.22 -36.06 80.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.764 0.316 . . . . 0.0 110.482 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 350' ' ' LEU . 89.8 t -61.47 -44.39 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.57 -44.83 99.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.915 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -66.67 -49.87 64.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.5 m -64.63 -44.43 90.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -87.46 4.86 41.68 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.94 41.99 29.25 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.04 0.448 . . . . 0.0 111.057 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 89.1 mt -76.76 133.87 39.32 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.153 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.35 144.68 49.29 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.947 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.11 111.98 2.79 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' B' ' 365' ' ' GLU . 33.8 t70 -83.53 119.98 25.38 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.376 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.455 ' CD ' HH22 ' B' ' 399' ' ' ARG . 68.4 mm-40 -63.66 -37.13 86.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.186 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . 0.4 ' HB2' ' OD2' ' B' ' 363' ' ' ASP . 61.2 mm-40 -63.43 -42.42 98.69 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.086 0.47 . . . . 0.0 109.885 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -60.2 -43.88 95.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.595 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.26 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.952 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.67 -44.53 96.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -61.95 -42.41 99.74 Favored Glycine 0 CA--C 1.511 -0.213 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.564 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.78 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 0.0 110.721 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.84 -42.75 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.825 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -64.96 -39.0 92.82 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -67.52 -40.85 85.11 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.347 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' B' ' 374' ' ' MET . 52.5 ttp -64.48 -42.37 95.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.642 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.66 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.285 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 18.2 t -67.59 -11.0 57.12 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.206 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 110.973 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -116.04 157.64 24.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.628 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.21 -47.21 86.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.557 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -121.71 105.63 38.07 Favored Pre-proline 0 CA--C 1.511 -0.537 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.03 -21.0 32.86 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.383 2.055 . . . . 0.0 113.078 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.53 -48.18 78.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.32 -34.56 72.84 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.855 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.11 -46.62 93.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.82 -43.25 97.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' B' ' 390' ' ' LYS . 45.1 tt0 -63.08 -42.85 99.72 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.162 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -60.57 -44.38 96.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.602 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -40.94 97.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.217 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 9.9 m -81.57 -9.0 59.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.505 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 386' ' ' GLU . 13.9 tptt -88.31 -40.07 13.89 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.686 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 28.4 t-20 -98.35 114.05 26.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.159 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.21 -34.56 77.92 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.516 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.638 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 4.2 tp10 -54.31 -52.06 62.68 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.153 0.502 . . . . 0.0 110.12 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.28 -39.68 94.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.342 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 95.9 mtp -60.42 -47.19 87.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.441 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.2 -45.98 82.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.861 0.362 . . . . 0.0 111.358 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.766 ' ND2' ' HA ' ' A' ' 38' ' ' LYS . 28.7 t-20 -62.79 -41.83 99.44 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.0 tpt -64.64 -36.78 85.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.271 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.616 ' HG3' ' O ' ' B' ' 395' ' ' MET . 92.8 mtt-85 -61.66 -40.67 95.76 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -62.92 -40.0 96.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.07 -46.78 92.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.17 0.51 . . . . 0.0 110.256 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.81 -39.88 91.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.675 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.24 -38.52 91.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.41 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.0 tt0 -59.11 -41.94 89.36 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 6.0 mm-40 -58.46 -44.77 89.38 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.15 177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -62.43 -41.43 98.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.988 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.48 98.24 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.195 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 404' ' ' GLU . 96.7 t -64.1 -44.19 97.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.173 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.0 mt-10 -61.38 -40.7 95.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.133 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.56 -44.26 96.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.24 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.66 -44.96 89.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.011 0.434 . . . . 0.0 111.069 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -23.36 66.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.402 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.19 -30.7 71.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -106.3 -7.88 17.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -92.09 158.74 16.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.032 0.444 . . . . 0.0 111.386 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -83.69 100.33 10.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.611 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.61 121.16 60.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.5 t -119.1 136.16 54.29 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.578 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.521 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 68.2 mt-10 -94.32 124.59 38.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -116.52 117.58 30.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.102 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -73.76 117.63 15.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.286 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 3.6 p -131.55 162.36 30.46 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.283 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 77.8 p -86.22 161.06 18.99 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -62.19 -41.38 98.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.082 0.468 . . . . 0.0 109.909 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -59.04 -40.95 86.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.057 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' B' ' 429' ' ' ASN . 15.0 tp10 -63.5 -43.49 97.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.878 0.37 . . . . 0.0 111.116 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.7 -34.88 76.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.882 0.372 . . . . 0.0 110.743 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 14.2 tpt -68.0 -9.45 45.75 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' B' ' 426' ' ' GLU . 93.0 m-20 -73.41 58.52 0.56 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 110.543 178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -96.46 60.91 1.94 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.597 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -86.51 99.47 11.7 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.923 -178.033 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -93.41 145.08 24.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.6 -178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -132.41 159.75 42.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.5 m -144.52 128.34 17.32 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.701 0.286 . . . . 0.0 111.074 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.77 132.77 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 6.7 mm-40 -125.12 166.43 16.43 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.911 0.485 . . . . 0.0 110.096 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.2 m -125.18 130.09 51.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.495 0.188 . . . . 0.0 110.778 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.7 p -88.06 -63.23 1.33 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.22 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -162.42 128.63 3.52 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.811 0.339 . . . . 0.0 111.232 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.33 -113.18 5.6 Favored Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.01 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -94.42 1.29 55.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.825 0.345 . . . . 0.0 110.657 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -82.43 130.01 9.43 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.511 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -122.23 159.51 27.15 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 111.045 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 32.4 ttm180 -123.98 131.62 53.59 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.69 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.24 -93.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.668 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 m 44.13 92.34 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.19 117.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -91.16 103.43 16.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.278 0.561 . . . . 0.0 112.119 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.87 167.6 25.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.886 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -89.7 179.14 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.417 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.34 -36.5 75.82 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -57.81 -50.56 72.88 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.257 0.551 . . . . 0.0 111.072 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -71.37 -33.3 69.42 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.008 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 20' ' ' ALA . 92.5 mt -62.75 -46.42 96.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.309 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -64.11 -47.48 79.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.3 m -62.2 -48.9 77.95 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.59 83.01 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG11 ' HB1' ' A' ' 55' ' ' ALA . 90.5 t -67.64 -42.98 87.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.658 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD3' ' HB3' ' A' ' 52' ' ' ASN . 50.1 mtmt -61.37 -43.98 97.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.985 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.4 m -63.63 -46.31 86.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.064 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -73.05 -41.98 63.58 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -62.19 -43.09 99.62 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.486 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 13.9 p -67.63 -32.1 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.119 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 55.9 t30 -62.8 -44.72 95.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.405 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.88 -41.69 85.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.32 71.88 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.909 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 50.6 mtmt -62.82 -41.83 99.48 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.394 0.616 . . . . 0.0 110.248 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HA ' ' OD1' ' B' ' 397' ' ' ASN . 39.7 ttpt -61.73 -42.74 99.35 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.997 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -86.02 2.39 4.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.045 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 62.94 43.97 6.4 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.018 0.527 . . . . 0.0 111.845 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' HG3' ' B' ' 317' ' ' GLN . 43.5 mm -115.28 -16.18 9.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.104 0.478 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -64.2 -36.29 83.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.778 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.24 -4.03 62.83 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.385 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -103.27 -1.4 28.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 117.171 0.486 . . . . 0.0 111.496 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 50' ' ' PRO . 53.8 ttt85 -73.89 115.62 13.56 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.03 -22.08 36.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 13.07 60.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.494 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -62.02 -43.3 99.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.555 0.677 . . . . 0.0 110.828 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.86 111.43 63.78 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HA ' HH12 ' A' ' 45' ' ' ARG . 72.2 Cg_exo -53.48 141.6 61.6 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.279 2.653 . . . . 0.0 112.314 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.01 -38.15 87.56 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.167 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 14.6 p-10 -63.08 -38.42 91.1 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.464 178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 50' ' ' PRO . 65.2 mt -63.9 -44.51 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.052 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 51' ' ' MET . 19.5 m -66.14 -34.39 69.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.131 0.491 . . . . 0.0 110.361 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.476 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -64.42 -42.78 95.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.066 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 9.8 pt20 -85.36 10.4 12.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -122.93 -40.09 2.45 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.4 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -107.86 5.22 26.25 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.692 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' O ' ' HD3' ' A' ' 63' ' ' ARG . . . -79.6 10.53 37.3 Favored Glycine 0 C--N 1.32 -0.317 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.659 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.33 -51.08 3.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 110.997 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' B' ' 323' ' ' GLY . 20.3 m -62.33 -43.34 99.06 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.05 0.452 . . . . 0.0 111.418 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 p -82.02 -1.91 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.124 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.578 ' HD3' ' O ' ' A' ' 59' ' ' GLY . 4.6 tpt180 -58.12 -43.1 87.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.752 -172.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.78 -43.02 69.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.38 -17.13 59.53 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.297 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 62' ' ' VAL . 54.1 t -62.76 -41.09 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.0 -38.1 84.87 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.88 -40.12 98.87 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.884 175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.42 -43.21 99.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.974 0.416 . . . . 0.0 110.077 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.25 -40.43 96.16 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.692 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 32.2 ttm -58.63 -46.53 86.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.4 m -62.97 -49.45 74.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.926 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' A' ' 73' ' ' ARG . 59.1 mtm180 -68.09 -40.96 82.53 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.93 -40.11 94.53 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.351 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -59.01 -47.13 86.32 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.728 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.44 -39.24 83.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.622 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.97 -44.0 97.24 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.225 0.536 . . . . 0.0 110.805 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.68 97.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.501 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 pt -68.96 -26.36 32.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.098 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.04 -44.46 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -79.08 -29.71 43.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.69 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.12 -6.28 57.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.126 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? 63.36 40.98 8.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.512 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.44 127.61 48.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -122.95 91.61 49.7 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.956 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.59 144.88 45.68 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.374 2.05 . . . . 0.0 112.006 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.0 121.86 34.77 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.675 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.75 -131.51 10.82 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -121.16 127.74 26.04 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-O 120.547 0.213 . . . . 0.0 110.681 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 27.7 Cg_exo -61.36 142.99 97.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.632 2.221 . . . . 0.0 111.327 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.4 m -104.7 120.81 42.22 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-O 120.932 0.396 . . . . 0.0 110.196 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 50.8 m-85 -104.57 116.6 32.36 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.74 102.7 46.33 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 92' ' ' TYR . 7.8 Cg_endo -85.76 141.96 7.71 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.748 2.299 . . . . 0.0 111.332 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.51 -151.49 28.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.916 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -93.85 143.36 26.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.902 0.382 . . . . 0.0 110.501 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -111.49 135.17 52.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.319 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -116.27 138.04 51.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.415 -0.812 . . . . 0.0 108.976 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.9 tp -70.81 113.41 7.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.072 0.463 . . . . 0.0 110.811 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.33 -20.79 29.85 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.812 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -106.83 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 0.0 111.621 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -77.75 166.57 22.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -123.03 137.19 55.01 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.034 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.4 m -116.9 130.27 56.59 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.876 0.37 . . . . 0.0 111.005 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.554 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 53.7 p90 -136.85 151.67 49.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.0 m -130.7 126.82 37.49 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.57 125.51 65.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.1 132.02 35.65 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.111 0.481 . . . . 0.0 111.584 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -147.22 169.21 19.83 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.536 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.11 167.38 11.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.777 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.45 164.16 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -125.91 145.28 51.39 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.689 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -101.24 -174.54 0.11 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.456 2.771 . . . . 0.0 112.725 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -127.2 161.75 27.78 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 349' ' ' LEU . 30.6 t -131.39 158.88 43.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -126.09 136.72 53.25 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -94.03 122.69 36.8 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -141.65 151.76 43.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.34 19.14 79.73 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.286 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.54 -43.24 97.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.968 0.413 . . . . 0.0 112.079 -176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.35 -7.88 59.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.9 0.381 . . . . 0.0 111.192 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.23 -0.78 57.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.1 mt -84.32 125.21 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.52 0.676 . . . . 0.0 110.897 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -109.73 128.97 55.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.958 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.7 t -119.19 128.87 75.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.943 0.401 . . . . 0.0 111.281 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.16 128.85 44.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.708 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.9 tttt -109.54 102.26 49.12 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.005 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.8 119.36 6.03 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.467 2.112 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 50.8 mm -98.17 104.61 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.72 167.48 24.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.753 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -140.2 166.57 24.33 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.746 0.308 . . . . 0.0 110.603 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.8 t -88.74 129.53 39.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -92.6 168.8 10.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 120.866 0.365 . . . . 0.0 111.471 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.05 -33.14 75.07 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.733 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.32 86.75 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.358 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -63.13 -36.48 83.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.775 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 94.9 t -61.39 -46.08 97.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.911 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -61.96 -39.59 92.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.58 -43.56 98.78 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.821 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.2 tpt -67.81 -39.61 83.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.875 0.369 . . . . 0.0 110.602 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.559 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 97.5 mt -61.63 -44.93 96.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.79 -40.61 97.87 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.406 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 94.0 m -61.65 -44.76 96.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.237 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.46 -40.72 97.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 13.3 mmm180 -62.6 -41.05 98.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -64.43 -32.97 74.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -57.98 -42.15 84.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -100.78 140.55 34.91 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.951 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.93 161.34 36.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.481 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.4 m -117.9 131.12 56.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 26.6 p90 -82.36 137.75 34.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.506 0.669 . . . . 0.0 112.612 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -136.63 128.58 29.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.021 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.97 129.22 38.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.775 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 242' ' ' GLU . 55.5 pttt -157.17 179.58 9.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -139.97 135.98 33.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.236 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.05 -110.36 0.44 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.661 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -125.04 169.12 12.45 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 120.882 0.372 . . . . 0.0 111.696 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.44 133.52 43.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.814 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' OD2' ' A' ' 162' ' ' ASP . 64.4 mm-40 -88.3 -73.38 0.49 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.772 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.43 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -176.74 -43.32 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.027 0.441 . . . . 0.0 112.102 -177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 243' ' ' ARG . 7.6 pt-20 -110.69 27.52 9.57 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.449 0.643 . . . . 0.0 111.274 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 159' ' ' GLU . 9.7 m-20 -89.22 177.29 6.65 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.501 -177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.438 HH11 ' CD ' ' A' ' 241' ' ' GLU . 4.7 tmm_? -115.69 122.37 45.33 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.13 161.55 36.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.664 0.269 . . . . 0.0 110.721 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 m -111.7 114.24 27.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.4 HG22 ' HD2' ' A' ' 168' ' ' PHE . 65.7 mt -111.13 123.57 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.386 0.612 . . . . 0.0 110.939 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.83 93.23 4.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.4 ' HD2' HG22 ' A' ' 166' ' ' ILE . 44.1 p90 -124.63 171.24 10.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.7 m -129.8 139.65 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.42 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.22 3.8 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.375 -0.916 . . . . 0.0 113.926 -177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.7 m -111.35 134.03 53.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 231' ' ' ALA . 25.5 t -79.86 -97.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.855 0.36 . . . . 0.0 110.933 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -98.7 -28.02 13.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.061 0.457 . . . . 0.0 110.72 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.26 6.78 0.04 OUTLIER Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.832 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -138.01 145.22 41.6 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -76.41 140.39 41.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -97.04 -178.95 4.37 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.223 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -60.69 -27.45 67.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.098 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -111.61 -172.91 19.41 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.659 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.8 19.73 67.26 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.354 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -97.97 99.29 10.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.85 155.74 18.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.123 0.487 . . . . 0.0 111.767 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -151.39 92.31 1.76 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.11 65.38 1.0 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.397 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -102.84 116.91 33.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.145 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.0 126.56 40.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.082 0.467 . . . . 0.0 110.029 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 53.7 tp -121.81 136.67 54.94 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.607 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -101.91 117.59 35.16 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 88.2 mtp -82.94 148.47 27.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.39 60.09 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.773 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.459 ' HB2' ' HG3' ' A' ' 193' ' ' ARG . 56.4 mt-30 -98.36 -2.79 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.121 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.66 38.16 85.59 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.053 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 191' ' ' GLN . 62.8 mtp180 -85.7 -14.98 43.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 23.2 mmt -111.84 -174.88 2.56 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.619 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.9 mm -59.14 131.71 87.31 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -54.33 122.39 11.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.592 1.528 . . . . 0.0 110.332 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.25 -30.75 9.7 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.256 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -63.25 -47.18 83.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.863 0.331 . . . . 0.0 111.16 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.2 -15.47 59.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.135 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.69 -24.96 28.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.78 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -79.44 -14.67 81.14 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.924 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.8 pt -98.52 1.41 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.082 0.468 . . . . 0.0 111.647 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 62.7 mtpt -71.64 110.39 6.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.541 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 112.14 3.48 26.15 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.121 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -96.86 155.16 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.087 0.443 . . . . 0.0 110.776 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -79.36 158.71 27.38 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.949 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.3 -15.98 61.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.544 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.3 49.87 0.91 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.981 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -133.07 150.18 52.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.906 0.853 . . . . 0.0 111.964 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -116.74 126.35 53.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.34 -64.27 1.32 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 37.4 m 83.44 107.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.741 0.816 . . . . 0.0 110.315 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 235' ' ' ILE . 9.7 tp -130.67 148.08 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.091 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.679 ' OD2' ' HE2' ' A' ' 232' ' ' LYS . 2.3 m-20 -84.33 120.27 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.522 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 72.4 t -116.32 122.16 69.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 25.4 m -108.19 121.97 45.96 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 226' ' ' LEU . 84.2 m-85 -86.56 145.15 38.83 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.644 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.82 149.07 85.58 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.47 2.114 . . . . 0.0 111.783 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 227' ' ' LYS . 21.4 mm-40 -59.54 -38.92 82.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.2 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.9 37.06 1.09 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.55 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -79.51 142.16 36.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -61.18 -26.94 68.05 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.45 117.55 30.29 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.444 ' OE2' ' HG2' ' A' ' 333' ' ' PRO . 43.3 tt0 -60.97 -38.53 86.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -75.67 -6.11 48.85 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.601 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 217' ' ' PHE . 92.0 mt -116.62 -26.5 7.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 219' ' ' GLU . 22.7 ptmt -61.94 124.48 20.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.119 0.485 . . . . 0.0 111.993 -177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.47 9.43 81.78 Favored Glycine 0 C--O 1.237 0.331 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.949 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.92 103.99 10.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.193 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 172' ' ' VAL . . . -101.24 154.54 18.68 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.927 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.679 ' HE2' ' OD2' ' A' ' 214' ' ' ASP . 98.0 mttt -123.09 111.66 16.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.932 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.8 m-85 -97.65 140.4 32.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.887 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 212' ' ' THR . . . -81.82 -22.59 36.97 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 213' ' ' ILE . 2.3 mp 67.75 94.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.508 0.67 . . . . 0.0 109.915 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -102.86 78.41 1.67 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.872 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.19 133.46 35.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.238 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -143.01 -35.66 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.49 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -129.62 120.48 25.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 76.9 t -123.69 127.48 73.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 162' ' ' ASP . 41.1 mt-10 -121.18 140.01 52.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.845 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.426 ' HB2' ' HE2' ' A' ' 154' ' ' LYS . 37.2 tt0 -87.57 150.37 23.74 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.856 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.558 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 2.2 ptp180 -95.81 150.4 20.45 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.9 0.381 . . . . 0.0 110.131 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.87 162.69 34.19 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 61.8 mt -69.7 134.48 88.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.333 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.6 148.21 36.93 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.001 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -73.28 105.44 4.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.352 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.21 31.43 0.33 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.337 0.589 . . . . 0.0 111.354 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 15.7 p -93.15 4.03 54.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.674 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.532 ' HA ' ' HB ' ' A' ' 253' ' ' ILE . . . 71.4 1.14 3.73 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.621 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.24 -53.25 52.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -96.49 -6.94 36.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.573 0.702 . . . . 0.0 109.693 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 250' ' ' ALA . 51.0 mt -94.04 9.94 4.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 122.088 0.947 . . . . 0.0 108.9 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -67.2 -14.64 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.627 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 24.7 tpp180 -69.83 -25.59 63.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 110.714 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.1 -33.94 77.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.692 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.37 -23.41 24.89 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.867 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 28.4 m -131.85 163.98 35.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 122.774 0.43 . . . . 0.0 109.89 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -73.5 147.21 44.26 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.949 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.58 165.64 11.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.38 -126.29 7.44 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.062 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.7 t 56.32 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.23 -44.91 93.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.31 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -42.32 86.42 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.043 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.21 -44.69 52.55 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.094 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.465 ' O ' HG23 ' A' ' 270' ' ' VAL . 53.0 tp -62.32 -44.2 97.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.693 0.282 . . . . 0.0 110.86 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -64.48 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.608 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.91 -39.66 93.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.388 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.546 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 42.5 tp10 -65.81 -37.19 85.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.977 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.8 t -65.98 -43.04 92.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.869 175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -46.67 87.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.807 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' ' 269' ' ' GLU . 17.6 ptmt -65.17 -46.28 81.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.254 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -67.02 -40.41 87.26 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 92.7 mmm -64.21 -42.64 96.53 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.318 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.19 -28.81 64.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.941 0.4 . . . . 0.0 110.245 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 -60.5 -47.17 87.32 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -83.53 -16.75 44.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.241 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.22 -42.16 99.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -60.71 -45.39 94.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.059 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.5 m -60.29 -42.04 94.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.866 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.98 87.25 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.995 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 68.7 mt -63.05 -48.31 88.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 120.934 0.397 . . . . 0.0 110.31 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -63.2 -42.87 99.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.888 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -63.17 -42.15 99.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -64.43 -41.26 96.69 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.147 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.29 -45.14 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.083 0.468 . . . . 0.0 110.108 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.58 -45.77 92.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.093 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 45.7 m -60.56 -41.35 94.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.657 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -63.03 -46.49 87.34 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.758 0.313 . . . . 0.0 111.689 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.12 -45.36 77.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.98 0.419 . . . . 0.0 111.641 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.08 -44.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.692 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -65.7 -36.94 85.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.467 -177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -61.82 -37.64 94.66 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.556 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.87 -51.67 13.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.24 -44.22 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -70.32 -17.89 63.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.824 0.345 . . . . 0.0 111.819 -176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -104.31 -31.46 9.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -131.57 124.31 29.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.621 0.248 . . . . 0.0 111.406 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -111.57 159.59 17.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.86 158.14 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.0 116.9 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 99.3 t -109.54 127.79 26.56 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 139.9 82.54 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.234 1.956 . . . . 0.0 111.072 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.0 79.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.57 75.91 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.05 -39.95 94.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.868 0.366 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.454 ' O ' HG13 ' A' ' 311' ' ' ILE . 60.0 mt -64.26 -44.21 97.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.067 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.02 -41.49 92.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.887 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.2 m -60.17 -42.64 95.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.409 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -64.46 -34.46 78.25 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.316 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 307' ' ' ILE . 90.2 mt -62.39 -42.34 95.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.57 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.636 ' O ' ' HG2' ' A' ' 316' ' ' ARG . 26.5 t70 -61.37 -41.54 97.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.839 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.02 -45.01 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.122 0.487 . . . . 0.0 109.953 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.48 -39.71 95.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.011 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 24.2 mtm180 -63.15 -40.73 98.42 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.722 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.636 ' HG2' ' O ' ' A' ' 312' ' ' ASP . 27.4 mmt180 -62.58 -41.98 99.27 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.45 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.2 OUTLIER -65.07 -43.89 90.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.939 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.89 87.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.651 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.53 91.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.662 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -63.19 -47.82 80.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.649 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -74.63 -22.47 58.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.818 0.342 . . . . 0.0 111.545 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -75.56 -20.2 58.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.968 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' B' ' 62' ' ' VAL . . . 162.28 -43.93 0.36 Allowed Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.622 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 125.05 104.3 1.5 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.749 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -158.86 107.74 1.92 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.859 0.361 . . . . 0.0 110.28 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.92 145.27 30.41 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 78.13 -39.69 0.28 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -75.09 -6.61 50.42 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.376 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -59.67 -25.79 65.02 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.194 0.521 . . . . 0.0 110.088 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.19 -25.5 68.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.039 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.3 0.32 54.15 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 78.7 mt -77.57 141.29 64.95 Favored Pre-proline 0 C--O 1.241 0.644 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.467 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.444 ' HG2' ' OE2' ' A' ' 224' ' ' GLU . 51.9 Cg_exo -55.81 129.74 36.64 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.072 2.514 . . . . 0.0 114.078 -177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.525 ' HD3' ' OE2' ' A' ' 338' ' ' GLU . 38.4 ttm-85 -62.96 -44.63 95.54 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.9 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 1.9 pm0 -59.5 -31.39 69.32 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 333' ' ' PRO . 10.6 mp -65.73 -33.82 76.76 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.0 -24.01 11.41 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.525 ' OE2' ' HD3' ' A' ' 334' ' ' ARG . 40.9 tt0 -63.42 -27.74 69.5 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.014 0.435 . . . . 0.0 110.828 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -54.47 29.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.59 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.6 pt20 -70.93 -30.25 66.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.249 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.53 -35.66 81.2 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.922 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.06 -42.33 90.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.691 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 347' ' ' VAL . 10.8 mmt180 -62.8 -42.32 99.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.589 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 18.0 mtp180 -62.42 -45.36 93.43 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.771 0.319 . . . . 0.0 111.017 -175.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.586 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 61.4 t -64.9 -45.83 93.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.221 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.6 -44.58 99.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.894 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 343' ' ' ARG . 69.9 t -61.7 -44.65 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.838 0.352 . . . . 0.0 110.199 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.28 -41.83 98.51 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.25 -43.87 93.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' VAL . 98.8 mt -63.93 -48.59 75.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.239 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 355' ' ' ILE . 83.2 mt -67.01 -39.77 87.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.049 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.42 -39.65 97.57 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.119 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.79 -33.83 75.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.796 0.332 . . . . 0.0 110.554 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 350' ' ' LEU . 85.4 t -60.86 -42.54 92.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 351' ' ' LEU . 66.8 mt -59.06 -46.32 91.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.414 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -70.39 -48.39 56.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 96.1 m -65.19 -43.66 90.92 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.33 3.84 52.5 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 122.365 -0.209 . . . . 0.0 111.448 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.12 56.61 7.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.049 0.54 . . . . 0.0 111.84 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.74 142.01 35.81 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.039 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 150.86 49.39 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.275 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -69.63 123.19 20.7 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.014 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 367' ' ' VAL . 19.5 t70 -93.16 114.11 26.52 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.914 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -63.49 -38.08 89.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.829 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -64.9 -42.19 94.98 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.276 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -61.45 -44.0 97.87 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.226 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 371' ' ' ILE . 79.5 t -64.25 -44.69 97.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.332 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -60.17 -44.88 94.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.785 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.41 99.68 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.572 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 69.8 mt -65.05 -38.94 92.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.766 0.317 . . . . 0.0 111.082 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 367' ' ' VAL . 64.1 mt -62.65 -42.75 97.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.278 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -58.39 -44.25 88.86 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.448 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -64.69 -43.02 94.85 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.008 0.433 . . . . 0.0 110.503 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 51.6 ttp -65.31 -44.43 87.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.803 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -69.71 -20.97 63.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.1 t -72.95 -5.26 37.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.456 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -89.3 0.24 56.95 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.702 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -113.43 166.8 11.14 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.32 -47.33 86.48 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.811 0.338 . . . . 0.0 110.628 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -124.55 109.07 28.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.598 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.06 -18.29 21.39 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.282 1.988 . . . . 0.0 112.95 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -63.94 -49.11 73.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.29 -31.61 65.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.19 -45.18 97.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.876 0.37 . . . . 0.0 110.922 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 85.2 mt -63.64 -42.87 97.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 CA-C-O 120.932 0.396 . . . . 0.0 110.242 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.54 -36.98 85.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.51 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.53 -46.38 90.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.81 0.338 . . . . 0.0 110.802 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.17 -28.76 70.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.096 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.3 m -86.24 -11.05 53.42 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -82.25 -44.41 16.35 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.297 0.57 . . . . 0.0 110.409 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 393' ' ' GLU . 19.3 t-20 -95.49 109.55 21.74 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.824 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -64.05 -32.41 73.96 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.378 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.529 ' HB3' ' OD1' ' A' ' 391' ' ' ASN . 50.0 tp10 -60.83 -45.14 95.64 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.909 0.385 . . . . 0.0 110.378 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.6 -37.79 88.65 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.734 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.584 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 89.9 mtp -60.67 -43.31 97.81 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.073 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -63.67 -50.32 69.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.386 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' B' ' 38' ' ' LYS . 8.4 t-20 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 17.2 tpt -61.22 -35.54 77.49 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.131 0.491 . . . . 0.0 110.428 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 395' ' ' MET . 94.4 mtt-85 -62.44 -35.44 79.27 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.651 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -63.91 -29.25 70.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.084 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 63.5 t -69.11 -51.88 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.984 0.421 . . . . 0.0 110.544 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.88 86.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.548 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.5 -39.41 94.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.995 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 408' ' ' VAL . 36.0 tt0 -59.34 -41.82 90.06 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.79 0.328 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -63.74 -39.36 94.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.816 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -63.16 -40.07 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.423 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -63.23 -39.93 96.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.504 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 404' ' ' GLU . 93.8 t -63.69 -44.19 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.498 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.44 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.703 0.287 . . . . 0.0 111.033 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 407' ' ' ALA . 86.5 t -67.52 -44.7 86.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.868 0.366 . . . . 0.0 110.572 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 93.2 mt -61.93 -37.83 86.16 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.592 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.18 73.93 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.075 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -104.32 -11.35 17.21 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -84.74 169.48 14.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.839 0.352 . . . . 0.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -95.49 108.0 20.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.33 -0.395 . . . . 0.0 109.985 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.53 127.77 61.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -116.58 124.87 50.89 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.912 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.571 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 56.5 mt-10 -88.85 137.75 32.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.065 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -138.98 122.71 17.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.199 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.409 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 54.2 mt-10 -78.78 120.7 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.17 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 1.4 p -140.7 161.87 36.74 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.215 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 28.4 p -83.22 161.58 21.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.191 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -65.49 -35.29 80.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -59.78 -41.69 91.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.843 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -66.38 -39.48 89.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 42.1 tp -65.4 -32.99 74.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.097 0.475 . . . . 0.0 110.773 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 27.7 ttt -66.25 -14.66 62.29 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.401 ' HA ' HE22 ' A' ' 431' ' ' GLN . 91.2 m-20 -78.73 84.13 4.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.37 0.605 . . . . 0.0 110.917 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -136.22 40.39 2.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 429' ' ' ASN . 22.3 mp0 -76.96 -12.65 59.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.922 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.805 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.195 -179.016 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 120.57 0.224 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -101.47 146.31 27.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.971 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.58 160.72 42.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.086 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 30.7 m -146.25 129.99 17.1 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.658 0.266 . . . . 0.0 110.682 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.32 127.71 7.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.184 0.516 . . . . 0.0 110.508 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 11.8 mm-40 -116.61 168.42 10.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.104 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 46.4 m -126.78 131.87 51.18 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 7.1 p -88.28 -60.72 1.89 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.724 0.297 . . . . 0.0 111.783 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -168.25 133.14 1.73 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.79 -116.43 8.97 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.794 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 8.7 mp -95.18 2.1 54.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.772 0.32 . . . . 0.0 111.142 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -80.01 130.15 9.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.97 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -120.87 159.2 26.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.9 ttm180 -124.54 129.38 50.48 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.743 0.817 . . . . 0.0 108.814 177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.6 t -93.0 -95.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.878 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m 43.64 91.54 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.4 119.01 42.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -89.69 106.03 18.19 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 112.098 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 12.1 pt -138.56 170.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -94.56 -178.13 4.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.989 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.52 -37.31 78.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.223 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -57.35 -52.14 66.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.364 0.602 . . . . 0.0 110.994 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -69.74 -34.56 74.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 20' ' ' ALA . 89.8 mt -62.71 -46.09 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.748 -0.205 . . . . 0.0 111.516 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.35 -46.53 79.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.297 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -62.13 -48.93 77.91 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.277 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.14 75.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' B' ' 55' ' ' ALA . 57.8 t -66.86 -42.97 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.741 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.636 ' HD3' ' HB3' ' B' ' 52' ' ' ASN . 48.7 mtmt -60.56 -43.99 96.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.828 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 41.0 m -64.2 -45.89 86.31 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.92 -41.28 64.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 69.1 mt -62.58 -42.95 99.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.988 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 9.4 p -68.52 -29.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.116 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.544 ' HA ' ' HE2' ' B' ' 37' ' ' LYS . 50.6 t30 -65.01 -48.06 75.28 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.59 -40.12 83.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.643 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.82 -35.84 64.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.538 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' B' ' 34' ' ' ASN . 50.7 mtmt -62.9 -42.18 99.69 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.364 0.602 . . . . 0.0 110.303 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' A' ' 397' ' ' ASN . 38.6 ttpt -63.02 -41.33 99.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.988 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -87.67 1.89 5.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.53 47.61 8.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.046 0.538 . . . . 0.0 112.063 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' HG3' ' A' ' 317' ' ' GLN . 42.3 mm -115.88 -18.23 7.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.055 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.08 -34.68 79.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.19 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.75 -4.0 65.02 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.278 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -103.58 -0.78 29.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 0.0 110.781 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.635 HH12 ' HA ' ' B' ' 50' ' ' PRO . 52.8 ttt85 -74.73 106.08 6.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.313 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.0 -37.3 81.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 173.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.77 14.13 23.98 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.614 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.46 -43.73 96.52 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.037 0.419 . . . . 0.0 111.66 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.96 109.09 61.99 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.635 ' HA ' HH12 ' B' ' 45' ' ' ARG . 51.1 Cg_exo -54.76 142.76 72.92 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.872 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.41 ' O ' HG22 ' B' ' 54' ' ' VAL . 4.9 tpt -61.81 -37.16 83.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.07 -173.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD3' ' B' ' 29' ' ' LYS . 23.2 p-10 -62.57 -39.33 93.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.503 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' B' ' 50' ' ' PRO . 66.0 mt -63.96 -44.31 97.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.96 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 51' ' ' MET . 24.8 m -66.62 -36.04 76.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 120.464 -0.495 . . . . 0.0 110.646 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' B' ' 28' ' ' VAL . . . -62.83 -39.48 94.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.144 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 10.9 pt20 -88.58 13.25 12.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -127.37 -47.21 1.45 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.744 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -98.8 3.31 47.42 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 120.983 0.42 . . . . 0.0 110.883 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.629 ' O ' ' HD3' ' B' ' 63' ' ' ARG . . . -77.23 8.39 32.3 Favored Glycine 0 C--O 1.222 -0.64 0 C-N-CA 121.123 -0.56 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.43 -49.49 4.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.886 0.343 . . . . 0.0 110.943 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 323' ' ' GLY . 16.5 m -61.59 -39.22 90.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.247 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.639 ' O ' HG23 ' B' ' 66' ' ' VAL . 8.8 p -85.89 -1.34 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.187 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.629 ' HD3' ' O ' ' B' ' 59' ' ' GLY . 6.2 tpt180 -56.34 -44.53 80.11 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -71.09 -42.55 69.2 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' B' ' 62' ' ' VAL . 4.5 p-10 -76.58 -17.57 59.13 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 62' ' ' VAL . 53.2 t -63.36 -41.85 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.04 -39.17 91.4 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.525 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.97 -40.3 98.24 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.976 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.81 -41.61 99.37 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.177 0.513 . . . . 0.0 110.207 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.45 -40.6 95.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.517 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 31.7 ttm -59.76 -46.23 89.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.402 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 43.4 m -62.25 -49.45 75.66 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.763 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -68.85 -40.73 79.22 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -65.15 -39.01 92.38 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.672 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.49 -46.96 87.32 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.595 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . 0.426 ' O ' HG13 ' B' ' 80' ' ' ILE . 15.8 tt -66.48 -38.51 81.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.999 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.47 -42.54 99.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.21 0.528 . . . . 0.0 110.564 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 -42.19 90.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.552 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -69.78 -28.8 38.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.065 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.426 HG13 ' O ' ' B' ' 76' ' ' ILE . 95.8 mt -64.88 -44.14 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.842 0.353 . . . . 0.0 111.14 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -79.78 -26.62 40.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.037 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -92.99 0.37 57.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.734 0.302 . . . . 0.0 111.081 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' LYS . 8.1 mmpt? 61.78 39.61 13.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.917 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.0 mt -100.92 125.62 54.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.058 0.456 . . . . 0.0 110.638 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -121.91 95.58 47.55 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.7 153.51 64.57 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.593 2.195 . . . . 0.0 112.697 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.98 119.68 35.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.883 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.0 -130.59 10.3 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.148 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -120.74 126.94 26.49 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-O 120.508 0.194 . . . . 0.0 110.547 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.56 134.28 62.27 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.37 2.047 . . . . 0.0 111.147 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -95.01 116.88 29.26 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.016 0.436 . . . . 0.0 109.842 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' B' ' 94' ' ' PRO . 64.8 m-85 -100.23 120.96 40.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.69 97.47 37.23 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' B' ' 92' ' ' TYR . 5.6 Cg_exo -75.95 143.43 26.16 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.784 2.323 . . . . 0.0 110.545 175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -97.26 -146.96 21.85 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.077 -1.059 . . . . 0.0 111.244 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -100.53 144.83 29.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.746 0.308 . . . . 0.0 110.38 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -113.84 141.26 47.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.3 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -123.23 142.0 51.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.096 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 47.5 tp -74.58 103.52 4.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.037 0.446 . . . . 0.0 110.65 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.21 -25.92 7.25 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.461 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -103.35 -172.8 2.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 111.585 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -81.28 171.64 14.58 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.67 0.748 . . . . 0.0 112.016 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -124.09 135.14 53.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.417 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 30.0 m -115.95 127.75 55.21 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.798 0.332 . . . . 0.0 110.822 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.611 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 48.6 p90 -136.02 154.91 50.91 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 63.0 m -133.88 128.59 34.93 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.26 120.39 61.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.86 136.02 36.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.959 0.409 . . . . 0.0 111.481 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -150.84 170.32 19.56 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.845 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -123.49 162.33 23.1 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.407 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.79 168.15 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' B' ' 113' ' ' PRO . 97.1 m-85 -126.93 144.97 52.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.792 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 112' ' ' TYR . 95.1 Cg_endo -100.38 -174.31 0.13 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.412 2.741 . . . . 0.0 112.312 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.49 160.94 29.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.93 157.26 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.704 0.288 . . . . 0.0 110.623 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -124.15 134.48 53.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' B' ' 354' ' ' VAL . 85.4 mt -91.39 117.66 29.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -136.21 152.01 50.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 111.387 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.72 18.28 79.08 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.156 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.86 -43.87 97.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.832 0.349 . . . . 0.0 111.784 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.33 1.86 34.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.91 0.386 . . . . 0.0 111.263 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.97 5.81 47.02 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.053 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 124.99 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.207 0.527 . . . . 0.0 110.843 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -107.9 129.77 55.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.929 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.45 127.87 75.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 120.864 0.364 . . . . 0.0 111.139 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -94.67 129.27 41.62 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 86.0 tttt -110.31 102.62 51.91 Favored Pre-proline 0 N--CA 1.439 -0.978 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.72 118.32 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.384 2.056 . . . . 0.0 111.819 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' B' ' 421' ' ' GLU . 49.3 mm -94.67 105.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.12 172.85 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.02 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.11 167.64 21.91 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.222 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 88.2 t -93.22 124.28 45.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 71.8 p -87.12 168.19 13.49 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.125 0.488 . . . . 0.0 111.281 -177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.61 -33.13 74.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.041 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.69 85.21 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -63.51 -35.1 79.34 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.89 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 95.1 t -61.74 -46.24 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.264 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -62.07 -40.5 96.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.68 -43.19 99.59 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.654 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.43 -39.26 85.45 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.024 0.44 . . . . 0.0 110.601 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 97.3 mt -61.88 -43.31 99.1 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.166 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -62.23 -40.6 96.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.933 0.396 . . . . 0.0 111.248 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 96.5 m -61.14 -45.79 93.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.145 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.7 -40.25 96.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.705 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 11.4 mmm180 -63.69 -37.11 86.13 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.266 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -72.93 -21.61 60.85 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -63.8 -43.78 95.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -99.22 139.92 34.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.087 0.47 . . . . 0.0 111.744 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.61 36.04 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.648 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 243' ' ' ARG . 56.3 m -114.42 130.53 56.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.785 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -82.76 137.13 34.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.174 0.512 . . . . 0.0 112.132 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -137.1 133.75 35.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.891 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.39 128.45 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.445 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 58.3 pttt -155.9 178.82 9.84 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -142.37 131.29 22.99 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 163.37 -109.68 0.39 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.06 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.55 172.13 8.99 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.911 0.386 . . . . 0.0 111.138 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.0 133.11 42.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.15 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . 0.567 ' HB2' ' OD1' ' B' ' 162' ' ' ASP . 69.2 mm-40 -86.74 -77.77 0.31 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.41 ' CB ' ' HE3' ' B' ' 203' ' ' LYS . . . 178.92 -26.1 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.575 ' OE2' ' HD2' ' B' ' 243' ' ' ARG . 7.8 pt-20 -124.61 23.22 8.13 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.756 0.788 . . . . 0.0 110.63 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.611 ' HB3' ' O ' ' B' ' 241' ' ' GLU . 5.7 m-20 -87.67 178.05 6.87 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.031 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -115.13 121.94 44.57 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' B' ' 240' ' ' VAL . 34.2 m -130.28 161.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.888 -176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 239' ' ' LYS . 28.6 m -109.94 116.89 32.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.81 119.72 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 121.292 0.568 . . . . 0.0 110.656 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -105.13 91.83 3.96 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -122.39 172.7 8.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -171.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 23.0 m -131.13 144.96 51.78 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.589 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -102.45 111.75 4.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.552 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' B' ' 176' ' ' GLU . 19.3 m -115.19 135.75 53.84 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' B' ' 231' ' ' ALA . 21.1 t -83.13 -97.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.888 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -95.87 -36.0 11.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.047 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -161.81 2.76 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.442 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -134.34 151.11 51.05 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' B' ' 171' ' ' SER . 4.2 mp0 -78.08 143.73 37.14 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -97.06 -178.97 4.38 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.264 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -62.54 -26.35 68.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.931 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -110.56 -173.81 20.24 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.526 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.79 76.01 Favored Glycine 0 C--N 1.321 -0.305 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.55 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -93.32 94.72 8.9 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -100.4 160.17 14.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.801 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 11.2 t -158.68 95.08 1.29 Allowed 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.309 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.94 49.62 4.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.129 0.49 . . . . 0.0 110.778 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -90.9 120.01 31.57 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.763 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 25.5 m -86.91 128.85 39.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.964 0.411 . . . . 0.0 110.14 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.35 142.37 50.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.061 0.458 . . . . 0.0 111.674 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.4 118.45 36.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 93.5 mtp -83.86 147.03 27.77 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.74 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 102.34 -16.25 55.42 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.618 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . 0.45 ' HB2' ' HG3' ' B' ' 193' ' ' ARG . 58.3 mt-30 -90.42 -8.76 49.75 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.406 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.08 56.67 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.071 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . 0.45 ' HG3' ' HB2' ' B' ' 191' ' ' GLN . 55.6 mtp180 -80.83 -17.14 51.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.382 . . . . 0.0 110.822 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 22.4 mmt -108.25 -178.38 3.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.516 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 37.9 mm -58.09 131.5 83.75 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.667 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -52.59 119.13 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.756 1.638 . . . . 0.0 110.716 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.99 -30.25 10.56 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.316 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -62.6 -47.89 81.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.774 0.321 . . . . 0.0 111.192 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -79.49 -11.98 59.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.993 0.425 . . . . 0.0 111.21 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' B' ' 203' ' ' LYS . 9.7 m-20 -87.66 -25.05 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.01 0.433 . . . . 0.0 110.706 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.01 -9.54 86.12 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.65 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 16.1 pt -103.19 2.29 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.047 0.451 . . . . 0.0 111.569 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.475 ' CD ' ' HA ' ' B' ' 200' ' ' ASP . 60.6 mtpt -71.13 108.19 4.53 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.848 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 114.87 -1.14 23.02 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.44 -0.885 . . . . 0.0 112.599 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.03 153.41 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.524 -0.398 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.31 157.77 24.97 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.91 -26.72 66.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.252 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.4 53.61 0.74 Allowed Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.699 -177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -133.93 150.24 51.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.337 0.589 . . . . 0.0 111.297 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -116.68 138.38 51.49 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' B' ' 212' ' ' THR . 47.1 t80 -127.19 -65.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 119.224 -0.99 . . . . 0.0 113.628 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 35.0 m 84.26 111.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.571 0.749 . . . . 0.0 110.354 -173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.488 HG22 HD11 ' B' ' 235' ' ' ILE . 9.8 tp -129.92 147.3 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.328 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.722 ' OD2' ' HE2' ' B' ' 232' ' ' LYS . 4.6 m-20 -84.51 116.13 22.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.528 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.6 122.45 68.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 40.8 m -107.53 125.23 51.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' B' ' 226' ' ' LEU . 91.1 m-85 -88.43 144.89 34.5 Favored Pre-proline 0 C--N 1.313 -0.984 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.341 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.94 148.52 88.43 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.473 2.115 . . . . 0.0 111.989 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . 0.538 ' O ' ' HE3' ' B' ' 227' ' ' LYS . 60.4 mm-40 -58.76 -36.59 74.61 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.192 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -97.32 35.32 1.63 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.367 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -78.35 141.01 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.282 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -59.36 -30.29 68.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.51 116.16 28.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.464 ' HA ' ' HG2' ' B' ' 227' ' ' LYS . 45.5 tt0 -62.54 -35.59 79.91 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.15 -5.06 47.63 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.365 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' B' ' 217' ' ' PHE . 92.7 mt -116.21 -28.9 6.41 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.622 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' B' ' 219' ' ' GLU . 21.7 ptmt -61.71 125.49 24.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.135 0.493 . . . . 0.0 111.883 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.72 81.45 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.433 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -106.38 151.4 24.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.326 0.584 . . . . 0.0 111.353 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -117.88 104.54 11.02 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.832 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 172' ' ' VAL . . . -106.18 148.79 27.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.163 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.722 ' HE2' ' OD2' ' B' ' 214' ' ' ASP . 96.9 mttt -117.65 112.57 20.69 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.013 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 212' ' ' THR . 89.1 m-85 -97.45 134.74 40.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.871 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 212' ' ' THR . . . -78.91 -14.56 59.16 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -175.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.488 HD11 HG22 ' B' ' 213' ' ' ILE . 3.3 mp 63.65 95.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.348 0.594 . . . . 0.0 110.225 -175.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -102.33 76.97 1.61 Allowed 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 98.1 mt -90.65 137.17 32.57 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.293 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -148.78 -32.67 0.23 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.95 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 165' ' ' THR . 75.7 mmtt -132.03 121.28 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.578 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 164' ' ' VAL . 91.5 t -123.9 129.94 74.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.36 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.611 ' O ' ' HB3' ' B' ' 162' ' ' ASP . 63.1 mt-10 -122.61 149.02 44.55 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' B' ' 154' ' ' LYS . 39.7 tt0 -97.82 148.56 23.27 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.513 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.575 ' HD2' ' OE2' ' B' ' 161' ' ' GLU . 1.7 ptp180 -93.72 152.23 19.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.99 164.5 29.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.9 129.68 84.48 Favored Pre-proline 0 C--N 1.321 -0.661 0 O-C-N 123.096 0.247 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.59 153.67 64.95 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.707 2.271 . . . . 0.0 112.428 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.01 110.1 9.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -84.66 30.47 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 110.786 -174.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 12.5 p -91.03 4.02 53.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.562 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . 0.56 ' HA ' ' HB ' ' B' ' 253' ' ' ILE . . . 67.32 7.69 5.7 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.4 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.55 -58.96 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.329 . . . . 0.0 110.927 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -85.34 -17.77 35.81 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.54 0.686 . . . . 0.0 110.109 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' B' ' 250' ' ' ALA . 52.0 mt -87.51 11.52 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.951 0.881 . . . . 0.0 109.997 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -68.43 -16.33 63.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.309 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -69.09 -23.2 63.98 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.65 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.38 -35.27 80.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.355 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 93.87 -25.9 19.29 Favored Glycine 0 CA--C 1.507 -0.46 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 31.4 m -129.25 164.27 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -72.09 143.95 48.86 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.078 0.466 . . . . 0.0 110.928 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -109.64 152.92 24.94 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.07 -126.93 8.93 Favored Glycine 0 N--CA 1.432 -1.617 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.136 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 33.4 t 56.85 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.27 -44.74 92.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.834 -173.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.756 0.312 . . . . 0.0 111.124 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -69.37 -42.33 74.61 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.095 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.402 ' O ' HG23 ' B' ' 270' ' ' VAL . 55.3 tp -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 122.615 0.366 . . . . 0.0 111.113 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -64.87 -37.76 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.456 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.71 94.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.153 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.574 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 36.1 tp10 -66.77 -38.68 87.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.235 0.541 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 266' ' ' LEU . 83.0 t -66.18 -43.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.27 -45.96 89.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.738 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' B' ' 269' ' ' GLU . 18.3 ptmt -65.19 -45.17 85.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.09 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.81 -41.3 87.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 98.9 mmm -64.35 -43.53 94.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.226 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.59 -26.93 63.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.362 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -61.43 -48.24 82.08 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.845 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -76.45 -24.66 53.9 Favored 'General case' 0 CA--C 1.524 -0.039 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.381 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.65 -42.15 98.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.36 -46.31 90.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.303 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 23.0 m -61.34 -39.88 92.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.03 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.43 -47.17 86.49 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.121 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.25 -48.05 89.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.017 0.437 . . . . 0.0 110.16 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -63.07 -42.88 99.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.27 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -64.59 -41.76 96.04 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.902 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.11 -44.74 99.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.018 0.437 . . . . 0.0 110.038 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.86 -45.62 93.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.736 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 42.4 m -60.62 -41.49 94.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.629 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -62.48 -47.22 84.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.637 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.2 84.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.459 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 33.2 mm -65.12 -44.22 95.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.613 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -65.12 -37.9 88.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.641 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -59.19 -41.94 96.94 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.291 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 89.2 mt -72.16 -49.13 38.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.71 -45.22 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -65.09 -33.83 76.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.501 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -89.71 -44.99 9.64 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -118.21 128.55 54.81 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -124.27 154.19 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 11.0 tp -135.76 162.05 37.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.469 -176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -76.19 120.18 21.12 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.42 127.2 27.1 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.23 136.71 61.63 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.087 1.858 . . . . 0.0 111.072 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.11 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.0 80.51 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 120.999 0.428 . . . . 0.0 111.15 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.42 -42.16 96.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.987 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.6 -43.47 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.236 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.34 -41.38 89.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.27 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 49.1 m -60.73 -41.63 95.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.135 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.17 -34.09 77.28 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.924 0.392 . . . . 0.0 111.32 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' B' ' 315' ' ' ARG . 95.2 mt -62.25 -42.45 95.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' B' ' 316' ' ' ARG . 16.2 t70 -60.48 -43.14 97.27 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.926 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 92.8 t -60.58 -44.71 97.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-O 121.17 0.509 . . . . 0.0 109.735 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -39.71 95.16 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.845 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 311' ' ' ILE . 23.7 mtm180 -63.14 -40.85 98.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.567 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' B' ' 312' ' ' ASP . 30.9 mmt180 -62.3 -42.55 99.46 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -66.32 -42.39 88.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.91 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.18 -46.34 87.54 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.783 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.46 91.07 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.794 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -62.77 -47.88 81.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.651 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -76.09 -20.05 58.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.587 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -76.23 -20.77 57.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.009 0.433 . . . . 0.0 110.443 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 61' ' ' SER . . . 159.01 -36.77 0.5 Allowed Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.392 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . . . . . . . . . . . 119.92 117.24 2.61 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.675 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -171.53 103.7 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.756 0.312 . . . . 0.0 110.175 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.8 145.21 31.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.553 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 1.5 ttmp? 78.97 -41.04 0.26 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.346 1.058 . . . . 0.0 113.161 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -73.94 -6.55 48.0 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.226 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.84 -25.38 66.58 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.331 0.586 . . . . 0.0 110.159 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.79 -26.53 68.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.986 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.78 4.13 45.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.402 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 71.7 mt -79.67 143.14 58.19 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.567 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 53.2 Cg_exo -55.92 130.45 40.38 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.19 2.593 . . . . 0.0 114.219 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' B' ' 338' ' ' GLU . 48.2 ttm-85 -62.13 -44.39 96.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.053 177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 335' ' ' GLU . 1.8 pm0 -60.88 -33.13 72.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.89 -31.41 72.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -111.54 -24.39 10.15 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' B' ' 334' ' ' ARG . 40.8 tt0 -62.74 -28.71 70.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.059 0.457 . . . . 0.0 110.821 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -55.51 23.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.805 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' B' ' 344' ' ' ARG . 10.8 pt20 -71.3 -28.83 64.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.57 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.31 82.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.707 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.01 -41.75 92.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.503 ' O ' HG23 ' B' ' 347' ' ' VAL . 12.7 mmt180 -62.59 -42.85 99.82 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.382 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' B' ' 340' ' ' GLN . 11.2 mtp180 -62.53 -45.25 93.82 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 59.2 t -65.67 -45.78 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.101 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.985 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.503 HG23 ' O ' ' B' ' 343' ' ' ARG . 75.5 t -61.58 -44.86 99.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.02 -41.15 99.34 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.728 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 84.8 mt -63.89 -44.45 92.97 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.82 0.343 . . . . 0.0 110.521 178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' HG23 ' B' ' 354' ' ' VAL . 96.9 mt -64.42 -49.86 69.85 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.422 ' O ' HG13 ' B' ' 355' ' ' ILE . 67.5 mt -66.65 -39.37 88.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.281 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -60.53 -40.47 97.82 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.64 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -67.56 -33.47 75.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.742 0.306 . . . . 0.0 110.524 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 350' ' ' LEU . 73.9 t -60.07 -43.24 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 351' ' ' LEU . 72.4 mt -60.1 -46.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.438 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -68.71 -46.29 69.37 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 19.6 m -65.61 -45.85 81.55 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -91.93 2.91 56.23 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.386 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 50.87 55.68 9.17 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.08 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 86.9 mt -75.49 136.42 40.64 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.57 149.48 43.07 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.666 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.08 118.81 11.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.868 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.05 111.74 23.47 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.488 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' B' ' 368' ' ' LYS . 30.1 mm-40 -62.06 -38.48 88.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.03 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.08 -42.96 96.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.302 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . 0.429 HH21 ' HD2' ' B' ' 366' ' ' ARG . 7.1 tpp180 -62.46 -43.0 99.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.348 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 -43.66 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' B' ' 364' ' ' GLU . 71.5 mmtt -60.43 -44.78 95.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.229 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -63.13 -42.13 99.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.684 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.14 -38.37 90.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.988 0.423 . . . . 0.0 110.719 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.89 -42.55 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.927 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.63 -45.43 81.56 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.594 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.64 -46.61 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.091 0.472 . . . . 0.0 110.208 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 50.3 ttp -63.61 -44.76 93.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.849 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.11 -23.31 63.02 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 25.1 t -71.36 -7.97 50.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.793 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.19 2.2 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -112.9 164.61 13.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.617 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.34 -49.11 75.31 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.77 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -127.32 105.76 21.67 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.515 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.99 -19.25 30.5 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.723 2.282 . . . . 0.0 113.03 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.05 -48.41 76.37 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.24 -33.79 72.06 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.038 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 94.4 t -62.78 -46.62 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.97 -43.19 97.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.57 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.24 -36.52 83.22 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.647 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.12 -45.75 91.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.058 0.456 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -63.66 -24.83 67.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.235 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 14.5 m -90.81 -7.37 52.55 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.954 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -87.85 -41.78 12.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.176 0.513 . . . . 0.0 110.209 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' B' ' 393' ' ' GLU . 21.6 t-20 -97.03 109.03 21.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.655 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -65.44 -32.35 73.93 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.133 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.551 ' HB3' ' OD1' ' B' ' 391' ' ' ASN . 44.4 tp10 -58.22 -45.7 87.19 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.064 0.459 . . . . 0.0 110.238 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.69 -37.72 88.41 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.296 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.639 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 91.9 mtp -58.81 -45.29 90.29 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.384 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.42 -49.03 73.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.172 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 38' ' ' LYS . 12.6 t-20 -65.13 -40.16 94.05 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 -177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 16.8 tpt -61.85 -36.25 80.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.176 0.513 . . . . 0.0 110.483 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.639 ' HG3' ' O ' ' B' ' 395' ' ' MET . 95.7 mtt-85 -60.97 -33.46 73.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.639 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.9 -26.1 68.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.443 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.87 -52.33 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.492 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.72 -39.76 91.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.639 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.35 -37.52 87.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.341 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.456 ' O ' HG23 ' B' ' 408' ' ' VAL . 39.4 tt0 -60.74 -41.34 95.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 409' ' ' GLU . 10.8 mm-40 -62.46 -40.13 95.63 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.748 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -62.59 -41.56 99.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.579 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . 0.452 ' O ' HG23 ' B' ' 411' ' ' VAL . . . -63.11 -40.21 96.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 404' ' ' GLU . 85.8 t -65.57 -43.49 94.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.767 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 405' ' ' GLU . 76.9 mt-10 -60.1 -41.72 93.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.87 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.49 -41.23 98.57 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.051 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 407' ' ' ALA . 94.2 t -66.26 -44.63 91.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.497 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.19 -38.44 89.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.44 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.36 -28.75 68.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.368 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -115.42 7.37 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -108.3 161.96 14.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.645 0.259 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -85.97 106.19 16.96 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.947 0.403 . . . . 0.0 110.698 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.44 130.21 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.471 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -118.26 129.64 55.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 31.1 mt-10 -95.56 124.85 39.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -125.98 125.05 42.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.163 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.408 ' HA ' ' HB ' ' B' ' 129' ' ' ILE . 46.7 mt-10 -79.99 120.08 23.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.345 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 1.9 p -139.82 163.4 32.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.28 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 81.0 p -84.98 164.84 18.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -68.09 -32.58 73.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.508 0.67 . . . . 0.0 109.234 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -61.25 -42.18 98.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.736 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -65.52 -40.49 93.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.459 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.09 -34.29 77.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.769 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.81 -14.27 61.09 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.611 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -78.6 68.25 4.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.076 0.465 . . . . 0.0 111.608 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -121.85 48.08 1.77 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.55 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.348 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.334 -179.684 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 120.749 0.309 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -97.56 141.46 30.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.165 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.69 156.64 42.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -147.42 126.11 12.58 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.81 0.338 . . . . 0.0 110.796 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 p -126.44 122.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 7.7 mm-40 -103.39 159.56 15.46 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.436 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.2 m -125.38 129.82 50.67 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.255 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.8 p -83.74 -58.43 2.8 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.571 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -171.48 131.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.327 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.14 -116.2 8.61 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.424 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.07 2.27 56.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.0 0.429 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 105' ' ' TYR . . . -74.25 127.03 9.72 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.256 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -121.08 158.31 28.15 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 33.3 ttm180 -133.25 132.78 41.85 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -93.12 -104.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m 46.15 88.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.22 112.32 29.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 p -89.66 106.39 18.43 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.304 0.573 . . . . 0.0 112.029 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.1 pt -133.57 171.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.819 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.82 152.96 44.73 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.052 0.453 . . . . 0.0 112.12 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.05 72.6 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.427 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -57.33 -49.68 75.34 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.882 0.372 . . . . 0.0 110.764 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -68.38 -40.63 81.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.895 0.379 . . . . 0.0 111.048 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 28' ' ' VAL . 72.7 mt -59.31 -53.35 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.375 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.751 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 15.3 tp10 -61.68 -39.65 92.19 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.932 0.396 . . . . 0.0 110.736 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 99.9 m -61.32 -44.1 97.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.754 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.18 -39.02 86.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.888 0.375 . . . . 0.0 111.32 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 24' ' ' ILE . 98.4 t -63.37 -39.77 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.751 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 75.1 mttt -53.53 -47.37 70.03 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -69.55 -40.98 76.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.778 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.9 tp10 -66.21 -45.2 81.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.557 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.3 mt -62.97 -42.59 99.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 11.4 p -66.71 -35.05 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.362 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -64.76 -42.23 95.28 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.075 0.464 . . . . 0.0 110.696 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 31' ' ' GLU . 97.4 t -64.84 -42.38 94.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.939 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -36.63 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 99.0 mttt -65.74 -37.07 85.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.972 0.415 . . . . 0.0 110.996 177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.18 -46.34 89.39 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.987 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -87.14 -8.39 11.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.769 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.2 mmt180 65.28 62.96 0.67 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.498 0.719 . . . . 0.0 112.781 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' B' ' 317' ' ' GLN . 26.9 mm -124.56 -14.79 4.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.743 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -64.35 -34.44 78.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.886 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.76 -5.25 73.77 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 116.024 -0.534 . . . . 0.0 113.507 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.89 7.58 39.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.552 0.692 . . . . 0.0 110.039 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 48.4 ttt85 -104.37 98.11 7.95 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.561 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -75.35 -37.89 60.4 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.627 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.37 146.92 7.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.274 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.2 tttp 175.8 -56.92 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -101.14 111.03 62.89 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' A' ' 53' ' ' ILE . 48.2 Cg_exo -58.66 149.49 76.21 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.893 2.396 . . . . 0.0 111.359 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.558 ' O ' HG22 ' A' ' 54' ' ' VAL . 6.5 tpt -62.24 -40.09 95.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 3.4 p-10 -67.89 -24.91 65.27 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.699 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' A' ' 50' ' ' PRO . 56.2 mt -82.69 -9.98 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.207 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 51' ' ' MET . 19.8 m -96.2 -30.7 3.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.199 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.941 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 12.1 pt20 -73.12 -4.52 33.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 53' ' ' ILE . 28.8 mmt180 -86.12 -74.34 0.42 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.533 0.682 . . . . 0.0 110.686 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -104.67 8.8 35.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.419 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.07 -34.91 81.53 Favored Glycine 0 C--N 1.321 -0.26 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.781 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.42 -42.23 96.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.66 0.267 . . . . 0.0 111.682 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.6 m -62.4 -40.96 98.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.095 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 66' ' ' VAL . 10.7 p -96.54 7.66 7.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.309 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' A' ' 24' ' ' ILE . 5.4 tpt180 -58.25 -43.62 87.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.9 -47.55 82.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.111 0.482 . . . . 0.0 110.605 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.15 -33.19 75.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.771 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 62' ' ' VAL . 90.8 t -60.88 -42.72 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.51 -40.09 93.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.289 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -63.51 -38.67 96.68 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.016 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.31 -40.56 97.69 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.235 0.541 . . . . 0.0 109.901 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.64 -39.91 93.01 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.495 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 68' ' ' GLY . 34.6 ttm -59.05 -45.64 90.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.8 m -61.62 -49.02 78.27 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -70.66 -41.0 72.66 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -65.73 -39.91 91.63 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -60.92 -47.11 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.649 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.2 tt -66.98 -38.18 80.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 110.912 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.08 -40.33 94.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.19 0.519 . . . . 0.0 110.883 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -47.48 83.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.18 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.7 pt -65.96 -32.5 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.735 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.62 -43.66 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 120.63 0.252 . . . . 0.0 111.475 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.3 -26.48 47.01 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.621 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -87.53 -6.2 58.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.766 0.317 . . . . 0.0 110.68 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.67 38.73 6.87 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.463 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.7 mt -103.58 129.82 54.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.303 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -118.45 96.98 50.49 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.73 149.57 67.25 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.78 2.32 . . . . 0.0 111.87 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -106.78 125.61 51.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.06 -157.9 32.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -97.4 121.13 59.35 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 122.082 0.153 . . . . 0.0 110.9 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 89' ' ' ALA . 22.5 Cg_exo -63.89 146.14 91.19 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.753 2.302 . . . . 0.0 111.969 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -103.0 124.12 47.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.096 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.91 -34.08 11.37 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.647 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t 54.57 90.87 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.44 124.98 1.72 Allowed 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.583 2.188 . . . . 0.0 112.012 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.78 -167.4 43.66 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.032 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -75.81 140.73 42.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.675 0.274 . . . . 0.0 110.661 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -117.08 124.62 49.7 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.862 0.363 . . . . 0.0 110.579 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.67 126.76 43.17 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.3 tp -61.81 105.98 0.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.992 0.425 . . . . 0.0 111.709 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.4 -1.75 29.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.211 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.28 -157.59 0.77 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.238 0.519 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -78.81 169.52 18.09 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.573 0.702 . . . . 0.0 112.393 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -133.98 145.17 49.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.871 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.5 m -126.67 130.62 50.77 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.784 0.326 . . . . 0.0 111.51 -177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 54.9 p90 -145.87 157.12 43.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.4 m -141.48 109.29 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.857 0.36 . . . . 0.0 111.282 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.67 121.65 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.334 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -77.65 133.81 38.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.373 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -150.73 164.4 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -113.23 166.37 11.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.16 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.3 p -143.48 156.73 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -123.88 140.47 34.6 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.812 0.445 . . . . 0.0 110.792 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -96.37 -171.64 0.19 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.51 2.807 . . . . 0.0 112.575 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -123.94 161.33 25.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.391 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 349' ' ' LEU . 6.4 t -133.35 161.64 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.633 0.254 . . . . 0.0 110.619 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -113.25 140.66 47.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.06 119.29 33.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -137.99 138.89 39.35 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.85 21.47 76.47 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.516 0.567 . . . . 0.0 114.516 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.4 -41.55 98.75 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.213 0.507 . . . . 0.0 111.706 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.78 -8.57 58.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.62 3.88 51.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.3 mt -87.46 116.12 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.46 122.32 42.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 286' ' ' VAL . 64.1 t -116.14 127.96 73.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 -176.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -96.62 132.34 42.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.493 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 419' ' ' GLU . 83.2 tttt -116.96 105.35 49.55 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.18 128.76 10.79 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.014 1.81 . . . . 0.0 111.563 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.48 112.6 30.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.0 m -132.33 164.01 36.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.92 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -133.69 159.59 40.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.624 0.249 . . . . 0.0 110.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.14 118.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.905 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.7 p -90.16 167.44 12.72 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.855 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.56 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.085 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.79 93.79 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.83 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -63.28 -42.36 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.412 0.625 . . . . 0.0 109.517 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 97.0 t -65.97 -43.52 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.979 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -56.96 -48.88 77.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.004 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.42 -39.57 97.89 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.279 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 tpt -65.77 -36.81 84.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.792 0.329 . . . . 0.0 110.505 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 145' ' ' ARG . 92.8 mt -61.16 -45.37 94.89 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.28 -40.56 97.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.936 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 23.4 m -61.83 -47.26 85.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.03 -40.81 97.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.705 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 141' ' ' LEU . 26.7 mmm180 -65.47 -37.89 88.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.141 -178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -66.27 -16.66 64.21 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' THR . 15.0 mm100 -75.62 -16.1 60.26 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.429 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -125.19 131.58 53.16 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.774 0.321 . . . . 0.0 111.704 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.97 19.38 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.263 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.626 ' OG1' ' HA ' ' A' ' 246' ' ' PRO . 1.5 m -89.68 147.24 23.99 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 44.0 p90 -93.82 137.23 33.28 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -134.95 177.78 7.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -120.36 140.99 50.48 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.564 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.9 pttt -152.91 -177.53 6.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.684 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -139.63 109.73 6.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.97 -130.32 1.87 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.685 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.53 171.8 7.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 111.948 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.21 128.9 42.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.01 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -90.19 -169.91 2.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 110.147 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -92.97 -5.12 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -145.58 29.17 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 242' ' ' GLU . 96.8 m-20 -80.68 173.88 12.17 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.5 0.667 . . . . 0.0 112.426 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -111.86 120.56 42.37 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 240' ' ' VAL . 27.5 m -125.0 155.16 33.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.44 -175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.9 m -115.3 114.14 24.78 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.3 mt -128.98 129.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -95.63 112.73 24.39 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -134.99 156.09 49.64 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.003 0.43 . . . . 0.0 111.344 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.4 m -126.63 133.02 51.1 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.383 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.05 85.98 1.44 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.586 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.4 m -100.78 129.07 46.61 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 t -76.9 -96.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.863 0.363 . . . . 0.0 111.052 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -108.17 15.8 23.85 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.18 0.514 . . . . 0.0 110.034 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.11 -1.62 2.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.95 142.17 50.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -86.42 149.53 24.94 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 120.917 0.389 . . . . 0.0 110.532 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.438 ' HD1' ' H ' ' A' ' 179' ' ' GLY . 33.2 p90 -103.04 -179.28 3.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.017 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.89 -6.56 22.45 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.438 ' H ' ' HD1' ' A' ' 177' ' ' PHE . . . -122.14 -162.3 11.54 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 71.09 39.15 63.31 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.656 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.04 106.67 15.39 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.49 148.93 50.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.919 0.39 . . . . 0.0 111.462 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -145.96 98.6 3.13 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.255 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.53 36.65 22.91 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.574 0.702 . . . . 0.0 110.677 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -77.44 129.31 35.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.012 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.2 m -91.05 126.04 43.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.371 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.7 tp -120.96 141.93 50.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.812 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -106.49 113.86 27.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.926 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.2 mtp -84.42 150.37 25.37 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.193 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 97.05 -15.54 62.35 Favored Glycine 0 CA--C 1.504 -0.636 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.833 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -92.78 -16.91 24.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.854 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.41 ' O ' HG23 ' B' ' 53' ' ' ILE . . . 75.94 67.83 1.64 Allowed Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.99 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -112.87 -21.47 11.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 18.0 mmt -109.81 155.59 21.44 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.554 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.5 mm -35.24 126.19 0.57 Allowed Pre-proline 0 N--CA 1.469 0.52 0 O-C-N 124.57 1.168 . . . . 0.0 110.993 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.04 121.08 4.74 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.762 2.308 . . . . 0.0 112.294 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.77 -28.58 14.8 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.434 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -62.54 -48.79 77.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 117.031 0.415 . . . . 0.0 111.559 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.48 -6.77 59.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 111.418 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -90.85 -34.37 15.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -67.83 -29.89 74.03 Favored Glycine 0 CA--C 1.515 0.08 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.69 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.78 -7.86 10.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -69.25 111.91 5.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.871 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 115.97 -5.16 20.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.586 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -94.82 165.62 12.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.676 0.274 . . . . 0.0 110.721 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -89.33 170.52 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -62.26 -28.38 69.67 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.57 84.92 0.26 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.762 -1.209 . . . . 0.0 113.581 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -153.8 145.03 22.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 235' ' ' ILE . 47.0 mt-10 -107.36 109.68 21.48 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -129.19 123.65 32.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.483 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 233' ' ' PHE . 78.7 m -84.78 125.73 32.82 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.571 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -114.19 137.27 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.157 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -95.86 109.28 21.64 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.613 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.4 130.65 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.5 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 24.6 m -111.18 125.4 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -92.54 152.94 42.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.17 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.63 151.89 80.98 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.614 2.209 . . . . 0.0 112.251 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -61.8 -38.31 87.65 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.253 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.38 30.48 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -69.17 141.22 54.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -60.3 -32.23 71.01 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.94 121.9 30.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.093 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 227' ' ' LYS . 38.9 tt0 -62.2 -38.71 90.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.082 0.468 . . . . 0.0 111.937 -176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -76.51 -6.87 53.69 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.319 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.2 -12.01 8.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 224' ' ' GLU . 20.9 ptmt -75.92 121.84 23.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.494 0.664 . . . . 0.0 111.847 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.28 78.18 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.583 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.79 148.95 33.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.898 0.38 . . . . 0.0 111.491 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.71 110.47 21.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -107.57 146.0 32.47 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.19 0.519 . . . . 0.0 111.583 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -111.22 111.16 22.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.093 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 212' ' ' THR . 87.6 m-85 -90.56 125.11 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.897 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.23 82.75 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.171 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 210' ' ' GLU . 50.5 mm 55.52 92.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 O-C-N 123.634 0.584 . . . . 0.0 112.079 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -86.54 -50.46 6.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.85 174.42 0.2 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.989 0.516 . . . . 0.0 112.151 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt 177.72 -45.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.086 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -126.56 138.86 53.52 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 42.0 t -137.53 98.24 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.739 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -95.6 118.01 31.51 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.555 ' HA ' ' OD1' ' A' ' 162' ' ' ASP . 40.6 tt0 -69.91 138.84 52.76 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.071 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -105.44 137.54 43.09 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.642 174.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.566 ' HG2' ' H ' ' A' ' 245' ' ' LEU . 18.2 tt0 -119.85 -176.3 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.225 -176.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' A' ' 244' ' ' GLU . 71.9 mt -44.76 131.77 5.1 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.264 0.625 . . . . 0.0 111.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.626 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 49.7 Cg_endo -66.78 149.02 83.55 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.542 2.161 . . . . 0.0 111.38 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 99.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.075 0.464 . . . . 0.0 110.489 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.457 HD13 HH12 ' A' ' 145' ' ' ARG . 34.9 tp -84.04 13.43 5.07 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.404 0.621 . . . . 0.0 110.921 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.1 m -76.58 -5.2 46.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 254' ' ' LYS . . . 70.36 2.4 4.01 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.976 0.911 . . . . 0.0 113.077 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.76 -44.06 91.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.999 0.428 . . . . 0.0 111.44 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.21 -50.07 6.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.184 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 20.1 tt -75.32 -4.05 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 250' ' ' ALA . 21.6 ptmt -64.86 -25.26 67.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.152 0.501 . . . . 0.0 111.308 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -90.56 -1.16 57.88 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.892 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.96 -19.26 61.27 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.142 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 149.15 -50.96 0.55 Allowed Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.535 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.33 161.88 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -75.64 103.76 5.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.99 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.33 156.62 38.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.17 -19.86 34.05 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.933 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 6.0 p -74.71 116.29 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.85 -48.85 86.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.782 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 264' ' ' GLU . 0.0 OUTLIER -71.41 -39.01 71.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.567 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.67 95.23 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.453 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 270' ' ' VAL . 64.9 tp -62.28 -43.87 97.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.665 0.269 . . . . 0.0 110.734 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -66.02 -38.66 89.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.602 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -64.67 -40.55 95.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.38 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 272' ' ' LYS . 41.3 tp10 -65.53 -40.38 92.84 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.556 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 266' ' ' LEU . 95.7 t -65.49 -40.8 89.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.093 0.473 . . . . 0.0 109.783 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.54 -47.16 85.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.779 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.8 ptmt -65.78 -41.6 91.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.145 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -64.82 -42.42 94.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.624 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 99.0 mmm -66.02 -44.43 84.71 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.53 -32.42 72.35 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -59.6 -45.78 90.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.43 0.633 . . . . 0.0 110.352 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.14 -21.74 29.11 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.734 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 53.3 tp -64.13 -42.04 96.98 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.12 -44.5 97.24 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.616 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 32.3 m -62.97 -41.16 99.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.73 72.21 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.799 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.3 pt -68.55 -40.34 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.321 . . . . 0.0 111.48 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -61.57 -44.93 96.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.071 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -64.02 -38.49 91.26 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.863 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -59.28 -43.85 92.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.967 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.492 HG13 HG11 ' A' ' 125' ' ' VAL . 76.4 t -66.9 -44.9 88.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.935 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -62.59 -46.09 89.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.078 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 31.4 p -61.86 -40.03 93.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.33 -42.92 99.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.573 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.54 -47.03 80.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.189 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.84 -46.77 93.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -69.8 -35.64 75.0 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.593 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -62.12 -37.84 95.14 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.187 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.23 -50.29 11.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.73 -43.76 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.974 0.416 . . . . 0.0 111.991 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -66.61 -35.28 79.81 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.05 -49.23 7.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -111.2 136.69 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.845 0.355 . . . . 0.0 111.226 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.86 157.56 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.129 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 10.1 tp -139.35 150.56 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.864 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -77.73 116.78 18.53 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 97.4 t -107.11 131.32 21.79 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.858 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 136.3 64.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.168 1.912 . . . . 0.0 110.436 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.14 -31.52 72.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -60.02 -41.82 92.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.937 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.86 -42.53 99.79 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 311' ' ' ILE . 65.2 mt -65.75 -43.6 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.387 0.613 . . . . 0.0 109.97 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.83 -44.92 91.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.737 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 40.7 m -61.71 -41.38 97.53 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.99 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.28 -31.91 73.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 307' ' ' ILE . 69.6 mt -60.75 -35.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.221 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 315' ' ' ARG . 25.0 t70 -60.54 -44.35 96.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.724 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.41 -44.34 99.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.544 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 340' ' ' GLN . 96.1 mt -63.36 -40.36 97.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.546 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 312' ' ' ASP . 37.7 mtm105 -60.88 -44.49 97.0 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.636 0.255 . . . . 0.0 111.056 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -64.06 -37.17 86.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.826 0.345 . . . . 0.0 111.203 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.555 ' HG3' HG13 ' B' ' 41' ' ' ILE . 0.3 OUTLIER -62.59 -46.42 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.85 89.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.774 0.321 . . . . 0.0 111.442 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.41 87.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.522 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 23.4 tm0? -64.87 -40.18 94.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.084 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -85.83 -3.98 59.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -100.39 -28.17 13.08 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.778 0.323 . . . . 0.0 111.148 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.26 -29.05 0.05 OUTLIER Glycine 0 C--O 1.213 -1.187 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.35 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' B' ' 62' ' ' VAL . . . 96.3 67.35 0.96 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.813 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -120.72 100.73 7.28 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 145.2 46.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.203 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.505 ' NZ ' ' HB2' ' A' ' 327' ' ' LYS . 3.0 ttmp? 74.99 -38.94 0.4 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.895 0.878 . . . . 0.0 113.043 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -73.02 -8.63 56.61 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.475 0.655 . . . . 0.0 109.402 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.18 -22.83 63.4 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.345 176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.37 -35.23 76.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.567 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.14 -17.47 64.36 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.566 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 85.4 mt -65.67 145.13 99.06 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 31.5 Cg_exo -59.21 131.28 40.3 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.743 2.295 . . . . 0.0 113.104 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -65.68 -43.42 89.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.681 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 335' ' ' GLU . 2.3 pm0 -62.59 -25.25 67.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -171.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 89.9 mt -64.42 -35.96 82.61 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.999 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -104.64 -4.73 22.15 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.51 -38.49 91.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.064 0.459 . . . . 0.0 110.786 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -70.59 -45.19 65.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.798 -176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.456 ' HG3' HD13 ' A' ' 314' ' ' LEU . 11.6 pt20 -70.91 -29.04 64.98 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.911 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.58 94.77 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.32 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.1 -42.15 97.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.253 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.416 HH21 ' HD2' ' A' ' 343' ' ' ARG . 12.8 mmt180 -61.39 -41.0 96.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.186 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.403 HH11 ' CD1' ' B' ' 41' ' ' ILE . 58.9 mtt180 -60.63 -49.45 77.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 349' ' ' LEU . 60.6 t -63.96 -46.47 93.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.613 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 97.9 t -63.06 -47.49 92.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.094 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 66.4 t -64.13 -44.59 97.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.85 -43.05 99.73 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.17 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 85.0 mt -64.7 -41.28 96.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.407 0.146 . . . . 0.0 111.033 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 354' ' ' VAL . 97.0 mt -62.32 -46.02 90.59 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 120.717 0.294 . . . . 0.0 110.516 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.65 -41.6 98.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.216 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.34 -42.0 99.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.291 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -68.19 -35.89 78.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.72 0.295 . . . . 0.0 110.572 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 350' ' ' LEU . 70.3 t -61.62 -44.15 98.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.998 0.428 . . . . 0.0 109.959 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.89 -43.96 98.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.385 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -71.27 -45.14 63.84 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.9 m -63.35 -43.43 97.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -88.7 7.26 34.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.875 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 42.66 52.32 4.94 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.109 0.964 . . . . 0.0 112.616 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.0 mt -78.15 154.21 31.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.938 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.02 151.62 50.97 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.85 127.55 32.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.486 ' OD2' ' HB2' ' A' ' 365' ' ' GLU . 28.1 t70 -100.2 116.75 32.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.54 -177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -65.38 -34.1 77.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.109 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HB2' ' OD2' ' A' ' 363' ' ' ASP . 38.6 mm-40 -62.56 -45.86 91.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.378 0.609 . . . . 0.0 109.517 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.413 HH21 ' HD2' ' A' ' 366' ' ' ARG . 12.5 tpp85 -62.78 -43.63 98.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.578 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 363' ' ' ASP . 77.3 t -62.83 -47.82 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.321 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -64.42 -42.34 96.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -58.97 -44.22 96.33 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.793 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.7 -38.23 86.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.88 0.371 . . . . 0.0 111.011 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.6 -42.97 98.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.984 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.13 -42.49 94.92 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -66.05 -40.22 90.78 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.365 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 64.0 ttp -66.18 -43.25 87.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.222 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -70.14 -18.5 63.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.781 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 12.8 t -73.84 -5.14 39.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.912 0.387 . . . . 0.0 111.032 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -91.25 5.06 50.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.316 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -119.79 162.81 18.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.357 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.52 -42.91 99.51 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 110.87 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.38 107.81 16.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.55 -19.84 24.21 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.435 2.09 . . . . 0.0 112.976 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -64.18 -48.8 74.54 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.5 -34.65 74.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.079 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.05 -46.89 92.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 90.0 mt -63.6 -43.21 98.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.605 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -63.18 -38.71 92.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.159 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.1 -45.05 96.29 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.867 0.365 . . . . 0.0 110.554 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.39 -28.63 69.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.274 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 10.7 m -87.44 -8.14 56.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.515 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -86.31 -49.73 7.46 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.772 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 395' ' ' MET . 22.9 t-20 -87.37 115.77 25.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.137 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.58 -38.39 84.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.036 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.2 -41.73 94.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.725 0.298 . . . . 0.0 110.954 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.49 -38.58 91.7 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.344 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.695 ' O ' ' HG3' ' A' ' 399' ' ' ARG . 92.9 mtp -59.94 -47.26 86.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.407 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -68.63 -44.37 74.34 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.837 0.351 . . . . 0.0 111.618 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -62.31 -41.71 98.75 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.689 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 14.3 tpt -63.49 -35.99 82.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.551 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 395' ' ' MET . 84.0 mtt-85 -61.9 -38.13 87.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -76.91 -2.51 33.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.266 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 98.0 t -95.73 -50.51 11.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.53 84.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.362 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 35.1 tp -64.02 -36.71 84.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.864 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -58.84 -41.79 87.76 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 409' ' ' GLU . 15.0 mm-40 -55.84 -46.58 78.14 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.22 176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -65.11 -40.15 94.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.296 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.02 98.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.001 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 412' ' ' LEU . 89.3 t -64.01 -43.31 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.918 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 405' ' ' GLU . 88.4 mt-10 -60.33 -39.25 86.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.1 -42.36 99.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 98.9 t -67.11 -43.62 88.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.113 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 408' ' ' VAL . 92.0 mt -62.76 -28.53 70.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.956 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.23 80.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.378 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -105.95 -6.26 18.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.5 160.44 15.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.71 102.56 14.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.952 0.406 . . . . 0.0 110.569 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.45 127.22 65.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.8 t -122.44 135.92 54.78 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.859 0.362 . . . . 0.0 110.259 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 127' ' ' LYS . 57.4 mt-10 -98.01 123.05 41.84 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -116.22 128.06 55.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -73.79 120.71 19.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 18.5 p -136.24 150.8 49.12 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.23 0.538 . . . . 0.0 112.447 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 21.4 m -83.15 147.88 27.81 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.66 -37.86 71.39 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.752 0.311 . . . . 0.0 111.389 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -57.99 -40.07 79.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.041 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.27 -37.42 87.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.255 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 43.6 tp -75.78 -17.27 59.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 14.3 tpt -91.1 -1.69 57.72 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.378 0.609 . . . . 0.0 110.865 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.88 34.2 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.598 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.77 62.09 5.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.965 0.412 . . . . 0.0 110.993 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.23 -6.68 30.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.507 -0.758 . . . . 0.0 110.849 -178.177 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.667 0.27 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -83.76 141.04 31.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.481 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.9 159.01 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 51.8 m -149.27 128.86 13.13 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.955 0.407 . . . . 0.0 111.457 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.72 127.52 61.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' B' ' 14' ' ' ARG . 5.8 mm-40 -109.76 157.61 18.97 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.172 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 92.3 m -124.44 130.39 52.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 4.4 p -85.69 -56.25 3.59 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.919 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -171.53 130.93 0.71 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.694 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.73 -112.15 4.77 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.53 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.77 2.73 49.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' B' ' 105' ' ' TYR . . . -74.89 129.94 11.19 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 111.968 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.72 158.88 30.64 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.841 0.353 . . . . 0.0 110.603 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.503 ' HB3' ' HB2' ' B' ' 6' ' ' GLU . 31.3 ttm180 -133.22 129.43 37.72 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 35.6 t -88.4 -95.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.774 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m 38.72 89.86 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -99.82 114.78 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -91.46 106.45 18.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.372 0.606 . . . . 0.0 111.931 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.48 168.12 24.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.916 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 24' ' ' ILE . . . -65.0 154.06 38.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -35.66 71.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.404 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -56.71 -49.67 74.48 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.959 0.409 . . . . 0.0 110.607 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -69.08 -39.39 79.07 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.952 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.596 ' O ' HG23 ' B' ' 28' ' ' VAL . 80.6 mt -60.44 -52.29 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.07 -177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 13.3 tp10 -64.72 -38.26 90.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.976 0.417 . . . . 0.0 110.422 -174.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 94.2 m -60.38 -46.06 91.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.72 -38.57 86.95 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.539 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 24' ' ' ILE . 72.1 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.039 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' B' ' 25' ' ' GLU . 90.0 mttt -53.56 -47.76 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.251 0.548 . . . . 0.0 109.614 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -68.89 -41.5 78.22 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.938 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.487 ' CD ' HH12 ' B' ' 73' ' ' ARG . 9.3 tp10 -68.38 -43.22 77.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.51 -42.34 99.44 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HG3' ' B' ' 37' ' ' LYS . 12.0 p -67.21 -35.13 73.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.958 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -64.8 -42.46 95.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.97 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 31' ' ' GLU . 98.2 t -65.16 -42.08 93.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.132 0.492 . . . . 0.0 110.008 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.63 75.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' B' ' 33' ' ' VAL . 99.4 mttt -65.21 -38.03 89.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.986 178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -61.57 -44.88 96.22 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.772 0.32 . . . . 0.0 110.504 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 33.0 m -88.83 -6.27 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.515 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 62.93 67.1 0.7 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.742 0.782 . . . . 0.0 112.651 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.555 HG13 ' HG3' ' A' ' 317' ' ' GLN . 20.8 mm -127.65 -12.49 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.641 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -65.09 -34.51 78.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.168 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.51 -6.27 80.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.287 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -100.26 9.23 43.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.525 0.679 . . . . 0.0 109.984 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -107.1 104.92 14.7 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.267 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -85.73 -31.74 22.26 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.38 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 148.92 9.52 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.559 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttp 175.85 -58.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.31 112.44 65.07 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' B' ' 53' ' ' ILE . 45.7 Cg_exo -58.44 149.59 73.61 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.639 2.226 . . . . 0.0 111.352 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' MET . . . . . 0.609 ' O ' HG22 ' B' ' 54' ' ' VAL . 7.8 tpt -62.22 -40.89 97.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 2.8 p-10 -66.42 -29.91 70.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.652 0.739 . . . . 0.0 109.333 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' B' ' 50' ' ' PRO . 46.1 mt -76.53 -13.71 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.438 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.609 HG22 ' O ' ' B' ' 51' ' ' MET . 15.6 m -92.79 -28.23 4.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.196 173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.25 80.25 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 52' ' ' ASN . 11.3 pt20 -72.86 -2.43 20.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.609 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' B' ' 53' ' ' ILE . 30.9 mmt180 -87.75 -76.47 0.38 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.33 0.586 . . . . 0.0 110.257 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -103.58 8.3 37.64 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.502 -173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.87 -34.45 82.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.801 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.21 95.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.727 0.299 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -63.81 -40.34 96.39 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.977 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 66' ' ' VAL . 11.8 p -97.91 9.65 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.248 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.575 HH12 HG23 ' B' ' 24' ' ' ILE . 5.2 tpt180 -58.48 -43.41 88.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 64' ' ' GLN . 3.9 tt0 -63.68 -48.09 78.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.485 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.55 -34.17 77.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.928 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 62' ' ' VAL . 80.4 t -60.37 -42.37 90.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.7 -38.85 89.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.507 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.2 -38.56 96.69 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.984 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -63.74 -40.92 97.91 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.229 0.538 . . . . 0.0 110.03 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.78 -40.21 94.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.556 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' MET . . . . . . . . . . . . . 35.3 ttm -59.01 -45.47 90.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.519 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 29.6 m -61.73 -48.36 81.07 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.615 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.487 HH12 ' CD ' ' B' ' 31' ' ' GLU . 61.0 mtm180 -70.37 -41.73 72.69 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -65.99 -40.14 90.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.8 -48.11 83.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.83 -39.74 84.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.57 -39.34 93.57 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.246 0.546 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.16 78.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.054 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 pt -67.52 -30.22 48.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.4 -44.06 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.704 0.288 . . . . 0.0 111.093 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.26 -24.08 43.2 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.253 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.28 -5.44 58.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.058 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.97 40.77 9.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.447 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 86.1 mt -107.88 128.9 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.197 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -119.39 97.36 50.22 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.627 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.57 152.55 59.75 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 123.157 2.572 . . . . 0.0 112.079 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -104.53 129.24 52.6 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.421 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.67 -159.92 44.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.69 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 90' ' ' PRO . . . -94.55 119.68 65.97 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.401 0.143 . . . . 0.0 110.67 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 89' ' ' ALA . 23.9 Cg_exo -62.53 145.32 95.43 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.545 2.163 . . . . 0.0 111.863 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.512 HG22 HG23 ' B' ' 93' ' ' VAL . 4.7 m -101.41 120.23 39.96 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.099 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.75 -33.83 12.75 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.83 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 91' ' ' THR . 44.6 t 53.04 94.95 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -87.73 133.89 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.439 2.093 . . . . 0.0 111.54 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.29 -170.61 37.92 Favored Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.906 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.05 148.72 39.57 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.788 0.328 . . . . 0.0 110.119 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -123.8 124.17 42.09 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.257 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.13 126.72 41.56 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 53.3 tp -62.39 117.09 5.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.096 0.474 . . . . 0.0 111.059 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.93 -2.39 56.84 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.386 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' B' ' 102' ' ' ASP . 46.1 mt-10 -123.77 -158.87 0.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.242 0.521 . . . . 0.0 112.134 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 101' ' ' GLU . 12.5 m-20 -78.54 174.9 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.629 0.728 . . . . 0.0 112.918 -176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -138.81 148.03 43.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.859 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -127.43 131.87 50.17 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.494 ' O ' ' HA2' ' B' ' 12' ' ' GLY . 54.0 p90 -147.17 156.68 43.18 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -143.1 113.18 7.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.034 0.445 . . . . 0.0 111.17 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.34 125.79 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -80.54 131.42 35.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.481 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.52 163.74 37.7 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.392 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -115.14 166.15 12.14 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 p -141.83 158.25 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.626 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -124.58 142.2 39.91 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 122.429 0.292 . . . . 0.0 111.273 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -95.65 -169.89 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.383 2.722 . . . . 0.0 112.799 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -125.7 161.39 27.39 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 349' ' ' LEU . 3.2 t -133.27 161.82 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.153 0.501 . . . . 0.0 111.276 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -113.77 137.72 51.25 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.95 113.76 25.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -135.33 133.76 39.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 111.6 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.58 20.78 59.39 Favored Glycine 0 C--O 1.228 -0.257 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.674 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.25 -42.5 99.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.95 0.375 . . . . 0.0 111.225 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.35 -13.82 60.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.189 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.77 -1.45 57.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.474 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 91.4 mt -81.08 120.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 121.088 0.47 . . . . 0.0 109.774 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -104.92 121.53 43.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.409 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.528 HG11 HG13 ' B' ' 286' ' ' VAL . 67.5 t -115.75 128.06 73.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.759 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -97.17 127.07 42.79 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.55 ' HD3' ' HG2' ' B' ' 419' ' ' GLU . 78.5 tttt -110.85 102.57 52.8 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.63 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.39 133.28 17.35 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.029 1.819 . . . . 0.0 111.289 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 46.3 mm -101.2 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.96 162.44 39.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.09 157.25 44.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t -94.19 117.53 38.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 65.5 p -87.9 167.11 14.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.27 -28.4 69.7 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.737 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -63.71 -42.94 97.88 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 98.3 t -64.26 -43.92 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.026 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.61 -47.5 84.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.37 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.59 98.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.022 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 14.5 tpt -65.47 -37.69 87.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.602 0.239 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.575 ' O ' ' HG2' ' B' ' 145' ' ' ARG . 94.8 mt -61.15 -44.02 97.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.24 -40.11 95.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.709 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 20.9 m -63.27 -47.67 81.39 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.54 -41.4 98.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.938 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' B' ' 141' ' ' LEU . 25.4 mmm180 -64.08 -34.11 77.28 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.939 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -70.33 -14.29 62.52 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.54 -11.86 59.87 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.191 -0.318 . . . . 0.0 111.343 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -129.2 136.0 49.56 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.455 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -162.38 154.62 19.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.49 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' THR . . . . . 0.661 ' OG1' ' HA ' ' B' ' 246' ' ' PRO . 5.8 m -95.68 134.37 38.67 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' TRP . . . . . 0.45 ' HA ' ' HG2' ' B' ' 243' ' ' ARG . 49.4 p90 -82.25 132.56 35.23 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -131.26 174.31 10.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.834 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -114.72 142.67 46.19 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.689 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.549 ' CD ' ' HB2' ' B' ' 242' ' ' GLU . 63.9 pttt -156.4 -177.78 6.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.967 0.413 . . . . 0.0 110.491 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -142.19 108.61 5.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.132 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 174.71 -125.37 1.09 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.853 -1.165 . . . . 0.0 113.417 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.47 177.43 5.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 111.723 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.08 125.77 58.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.325 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -88.36 -171.47 3.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.487 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -94.54 -4.36 48.12 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -139.64 27.08 2.28 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ASP . . . . . 0.556 ' OD1' ' HA ' ' B' ' 242' ' ' GLU . 99.5 m-20 -84.02 174.93 9.9 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.509 0.671 . . . . 0.0 112.537 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -114.83 120.21 39.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 240' ' ' VAL . 31.6 m -122.88 155.69 28.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.981 -176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.9 m -114.67 114.78 26.11 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.0 129.77 68.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ASP . . . . . 0.415 ' OD1' ' HA ' ' B' ' 183' ' ' SER . 14.1 m-20 -96.61 110.42 22.84 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -133.67 161.01 35.82 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.765 0.316 . . . . 0.0 111.025 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 26.8 m -132.21 138.93 48.14 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.668 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.21 86.68 1.55 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.583 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -105.26 123.19 47.42 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.73 -90.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.971 0.415 . . . . 0.0 111.197 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -113.46 12.81 18.78 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.415 0.626 . . . . 0.0 110.167 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . 147.0 -12.71 1.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -120.72 143.11 48.94 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -86.82 154.22 21.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.334 . . . . 0.0 110.48 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.461 ' HD1' ' H ' ' B' ' 179' ' ' GLY . 34.4 p90 -106.34 -176.64 3.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -62.82 -22.75 66.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . 0.461 ' H ' ' HD1' ' B' ' 177' ' ' PHE . . . -113.19 -162.54 15.17 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.719 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.23 37.04 29.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.489 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -111.17 109.12 19.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . . . . . . . . . . . -131.57 146.08 52.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.829 0.347 . . . . 0.0 111.677 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' B' ' 167' ' ' ASP . 18.2 t -147.83 104.12 3.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 58.31 37.11 25.98 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.339 0.59 . . . . 0.0 110.567 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.21 125.52 29.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.518 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 13.5 m -89.67 125.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.534 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' LEU . . . . . . . . . . . . . 49.3 tp -119.51 140.14 50.98 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.189 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ALA . . . . . . . . . . . . . . . -105.93 115.02 29.52 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' MET . . . . . . . . . . . . . 94.2 mtp -84.28 150.35 25.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.781 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.18 -15.73 61.02 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.088 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -92.2 -18.44 23.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.46 70.85 1.26 Allowed Glycine 0 N--CA 1.438 -1.208 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -114.28 -21.94 10.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.217 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' MET . . . . . . . . . . . . . 15.9 mmt -109.12 156.28 20.01 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.614 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 50.4 mm -34.85 129.43 0.49 Allowed Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 124.658 1.224 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.43 123.52 10.44 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.293 1.995 . . . . 0.0 111.988 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' GLY . . . . . . . . . . . . . . . 102.84 -26.85 22.63 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.213 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -64.59 -50.21 68.12 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.57 -9.06 58.66 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 111.051 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' B' ' 203' ' ' LYS . 4.7 m-20 -90.18 -29.88 17.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.199 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' GLY . . . . . . . . . . . . . . . -76.95 -22.68 71.04 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.713 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . . . . . . . . . 23.7 pt -85.59 -7.08 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.995 0.426 . . . . 0.0 111.804 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' B' ' 200' ' ' ASP . 54.5 mtpt -67.89 118.42 11.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.836 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 108.93 -9.69 34.19 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.155 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -88.08 164.65 15.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.737 0.303 . . . . 0.0 110.452 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -85.27 167.05 15.99 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.306 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.7 -25.43 67.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.32 78.49 0.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.637 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.7 145.92 31.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.73 0.3 . . . . 0.0 110.52 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 235' ' ' ILE . 62.5 mt-10 -104.56 113.38 26.91 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -134.47 122.6 22.71 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.812 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' B' ' 233' ' ' PHE . 50.0 m -85.92 131.49 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.875 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 7.8 tp -124.94 139.37 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.963 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.517 ' OD1' ' HE2' ' B' ' 232' ' ' LYS . 11.2 m-20 -88.36 111.27 21.55 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.926 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.49 122.5 69.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.885 0.374 . . . . 0.0 110.311 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' THR . . . . . . . . . . . . . 28.5 m -106.61 126.96 52.94 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.762 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -94.79 150.34 37.76 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.5 149.93 89.26 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.511 2.141 . . . . 0.0 111.714 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -59.88 -32.21 70.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.029 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -97.07 26.64 4.56 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.03 141.22 56.27 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.361 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -60.02 -30.59 69.27 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -88.77 122.65 32.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.98 -39.5 89.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.276 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.64 -5.7 53.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.67 -17.55 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -69.76 121.09 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 0.0 111.826 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.21 14.7 82.06 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.892 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -105.9 150.92 25.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -110.92 106.05 15.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ALA . . . . . . . . . . . . . . . -102.09 144.99 29.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.037 0.446 . . . . 0.0 111.662 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' LYS . . . . . 0.517 ' HE2' ' OD1' ' B' ' 214' ' ' ASP . 99.0 mttt -111.73 111.32 22.21 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.461 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' B' ' 212' ' ' THR . 84.3 m-85 -89.68 130.05 36.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.288 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.71 70.62 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.258 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' B' ' 210' ' ' GLU . 46.2 mm 58.99 91.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.896 0.479 . . . . 0.0 111.682 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.57 -53.37 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' LEU . . . . . . . . . . . . . 97.9 mt 65.69 171.19 0.22 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.374 0.67 . . . . 0.0 112.277 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -179.4 -45.59 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.978 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -125.55 138.64 53.96 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.916 0.388 . . . . 0.0 112.038 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.5 ' HA ' HG12 ' B' ' 164' ' ' VAL . 48.4 t -138.8 99.68 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.33 114.4 26.7 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.158 0.504 . . . . 0.0 110.089 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' OD1' ' B' ' 162' ' ' ASP . 41.4 tt0 -68.34 138.57 55.51 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.303 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' B' ' 151' ' ' TRP . 65.0 mtm180 -105.85 135.99 46.29 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.033 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' B' ' 245' ' ' LEU . 28.7 tt0 -115.98 -178.66 3.45 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.517 ' H ' ' HG2' ' B' ' 244' ' ' GLU . 92.4 mt -43.65 129.69 3.94 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 123.145 0.578 . . . . 0.0 111.802 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . 0.661 ' HA ' ' OG1' ' B' ' 150' ' ' THR . 41.3 Cg_endo -66.06 147.5 84.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.633 2.222 . . . . 0.0 111.332 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.33 99.33 0.19 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.29 0.567 . . . . 0.0 110.587 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' LEU . . . . . 0.543 HD13 HH12 ' B' ' 145' ' ' ARG . 35.6 tp -80.48 7.3 10.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.976 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' THR . . . . . . . . . . . . . 2.5 m -71.17 -3.36 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.289 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ALA . . . . . . . . . . . . . . . 69.51 1.37 3.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.786 0.835 . . . . 0.0 112.89 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -64.46 -43.47 94.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -89.55 -50.62 5.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.2 -4.14 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -172.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.11 -31.82 72.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.813 -0.554 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -83.97 -3.14 57.76 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -69.73 -22.3 63.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.191 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 156.57 -57.08 0.38 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.22 162.95 39.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -72.66 109.51 6.34 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 120.81 0.338 . . . . 0.0 110.351 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -75.53 158.71 32.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.07 -18.87 45.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.693 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.7 p -77.09 114.55 16.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' VAL . . . . . . . . . . . . . 93.7 t -60.81 -48.78 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.976 -174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 264' ' ' GLU . 0.1 OUTLIER -70.73 -38.63 73.57 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.695 0.283 . . . . 0.0 110.696 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . -64.53 -45.81 92.01 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.187 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' LEU . . . . . 0.447 ' O ' HG23 ' B' ' 270' ' ' VAL . 60.9 tp -63.03 -44.29 96.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.406 0.146 . . . . 0.0 111.305 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -64.99 -38.42 90.91 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.57 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' B' ' 272' ' ' LYS . . . -65.86 -41.28 91.86 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.645 177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 272' ' ' LYS . 37.3 tp10 -64.3 -41.45 96.86 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.369 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 266' ' ' LEU . 98.0 t -64.84 -40.94 90.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' ARG . . . . . 0.418 ' HE ' ' CD ' ' B' ' 275' ' ' GLU . 8.6 tpt180 -58.24 -47.55 83.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.667 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' B' ' 268' ' ' ALA . 9.6 ptmt -64.95 -41.69 95.28 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.795 0.331 . . . . 0.0 111.071 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -64.87 -43.41 93.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.455 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' MET . . . . . . . . . . . . . 96.1 mmm -66.1 -44.58 83.94 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' GLU . . . . . 0.418 ' CD ' ' HE ' ' B' ' 271' ' ' ARG . 58.6 mt-10 -67.57 -32.12 72.66 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.577 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -59.94 -45.49 92.46 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.537 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.48 -24.13 31.9 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.81 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 54.4 tp -63.19 -41.82 99.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.05 -44.67 97.04 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.79 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' SER . . . . . . . . . . . . . 39.1 m -63.92 -40.47 96.55 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.537 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.33 74.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.771 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' ILE . . . . . . . . . . . . . 36.9 pt -69.25 -40.0 79.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.684 0.278 . . . . 0.0 111.287 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -60.79 -45.34 94.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.121 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -64.11 -38.95 92.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.342 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -58.81 -43.79 90.66 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . 0.528 HG13 HG11 ' B' ' 125' ' ' VAL . 79.7 t -65.92 -45.54 90.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.717 177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.79 -44.79 95.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.876 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' SER . . . . . . . . . . . . . 26.3 p -62.64 -40.81 98.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.445 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -62.96 -43.7 98.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.714 0.292 . . . . 0.0 110.638 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.03 -48.36 74.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.31 -46.56 92.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.993 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -68.01 -38.41 82.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.415 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' GLY . . . . . . . . . . . . . . . -60.16 -47.13 92.58 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.947 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.01 -46.24 75.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.46 -43.8 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.013 0.435 . . . . 0.0 111.981 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -66.56 -35.53 80.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.957 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.8 -50.32 6.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -107.16 144.62 33.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 0.0 111.484 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.81 156.28 47.42 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' ILE . . . . . . . . . . . . . 9.3 tp -136.41 148.44 27.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.42 112.03 11.31 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' VAL . . . . . . . . . . . . . 62.2 t -101.31 129.73 26.35 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.993 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.31 139.93 80.05 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.39 2.06 . . . . 0.0 110.44 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' ALA . . . . . . . . . . . . . . . -65.23 -32.49 74.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.77 88.04 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' LEU . . . . . . . . . . . . . 93.2 mt -63.37 -42.82 98.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 111.526 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' ILE . . . . . 0.476 ' O ' HG13 ' B' ' 311' ' ' ILE . 62.8 mt -67.9 -42.99 86.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -58.67 -46.1 87.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.623 -177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' SER . . . . . . . . . . . . . 67.7 m -60.42 -40.61 91.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -65.65 -31.59 72.7 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 307' ' ' ILE . 68.9 mt -60.71 -35.78 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.019 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' B' ' 315' ' ' ARG . 23.4 t70 -59.86 -46.33 89.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.189 0.519 . . . . 0.0 110.875 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.75 -44.39 98.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.786 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.55 HD13 ' HG3' ' B' ' 340' ' ' GLN . 96.1 mt -63.67 -40.71 97.5 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.52 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' B' ' 312' ' ' ASP . 43.3 mtm105 -61.02 -44.1 97.91 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.68 0.276 . . . . 0.0 111.01 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -63.88 -37.2 86.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.89 0.376 . . . . 0.0 111.51 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' GLN . . . . . 0.534 ' HG3' HG13 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -62.53 -46.75 86.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.004 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.24 88.46 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.44 -36.36 83.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.397 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' GLN . . . . . 0.48 ' HA ' ' HA2' ' B' ' 324' ' ' GLY . 23.1 tm0? -64.64 -43.13 94.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.942 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -81.67 -10.56 59.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -93.27 -26.71 17.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.897 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' GLY . . . . . . . . . . . . . . . -179.68 -35.12 0.07 OUTLIER Glycine 0 C--O 1.209 -1.455 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.514 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 320' ' ' GLN . . . 104.22 65.95 0.7 Allowed Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.825 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -121.5 100.66 7.15 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.893 0.378 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.64 144.84 47.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.612 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.484 ' HB2' ' NZ ' ' B' ' 327' ' ' LYS . 3.2 ttmp? 75.71 -39.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.844 0.858 . . . . 0.0 113.019 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -72.79 -10.29 59.62 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.527 0.679 . . . . 0.0 109.26 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.11 -23.65 64.02 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.105 175.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.457 ' HA ' ' NH2' ' B' ' 315' ' ' ARG . 61.6 tp -63.73 -23.95 67.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.727 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.85 -11.58 60.0 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.879 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' B' ' 333' ' ' PRO . 88.4 mt -71.34 144.91 89.97 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 332' ' ' LEU . 31.2 Cg_exo -59.91 135.01 60.4 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.968 2.445 . . . . 0.0 112.913 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -66.81 -42.93 85.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.227 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' B' ' 335' ' ' GLU . 1.9 pm0 -60.83 -25.94 66.97 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.681 0.277 . . . . 0.0 111.647 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -107.93 -5.22 17.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -60.66 -40.91 93.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.27 -46.78 63.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.002 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' GLN . . . . . 0.55 ' HG3' HD13 ' B' ' 314' ' ' LEU . 11.3 pt20 -70.36 -30.38 67.29 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.42 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' ALA . . . . . 0.425 ' O ' HG23 ' B' ' 345' ' ' VAL . . . -63.89 -39.34 93.95 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.304 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.44 -41.3 96.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.148 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' ARG . . . . . 0.4 HH21 ' HD2' ' B' ' 343' ' ' ARG . 13.0 mmt180 -61.77 -39.64 92.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.372 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -61.58 -47.3 86.11 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' B' ' 349' ' ' LEU . 39.4 t -65.31 -45.99 91.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.028 -175.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' B' ' 350' ' ' LEU . 91.9 t -62.02 -48.52 88.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.722 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 68.0 t -64.8 -45.31 95.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.682 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . -60.67 -43.49 98.97 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.174 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 345' ' ' VAL . 61.7 mt -64.61 -40.6 95.79 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.552 0.215 . . . . 0.0 110.878 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' HG23 ' B' ' 354' ' ' VAL . 93.2 mt -62.48 -45.96 90.64 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 120.837 0.351 . . . . 0.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.41 -42.06 96.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.236 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' GLY . . . . . . . . . . . . . . . -61.28 -41.32 99.47 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.378 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' B' ' 353' ' ' GLU . 5.9 tp10 -68.04 -35.77 78.81 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 350' ' ' LEU . 69.9 t -61.63 -43.33 96.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.06 0.457 . . . . 0.0 109.853 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.46 -44.83 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.372 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -71.17 -45.07 64.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' THR . . . . . . . . . . . . . 28.4 m -63.22 -43.8 97.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.0 0.429 . . . . 0.0 111.584 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -90.28 11.05 22.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.128 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 40.2 50.31 2.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.074 0.95 . . . . 0.0 112.67 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.8 153.55 36.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.109 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.9 149.98 49.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.17 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' ALA . . . . . . . . . . . . . . . -64.95 128.02 34.01 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' ASP . . . . . 0.429 ' O ' HG23 ' B' ' 367' ' ' VAL . 14.2 t70 -101.19 113.82 27.2 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.448 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -59.64 -38.63 81.92 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.312 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -64.91 -45.34 86.26 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.111 0.481 . . . . 0.0 110.146 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -61.46 -43.95 97.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.545 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 363' ' ' ASP . 93.1 t -63.85 -46.44 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.235 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -62.85 -43.06 99.81 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' GLY . . . . . . . . . . . . . . . -59.6 -44.14 97.07 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.696 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' LEU . . . . . . . . . . . . . 95.0 mt -65.14 -39.11 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.036 0.446 . . . . 0.0 111.08 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.96 -43.17 98.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.118 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -61.6 -40.89 96.43 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.731 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.76 -42.68 85.75 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.394 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' MET . . . . . . . . . . . . . 54.6 ttp -64.12 -43.72 94.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.434 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.59 -12.63 61.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.06 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 34.9 t -75.62 -6.96 52.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' ALA . . . . . . . . . . . . . . . -90.52 9.11 30.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.245 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -122.44 162.3 21.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.902 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -61.87 -39.44 91.91 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.252 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -133.45 109.63 12.39 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.807 0.337 . . . . 0.0 111.055 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 -19.01 22.05 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.474 2.116 . . . . 0.0 113.149 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.27 -49.24 72.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.71 -33.73 69.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.017 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' VAL . . . . . . . . . . . . . 96.1 t -63.16 -46.65 95.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.661 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.66 -42.64 96.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.517 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -60.75 -42.31 97.16 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.425 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -60.68 -44.43 96.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -35.93 81.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.807 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' SER . . . . . . . . . . . . . 7.2 m -85.87 -2.06 57.88 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.944 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -92.18 -42.46 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.411 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 395' ' ' MET . 23.8 t-20 -94.19 117.01 29.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.206 0.527 . . . . 0.0 111.227 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -59.36 -39.69 84.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.476 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' B' ' 393' ' ' GLU . 1.5 tp10 -65.28 -41.0 94.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.803 0.335 . . . . 0.0 111.052 -176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.76 -39.02 93.25 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.888 176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' MET . . . . . 0.678 ' O ' ' HG3' ' B' ' 399' ' ' ARG . 92.2 mtp -60.25 -46.23 90.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.314 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.61 -42.08 74.87 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.736 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.65 -41.54 99.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.354 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' MET . . . . . . . . . . . . . 14.1 tpt -63.27 -36.76 84.75 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.438 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' B' ' 395' ' ' MET . 91.7 mtt-85 -60.39 -42.31 95.62 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.942 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -66.65 -25.55 66.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.238 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 401' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.95 -51.59 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.02 0.438 . . . . 0.0 110.436 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 402' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.71 81.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.543 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 403' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.02 -34.88 79.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.078 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 404' ' ' GLU . . . . . 0.445 ' O ' HG23 ' B' ' 408' ' ' VAL . 41.9 tt0 -60.0 -39.19 84.9 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 405' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.86 -45.36 86.4 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.01 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 406' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -64.24 -41.06 97.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.087 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.75 97.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 408' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' B' ' 412' ' ' LEU . 94.1 t -64.69 -43.98 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.089 0.471 . . . . 0.0 109.915 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -61.29 -39.37 90.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.282 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 410' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.39 89.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.358 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 411' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.55 -44.39 90.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.618 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 408' ' ' VAL . 96.6 mt -61.29 -31.27 71.1 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.124 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.42 75.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.21 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -104.2 -6.99 20.44 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.91 158.86 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.863 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 416' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -86.84 102.4 14.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.191 0.52 . . . . 0.0 110.736 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 417' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.2 127.87 62.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 9.0 t -122.36 134.31 54.63 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.597 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' GLU . . . . . 0.55 ' HG2' ' HD3' ' B' ' 127' ' ' LYS . 61.6 mt-10 -97.99 124.84 42.65 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.409 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -121.31 129.24 53.0 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.954 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -72.05 118.6 15.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' THR . . . . . . . . . . . . . 18.0 p -134.32 148.82 50.81 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.192 0.52 . . . . 0.0 111.996 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' THR . . . . . . . . . . . . . 5.8 m -82.02 153.59 26.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -60.51 -36.28 77.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.919 0.39 . . . . 0.0 110.997 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -58.91 -40.61 85.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.838 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -60.36 -42.51 95.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.35 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 37.5 tp -72.26 -25.06 61.47 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.306 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' MET . . . . . . . . . . . . . 13.6 tpt -83.72 -4.83 58.94 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.178 0.514 . . . . 0.0 111.179 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.35 36.82 0.31 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.972 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -80.83 56.0 2.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.041 0.448 . . . . 0.0 110.919 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.96 -11.65 43.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.88 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.064 -179.107 . . . . . . . . 0 0 . 1 stop_ save_